Gene Expression Technique

Abstract

The present invention provides a host cell suitable for enhanced production of a protein product of choice characterised in that the host cell is genetically modified to cause over-expression of two or more helper proteins selected from a DnaJ-like protein (such as JEM1), an Hsp70 family protein (such as LHS1) and SIL1 wherein at least one of the over-expressed two or more helper proteins is selected from JEM1, LHS1 and SIL1, and wherein the DnaJ-like protein is not SCJ1.

Description

FIELD OF THE INVENTION

[0001] The present application relates to gene expression techniques.

BACKGROUND OF THE INVENTION

[0002] The listing or discussion of a prior-published document in this specification should not necessarily be taken as an acknowledgement that the document is part of the state of the art or is common general knowledge.

[0003] A key parameter in the development of a commercially viable process for the production of a recombinant protein is the yield of the product from the host organism.

[0004] Factors that influence the yield of a particular heterologous protein are complex and include the biochemical and biophysical properties of the protein itself; its influence on, and modification of, the host's own cellular functions; and the choice and deployment of those sequences that are necessary for efficient transcription, translation, secretion (if required) and plasmid stability.

SUMMARY OF THE INVENTION

[0005] We have identified a series of proteins (hereinafter "helper" proteins) that are over-expressed in a (non-publicly available) S. cerevisiae that possesses increased production of a protein product of choice, such as a recombinant protein. These overexpressed helper proteins have all, individually, been previously identified.

[0006] In the case of some of these helper proteins, there is nothing in the art to suggest that their over-expression would aid in the increased production of a recombinant heterologous protein product of choice.

[0007] In the case of some of the other identified helper proteins, the (as yet unpublished) art has recognised that their over-expression can aid in increasing the production of a recombinant heterologous protein product of choice (see PCT/GB2004/005462). However, there is nothing in the art to suggest that the combined and simultaneous over-expression of such helper proteins would further enhance the production of a protein product of choice.

[0008] Accordingly, the present invention provides a host cell suitable for enhanced production of a protein product of choice wherein the host cell is genetically modified to cause over-expression of one or more of the identified helper proteins.

[0009] Thus the present invention provides a host cell that is suitable for enhanced production of a protein product of choice characterised in that the host cell comprises a first gene encoding a first helper protein as defined herein, or a variant thereof, and a second gene encoding a desired protein product of choice, wherein the host cell is genetically modified to cause over-expression of the first helper protein, and-- [0010] (a) wherein the first and second genes are not both present within the host cell on the same 2 .mu.m-family plasmid (and optionally the first gene is not present within the host cell on any 2 .mu.m-family plasmid; and further optionally the second gene is not present within the host cell on any 2 .mu.m-family plasmid); and [0011] (b) wherein the host cell is not genetically modified to cause over-expression of a further helper protein that is different from the first helper protein and is selected from the group consisting of AHA1, CCT2, CCT3, CCT4, CCT5, CCT6, CCT7, CCT8, CNS1, CPR3, CPR6, ERO1, EUG1, FMO1, HCH1, HSP10, HSP12, HSP104, HSP26, HSP30, HSP42, HSP60, HSP78, HSP82, JEM1, MDJ1, MDJ2, MPD1, MPD2, PDI1, PFD1, ABC1, APJ1, ATP11, ATP12, BTT1, CDC37, CPR7, HSC82, KAR2, LHS1, MGE1, MRS11, NOB1, ECM10, SSA1, SSA2, SSA3, SSA4, SSC1, SSE2, SIL1, SLS1, ORM1, ORM2, PER1, PTC2, PSE1, UBI4 and HAC1 or a truncated intronless HAC1 (and optionally, the host cell is not genetically modified to cause over-expression of any further helper protein that is different from the first helper protein).

[0012] The thus over-expressed first helper protein may be any helper protein defined below. For example, the over-expressed first helper protein may be a DnaJ-like protein (such as JEM1), an Hsp70 family member protein (such as LHS1) or SIL1, or a variant of any of these. Over-expression of the first helper protein may be achieved by any suitable means of genetic modification known in the art. Suitable examples of such approaches for genetic modification are discussed in more detail below.

[0013] The host cell may or may not comprise a recombinant copy, such as a plasmid encoded copy, or a chromosomally integrated recombinant copy, of a gene encoding the further helper protein as defined in (b) above. Thus, in one embodiment, the first helper protein may be the only helper protein that is over-expressed by the host cell.

[0014] In another embodiment, the invention provides a host cell that is suitable, for enhanced production of a protein product of choice characterised in that the host cell is genetically modified to cause over-expression of a helper protein selected from the list comprising SCJ1, FKB2, SSE1, ERV2, DER1, DER3, HRD3, UBC7 and DOA4. The host cell may or may not be genetically modified to cause over-expression of two or more helper proteins, at least one of which is a helper protein selected from the list comprising SCJ1, FKB2, SSE1, ERV2, DER1, DER3, HRD3, UBC7 and DOA4. In that case, at least one other helper may or may not be selected from the list comprising-- [0015] (a) chaperones selected from a DnaJ-like protein (such as JEM1), an Hsp70 family member protein (such as LHS1), SCJ1, KAR2, SIL1 (note that, SIL1 has previously been referred to as SLS1), FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1 and MDJ2. [0016] (b) proteins involved in the formation of disulphide bonds in other proteins selected from ERO1, ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1; [0017] (c) proteins involved in protein degradation selected from DER1, DER3, HRD3, UBC7 and DOA4; and [0018] (d) HAC1.

[0019] For example, the host cell may or may not be genetically modified to cause over-expression of two or more helper proteins selected from a DnaJ-like protein (such as JEM1), an Hsp70 family protein (such as LHS1) and SIL1. For example, the host cell according to may or may not be genetically modified to cause over-expression of-- [0020] (a) a DnaJ-like protein and an Hsp70 family protein; or [0021] (b) a DnaJ-like protein and SIL1; or [0022] (c) an Hsp70 family protein and SIL1.

[0023] The host may or may not be genetically modified to cause over-expression of three or more helper proteins, wherein the three or more helper proteins comprise a DnaJ-like protein, an Hsp70 family protein and SIL1 for example JEM1, LHS1 and SIL1.

[0024] The Hsp70 family protein may or may not be a protein that localises to the lumen of the ER. The Hsp70 family protein may or may not be a prokaryotic Hsp70 family protein. The Hsp70 family protein may or may not be a eukaryotic Hsp70 family protein. The Hsp70 family protein may or may not be LHS1, KAR2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 or ECM10, such as from yeast, for example, from S. cerevisiae. LHS1 may or may not be a preferred Hsp70 family protein for use in the present invention. Other Hsp70 family proteins for use in the present invention may or may not include a mammalian BiP (GRP78) (, such as the protein described by Haas and Wabl (1983) Nature 306, 387), a mammalian HSP72 (HSP70), HSP73 (HSC70) or mtp70, a mammalian GRP170 (such as the protein described by Lin et al (1993) Mol. Biol. Cell 4, 1109), a mammalian HSP70 protein (such as a protein as reviewed by Ohtsuka and Hata. (2000) International Journal of Hyperthermia 16, 231; Gething and Sambrook (1992) Nature 355, 33; and/or Craig and Gross (1991) TIBS 16, 135), a Gallus gallus HSP70 protein, such as the protein defined by accession number to AAO44921 (Mazzi et al (2003) Genet. Mol. Biol. 26, 275-281), a Nicotiana tabacum luminal binding protein (BiP), such as the protein defined by accession number CAA42661 (Denecke et al (1991) Plant Cell 3, 1025), a Paramecium caudatum HSP70 protein, such as the protein defined by accession number BAE16705 (Hori et al (2006) Mol. Phylogenet. Evol. 38, 697), a Hordeum vulgare HSP70 protein, such as a subsp. vulgare HSP70 protein accession number, such as the protein defined by AAA62325 (Chen et al (1994) Plant Physiol. 106, 815), an Arabidopsis thaliana HSP70 protein accession number NP.sub.--187864, the Chlamydia trachomatis A/HAR-13 chaperone protein dnaK (Heat shock protein 70) (Heat shock 70 kDa protein) (HSP70), such as the protein defined by accession number Q3KLV7 (Carlson et al (2005) Infect. Immun. 73, 6407), a Pongo pygmaeus hsp70 protein, such as the protein defined by accession number CAH92327, a Haemophilus influenzae 86-028NP HSP70 protein, such as the protein defined by accession number YP.sub.--249343 (Harrison et al (2005) J. Bacteriol. 187, 4627), a Streptococcus pneumoniae HSP70 protein, such as the protein defined by accession number AAB39221, a Mus musculus HSP70 protein, such as the protein defined by accession number AAC84169 (Xie et al (2003) Genome Res. 13, 2621), a Bacillus subtilis HSP70 protein, such as the protein defined by accession number BAA12464 (Mizuno et al. (1996) Microbiology (Reading, Engl.) 142, 3103), and a Escherichia coli DnaK protein, such as the protein defined by Slepenkov and Witt (2002) Mol. Microbiol. 45, 1197. It will be appreciated that, in the rest of this specification, reference to LHS1 may or may not be taken to be, by extension, a reference to an equivalent Hsp70 family protein, such as an Hsp70 family protein as defined in this paragraph.

[0025] Other preferred Hsp70 family proteins may have an activity equivalent to LHS1, when co-expressed with one or both of JEM1 and SIL1 for example in the manner as set out in the present examples. Thus, a host cell of the present invention, when genetically modified to cause simultaneous over-expression of a preferred Hsp70 family protein with one or both of JEM1 and SIL1, will provide at least substantially the same increase in the production of a protein product and/or at least substantially the same reduction of fragmentation of a protein product, as is observed in the same host cell when genetically modified to cause simultaneous over-expression of LHS1 with one or both of JEM1 and SIL1 the increase being compared to the to the level of production of the same protein product, and/or the level of fragmentation of the same protein product, in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1.

[0026] By "substantially the same increase in the production of a protein product", we, mean at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, substantially 100% or greater than 100% of the increase in production of a protein product that is observed when the host cell is genetically modified to cause simultaneous over-expression of LHS1 with one or both of JEM1 and SIL1 (the increased being compared to the level of production of the same protein product in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1).

[0027] By "substantially the same reduction of fragmentation of a protein product", we mean at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, substantially 100% or greater than 100% of the reduction of fragmentation of a protein product that is observed when the host cell is genetically modified to cause simultaneous over-expression of LHS1 with one or both of JEM1 and SIL1 (the reduction of fragmentation of a protein product being compared to the level of fragmentation of the same protein product in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1).

[0028] DnaJ-like proteins are reviewed in Walsh et al, 2004, EMBO reports, 5, 567-571. The DnaJ-like protein typically comprises a J-domain as defined in Walsh et al, 2004, op. cit. the contents of which are incorporated herein by reference. The DnaJ-like protein may or may not be a prokaryotic DnaJ-like protein. The DnaJ-like protein may or may not be a eukaryotic DnaJ-like protein. The DnaJ-like protein may or may not be any one of the yeast DnaJ proteins such as a protein selected from JEM1, MDJ1, MDJ2, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, SCJ1, HLJ1 to and ERJ5. The DnaJ-like protein may or may not be a protein that localises to the ER, such as JEM1, SCJ1, HLJ1, SEC63 or ERJ5, and may or may not be a protein that localises to the ER membrane. The DnaJ-like protein may or may not be a protein that localises to the cytoplasm of the host cell, such as YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2 or JJJ3. The DnaJ-like protein may or may not be a protein that localises to the nucleoplasm of the host cell, such as CAJ1 or CWC23. The DnaJ-like protein may or may not be a protein that localises to the mitochondria of the host cell, such as MDJ1, MDJ2, PAM18, JAC1 or JID1. The DnaJ-like protein is typically not SCJ1. JEM1 may or may not be a preferred DnaJ-like protein for use in the present invention. Other DnaJ-like proteins may or may not include the following proteins or proteins families, or fragments or variants thereof-- [0029] the HSP40 class of proteins (reviewed by Ohtsuka and Hata. (2000) International Journal of Hyperthermia 16, 231 and Table 1 therein); [0030] a mammalian Erdj1 (such as MTJ1, Chevalier et al (2000) J. Biol. Chem. 275 19620); [0031] a mammalian Erdj2 such as hSec63, Skowronek et al (1999) J. Biol. Chem. 380, 1133); [0032] a mammalian Erdj3 (such as HEDJ/Scj1p, Shen and Hendershot (2005) Mol. Biol. Cell. 16, 40); [0033] a mammalian Erdj4 (such as described in Shen et al (2002) J. Biol. Chem. 277, 15947); [0034] a mammalian Erdj5 (such as described in Cunnea et al (2003) J. Biol. Chem. 278, 1059); [0035] a Gallus gallus DnaJ homolog subfamily B member 11 precursor, such as the ER-associated dnaJ protein 3 ErJ3, the ER-associated Hsp40 co-chaperone (hDj9, or the PWP1-interacting protein 4, such as defined by accession number XP.sub.--422682; [0036] a Nicotiana tabacum DnaJ homolog, such as the protein defined by accession number BAC53943; [0037] a Arabidopsis thaliana DnaJ homolog, such as the protein defined by accession number AAB49030 (Zhou et al (1999) Plant Physiol. 121, 1053); [0038] a Chlamydia trachomatis A/HAR-13 Chaperone protein dnaJ, such as the protein defined by accession number YP.sub.--328153 (Carlson et al (2005) Infect. Immun. 73, 6407); [0039] a Pongo pygmaeus DnaJ homolog subfamily B member 9, such as the protein defined by accession number Q5R9A4; [0040] a Haemophilus influenzae Rd KW20 Dna-J like membrane chaperone protein, such as the protein defined by accession number NP.sub.--438440 (Fleischmann et al (1995) Science 269, 496); [0041] a Escherichia coli DnaJ protein, such as the protein defined by accession number AAA00009 (Ohki et al (1986) J. Biol. Chem. 261, 1778); [0042] a Escherichia coli DnaJ-like protein, such as the protein defined by accession number BAB96590 (Musso et al (1977) Proc. Natl. Acad. Sci. U.S.A. 74, 106); [0043] a Streptococcus pneumoniae DnaJ protein, such as the protein defined by accession number AAB39222; [0044] a Mus musculus DnaJ homolog, such as a subfamily B member 6 (Heat shock protein. J2) (HSJ-2) (MRJ) (mDj4) such as the protein defined by accession number XP.sub.--987742; [0045] a Bacillus subtilis DnaJ protein, such as the protein defined by accession number BAA12465 (Mizuno et al (1996) Microbiology (Reading Engl.) 142, 3103); and [0046] a plant Sorghum bicolour DNAJ domain protein, such as the protein defined by accession number ABF48023.

[0047] It will be appreciated that, in the rest of this specification, reference to JEM1 may or may not be taken to be, by extension, a reference to an equivalent DnaJ-like protein, such as a DnaJ-like protein as defined in the above paragraph.

[0048] Other preferred DnaJ-like proteins may have an activity equivalent to JEM1, when co-expressed with one or both of LHS1 and SIL1, for example in the manner as set out in the present examples. Thus, a host cell of the present invention, when genetically modified to cause simultaneous over-expression of a preferred DnaJ-like protein with one or both of LHS1 and SIL1, will provide at least substantially the same increase in the production of a protein product and/or at least substantially the same reduction of fragmentation of a protein product, as is observed in the same host cell when genetically modified to cause simultaneous over-expression of JEM1 with one or both of LHS1 and SIL1, the increase being compared to the level of production of the same protein product, and/or the level of fragmentation of the same protein product, in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1.

[0049] By "substantially the same increase in the production of a protein product", we mean at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, substantially 100% or greater than 100% of the increase in production of a protein product that is observed when the host cell is genetically modified to cause simultaneous over-expression of JEM1 with one or both of LHS1 and SIL1 (the increase being compared to the level of production of the same protein product in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1).

[0050] By "substantially the same reduction of fragmentation of a protein product", we mean at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, substantially 100% or greater than 100% of the reduction of fragmentation of a protein product that is observed when the host cell is genetically modified to cause simultaneous over-expression of JEM1 with one or both of LHS1 and SIL1 (the reduction of fragmentation of a protein product being compared to the level of fragmentation of the same protein product in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1).

[0051] The host cell that is genetically modified to cause over-expression of two or more; such as at least three, helper proteins selected from a DnaJ-like protein, an Hsp70 family protein and SIL1 may or may not be further genetically modified to cause over-expression of at least one, two, three, four, five, six or seven proteins involved in the formation of disulphide bonds in other proteins selected from the group consisting of ERO1, ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1. PDI1 may or may not be preferred.

[0052] In another embodiment, the invention provides a host cell suitable for enhanced production of a protein product of choice characterised in that the host cell is genetically modified to cause over-expression of three or more helper proteins, wherein the three or more helper proteins are selected from the list comprising-- [0053] (a) chaperones selected from a DnaJ-like protein (such as JEM1), an Hsp70 family member protein (such as LHS1), SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1 and MDJ2. [0054] (b) proteins involved in the formation of disulphide bonds in other proteins selected from ERO1, ERV2, EUG1, MPD1., MPD2, EPS1 and PDI1; [0055] (c) proteins involved in protein degradation selected from DER1, DER3, HRD3, UBC7 and DOA4; and [0056] (d) HAC1.

[0057] The three or more helper proteins may or may not comprise at least one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or seventeen of the chaperones selected from the group consisting of JEM1, an Hsp70 family member protein (such as LHS1), SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1 and MDJ2. The three or more helper proteins may or may not comprise at least one, two, three, four, five, six or seven proteins involved in the formation of disulphide bonds in other proteins selected from the group consisting of ERO1, ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1. The three or more helper proteins may or may not comprise at least one, two, three, four or five of the proteins involved in protein degradation selected from DER1, DER3, HRD3, UBC7 and DOA4.

[0058] It will be appreciated that the host cell may or may not comprise a polynucleotide sequence that encodes a protein product of choice.

[0059] In one embodiment, the host cell comprises a polynucleotide sequence that encodes a protein product of choice. The protein product of choice may or may not be a protein that is naturally produced by the host cell or may or may not be a heterologous protein. In this context, a "heterologous protein" is a protein that is not naturally encoded by the host cell. The polynucleotide sequence that encodes the protein product of choice may or may not be an endogenous polynucleotide sequence or (in particular, where the protein product of choice is a heterologous protein) the polynucleotide sequence that encodes the protein product of choice may or may not be an exogenous polynucleotide, and the exogenous polynucleotide may or may not be integrated into the chromosome of the host cell or present in the host cell as part of a replicable vector, such as a plasmid.

[0060] However, the present invention also contemplates the production of host cells suitable for enhanced production of a protein product of choice, into which an appropriate polynucleotide sequence, encoding the protein product of choice, can be later introduced. Therefore, in another embodiment, the host cell does not comprise a polynucleotide sequence that encodes a protein product of choice.

[0061] Suitable host cells are discussed below.

[0062] By "enhanced production" we include the meaning that the level of production of protein product of choice is greater in a cultured population of the genetically modified host cell than in a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins. Typically, the measurement can be made under culture conditions that are standard for the growth of the host cell that is being used.

[0063] Thus the production of the protein product of choice in a cultured population of the genetically modified host cell of the invention be greater than, typically at least 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% (i.e. 1.1-fold), 20% (i.e. 1.2-fold), 30% (i.e. 1.3-fold), 40% (i.e. 1.4-fold), 50% (i.e. 1.5-fold), 60% (i.e. 1.6-fold), 70% (i.e. 1.7 fold), 80% (i.e. 1.8-fold), 90% (i.e. 1.9-fold), 100% (i.e. 2-fold), 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 20-fold, 30-fold, 40-fold, 50-fold, 60-fold, 70-fold, 80-fold, 90-fold, 100-fold, 200-fold, 300-fold, 400-fold, 500-fold, 600-fold, 700-fold, 800-fold, 900-fold, or 1000-fold greater than, the production of the protein product of choice in a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins. These figures may, or may not, be figures that have been normalised to account for differences in the cell growth of the two cultured populations, as compared.

[0064] For example, the production of the protein product of choice in a cultured population of the genetically modified host cell of the invention may be up to 10% (i.e. 1.1-fold), 20% (i.e. 1.2-fold), 30% (i.e. 1.3-fold), 40% (i.e. 1.4-fold), 50% (i.e. 1.5-fold), 60% (i.e. 1.6-fold), 70% (i.e. 1.7 fold), 80% (i.e. 1.8-fold), 90% (i.e. 1.9-fold), 100% (i.e. 2-fold), 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 15-fold, 20-fold, 30-fold, 40-fold, 50-fold, 60-fold, 70-fold, 80-fold, 90-fold, 100-fold, 200-fold, 300-fold, 400-fold, 500-fold, 600-fold, 700-fold, 800-fold, 900-fold, 1000-fold or 2000-fold greater than the production of the protein product of choice in a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins. These figures may, or may not, be figures that have been normalised to account for differences in the cell growth of the two cultured populations, as compared.

[0065] Typically, the protein product of choice may be produced in a cultured population of the genetically modified host cell of the invention to produce a culture containing at least 0.001 gL.sup.-1, such as at least 0.01 at least 0.1 gL.sup.-1, 1 gL.sup.-1, 2 gL.sup.-1, 3 gL.sup.-1, 4 gL.sup.-1, 5 gL.sup.-1, 6 gL.sup.-1, 7 gL.sup.-1, 8 gL.sup.-1, 9 gL.sup.-1, 10 gL.sup.-1, 20 gL.sup.-1, 30 gL.sup.-1, 40 gL.sup.-1, 50 gL.sup.-1, 60 gL.sup.-1, 70 gL.sup.-1, 80 gL.sup.-1, 90 gL.sup.-1, or 100 gL.sup.-1 of the protein product of choice. The protein product of choice may be produced in a cultured population of the genetically modified host cell of the invention to produce a culture containing up to 0.01 gL.sup.-1, 0.1 gL.sup.-1, 2 gL.sup.-1, 3 gL.sup.-1, 4 gL.sup.-1, 5 gL.sup.-1, 6 gL.sup.-1, 7 gL.sup.-1, 8 gL.sup.-1, 9 gL.sup.-1, 10 gL.sup.-1, 20 gL.sup.-1, 30 gL.sup.-1, 40 gL.sup.-1, 50 gL.sup.-1, 60 gL.sup.-1, 70 gL.sup.-1, 80 gL.sup.-1, 90 gL.sup.-1, 100 gL.sup.-1 or 200 gL.sup.-1 of the protein product of choice.

[0066] By "enhanced production" we also include the meaning that the level of activity of the protein product of choice that is produced by the host cell is greater in a cultured population of the genetically modified host cell than in a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins. The nature of the activity will depend on the identity of the protein product of choice and may, for example, be a measurement of the catalytic activity of the protein upon a substrate or the binding properties of the protein to a ligand. Typically, the measurement of protein activity can be made under culture conditions that are standard for the growth of the host cell that is being used or following isolation of the protein from the culture medium. In either case, the comparison should be made on the basis of activity per unit volume of culture or protein recovered therefrom. The comparison may, or may not, be normalised to account for differences in the cell growth of the two cultured populations, as compared.

[0067] Thus the activity of the protein product of choice that is produced in a cultured population of the genetically modified host cell of the invention may be greater than, typically at least 10% (i.e. 1.1-fold), 20% (i.e. 1.2-fold), 30% (i.e. 1.3-fold), 40% (i.e. 1.4-fold), 50% (i.e. 1.5-fold), 60% (i.e. 1.6-fold), 70% (i.e. 1.7-fold), 80% (i.e. 1.8-fold), 90% (i.e. 1.9-fold), 100% (i.e. 2-fold), 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 20-fold, 30-fold, 40-fold, 50-fold, 60-fold, 70-fold, 80-fold, 90-fold, 100-fold, 200-fold, 300-fold, 400-fold, 500-fold, 600-fold, 700-fold, 800-fold, 900-fold, 1000-fold, 10.sup.4-fold, 10.sup.5-fold, or 10.sup.6-fold greater than, the activity of the protein product of choice in a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins.

[0068] For example, the activity of the protein product of choice in a cultured population of the genetically modified host cell of the invention may be up to 10% (i.e. 1.1-fold), 20% (i.e. 1.2-fold), 30% (i.e. 1.3-fold), 40% (i.e. 1.4-fold), 50% (i.e. 1.5-fold), 60% (i.e. 1.6-fold), 70% (i.e. 1.7 fold), 80% (i.e. 1.8-fold), 90% (i.e. 1.9-fold), 100% (i.e. 2-fold), 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 15-fold, 20-fold, 30-fold, 40-fold, 50-fold, 60-fold, 70-fold, 80-fold, 90-fold, 100-fold, 200-fold, 300-fold, 400-fold, 500-fold, 600-fold, 700-fold, 800-fold, 900-fold, 1000-fold, 10.sup.4-fold, 10.sup.5-fold, or 10.sup.6-fold greater than the activity of the protein product of choice in a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins.

[0069] By "enhanced production" we include the additional or alternative meaning that the level of degradation of the protein product of choice is reduced when produced by a cultured population of the genetically modified host cell of the present invention compared to the level of degradation of the protein product of choice when produced by a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins according to the present invention. The level of protein degradation can be determined by quantification of fragments of the protein product of choice relative to the total of the protein product of choice, for example when by analysis of SDS-PAGE using densitometry. When expressed as a percentage of detected protein product fragments relative to total protein product levels detected (i.e. total protein product detected=full length protein product+degradation products) then the percentage of detected protein product fragments when produced by a cultured population of the genetically modified host cell of the present invention may be, or be less than, 99%, 98%, 97%, 96%, 05%, 04%, 03%, 92%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1% or less, such as up to 98%, 97%, 96%, 95%, 94%, 93%, 92%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1% or less of the percentage of detected protein product fragments when produced by a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins according to the present invention. These values may or may not be normalised, for example based on culture optical density readings, to account for different growth rates observed between strains.

[0070] By "enhanced production" we include the additional or alternative meaning that the level of post-translational modification of the protein product of choice is increased or reduced when produced by a cultured population of the genetically modified host cell of the present invention compared to the level of post-translational modification of the protein product of choice when produced by a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins according to the present invention. For example, the altered (i.e. increased or reduced) level of post-translational modification may be an alteration in the level of proteolytic cleavage, hexosylation (for example mannosylation), glycosylation, phosphorylation, phosphopantetheinylation, carbamylation, carboxylation (such as .gamma.-carboxylation), sialation, sulphonation, hydroxylation, prenylation, isoprenylation, acylation, ubiquitination, lipoylation, biotinylation, glycylation, glutamylation, methylation, alkylation, acetylation, formylation, selenation, disulphide bond formation or oligomerisation of the protein product of choice. The level of post-translational modification of the protein product of choice can be determined by methods well known in the art, such as by mass spectrometry techniques (for example, see Larsen et al, 2006, BioTechniques, 40, 790-798) well known in the art.

[0071] By "enhanced production" we include the additional or alternative meaning that the level of stress experienced by a cell that is being cultured to produce the protein product of choice is reduced, compared to the level of stress experienced by a cultured population of the same host cell that has not been genetically modified to cause over-expression of one or more of the identified helper proteins according to the present invention. For example, "enhanced production" can include the additional or alternative meaning that the unfolded protein response is reduced in a host cell. The level of stress, and the level of the unfolded protein response, can be measured by determination of the proportion of HAC1.sup.i to total HAC1 transcript levels. Total HAC1 transcript levels are the sum of HAC1.sup.i transcript levels and unspliced HAC1 (HAC1.sup.u) transcript levels in a cell. A reduced proportion of HAC1.sup.i transcript levels compared to total HAC1 transcript level, relative to a control, is indicative of reduced stress and reduced. UPR signalling relative to that control. Helper proteins suitable for achieving this effect may include Hsp70 family proteins (such as LHS1) and DnaJ-like proteins (such as JEM1) and combinations of other helper proteins such as disclosed in the present application.

[0072] In principle, any "protein product of choice" can be produced. The identity of preferred embodiments of the "protein product of choice" is discussed further below.

[0073] The host cell is genetically modified to cause over-expression of one or more of the helper proteins. By "over-expression", in the context of helper proteins, we mean that the measurable level of mRNA encoding the one or more helper proteins, and/or the measurable level of the one or more helper proteins themselves, and/or the measurable level of the helper protein activity, is greater than the measurable level in a host cell that has not been genetically modified. Typically, the measurement will be made under culture conditions that are standard for the growth of the host cell that is being used. Standard conditions for yeast cell growth are discussed, for example, in WO 96/37515, WO 00/44772 and WO 99/00504, the contents of which are incorporated herein by reference.

[0074] Thus the host cell may or may not be genetically modified to cause a level of expression of one or more of the helper proteins that is at least a 1.1-fold, 1.2-fold, 1.3-fold, 1.4-fold, 1.5-fold, 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 20-fold, 30-fold, 40-fold, 50-fold or more, of unmodified level of expression of one or more of the helper proteins.

[0075] For example, the host cell may or may not be genetically modified to cause a level of expression of one or more of the helper proteins that is up to 1.2-fold, 1.3-fold, 1.4-fold, 1.5-fold, 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 15-fold, 20-fold, 30-fold, 40-fold, 50-fold, 60-fold, 70-fold, 80-fold, 90-fold or 100-fold of the unmodified-type level of expression of one or more of the helper proteins.

[0076] For example, the host cell may be genetically modified to cause a level of expression of one or more of the helper proteins that is between 1- to 30-fold, such as about 2- to 25-fold, of the unmodified-type level of expression of one or more of the helper proteins.

[0077] The host cell may or may not be genetically modified to cause over-expression of one or more of the helper proteins by the introduction of one or more recombinant copies of one or more polynucleotides that each comprise a region (the "coding region", or "open reading frame", which can be abbreviated to "ORF") that encodes one or more helper proteins.

[0078] A copy of the polynucleotide may or may not be introduced into the chromosome of the host cell and/or may or may not be encoded by a plasmid or other vector that is used to transform the host cell.

[0079] The polynucleotide may or may not comprise some or all of the regulatory sequences necessary to cause transcription and/or translation of the ORF of the polynucleotide.

[0080] Regulatory sequences necessary to cause transcription and/or translation of the ORF of the polynucleotide include sequences that modulate (i.e., promotes or reduces, typically promotes) the expression (i.e., the transcription and/or translation) of an ORF to which it is operably linked. Regulatory regions typically include promoters, terminators, ribosome binding sites and the like. The skilled person will appreciate that the choice of regulatory region will depend upon the intended expression system. For example, promoters may or may not be constitutive or inducible and may or may not be cell- or tissue-type specific or non-specific.

[0081] Suitable regulatory regions, may be about, or up to, 5 bp, 10 bp, 15 bp, 20 bp, 25 bp, 30 bp, 35 bp, 40 bp, 45 bp, 50 bp, 60 bp, 70 bp, 80 bp, 90 bp, 100 bp, 120 bp, 140 bp, 160 bp, 180 bp, 200 bp, 220 bp, 240 bp, 260 bp, 280 bp, 300 bp, 350 bp, 400 bp, 450 bp, 500 bp, 550 bp, 600 bp, 650 bp, 700 bp, 750 bp, 800 bp, 850 bp, 900 bp, 950 bp, 1000 bp, 1100 bp, 1200 bp, 1300 bp, 1400 bp, 1500 bp or greater, in length.

[0082] Such non-coding regions and regulatory regions are not restricted to the native non-coding regions and/or regulatory regions naturally associated with the ORF.

[0083] Where the host cell is yeast, such as Saccharomyces cerevisiae, suitable promoters for S. cerevisiae include those associated with the PGK1 gene, GAL1 or GAL10 genes, TEF1, TEF2, PYK1, PMA1, CYC1, PHO5, TRP1, ADH1; ADH2, the genes for glyceraldehyde-3-phosphate dehydrogenase (for example, TDH1, TDH2 or TDH3), hexokinase (for example, HXK1 or HXK2), pyruvate decarboxylase (for example, PDC1, PDC5 or PDC6), phosphofructokinase (for example, PFK1 or PFK2), triose phosphate isomerase (for example, TPI1), phosphoglucose isomerase (for example, PGI1), glucokinase (for example, GLK1), .alpha.-mating factor pheromone (for example, MF.alpha.-1 or MF.alpha.-2), .alpha.-mating factor pheromone (for example, MFA1 or MFA2), PRB1, PRA1, GPD1, and hybrid promoters involving hybrids of parts of 5' regulatory regions with parts of 5' regulatory regions of other promoters or with upstream activation sites (e.g. the promoter of EP-A-258 067). Where multiple ORFs are to be expressed, a different promoter may or may not be chosen for each ORF. The skilled person can readily determine appropriate combinations of promoters. For example, the promoters from the ADH1, PGK1, TDH1 and TEF1 genes are used in combination to recombinantly over-express four helper proteins in Example 3 below.

[0084] Suitable transcription termination signals are well known in the art. Where the host cell is eukaryotic, the transcription termination signal is preferably derived from the 3' flanking sequence of a eukaryotic gene, which contains proper signals for transcription termination and polyadenylation. Suitable 3' flanking sequences may, for example, be those of the gene naturally linked to the expression control sequence used, i.e. may correspond to the promoter. Alternatively, they may be different. In that case, and where the host is a yeast, preferably S. cerevisiae, then the termination signal of the S. cerevisiae ADH1, ADH2, CYC1, or PGK1 genes are preferred.

[0085] It may be beneficial for the promoter and open reading frame to be flanked by transcription termination sequences so that the transcription termination sequences are located both upstream and downstream of the promoter and open reading frame, in order to prevent transcriptional read-through into neighbouring genes, and visa versa.

[0086] In one embodiment, a suitable regulatory sequences in yeast, such as Saccharomyces cerevisiae, includes: a yeast promoter (e.g. the Saccharomyces cerevisiae PRB1 promoter), as taught in EP 431 880; and a transcription terminator, preferably the terminator from Saccharomyces ADH1, as taught in EP 60 057. Other suitable regulatory sequences are given in the examples, and include TEF1, PGK1 and TDH1 promoters.

[0087] It may be beneficial for the non-coding region to incorporate more than one DNA sequence encoding a translational stop codon, such as UAA, UAG or UGA, in order to minimise translational read-through and thus avoid the production of elongated, non-natural fusion proteins. The translation stop codon UAA is preferred. Preferably, the polynucleotide incorporates at least two translation stop codons.

[0088] The term "operably linked" includes within its meaning that a regulatory sequence is positioned within any non-coding region in a gene such that it forms a relationship with an ORF that permits the regulatory region to exert an effect on the ORF in its intended manner. Thus a regulatory region "operably linked" to an ORF is positioned in such a way that the regulatory region is able to influence transcription and/or translation of the ORF in the intended manner, under conditions compatible with the regulatory sequence.

[0089] Alternatively, the polynucleotide may or may not be formed in such a manner that it can take advantage of endogenous regulatory sequences within the chromosome or plasmid to cause transcription and/or translation of the coding region of the polynucleotide. For example, the use of promoterless constructs is well known in the art as a way of allowing an endogenous promoter sequence to drive the expression of a recombinantly-introduced polynucleotide coding region.

[0090] The skilled person will appreciate that the host cell may or may not comprise endogenous copies of genes encoding one or more of the helper proteins. Therefore, this invention also contemplates genetic modifications to the host cell that cause increased steady state levels of mRNA molecules encoding one or more helper proteins and/or increased steady state levels of one or more helper proteins.

[0091] This can include the genetic modification of operably linked endogenous regulatory regions. For example, the endogenous promoter in the gene of an endogenously encoded helper protein can be replaced by a promoter that causes greater levels of expression of the helper protein under culture conditions.

[0092] Alternatively, genetic modifications can be made to cis or trans regulators of the gene of an endogenously encoded helper protein, so as to increase the expression of the helper protein under culture conditions. Thus, the polynucleotide region that encodes a genetically encoded repressor of a gene of an endogenously encoded helper protein could be genetically modified to reduce or prevent repression of the endogenous helper protein gene.

[0093] Alternative genetic modifications to increase the expression of a helper protein or protein product of choice can involve transient expression techniques known in to the art. For example, suitable techniques are disclosed in Chen et al, 1997, Nucleic Acids Research, 25, 4416-4418 and in Behr et al, 1989, Proc. Natl. Acad. Sci. USA, 86, 6982-6986.

[0094] Thus, a number of techniques are available to the skilled person to genetically modify a cell to cause over-expression of a helper protein (and the same techniques may be used to cause expression of a protein product of choice). Suitable techniques include-- [0095] (i) introduction of a recombinant copy of an encoding polynucleotide by integration into the chromosome of the host cell (for example, either with associated regulatory sequences or without associated regulatory sequences so as to take advantage of endogenous regulatory sequences at the site of integration); [0096] (ii) introduction of plasmid or other vector comprising a recombinant copy of an encoding polynucleotide into the cell; [0097] (iii) genetic modifications of a host cell's endogenous regulatory region operably linked to the host cell's endogenous copy of an ORF encoding a helper protein or protein product of choice, to cause increased steady state levels of mRNA molecules encoded by said ORF; [0098] (iv) genetic modifications to a cis or trans regulator of the gene of an endogenously encoded helper protein or protein product of choice; or [0099] (v) transient expression of a helper protein or protein product of choice.

[0100] Where the host cell comprises a first gene encoding a protein product of choice, and a second gene encoding a first helper protein, then for example, [0101] the first gene may be a gene as defined in (i) above and the second gene may be a gene as defined in (i), (ii), (iii), (iv) or (v) above; [0102] the first gene may be a gene as defined in (ii) above and the second gene may be a gene as defined in (i), (ii), (iv) or (v) above (and where both the first and second genes are introduced on plasmid or vector, the first gene may or may not be introduced on the same plasmid or vector as the to second gene); [0103] the first gene may be a gene as defined in (iii) above and the second gene may be a gene as defined in (i), (iv) or (v) above; [0104] the first gene may be a gene as defined in (iv) above and the second gene may be a gene as defined in (i), (iv) or (v) above; or [0105] the first gene may be a gene as defined in (v) above and the second gene may be a gene as defined in (i), (iv) or (v) above.

[0106] Where the host cell comprises a first gene encoding a protein product of choice, and a second gene encoding a first helper protein and a third gene encoding a second helper protein, then for example, [0107] the first gene may be a gene as defined in (i) above, and the second gene may be a gene as defined in (i) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0108] the first gene may be a gene as defined in (i) above, and the second gene may be a gene as defined in (ii) above, and the third gene may be a gene as defined in (i), (ii), (iv) or (v) above (and where both the second and third genes are introduced on plasmid or vector, the second gene may or may not be introduced on the same plasmid or vector as the third gene); [0109] the first gene may be a gene as defined in (i) above, and the second gene may be a gene as defined in (iii) above, and the third gene may be a gene as defined in (i), (ii), (iv) or (v) above; [0110] the first gene may be a gene as defined in (i) above, and the second gene may be a gene as defined in (iv) above, and the third gene may be a gene as defined in (i), (ii), (iii), (iv) or (v) above; [0111] the first gene may be a gene as defined in (i) above, and the second gene may be a gene as defined in (v) above, and the third gene may be a gene as defined in (i), (ii), (iii), (iv) or (v) above; [0112] the first gene may be a gene as defined in (ii) above, and the second gene may be a gene as defined in (i) above, and the third gene may be a gene as defined in (i), (iii), (iv) or (v) above (and where both the first and third genes are introduced on plasmid or vector, the first gene may or may not be introduced on the same plasmid or vector as the third gene); [0113] the first gene may be a gene as defined in (ii) above, and the second gene may be a gene as defined in (ii) above, and the third gene may be a gene as defined in (i), (iv) or (v) above (and where the first, second and third genes are introduced on plasmid or vector, the first gene may or may not be introduced on the same plasmid or vector as the second gene, the first gene may or may not be introduced on the same plasmid or vector as the third gene and the second gene may or may not be introduced on the same plasmid or vector as the third gene); [0114] the first gene may be a gene as defined in (ii) above, and the second gene may be a gene as defined in (iii) above, and the third gene may be a gene as defined in (i), (iii), (iv) or (v) above; [0115] the first gene may be a gene as defined in (ii) above, and the second gene may be a gene as defined in (iv) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0116] the first gene may be a gene as defined in (ii) above, and the second gene may be a gene as defined in (V) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0117] the first gene may be a gene as defined in (iii) above, and the second gene may be a gene as defined in (i) above,- and the third gene may be a gene as defined in (i), (iii), (iv) or (v) above; [0118] the first gene may be a gene as defined in (iii) above, and the second gene may be a gene as defined in (ii) above, and the third gene may be a gene as defined in (i), (iv) or (v) above (and where both the second and third genes are introduced on plasmid or vector, the second gene may or may not be introduced on the same plasmid or vector as the third gene); [0119] the first gene may be a gene as defined in (i) above, and the second gene may be a gene as defined in (iii) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0120] the first gene may be a gene as defined in (iii) above, and the second gene may be a gene as defined in (iv) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0121] the first gene may be a gene as defined in (iii) above, and the second gene may be a gene as defined in (v) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0122] the first gene may be a gene as defined in (iv) above, and the second gene may be a gene as defined in (i) above, and the third gene may be a gene as defined in (i), (ii), (iv) or (v) above; [0123] the first gene may be a gene as defined in (iv) above, and the second gene may be a gene as defined in (ii) above, and the third gene may be a gene as defined in (i), (iii), (iv) or (v) above (and where both the second and third genes are introduced on plasmid or vector, the second gene may or may not be introduced on the same plasmid or vector as the third gene); [0124] the first gene may be a gene as defined in (iv) above, and the second gene may be a gene as defined in (iii) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0125] the first gene may be a gene as defined in (iv).above, and the second gene may be a gene as defined in (iv) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0126] the first gene may be a gene as defined in (iv) above, and the second gene may be a gene as defined in (v) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0127] the first gene may be a gene as defined in (v) above, and the second gene may be a gene as defined in (i) above, and the third gene may be a gene as defined in (i), (ii), (iv) or (v) above; [0128] the first gene may be a gene as defined in (v) above, and the second gene may be a gene as defined in (ii) above, and the third gene may be a gene as defined in (i), (iv) or (v) above (and where both the second and third genes are introduced on plasmid or vector, the second gene may or may not be introduced on the same plasmid or vector as the third gene); [0129] the first gene may be a gene as defined in (v) above, and the second gene may be a gene as defined in (iii) above, and the third gene may be a gene as defined in (i), (iv) or (v) above; [0130] the first gene may be a gene as defined in (v) above, and the second gene may be a gene as defined in (iv) above, and the third gene may be a gene as defined in (i), (iii), (iv) or (v) above; or [0131] the first gene may be a gene as defined in (v) above, and the second gene may be a gene as defined in (v) above, and the third gene may be a gene as defined in (i), (iv) or (v) above.

[0132] Further combinations of possible genetic modifications will be apparent to the skilled person, in light of the above disclosure, when further genes (for example a fourth gene encoding a third helper protein; a fifth gene encoding a fourth helper protein, etc.) are to be over-expressed in the host cell of the invention.

[0133] The skilled person can readily choose the most appropriate and convenient method to achieve over-expression of one or more helper proteins in a host cell. It will be appreciated that, in the case that multiple helper proteins are over-expressed in the host cell, at least one helper protein may or may not be over-expressed by the introduction of an appropriate recombinant polynucleotide sequence as discussed above, whereas at least one other helper protein may or may not be over-expressed by a genetic modification to the host cell to cause over-expression of the helper protein from the endogenous gene that encodes it.

Helper Proteins

[0134] As discussed above, we have identified a series of proteins (hereinafter "helper" proteins) that are over-expressed in a S. cerevisiae strain identified as possessing increased production of a recombinant protein. These over-expressed helper proteins have all, individually, been previously identified.

[0135] The helper proteins identified include proteins that can be categorised as follows--

(i) chaperones, (ii) proteins involved in disulphide bond formation, (iii) proteins involved in the protein degradation pathway, and (iv) HAC1 (encoded by a spliced or unspliced polynucleotide).

[0136] These groups are individually described further below.

Chaperones

[0137] The class of proteins known as chaperones have been defined by Hartl (1996, Nature, 381, 571-580) as a protein that binds to and stabilises an otherwise unstable conformer of another protein and, by controlled binding and release, facilitates its correct fate in vivo, be it folding, oligomeric assembly, transport to a particular subcellular compartment, or disposal by degradation.

[0138] For the purposes of the present invention, chaperones of interest can be broadly split into the following three functional sub-groups-- [0139] ER luminal localised chaperones; [0140] Chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation; and [0141] Mitochondrial chaperone and translocation proteins

[0142] Each of these groups are discussed in more detail below.

ER Luminal Localised Chaperones

[0143] ER luminal localised chaperones, involved in "protein folding" include DnaJ-like proteins (such as JEM1), Hsp70 family member proteins (such as LHS1), SCJ1, KAR2, SIL1 and FKB2. A detailed description of these proteins and their genes is given separately below.

[0144] In one embodiment, the host cell may or may not be genetically modified to cause over-expression of one, or more, of the above ER luminal localised chaperones. For example, SCJ1 may or may not be over-expressed. Alternatively, FKB2 may or may not be over-expressed.

[0145] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of two of the above ER luminal localised chaperones. For example, one of the following combinations may or may not be chosen-- [0146] A DnaJ-like proteins (such as JEM1) in combination with one of an Hsp70 family member protein (such as LHS1), SCJ1, KAR2, SIL1 or FKB2; [0147] An Hsp70 family member protein (such as LHS1) in combination with one of SCJ1, KAR2, SIL1 or FKB2; [0148] SCJ1 in combination with one of KAR2, KU or FKB2; [0149] KAR2 in combination with one of SIL1 or FKB2; or [0150] SIL1 in combination with FKB2.

[0151] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of three of the above ER luminal localised chaperones. For example, one of the following combinations may or may not be chosen--

JEM1, LHS1 and SCJ1; JEM1, LHS1 and KAR2; JEM1, LHS1 and SIL1; JEM1, LHS1 and FKB2; JEM1, SCJ1 and KAR2; JEM1, SCJ1 and SIL1; JEM1, SCJ1 and FKB2; JEM1, KAR2 and SIL1; JEM1, KAR2 and FKB2; JEM1, SIL1 and FKB2; LHS1, SCJ1 and KAR2; LHS1, SCJ1 and SIL1; LHS1, SCJ1 and FKB2; LHS1, KAR2 and SIL1 LHS1, KAR2 and FKB2; LHS1, SIL1 and FKB2; SCJ1, KAR2 and SIL1; SCJ1, KAR2 and FKB2; SCJ1, SIL1 and FKB2; or KAR2, SIL1 and FKB2.

[0152] In one embodiment, the host cell may or may not be genetically modified to cause over-expression of four of the above ER luminal localised chaperones. For example, one of the following combinations may or may not be chosen--

JEM1, LHS1, SCJ1 and KAR2; JEM1, LHS1, SCJ1 and SIL1; JEM1, LHS1, SCJ1 and FKB2; JEM1, LHS1, KAR2 and SIL1; JEM1, LHS1, KAR2 and FKB2; JEM1, LHS1, SIL1 and FKB2; JEM1, SCJ1, KAR2 and SIL1; JEM1, SCJ1, KAR2 and FKB2; JEM1, SCJ1, SIL1 and FKB2; JEM1, KAR2, SIL1 and FKB2; LHS1, SCJ1, KAR2 and SIL1; LHS1, SCJ1, KAR2 and FKB2; LHS1, SCJ1, SIL1 and FKB2; LHS1, KAR2, SIL1 and FKB2; or SCJ1, KAR2, SIL1 and FKB2.

[0153] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of five of the above ER luminal localised chaperones. For example, one of the following combinations may or may not be chosen--

JEM1, LHS1, SCJ1, KAR2 and SIL1; JEM1, LHS1, SCJ1, KAR2 and FKB2; JEM1, LHS1, SCJ1, SIL1 and FKB2; JEM1, LHS1, KAR2, SIL1 and FKB2; JEM1, SCJ1, KAR2, SIL1 and FKB2; or LHS1, SCJ1, KAR2, SIL1 and FKB2.

[0154] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of all six of the above ER luminal localised chaperones. In other words, the following combination may or may not be chosen--

JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2.

[0155] In one preferred embodiment, the host cell may or may not be genetically modified to cause over-expression of two, three or four helper proteins selected from LHS1, SELL JEM1 and SCJ1, such as one of the following combinations--

LHS1 and SIL1 LHS1 and JEM1; LHS1 and SCJ1; SIL1 and JEM1; SIL1 and SCJ1; JEM1 and SCJ1; LHS1, SIL1 and JEM1; LHS1, SIL1 and SCJ1; LHS1, JEM1 and SCJ1; SIL1 JEM1 and SCJ1; or LHS1, SIL1 JEM1 and SCJ1.

Chaperones Involved in Cytoplasmic Folding and Maintenance of Proteins in a Translocation Competent State Prior to Translocation

[0156] Chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation include SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2. A detailed description of these proteins and their genes is given separately below.

[0157] In one embodiment, the host cell may or may not be genetically modified to cause over-expression of one of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. For example, SSE1 may or may not be chosen.

[0158] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of two of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. For example, one of the following combinations may or may not be chosen--

SSA1 in combination with one of SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; SSA2 in combination with one of SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; SSA3 in combination with one of SSA4, SSE1, SSE2, SSB1, SSB2; SSA4 in combination with one of SSE1, SSE2, SSB1, SSB2; SSE1 in combination with one of SSE2, SSB1, SSB2; SSE2 in combination with one of SSB1, SSB2; or SSB1 in combination with SSB2.

[0159] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of three of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. For example, one of the following combinations may or may not be chosen--

SSA1, SSA2 and SSA3; SSA1, SSA2 and SSA4; SSA1, SSA2 and SSE1; SSA1, SSA2 and SSE2; SSA1, SSA2 and SSB1; SSA1, SSA2 and SSB2; SSA1, SSA3 and SSA4; SSA1, SSA3 and SSE1; SSA1, SSA3 and SSE2; SSA1, SSA3 and SSB1; SSA1, SSA3 and SSB2; SSA1, SSA4 and SSE1; SSA1, SSA4 and SSE2; SSA1, SSA4 and SSB1; SSA1, SSA4 and SSB2; SSA1, SSE1 and SSE2; SSA1, SSE1 and SSB1; SSA1, SSE1 and SSB2; SSA1, SSE2 and SSB1; SSA1, SSE2 and SSB2; SSA1, SSB1 and SSB2; SSA2, SSA3 and SSA4; SSA2, SSA3 and SSE1; SSA2, SSA3 and SSE2; SSA2, SSA3 and SSB1; SSA2, SSA3 and SSB2; SSA2, SSA4 and SSE1; SSA2, SSA4 and SSE2; SSA2, SSA4 and SSB1; SSA2, SSA4 and SSB2; SSA2, SSE1 and SSE2; SSA2, SSE1 and SSB1; SSA2, SSE1 and SSB2; SSA2, SSE2 and SSB1; SSA2, SSE2 and SSB2; SSA2, SSB1 and SSB2; SSA3, SSA4 and SSE1; SSA3, SSA4 and SSE2; SSA3, SSA4 and SSB1; SSA3, SSA4 and SSB2; SSA3, SSE1 and SSE2; SSA3, SSE1 and SSB1; SSA3, SSE1 and SSB2; SSA3, SSE2 and SSB1; SSA3, SSE2 and SSB2; SSA3, SSB1 and SSB2; SSA4, SSE1 and SSE2; SSA4, SSE1 and SSB1; SSA4, SSE1 and SSB2; SSA4, SSE2 and SSB1; SSA4, SSE2 and SSB2; SSA4, SSB1 and SSB2; SSE1, SSE2 and SSB1; SSE1, SSE2 and SSB2; SSE1, SSB1 and SSB2; or SSE2, SSB1 and SSB2.

[0160] In another embodiment, the host cell mayor may not be genetically modified to cause over-expression of four of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. For example, one of the following combinations may or may not be chosen--

SSA1, SSA2, SSA3 and SSA4; SSA1, SSA2, SSA3 and SSE1; SSA1, SSA2, SSA3 and SSE2; SSA1, SSA2, SSA3 and SSB1; SSA1, SSA2, SSA3 and SSB2; SSA1, SSA2, SSA4 and SSE1; SSA1, SSA2, SSA4 and SSE2; SSA1, SSA2, SSA4 and SSB1; SSA1, SSA2, SSA4 and SSB2; SSA1, SSA2, SSE1 and SSE2; SSA1, SSA2, SSE1 and SSB1; SSA1, SSA2, SSE1 and SSB2; SSA1, SSA2, SSE2 and SSB1; SSA1, SSA2, SSE2 and SSB2; SSA1, SSA2, SSB1 and SSB2; SSA1, SSA3, SSA4 and SSE1; SSA1, SSA3, SSA4 and SSE2; SSA1, SSA3, SSA4 and SSB1; SSA1, SSA3, SSA4 and SSB2; SSA1, SSA3, SSE1 and SSE2; SSA1, SSA3, SSE1 and SSB1; SSA1, SSA3, SSE1 and SSB2; SSA1, SSA3, SSE2 and SSB1; SSA1, SSA3, SSE2 and SSB2; SSA1, SSA3, SSB1 and SSB2; SSA1, SSA4, SSE1 and SSE2; SSA1, SSA4, SSE1 and SSB1; SSA1, SSA4, SSE1 and SSB2; SSA1, SSA4, SSE2 and SSB1; SSA1, SSA4, SSE2 and SSB2; SSA1, SSA4, SSB1 and SSB2; SSA1, SSE1, SSE2 and SSB1; SSA1, SSE1, SSE2 and SSB2; SSA1, SSE1, SSB1 and SSB2; SSA1, SSE2, SSB1 and SSB2; SSA2, SSA3, SSA4 and SSE1; SSA2, SSA3, SSA4 and SSE2; SSA2, SSA3, SSA4 and SSB1; SSA2, SSA3, SSA4 and SSB2; SSA2, SSA3, SSE1 and SSE2; SSA2, SSA3, SSE1 and SSB1; SSA2, SSA3, SSE1 and SSB2; SSA2, SSA3, SSE2 and SSB1; SSA2, SSA3, SSE2 and SSB2; SSA2, SSA3, SSB1 and SSB2; SSA2, SSA4, SSE1 and SSE2; SSA2, SSA4, SSE1 and SSB1; SSA2, SSA4, SSE1 and SSB2; SSA2, SSA4, SSE2 and SSB1; SSA2, SSA4, SSE2 and SSB2; SSA2, SSA4, SSB1 and SSB2; SSA2, SSE1, SSE2 and SSB1; SSA2, SSE1, SSE2 and SSB2; SSA2, SSE1, SSB1 and SSB2; SSA2, SSE2, SSB1 and SSB2; SSA3, SSA4, SSE1 and SSE2; SSA3, SSA4, SSE1 and SSB1; SSA3, SSA4, SSE1 and SSB2; SSA3, SSA4, SSE2 and SSB1; SSA3, SSA4, SSE2 and SSB2; SSA3, SSA4, SSB1 and SSB2; SSA3, SSE1, SSE2 and SSB1; SSA3, SSE1, SSE2 and SSB2; SSA3, SSE1, SSB1 and SSB2; SSA3, SSE2, SSB1 and SSB2; SSA4, SSE1, SSE2 and SSB1; SSA4, SSE1, SSE2 and SSB2; SSA4, SSE1, SSB1 and SSB2; SSA4, SSE2, SSB1 and SSB2; or SSE1, SSE2, SSB1 and SSB2.

[0161] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of five of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. For example, one of the following combinations may or may not be chosen--

SSA1, SSA2, SSA3, SSA4 and SSE1; SSA1, SSA2, SSA3, SSA4 and SSE2; SSA1, SSA2, SSA3, SSA4 and SSB1; SSA1, SSA2, SSA3, SSA4 and SSB2; SSA1, SSA2, SSA3, SSE1 and SSE2; SSA1, SSA2, SSA3, SSE1 and SSB1; SSA1, SSA2, SSA3, SSE1 and SSB2; SSA1, SSA2, SSA3, SSE2 and SSB1; SSA1, SSA2, SSA3, SSE2 and SSB2; SSA1, SSA2, SSA3, SSB1 and SSB2; SSA1, SSA2, SSA4, SSE1 and SSE2; SSA1, SSA2, SSA4, SSE1 and SSB1; SSA1, SSA2, SSA4, SSE1 and SSB2; SSA1, SSA2, SSA4, SSE2 and SSB1; SSA1, SSA2, SSA4, SSE2 and SSB2; SSA1, SSA2, SSA4, SSB1 and SSB2; SSA1, SSA2, SSE1, SSE2 and SSB1; SSA1, SSA2, SSE1, SSE2 and SSB2; SSA1, SSA2, SSE1, SSB1 and SSB2; SSA1, SSA2, SSE2, SSB1 and SSB2; SSA1, SSA3, SSA4, SSE1 and SSE2; SSA1, SSA3, SSA4, SSE1 and SSB1; SSA1, SSA3, SSA4, SSE1 and SSB2; SSA1, SSA3, SSA4, SSE2 and SSB1; SSA1, SSA3, SSA4, SSE2 and SSB2; SSA1, SSA3, SSA4, SSB1 and SSB2; SSA1, SSA3, SSE1, SSE2 and SSB1; SSA1, SSA3, SSE1, SSE2 and SSB2; SSA1, SSA3, SSE1, SSB1 and SSB2; SSA1, SSA3, SSE2, SSB1 and SSB2; SSA1, SSA4, SSE1, SSE2 and SSB1; SSA1, SSA4, SSE1, SSE2 and SSB2; SSA1, SSA4, SSE1, SSB1 and SSB2; SSA1, SSE1, SSE2, SSB1 and SSB2; SSA2, SSA3, SSA4, SSE1 and SSE2; SSA2, SSA3, SSA4, SSE1 and SSB1; SSA2, SSA3, SSA4, SSE1 and SSB2; SSA2, SSA3, SSA4, SSE2 and SSB1; SSA2, SSA3, SSA4, SSE2 and SSB2; SSA2, SSA3, SSA4, SSB1 and SSB2; SSA2, SSA3, SSE1, SSE2 and SSB1; SSA2, SSA3, SSE1, SSE2 and SSB2; SSA2, SSA3, SSE1, SSB1 and SSB2; SSA2, SSA3, SSE2, SSB1 and SSB2; SSA2, SSA4, SSE1, SSE2 and SSB1; SSA2, SSA4, SSE1, SSE2 and SSB2; SSA2, SSA4, SSE1, SSB1 and SSB2; SSA2, SSA4, SSE2, SSB1 and SSB2; SSA2, SSE1, SSE2, SSB1 and SSB2; SSA3, SSA4, SSE1, SSE2 and SSB1; SSA3, SSA4, SSE1, SSE2 and SSB2; SSA3, SSA4, SSE1, SSB1 and SSB2; SSA3, SSA4, SSE2, SSB1 and SSB2; SSA3, SSE1, SSE2, SSB1 and SSB2; or SSA4, SSE1, SSE2, SSB1 and SSB2.

[0162] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of six of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. For example, one of the following combinations may or may not be chosen--

SSA1, SSA2, SSA3, SSA4, SSE1 and SSE2; SSA1, SSA2, SSA3, SSA4, SSE1 and SSB1; SSA1, SSA2, SSA3, SSA4, SSE1 and SSB2; SSA1, SSA2, SSA3, SSA4, SSE2 and SSB1; SSA1, SSA2, SSA3, SSA4, SSE2 and SSB2; SSA1, SSA2, SSA3, SSA4, SSB1 and SSB2; SSA1, SSA2, SSA3, SSE1, SSE2 and SSB1; SSA1, SSA2, SSA3, SSE1, SSE2 and SSB2; SSA1, SSA2, SSA3, SSE1, SSB1 and SSB2; SSA1, SSA2, SSA3, SSE2, SSB1 and SSB2; SSA1, SSA2, SSA4, SSE1, SSE2 and SSB1; SSA1, SSA2, SSA4, SSE1, SSE2 and SSB2; SSA1, SSA2, SSA4, SSE1, SSB1 and SSB2; SSA1, SSA2, SSA4, SSE2, SSB1 and SSB2; SSA1, SSA2, SSE1, SSE2, SSB1 and SSB2; SSA1, SSA3, SSA4, SSE1, SSE2 and SSB1; SSA1, SSA3, SSA4, SSE1, SSE2 and SSB2; SSA1, SSA3, SSA4, SSE1, SSB1 and SSB2; SSA1, SSA3, SSA4, SSE2, SSB1 and SSB2; SSA1, SSA3, SSE1, SSE2, SSB1 and SSB2; SSA1, SSA4, SSE1, SSE2, SSB1 and SSB2; SSA2, SSA3, SSA4, SSE1, SSE2 and SSB1; SSA2, SSA3, SSA4, SSE1, SSE2 and SSB2; SSA2, SSA3, SSA4, SSE1, SSB1 and SSB2; SSA2, SSA3, SSA4, SSE2, SSB1 and SSB2; SSA2, SSA3, SSE1, SSE2, SSB1 and SSB2; SSA2, SSA4, SSE1, SSE2, SSB1 and SSB2; or SSA3, SSA4, SSE1, SSE2, SSB1 and SSB2.

[0163] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of seven of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. For example, one of the following combinations may or may not be chosen--

SSA1, SSA2, SSA3, SSA4, SSE1, SSE2 and SSB1; SSA1, SSA2, SSA3, SSA4, SSE1, SSE2 and SSB; SSA1, SSA2, SSA3, SSA4, SSE1, SSB1 and SSB2; SSA1, SSA2; SSA3, SSA4, SSE2, SSB1 and SSB2; SSA1, SSA2, SSA3, SSE1, SSE2, SSB1 and SSB2; SSA1, SSA2, SSA4, SSE1, SSE2, SSB1 and SSB2; SSA1, SSA3, SSA4, SSE1, SSE2, SSB1 and SSB2; or SSA2, SSA3, SSA4, SSE1, SSE2, SSB1 and SSB2.

[0164] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of all eight of the above chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation. In other words, the following combination may or may not be chosen--

SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1 and SSB2.

Mitochondrial Chaperone and Translocation Proteins

[0165] Mitochondrial chaperone and translocation proteins include ECM10, MDJ1, MDJ2. A detailed description of these proteins and their genes is given separately below.

[0166] In one embodiment, the host cell may or may not be genetically modified to cause over-expression of one of the above mitochondrial chaperone and translocation proteins.

[0167] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of two of the above mitochondrial chaperone and translocation proteins. For example, one of the following combinations may or may not be chosen--

ECM10 and MDJ1; ECM10 and MDJ2; or MDJ1 and MDJ2.

[0168] In another embodiment, the host cell may or may not be genetically modified to cause over-expression of all three of the above mitochondrial chaperone and translocation proteins. In that case the following combination may or may not be chosen--

ECM10, MDJ1 and MDJ2.

Other Combinations of Chaperones

[0169] The skilled person will appreciate that it is possible to combine genes that encode one or more proteins from the above-defined groups of chaperones.

[0170] Thus, the host cell may or may not be genetically modified to cause simultaneous over-expression of at least one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or seventeen of the chaperones selected from the group consisting of JEM1, LHS1, SCJ1, KAR2, SIL1 FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1 and MDJ2.

[0171] Where the host cell is genetically modified to cause simultaneous over-expression of one or two of the above defined chaperones, it may or may not be preferred that the host cell is genetically modified to cause simultaneous over-expression of at least three helper proteins and the one or two other helper proteins may or may not be helper proteins involved in disulphide bond formation or protein degradation, as discussed below.

[0172] Over-expression of one (or more) of the ER luminal localised chaperones may or may not be combined with the over-expression of at least one of the chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation and/or the over-expression of at least one of the mitochondrial chaperone and translocation proteins.

[0173] For example, any one of the following combinations may or may not be chosen-- [0174] SCJ1 in combination with any one, two, three, four, five, six, seven, eight, nine, ten or eleven of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1 or MDJ2; or [0175] FKB2 in combination with any one, two, three, four, five, six, seven, eight, nine, ten or eleven of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1 or MDJ2. [0176] JEM1 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0177] LHS1 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0178] SCJ1 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0179] KAR2 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0180] SIL1 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 and/or in combination with ECM10, MDJ1 and MDJ2; or [0181] FKB2 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 and/or in combination with ECM10, MDJ1 and MDJ2.

[0182] Alternatively, for example, one (or more) of the chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation may or may not be simultaneously over-expressed with at least one of the ER luminal localised chaperones and/or at least one of the mitochondrial chaperone and translocation proteins. For example, the following combinations may or may not be chosen-- [0183] SSE1 in combination with any one, two, three, four, five, six, seven, eight or nine of JEM1, LHS1, SCJ1, KAR2, SIL1, FKB2, ECM10, MDJ1 or MDJ2. [0184] SSA1 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0185] SSA2 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0186] SSA3 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0187] SSA4 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0188] SSE1 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0189] SSE2 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2; [0190] SSB1 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2; or [0191] SSB2 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and/or in combination with ECM10, MDJ1 and MDJ2.

[0192] Alternatively, one of the mitochondrial chaperone and translocation proteins may or may not be simultaneously over-expressed with at least one of the chaperones involved in cytoplasmic folding and maintenance of proteins in a translocation competent state prior to translocation and/or at least one of the ER luminal localised chaperones.

[0193] For example, one of the following combinations may or may not be chosen-- [0194] ECM10 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2; [0195] ECM10 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0196] ECM10 in combination with any of the above-listed combinations of one, two, three of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0197] ECM10 in combination with any of the above-listed combinations of four of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0198] ECM10 in combination with any of the above-listed combinations of five of JEM1, LHS1, SCJ1, KAR2, SILT and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0199] ECM10 in combination with all six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0200] MDJ1 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, --SCJ1, KAR2, SIL1 and FKB2; [0201] MDJ1 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0202] MDJ1 in combination with any of the above-listed combinations of one, two, three of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0203] MDJ1 in combination with any of the above-listed combinations of four of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0204] MDJ1 in combination with any of the above-listed combinations of five of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0205] MDJ1 in combination with all six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0206] MDJ2 in combination with any of the above-listed combinations of one, two, three, four, five or six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2; [0207] MDJ2 in combination with any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0208] MDJ2 in combination with any of the above-listed combinations of one, two, three of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0209] MDJ2 in combination with any of the above-listed combinations of four of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; [0210] MDJ2 in combination with any of the above-listed combinations of five of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2; or [0211] MDJ2 in combination with all six of JEM1, LHS1, SCJ1, KAR2, SIL1 and FKB2 and any of the above-listed combinations of one, two, three, four, five, six, seven or eight of SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2.

[0212] In another embodiment, representative members of each of the above three groups of chaperone proteins (such as one member of each group) may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

JEM1, SSA1 and ERM10; JEM1, SSA1 and MDJ1; JEM1, SSA1 and MDJ2; JEM1, SSA2 and ERM10; JEM1, SSA2 and MDJ1; JEM1, SSA2 and MDJ2; JEM1, SSA3 and ERM10; JEM1, SSA3 and MDJ1; JEM1, SSA3 and MDJ2; JEM1, SSA4 and ERM10; JEM1, SSA4 and MDJ1; JEM1, SSA4 and MDJ2; JEM1, SSE1 and ERM10; JEM1, SSE1 and MDJ1; JEM1, SSE1 and MDJ2; JEM1, SSE2 and ERM10; JEM1, SSE2 and MDJ1; JEM1, SSE2 and MDJ2; JEM1, SSB1 and ERM10; JEM1, SSB1 and MDJ1; JEM1, SSB1 and MDJ2; JEM1, SSB2 and ERM10; JEM1, SSB2 and MDJ1; JEM1, SSB2 and MDJ2; LHS1, SSA1 and ERM10; LHS1, SSA1 and MDJ1; LHS1, SSA1 and MDJ2; LHS1, SSA2 and ERM10; LHS1, SSA2 and MDJ1; LHS1, SSA2 and MDJ2; LHS1, SSA3 and ERM10; LHS1, SSA3 and MDJ1 LHS1, SSA3 and MDJ2; LHS1, SSA4 and ERM10; LHS1, SSA4 and MDJ1; LHS1, SSA4 and MDJ2; LHS1, SSE1 and ERM10; LHS1, SSE1 and MDJ1; LHS1, SSE1 and MDJ2; LHS1, SSE2 and ERM10; LHS1, SSE2 and MDJ1; LHS1, SSE2 and MDJ2; LHS1, SSB1 and ERM10; LHS1, SSB1 and MDJ1; LHS1, SSB1 and MDJ2; LHS1, SSB2 and ERM10; LHS1, SSB2 and MDJ1; LHS1, SSB2 and MDJ2; SCJ1, SSA1 and ERM10; SCJ1, SSA1 and MDJ1; SCJ1, SSA1 and MDJ2; SCJ1, SSA2 and ERM10; SCJ1, SSA2 and MDJ1; SCJ1, SSA2 and MDJ2; SCJ1, SSA3 and ERM10; SCJ1, SSA3 and MDJ1; SCJ1, SSA3 and MDJ2; SCJ1, SSA4 and ERM10; SCJ1, SSA4 and MDJ1; SCJ1, SSA4 and MDJ2; SCJ1, SSE1 and ERM10; SCJ1, SSE1 and MDJ1; SCJ1, SSE1 and MDJ2; SCJ1, SSE2 and ERM10; SCJ1, SSE2 and MDJ1; SCJ1, SSE2 and MDJ2; SCJ1, SSB1 and ERM10; SCJ1, SSB1 and MDJ1; SCJ1, SSB1 and MDJ2; SCJ1, SSB2 and ERM10; SCJ1, SSB2 and MDJ1; SCJ1, SSB2 and MDJ2; KAR2, SSA1 and ERM10; KAR2, SSA1 and MDJ1; KAR2, SSA1 and MDJ2; KAR2, SSA2 and ERM10; KAR2, SSA2 and MDJ1; KAR2, SSA2 and MDJ2; KAR2, SSA3 and ERM10; KAR2, SSA3 and MDJ1; KAR2, SSA3 and MDJ2; KAR2, SSA4 and ERM10; KAR2, SSA4 and MDJ1; KAR2, SSA4 and MDJ2; KAR2, SSE1 and ERM10; KAR2, SSE1 and MDJ1; KAR2, SSE1 and MDJ2; KAR2, SSE2 and ERM10; KAR2, SSE2 and MDJ1; KAR2, SSE2 and MDJ2; KAR2, SSB1 and ERM10; KAR2, SSB1 and MDJ1; KAR2, SSB1 and MDJ2; KAR2, SSB2 and ERM10; KAR2, SSB2 and MDJ1; KAR2, SSB2 and MDJ2; SIL1 SSA1 and ERM10; SIL1 SSA1 and MDJ1; SIL1 SSA1 and MDJ2; SSA2 and ERM10; SIL1 SSA2 and MDJ1; SIL1 SSA2 and MDJ2; SIL1, SSA3 and ERM10; SIL1 SSA3 and MDJ1; SIL1 SSA3 and MDJ2; SIL1 SSA4 and ERM10; SIL1 SSA4 and MDJ1; SIL1 SSA4 and MDJ2; SIL1, SSE1 and ERM10; SIL1, SSE1 and MDJ1; SIL1, SSE1 and MDJ2; SIL1, SSE2 and ERM10; SIL1, SSE2 and MDJ1; SIL1, SSE2 and MDJ2; SIL1, SSB1 and ERM10; SIL1, SSB1 and MDJ1; SIL1, SSB1 and MDJ2; SIL1, SSB2 and ERM10; SIL1, SSB2 and MDJ1; SIL1, SSB2 and MDJ2; FKB2, SSA1 and ERM10; FKB2, SSA1 and MDJ1; FKB2, SSA1 and MDJ2; FKB2, SSA2 and ERM10; FKB2, SSA2 and MDJ1; FKB2, SSA2 and MDJ2; FKB2, SSA3 and ERM10; FKB2, SSA3 and MDJ1; FKB2, SSA3 and MDJ2; FKB2, SSA4 and ERM10; FKB2, SSA4 and MDJ1; FKB2, SSA4 and MDJ2; FKB2, SSE1 and ERM10; FKB2, SSE1 and MDJ1; FKB2, SSE1 and MDJ2; FKB2, SSE2 and ERM10; FKB2, SSE2 and MDJ1; FKB2, SSE2 and MDJ2; FKB2, SSB1 and ERM10; FKB2, SSB1 and MDJ1; FKB2, SSB1 and MDJ2; FKB2, SSB2 and ERM10; FKB2, SSB2 and MDJ1; or FKB2, SSB2 and MDJ2.

[0213] The skilled person will also appreciate that any of the above defined combinations may or may not also be combined with any of the following genes or combinations of genes encoding other helper proteins, in particular helper proteins involved in disulphide bond formation or helper proteins involved in protein degradation, as discussed below.

Proteins Involved in Disulphide Bond Formation

[0214] Proteins involved in the formation of disulphide bonds in other proteins include ERO1, ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1. A detailed description of these proteins and their genes is given separately below.

[0215] In one embodiment, one of the above disulphide bond formation proteins may or may not be over-expressed in the host cell. For example, ERV2 may or may not be chosen.

[0216] In another embodiment, two of the above disulphide bond formation proteins may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen-- [0217] ERO1 in combination with one of ERV2, EUG1, MPD1, MPD2, EPS1 or PDI1; [0218] ERV2 in combination with one of EUG1, MPD1, MPD2, EPS1 or PDI1; [0219] EUG1 in combination with one of MPD1, MPD2, EPS1 or PDI1; [0220] MPD1 in combination with one of MPD2, EPS1 or PDI1; [0221] MPD2 in combination with one of EPS1 or PDI1; or [0222] EPS1 in combination with PDI1.

[0223] In another embodiment, three of the above helper proteins may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

ERO1, ERV2 and EUG1; ERO1, ERV2 and MPD1; ERO1, ERV2 and MPD2; ERO1, ERV2 and EPS1; ERO1, ERV2 and PDI1; ERO1, EUG1 and MPD1; ERO1, EUG1 and MPD2; ERO1, EUG1 and EPS1; ERO1, EUG1 and PDI1; ERO1, MPD1 and MPD2; ERO1, MPD1 and EPS1; ERO1, MPD1 and PDI1; ERO1, MPD2 and EPS1; ERO1, MPD2 and PDI1; ERO1, EPS1 and PDI1; ERV2, EUG1 and MPD1; ERV2, EUG1 and MPD2; ERV2, EUG1 and EPS1; ERV2, EUG1 and PDI1; ERV2, MPD1 and MPD2; ERV2, MPD1 and EPS1; ERV2, MPD1 and PDI1; ERV2, MPD2 and EPS1; ERV2, MPD2 and PDI1; ERV2, EPS1 and PDI1; EUG1, MPD1 and MPD2; EUG1, MPD1 and EPS1; EUG1, MPD1 and PDI1; EUG1, MPD2 and EPS1; EUG1, MPD2 and PDI1; EUG1, EPS1 and PDI1; MPD1, MPD2 and EPS1; MPD1, MPD2 and PDI1; MPD1, EPS1 and PDI1; or MPD2; EPS1 and PDI1.

[0224] In another embodiment, four of the above helper proteins may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

ERO1, ERV2, EUG1 and MPD1; ERO1, ERV2, EUG1 and MPD2; ERO1, ERV2, EUG1 and EPS1; ERO1, ERV2, EUG1 and PDI1; ERO1, ERV2, MPD1 and MPD2; ERO1, ERV2, MPD1 and EPS1; ERO1, ERV2, MPD1 and PDI1; ERO1, ERV2, MPD2 and EPS1; ERO1, ERV2, MPD2 and PDI1; ERO1, ERV2, EPS1 and PDI1; ERO1, EUG1, MPD1 and MPD2; ERO1, EUG1, MPD1 and EPS1; ERO1, EUG1, MPD1 and PDI1; ERO1, EUG1, MPD2 and EPS1; ERO1, EUG1, MPD2 and PDI1; ERO1, EUG1, EPS1 and PDI1; ERO1, MPD1, MPD2 and EPS1; ERO1, MPD1, MPD2 and PDI1; ERO1, MPD1, EPS1 and PDI1; ERO1, MPD2, EPS1 and PDI1; ERV2, EUG1, MPD1 and MPD2; ERV2, EUG1, MPD1 and EPS1; ERV2, EUG1, MPD1 and PDI1; ERV2, EUG1, MPD2 and EPS1; ERV2, EUG1, MPD2 and PDI1; ERV2, EUG1, EPS1 and PDI1; ERV2, MPD1, MPD2 and EPS1; ERV2, MPD1, MPD2 and PDI1; ERV2, MPD1, EPS1 and PDI1; ERV2, MPD2, EPS1 and PDI1; EUG1, MPD1, MPD2 and EPS1; EUG1, MPD1, MPD2 and PDI1; EUG1, MPD1, EPS1 and PDI1; EUG1, MPD2, EPS1 and PDI1; or MPD1, MPD2, EPS1 and PDI1.

[0225] In another embodiment, five of the above helper proteins may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

ERO1, ERV2, EUG1, MPD1 and MPD2; ERO1, ERV2, EUG1, MPD1 and EPS1; ERO1, ERV2, EUG1, MPD1 and PDI1; ERO1, ERV2, EUG1, MPD2 and EPS1; ERO1, ERV2, EUG1, MPD2 and PDI1; ERO1, ERV2, EUG1, EPS1 and PDI1; ERO1, ERV2, MPD1, MPD2 and EPS1; ERO1, ERV2, MPD1, MPD2 and PDI1; ERO1, ERV2, MPD1, EPS1 and PDI1; ERO1, ERV2, MPD2, EPS1 and PDI1; ERO1, EUG1, MPD1, MPD2 and EPS1; ERO1, EUG1, MPD1, MPD2 and PDI1; ERO1, EUG1, MPD1, EPS1 and PDI1; ERO1, EUG1, MPD2, EPS1 and PDI1; ERO1, MPD1, MPD2, EPS1 and PDI1; ERV2, EUG1, MPD1, MPD2 and EPS1; ERV2, EUG1, MPD1, MPD2 and PDI1; ERV2, EUG1, MPD1, EPS1 and PDI1; ERV2, EUG1, MPD2, EPS1 and PDI1; ERV2, MPD1, MPD2, EPS1 and PDI1; or EUG1, MPD1, MPD2, EPS1 and PDI1

[0226] In another embodiment, six of the above helper proteins may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

ERO1, ERV2, EUG1, MPD1, MPD2 and EPS1; ERO1, ERV2, EUG1, MPD1, MPD2 and PDI1; ERO1, ERV2, EUG1, MPD1, EPS1 and PDI1; ERO1, ERV2, EUG1, MPD2, EPS1 and PDI1; ERO1, ERV2, MPD1, MPD2, EPS1 and PDI1; ERO1, EUG1, MPD1, MPD2, EPS1 and PDI1; or ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1.

[0227] It is anticipated that ERO1 and ERV2 may function independently of each other or they may co-operate. Therefore, in one embodiment disclosure of ERO1 may or may not also include the combinations of ERO1 and ERV2, or ERV2 in its place. Similarly, in another embodiment disclosure of ERV2 may or may not also include the combinations of ERV2 and ERO1, or ERO1 in its place.

[0228] In another embodiment, all seven of the above helper proteins may or may not be simultaneously over-expressed in the host cell. In that case, the following combinations may or may not be chosen--

ERO1, ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1.

[0229] Where the host cell is genetically modified to cause simultaneous over-expression of one or two of the above defined disulphide bond formation helper proteins, it may or may not be preferred that the host cell is genetically modified to cause simultaneous over-expression of at least three helper proteins and the one or two other helper proteins may or may not be chaperones or helper proteins involved in protein degradation, as discussed above, and below, respectively.

[0230] Where one of the helper proteins is a protein disulphide isomerase, such as a yeast and mammalian PDI, mammalian Erp59, mammalian prolyl-4-hydroxylase B-subunit, yeast GSBP, yeast EUG1 and mammalian T3BP, then it may or may not be preferred, in one embodiment, to avoid co-expression with KAR2 or an equivalent thereof including hsp chaperone proteins such as other yeast Hsp70 proteins, BiP, SSA1-4, SSB1, SSC1 and SSD1 gene products and eukaryotic hsp70 proteins such as HSP68, HSP72, HSP73, HSC70, clathrin uncoating ATPase, IgG heavy chain binding protein (BiP), glucose-regulated proteins 75, 78 and 80 (GRP75, GPR78 and GRP80) and the like, particularly where these are the sole helper proteins that are overexpressed in the host cell.

Proteins Involved in Protein Degradation

[0231] Proteins involved in protein degradation include DER1, DER3, HRD3, UBC7 and DOA4. A detailed description of these proteins and their genes is given separately below.

[0232] In one embodiment, one of the above proteins involved in protein degradation may or may not be over-expressed in the host cell. For example, DER1 may or may not be chosen, DER3 may or may not be chosen, HRD3 may or may not be chosen, UBC7 may or may not be chosen, or DOA4 may or may not be chosen.

[0233] In another embodiment, two of the above proteins involved in protein degradation may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; HRD3 and UBC7; HRD3 and DOA4; or UBC7 and DOA4.

[0234] In another embodiment, three of the above proteins involved in protein degradation may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

DER1, DER3 and HRD3; DER1, DER3 and UBC7; DER1, DER3 and DOA4; DER1, HRD3 and UBC7; DER1, HRD3 and DOA4; DER1, UBC7 and DOA4; DER3, HRD3 and UBC7; DER3, HRD3 and DOA4; DER3, UBC7 and DOA4; or HRD3, UBC7 and DOA4.

[0235] In another embodiment, four of the above proteins involved in protein degradation may or may not be simultaneously over-expressed in the host cell. For example, one of the following combinations may or may not be chosen--

DER1, DER3, HRD3 and UBC7; DER1, DER3, HRD3 and DOA4; DER1, DER3, UBC7 and DOA4; DER1, HRD3, UBC7 and DOA4; or DER3, HRD3, UBC7 and DOA4.

[0236] In another embodiment, all five of the above proteins involved in protein degradation may or may not be simultaneously over-expressed in the host cell. In that case, the following combination is chosen--

DER1, DER3, HRD3, UBC7 and DOA4.

[0237] Where the host cell is genetically modified to cause simultaneous over-expression of one or two of the above defined protein degradation helper proteins, it may or may not be preferred that the host cell is genetically modified to cause simultaneous over-expression of at least three helper proteins in total and the one or two other helper proteins may or may not be chaperones or disulphide bond formation helper proteins, as discussed above.

HAC1 (Encoded by a Spliced or Unspliced Polynucleotide)

[0238] Valkonen et al. 2003 (Applied Environ. Micro., 69, 2065) reported investigations into the possibility to obtain better yields of secreted proteins. The authors found that the manipulation of the unfolded-protein response (UPR) pathway regulator, HAC1, affected the production of both native and foreign proteins in the yeast Saccharomyces cerevisiae. For example, it is reported that constitutive over-expression of HAC1 caused a 70% increase in alpha-amylase secretion. WO 01/72783 also reports that. HAC1 overexpression can be used to increase the secretion of a heterologous protein in a eukaryotic cell by inducing an elevated UPR, and PTC2 and IRE1 are also suggested for use in place of HAC1.

[0239] Over-expression of HAC1 can be achieved, for example, by the introduction of a recombinant polynucleotide that comprises the endogenous. HAC1 gene coding sequence or a truncated intronless HAC1 coding sequence (Valkonen et al. 2003, Applied Environ. Micro., 69, 2065). A detailed description of this protein and its gene is given separately below. The same techniques can be used to over-express PTC2 or IRE1.

[0240] In one embodiment of the present invention, a host cell of the present invention may or may not be genetically engineered to cause over-expression HAC1, PTC2 or IRE1, such as by modification of an endogenous gene encoding HAC1, PTC2 or IRE1, or by transformation with a recombinant gene encoding HAC1, PTC2 or IRE1. For example HAC1, PTC2 or IRE1 may or may not be simultaneously over-expressed with any of the above-defined combinations of other helper proteins.

[0241] In one embodiment, the host cell of the present invention is not genetically engineered to cause HAC1 over-expression, such as by modification of an endogenous HAC1 gene or transformation with a recombinant HAC1 gene.

[0242] In another embodiment where the host cell is genetically engineered to cause over-expression of HAC1, PTC2 or IRE1, the host cell is additionally genetically modified by the introduction of at least one recombinant gene encoding at least one other helper protein, such as a DnaJ-like protein, an Hsp70 family protein and/or SIL1 or by the modification of the sequence of an endogenous gene encoding one or more other helper proteins at least one of a DnaJ-like protein, an Hsp70 family protein (such as LHS1) and SIL1 to cause increased expression of the thus modified gene.

Other Combinations

[0243] In light of the above disclosure, the skilled person will appreciate that the present invention also encompasses simultaneous over-expression of any combination of helper proteins derived from any of the above-defined groups.

[0244] For example, two helper proteins may or may not be simultaneously over-expressed. Suitable combinations include any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PIM and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; DOA4 and HAC1.

[0245] The skilled person will also appreciate that the present invention encompasses simultaneous over-expression of at least three helper proteins, and that the at least three helper proteins may or may not be taken from any combination of helper proteins derived from any of the above-defined groups.

[0246] For example, one of the following combinations of three helper proteins may or may not be simultaneously over-expressed, with or without the over-expression of one or more additional helper proteins:

[0247] JEM1 in combination with any one of the following combinations: LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; KU and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1, FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1, and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0248] LHS1 in combination with any one of the following combinations: JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1, and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0249] SCJ1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1, and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; HU and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0250] KAR2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SEM and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0251] SIL1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10, and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0252] FKB2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and SSA1; SILT and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MIDI; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2- and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0253] SSA1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA2; SIL1 and SSA3; SEM and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 acid SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0254] SSA2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; Sad and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0255] SSA3 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCH and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCH and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SILT and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0256] SSA4 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; KU and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS I and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0257] SSE1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS-1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0258] SSE2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; Sail and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0259] SSB1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0260] SSB2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SILT and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0261] ECM10 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; EMI and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEW and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SID; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SILT and SSB1; SIL1 and SSB2; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0262] MDJ1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSE2; KAR2 and ECM10; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0263] MDJ2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3'; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0264] ERO1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and, SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; Slid and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 MDJ2; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0265] ERV2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and MeI; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0266] EUG1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0267] MPD1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEW and ERV2; JEM1 and EUG1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SEM and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0268] MPD2 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and MIA; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0269] EPS1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAM; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0270] PDI1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2, and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0271] DER1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0272] DER3 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1, SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; HRD3 and UBC7; HRD3 and DOA4; HRD3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0273] HRD3 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and UBC7; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and UBC7; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and UBC7; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and UBC7; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SEM and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and UBC7; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and UBC7; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; to SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and UBC7; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and UBC7; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and UBC7; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and UBC7; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and UBC7; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and UBC7; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and UBC7; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and UBC7; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and UBC7; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and UBC7; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and UBC7; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and UBC7; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and UBC7; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and UBC7; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and UBC7; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and UBC7; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and UBC7; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and UBC7; DER1 and DOA4; DER1 and HAC1; DER3 and UBC7; DER3 and DOA4; DER3 and HAC1; UBC7 and DOA4; UBC7 and HAC1; or DOA4 and HAC1.

[0274] UBC7 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and DOA4; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and DOA4; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and DOA4; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and DOA4; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and DOA4; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and DOA4; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and DOA4; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and DOA4; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and DOA4; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and DOA4; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and DOA4; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and DOA4; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and DOA4; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and DOA4; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and DOA4; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and DOA4; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and DOA4; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and DOA4; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and DOA4; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and DOA4; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and DOA4; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and DOA4; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and DOA4; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and DOA4; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and DOA4; DER1 and HAC1; DER3 and HRD3; DER3 and DOA4; DER3 and HAC1; HRD3 and DOA4; HRD3 and HAC1; or DOA4 and HAC1.

[0275] DOA4 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SIL1; JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and HAC1; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1; LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and HAC1; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and HAC1; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and HAC1; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and HAC1; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and HAC1; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and HAC1; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and HAC1; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and HAC1; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and HAC1; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and HAC1; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and HAC1; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and HAC1; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and HAC1; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and HAC1; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and HAC1; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and HAC1; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and HAC1; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and HAC1; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and HAC1; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and HAC1; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and HAC1; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and HAC1; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and HAC1; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and HAC1; DER3 and HRD3; DER3 and UBC7; DER3 and HAC1; HRD3 and UBC7; HRD3 and HAC1; or UBC7 and HAC1.

[0276] HAC1 in combination with any one of the following combinations: JEM1 and LHS1; JEM1 and SCJ1; JEM1 and KAR2; JEM1 and SELL JEM1 and FKB2; JEM1 and SSA1; JEM1 and SSA2; JEM1 and SSA3; JEM1 and SSA4; JEM1 and SSE1; JEM1 and SSE2; JEM1 and SSB1; JEM1 and SSB2; JEM1 and ECM10; JEM1 and MDJ1; JEM1 and MDJ2; JEM1 and ERO1; JEM1 and ERV2; JEM1 and EUG1; JEM1 and MPD1; JEM1 and MPD2; JEM1 and EPS1; JEM1 and PDI1; JEM1 and DER1; JEM1 and DER3; JEM1 and HRD3; JEM1 and UBC7; JEM1 and DOA4; LHS1 and SCJ1; LHS1 and KAR2; LHS1 and SIL1 LHS1 and FKB2; LHS1 and SSA1; LHS1 and SSA2; LHS1 and SSA3; LHS1 and SSA4; LHS1 and SSE1; LHS1 and SSE2; LHS1 and SSB1; LHS1 and SSB2; LHS1 and ECM10; LHS1 and MDJ1; LHS1 and MDJ2; LHS1 and ERO1; LHS1 and ERV2; LHS1 and EUG1; LHS1 and MPD1; LHS1 and MPD2; LHS1 and EPS1; LHS1 and PDI1; LHS1 and DER1; LHS1 and DER3; LHS1 and HRD3; LHS1 and UBC7; LHS1 and DOA4; SCJ1 and KAR2; SCJ1 and SIL1; SCJ1 and FKB2; SCJ1 and SSA1; SCJ1 and SSA2; SCJ1 and SSA3; SCJ1 and SSA4; SCJ1 and SSE1; SCJ1 and SSE2; SCJ1 and SSB1; SCJ1 and SSB2; SCJ1 and ECM10; SCJ1 and MDJ1; SCJ1 and MDJ2; SCJ1 and ERO1; SCJ1 and ERV2; SCJ1 and EUG1; SCJ1 and MPD1; SCJ1 and MPD2; SCJ1 and EPS1; SCJ1 and PDI1; SCJ1 and DER1; SCJ1 and DER3; SCJ1 and HRD3; SCJ1 and UBC7; SCJ1 and DOA4; KAR2 and SIL1; KAR2 and FKB2; KAR2 and SSA1; KAR2 and SSA2; KAR2 and SSA3; KAR2 and SSA4; KAR2 and SSE1; KAR2 and SSE2; KAR2 and SSB1; KAR2 and SSB2; KAR2 and ECM10; KAR2 and MDJ1; KAR2 and MDJ2; KAR2 and ERO1; KAR2 and ERV2; KAR2 and EUG1; KAR2 and MPD1; KAR2 and MPD2; KAR2 and EPS1; KAR2 and PDI1; KAR2 and DER1; KAR2 and DER3; KAR2 and HRD3; KAR2 and UBC7; KAR2 and DOA4; SIL1 and FKB2; SIL1 and SSA1; SIL1 and SSA2; SIL1 and SSA3; SIL1 and SSA4; SIL1 and SSE1; SIL1 and SSE2; SIL1 and SSB1; SIL1 and SSB2; SIL1 and ECM10; SIL1 and MDJ1; SIL1 and MDJ2; SIL1 and ERO1; SIL1 and ERV2; SIL1 and EUG1; SIL1 and MPD1; SIL1 and MPD2; SIL1 and EPS1; SIL1 and PDI1; SIL1 and DER1; SIL1 and DER3; SIL1 and HRD3; SIL1 and UBC7; SIL1 and DOA4; FKB2 and SSA1; FKB2 and SSA2; FKB2 and SSA3; FKB2 and SSA4; FKB2 and SSE1; FKB2 and SSE2; FKB2 and SSB1; FKB2 and SSB2; FKB2 and ECM10; FKB2 and MDJ1; FKB2 and MDJ2; FKB2 and ERO1; FKB2 and ERV2; FKB2 and EUG1; FKB2 and MPD1; FKB2 and MPD2; FKB2 and EPS1; FKB2 and PDI1; FKB2 and DER1; FKB2 and DER3; FKB2 and HRD3; FKB2 and UBC7; FKB2 and DOA4; SSA1 and SSA2; SSA1 and SSA3; SSA1 and SSA4; SSA1 and SSE1; SSA1 and SSE2; SSA1 and SSB1; SSA1 and SSB2; SSA1 and ECM10; SSA1 and MDJ1; SSA1 and MDJ2; SSA1 and ERO1; SSA1 and ERV2; SSA1 and EUG1; SSA1 and MPD1; SSA1 and MPD2; SSA1 and EPS1; SSA1 and PDI1; SSA1 and DER1; SSA1 and DER3; SSA1 and HRD3; SSA1 and UBC7; SSA1 and DOA4; SSA2 and SSA3; SSA2 and SSA4; SSA2 and SSE1; SSA2 and SSE2; SSA2 and SSB1; SSA2 and SSB2; SSA2 and ECM10; SSA2 and MDJ1; SSA2 and MDJ2; SSA2 and ERO1; SSA2 and ERV2; SSA2 and EUG1; SSA2 and MPD1; SSA2 and MPD2; SSA2 and EPS1; SSA2 and PDI1; SSA2 and DER1; SSA2 and DER3; SSA2 and HRD3; SSA2 and UBC7; SSA2 and DOA4; SSA3 and SSA4; SSA3 and SSE1; SSA3 and SSE2; SSA3 and SSB1; SSA3 and SSB2; SSA3 and ECM10; SSA3 and MDJ1; SSA3 and MDJ2; SSA3 and ERO1; SSA3 and ERV2; SSA3 and EUG1; SSA3 and MPD1; SSA3 and MPD2; SSA3 and EPS1; SSA3 and PDI1; SSA3 and DER1; SSA3 and DER3; SSA3 and HRD3; SSA3 and UBC7; SSA3 and DOA4; SSA4 and SSE1; SSA4 and SSE2; SSA4 and SSB1; SSA4 and SSB2; SSA4 and ECM10; SSA4 and MDJ1; SSA4 and MDJ2; SSA4 and ERO1; SSA4 and ERV2; SSA4 and EUG1; SSA4 and MPD1; SSA4 and MPD2; SSA4 and EPS1; SSA4 and PDI1; SSA4 and DER1; SSA4 and DER3; SSA4 and HRD3; SSA4 and UBC7; SSA4 and DOA4; SSE1 and SSE2; SSE1 and SSB1; SSE1 and SSB2; SSE1 and ECM10; SSE1 and MDJ1; SSE1 and MDJ2; SSE1 and ERO1; SSE1 and ERV2; SSE1 and EUG1; SSE1 and MPD1; SSE1 and MPD2; SSE1 and EPS1; SSE1 and PDI1; SSE1 and DER1; SSE1 and DER3; SSE1 and HRD3; SSE1 and UBC7; SSE1 and DOA4; SSE2 and SSB1; SSE2 and SSB2; SSE2 and ECM10; SSE2 and MDJ1; SSE2 and MDJ2; SSE2 and ERO1; SSE2 and ERV2; SSE2 and EUG1; SSE2 and MPD1; SSE2 and MPD2; SSE2 and EPS1; SSE2 and PDI1; SSE2 and DER1; SSE2 and DER3; SSE2 and HRD3; SSE2 and UBC7; SSE2 and DOA4; SSB1 and SSB2; SSB1 and ECM10; SSB1 and MDJ1; SSB1 and MDJ2; SSB1 and ERO1; SSB1 and ERV2; SSB1 and EUG1; SSB1 and MPD1; SSB1 and MPD2; SSB1 and EPS1; SSB1 and PDI1; SSB1 and DER1; SSB1 and DER3; SSB1 and HRD3; SSB1 and UBC7; SSB1 and DOA4; SSB2 and ECM10; SSB2 and MDJ1; SSB2 and MDJ2; SSB2 and ERO1; SSB2 and ERV2; SSB2 and EUG1; SSB2 and MPD1; SSB2 and MPD2; SSB2 and EPS1; SSB2 and PDI1; SSB2 and DER1; SSB2 and DER3; SSB2 and HRD3; SSB2 and UBC7; SSB2 and DOA4; ECM10 and MDJ1; ECM10 and MDJ2; ECM10 and ERO1; ECM10 and ERV2; ECM10 and EUG1; ECM10 and MPD1; ECM10 and MPD2; ECM10 and EPS1; ECM10 and PDI1; ECM10 and DER1; ECM10 and DER3; ECM10 and HRD3; ECM10 and UBC7; ECM10 and DOA4; MDJ1 and MDJ2; MDJ1 and ERO1; MDJ1 and ERV2; MDJ1 and EUG1; MDJ1 and MPD1; MDJ1 and MPD2; MDJ1 and EPS1; MDJ1 and PDI1; MDJ1 and DER1; MDJ1 and DER3; MDJ1 and HRD3; MDJ1 and UBC7; MDJ1 and DOA4; MDJ2 and ERO1; MDJ2 and ERV2; MDJ2 and EUG1; MDJ2 and MPD1; MDJ2 and MPD2; MDJ2 and EPS1; MDJ2 and PDI1; MDJ2 and DER1; MDJ2 and DER3; MDJ2 and HRD3; MDJ2 and UBC7; MDJ2 and DOA4; ERO1 and ERV2; ERO1 and EUG1; ERO1 and MPD1; ERO1 and MPD2; ERO1 and EPS1; ERO1 and PDI1; ERO1 and DER1; ERO1 and DER3; ERO1 and HRD3; ERO1 and UBC7; ERO1 and DOA4; ERV2 and EUG1; ERV2 and MPD1; ERV2 and MPD2; ERV2 and EPS1; ERV2 and PDI1; ERV2 and DER1; ERV2 and DER3; ERV2 and HRD3; ERV2 and UBC7; ERV2 and DOA4; EUG1 and MPD1; EUG1 and MPD2; EUG1 and EPS1; EUG1 and PDI1; EUG1 and DER1; EUG1 and DER3; EUG1 and HRD3; EUG1 and UBC7; EUG1 and DOA4; MPD1 and MPD2; MPD1 and EPS1; MPD1 and PDI1; MPD1 and DER1; MPD1 and DER3; MPD1 and HRD3; MPD1 and UBC7; MPD1 and DOA4; MPD2 and EPS1; MPD2 and PDI1; MPD2 and DER1; MPD2 and DER3; MPD2 and HRD3; MPD2 and UBC7; MPD2 and DOA4; EPS1 and PDI1; EPS1 and DER1; EPS1 and DER3; EPS1 and HRD3; EPS1 and UBC7; EPS1 and DOA4; PDI1 and DER1; PDI1 and DER3; PDI1 and HRD3; PDI1 and UBC7; PDI1 and DOA4; DER1 and DER3; DER1 and HRD3; DER1 and UBC7; DER1 and DOA4; DER3 and HRD3; DER3 and UBC7; DER3 and DOA4; HRD3 and UBC7; HRD3 and DOA4; or UBC7 and DOA4.

Protein Product of Choice

[0277] In principle, any protein can be expressed as the protein product of choice.

[0278] As discussed above, the protein product of choice may or may not be a protein that is naturally produced by the host cell, in which case the protein may or may not be encoded by the host cell's endogenous gene for that protein or the protein may or may not be encoded (fully, or in part) by an exogenous polynucleotide sequence.

[0279] Thus, it is possible to produce enhanced levels of naturally produced proteins by transforming the host cell with a polynucleotide encoding a further, or replacement, copy of an endogenous gene, or otherwise genetically modifying the host cell to increase the expression of a naturally produced protein. In one embodiment, a recombinant or genetically modified endogenous gene has a sequence that is different to the endogenous genetic material of the host cell.

[0280] The protein product of choice may or may not be a heterologous protein, by which we mean that the protein is one that is not naturally produced by the host cell. In the case of a heterologous protein product of choice, the protein may or may not be encoded by an exogenous polynucleotide sequence.

[0281] In one embodiment, the protein product of choice is secreted. In that case, a sequence encoding a secretion leader sequence which, for example, comprises most of the natural HSA secretion leader, plus a small portion of the S. cerevisiae .alpha.-mating factor secretion leader as taught in WO 90/01063 may or may not be included in the open reading frame that encodes the protein product of choice.

[0282] Alternatively, the protein product of choice may or may not be intracellular.

[0283] It is known in the prior art that enhanced protein production can be achieved by co-expression of a protein product and a chaperone in different compartments of the cell. For example, WO 2005/061718 (Example 12) describes the co-over-expression of the cytoplasmic chaperone SSA1 and a secreted recombinant transferrin, in order to increase the production of the secreted recombinant transferrin.

[0284] In another preferred embodiment, the protein product of choice comprises the sequence of a eukaryotic protein, or a fragment or variant thereof. Suitable eukaryotes include fungi, plants and animals. In one preferred embodiment the protein product of choice is a fungal protein, such as a yeast protein. In another preferred embodiment the protein product of choice is an animal protein. Exemplary animals include vertebrates and invertebrates. Exemplary vertebrates include mammals, such as humans, and non-human mammals.

[0285] Thus the protein product of choice may or may not comprise the sequence of a yeast protein.

[0286] The protein product of choice may or may not comprise albumin, a monoclonal antibody, an etoposide, a serum protein (such as a blood clotting factor), antistasin, a tick anticoagulant peptide, transferrin, lactoferrin, endostatin, angiostatin, collagens, immunoglobulins or immunoglobulin-based-molecules or fragment of either (e.g. a Small Modular ImmunoPharmaceutical.TM. ("SMTP") or dAb, Fab' fragments, F(ab').sub.2, scAb, scFv or scFv fragment), a Kunitz domain protein (such as aprotinin, amyloid precursor protein and those described in WO 03/066824, with or without albumin fusions), interferons (such as interferon .alpha. species and sub-species, interferon (3 species and sub-species, interferon .gamma. species and sub-species), interleukins (such as IL10, IL11 and IL2), leptin, CNTF and fragment thereof (such as CNTF.sub.Ax15 (Axokine.TM.)), IL1-receptor antagonist, erythropoietin (EPO) and EPO mimics, thrombopoietin (TPO) and TPO mimics, prosaptide, cyanovirin-N, 5-helix, T20 peptide, T1249 peptide, HIV gp41, HIV gp120, urokinase, prourokinase, tPA, hirudin, platelet derived growth factor, parathyroid hormone, proinsulin, insulin, glucagon, glucagon-like peptides, insulin-like growth factor, calcitonin, growth hormone, transforming growth factor .beta., tumour necrosis factor, G-CSF, GM-CSF, M-CSF, FGF, coagulation factors in both pre and active forms, including but not limited to plasminogen, fibrinogen, thrombin, pre-thrombin, pro-thrombin, von Willebrand's factor, .alpha..sub.1-antitrypsin, plasminogen activators, Factor VII, Factor Vac Factor IX, Factor X and Factor Mil, nerve growth factor, LACI, platelet-derived endothelial cell growth factor (PD-ECGF), glucose oxidase, serum cholinesterase, inter-alpha trypsin inhibitor, antithrombin III, apo-lipoprotein species, Protein C, Protein S, or a variant or fragment of any of the above.

[0287] A "variant", in the context of the above-listed proteins, refers to a protein wherein at one or more positions there have been amino acid insertions, deletions, or substitutions, either conservative or non-conservative, provided that such changes result in a protein whose basic properties, for example enzymatic activity or receptor binding (type of and specific activity), thermostability, activity in a certain pH-range (pH-stability) have not significantly been changed. "Significantly" in this context means that one skilled in the art would say that the properties of the variant may still be different but would not be unobvious over the ones of the original protein.

[0288] By "conservative substitutions" is intended combinations such as Val, Ile, Leu, Ala, Met; Asp, Glu; Asn, Gln; Ser, Thr, Gly, Ala; Lys, Arg, His; and Phe, Tyr, Trp. Preferred conservative substitutions include Gly, Ala; Val, Ile, Leu; Asp, Glu; Asn, Gln; Ser, Thr; Lys, Arg; and Phe, Tyr.

[0289] A "variant" typically has at least 25%, at least 50%, at least 60% or at least 70%, preferably at least 80%, more preferably at least 90%, even more preferably at least 95%, yet more preferably at least 99%, most preferably at least 99.5% sequence identity to the polypeptide from which it is derived.

[0290] The percent sequence identity between two polypeptides may be determined using suitable computer programs, for example the GAP program of the University of Wisconsin Genetic Computing Group and it will be appreciated that percent identity is calculated in relation to polypeptides whose sequence has been aligned optimally.

[0291] The alignment may alternatively be carried out using the Clustal W program (Thompson et al., (1994) Nucleic Acids Res., 22(22), 4673-80). The parameters used may be as follows: [0292] Fast pairwise alignment parameters: K-tuple(word) size; 1, window size; 5, gap penalty; 3, number of top diagonals; 5. Scoring method: x percent. [0293] Multiple alignment parameters: gap open penalty; 10, gap extension penalty; 0.05. [0294] Scoring matrix: BLOSUM.

[0295] Such variants may or may not be natural or made using the methods of protein engineering and site-directed mutagenesis as are well known in the art.

[0296] A "fragment", in the context of the above-listed proteins, refers to a protein wherein at one or more positions there have been deletions. Thus the fragment may comprise at most 5, 10, 20, 30, 40 or 50% of the complete sequence of the full mature polypeptide. Typically a fragment comprises up to 60%, more typically up to 70%, preferably up to 80%, more preferably up to 90%, even more preferably up to 95%, yet more preferably up to 99% of the complete sequence of the full desired protein. Particularly preferred fragments of a protein comprise one or more whole domains of the protein.

[0297] In one particularly preferred embodiment the protein product of choice comprises the sequence of albumin or a variant or fragment thereof.

[0298] By "albumin" we include a protein comprising the sequence of an albumin protein obtained from any source. Typically the source is mammalian. In one preferred embodiment the serum albumin is human serum albumin ("HSA"). The term "human serum albumin" includes the meaning of a serum albumin having an amino acid sequence naturally occurring in humans, and variants thereof. Preferably the albumin has the amino acid sequence disclosed in WO 90/13653 or a variant thereof. The HSA coding sequence is obtainable by known methods for isolating cDNA corresponding to human genes, and is also disclosed in, for example, EP 73 646 and EP 286 424.

[0299] In another preferred embodiment the "albumin" comprises the sequence of bovine serum albumin. The term "bovine serum albumin" includes the meaning of a serum albumin having an amino acid sequence naturally occurring in cows, for example as taken from Swissprot accession number P02769, and variants thereof as defined below. The term "bovine serum albumin" also includes the meaning of fragments, of full-length bovine serum albumin or variants thereof, as defined below.

[0300] In another preferred embodiment the albumin comprises the sequence of an albumin derived from one of serum albumin from dog (e.g. see Swissprot accession number P49822), pig (e.g. see Swissprot accession number P08835), goat (e.g. as available from Sigma as product no. A2514 or A4164), turkey (e.g. see Swissprot accession number O73860), baboon (e.g. as available from Sigma as product no. A1516), cat (e.g. see Swissprot accession number P49064), chicken (e.g. see Swissprot accession number P19121), ovalbumin (e.g. chicken ovalbumin) (e.g. see Swissprot accession number P01012), donkey (e.g. see Swissprot accession number P39090), guinea pig (e.g. as available from Sigma as product no. A3060, A2639, O5483 or A6539), hamster (e.g. as available from Sigma as product no. A5409), horse (e.g. see Swissprot accession number P35747), rhesus monkey (e.g. see Swissprot accession number Q28522), mouse (e.g. see Swissprot accession number O89020), pigeon (e.g. as defined by Khan et al, 2002, Int. J. Biol. Macromol., 30(3-4)371-8), rabbit (e.g. see Swissprot accession number P49065), rat (e.g. see Swissprot accession number P36953) and sheep (e.g. see Swissprot accession number P14639) and includes variants and fragments thereof as defined below.

[0301] Many naturally occurring mutant forms of albumin are known. Many are described in Peters, (1996, All About Albumin: Biochemistry, Genetics and Medical Applications, Academic Press, Inc., San Diego, Calif., p. 170-181). A variant as defined above may or may not be one of these naturally occurring mutants.

[0302] A "variant albumin" refers to an albumin protein wherein at one or more positions there have been amino acid insertions, deletions, or substitutions, either conservative or non-conservative, provided that such changes result in an albumin protein for which at least one basic property, for example binding activity (type of and specific activity e.g. binding to bilirubin), osmolarity (oncotic pressure, colloid osmotic pressure), behaviour in a certain pH-range (pH-stability) has not significantly been changed. "Significantly" in this context means that one skilled in the art would say that the properties of the variant may still be different but would not be unobvious over the ones of the original protein.

[0303] By "conservative substitutions" is intended combinations such as Gly, Ala; Val, Ile, Leu; Asp, Glu; Asn, Gln; Ser, Thr, Lys, Arg; and Phe, Tyr. Such variants may be made by techniques well known in the art, such as by site-directed mutagenesis as disclosed in U.S. Pat. No. 4,302,386 issued 24 Nov. 1981 to Stevens, incorporated herein by reference.

[0304] Typically an albumin variant will have more than 40%, usually at least 50%, more typically at least 60%, preferably at least 70%, more preferably at least 80%, yet more preferably at least 90%, even more preferably at least 95%, most preferably at least 98% or more sequence identity with naturally occurring albumin. The percent sequence identity between two polypeptides may be determined using suitable computer programs, for example the GAP program of the University of Wisconsin Genetic Computing Group and it will, be appreciated that percent identity is calculated in relation to polypeptides whose sequence has been aligned optimally. The alignment may alternatively be carried out using the Clustal W program (Thompson et al., 1994). The parameters used may be as follows:

[0305] Fast pairwise alignment parameters: K-tuple(word) size; 1, window size; 5, gap penalty; 3, number of top diagonals; 5. Scoring method: x percent. Multiple alignment parameters: gap open penalty; 10, gap extension penalty; 0.05. Scoring matrix: BLOSUM.

[0306] The term "fragment" as used above includes any fragment of full-length albumin or a variant thereof, so long as at least one basic property, for example binding activity (type of and specific activity e.g. binding to bilirubin), osmolarity (oncotic pressure, colloid osmotic pressure), behaviour in a certain pH-range (pH-stability) has not significantly been changed. "Significantly" in this context means that one skilled in the art would say that the properties of the variant may still be different but would not be unobvious over the ones of the original protein. A fragment will typically be at least 50 amino acids long. A fragment may or may not comprise at least one whole sub-domain of albumin Domains of HSA have been expressed as recombinant proteins (Dockal, M. et al., 1999, J. Biol. Chem., 274, 29303-29310), where domain I was defined as consisting of amino acids 1-197, domain II was defined as consisting of amino acids 189-385 and domain III was defined as consisting of amino acids 381-585. Partial overlap of the domains occurs because of the extended .alpha.-helix structure (h10-h1) which exists between domains I and II, and between domains II and III (Peters, 1996, op. cit., Table 2-4). HSA also comprises six sub-domains (sub-domains IA, IB, IIA, IIB, IIIA and IIIB). Sub-domain IA comprises amino acids 6-105, sub-domain IB comprises amino acids 120-177, sub-domain IIA comprises amino acids 200-291, sub-domain IIB comprises amino acids 316-369, sub-domain IIIA comprises amino acids 392-491 and sub-domain IIIB comprises amino acids 512-583. A fragment may or may not comprise a whole or part of one or more domains or sub-domains as defined above, or any combination of those domains and/or sub-domains.

[0307] In another particularly preferred embodiment the protein product of choice comprises the sequence of transferrin or a variant or fragment thereof. The term "transferrin" as used herein includes all members of the transferrin family (Testa, Proteins of iron metabolism, CRC Press, 2002; Harris & Aisen, Iron carriers and iron proteins, Vol. 5, Physical Bioinorganic Chemistry, VCH, 1991) and their derivatives, such as transferrin, mutant transferrins (Mason et al, 1993, Biochemistry, 32, 5472; Mason et al, 1998, Biochem. J., 330(1), 35), truncated transferrins, transferrin lobes (Mason et al, 1996, Protein Expr. Purif., 8, 119; Mason et al, 1991, Protein Expr. Purif., 2, 214), lactoferrin, mutant lactoferrins, truncated lactoferrins, lactoferrin lobes or fusions of any of the above to other peptides, polypeptides or proteins (Shin et al, 1995, Proc. Natl. Acad Sci. USA, 92, 2820; Ali et al, 1999, J. Biol. Chem., 274, 24066; Mason et al, 2002, Biochemistry, 41, 9448).

[0308] The transferrin may or may not be human transferrin. The term "human transferrin" is used herein to denote material which is indistinguishable from transferrin derived from a human or which is a variant or fragment thereof. A "variant" includes insertions, deletions and substitutions, either conservative or non-conservative, where such changes do not substantially alter the useful ligand-binding or immunogenic properties of transferrin.

[0309] Mutants of transferrin are included in the invention. Such mutants may or may not have altered immunogenicity. For example, transferrin mutants may or may not display modified (e.g. reduced) glycosylation. The N-linked glycosylation pattern of a transferrin molecule can be modified by adding/removing amino acid glycosylation consensus sequences such as N-X-S/T, at any or all of the N, X, or S/T position. Transferrin mutants may or may not be altered in their natural binding to metal ions and/or other proteins, such as transferrin receptor. An example of a transferrin mutant modified in this manner is exemplified below.

[0310] We also include naturally-occurring polymorphic variants of human transferrin or human transferrin analogues. Generally, variants or fragments of human transferrin will have at least 5%, 10%, 15%, 20%, 30%, 40% or 50% (preferably at least 80%, 90% or 95%) of human transferrin's ligand binding activity (for example iron-binding), weight for weight. The iron binding activity of transferrin or a test sample can be determined spectrophotometrically by 470 nm:280 nm absorbance ratios for the proteins in their iron-free and fully iron-loaded states. Reagents should be iron-free unless stated otherwise. Iron can be removed from transferrin or the test sample by dialysis against 0.1M citrate, 0.1M acetate, 10 mM EDTA pH4.5. Protein should be at approximately 20 mg/mL in 100 mM HEPES, 10 mM NaHCO.sub.3 pH8.0. Measure the 470 nm:280 nm absorbance ratio of apo-transferrin (Calbiochem, CN Biosciences, Nottingham, UK) diluted in water so that absorbance at 280 nm can be accurately determined spectrophotometrically (0% iron binding). Prepare 20 mM iron-nitrilotriacetate (FeNTA) solution by dissolving 191 mg nitrotriacetic acid in 2 mT, 1M NaOH, then add 2 mL 0.5M ferric chloride. Dilute to 50 mL with deionised water. Fully load apo-transferrin with iron (100% iron binding) by adding a sufficient excess of freshly prepared 20 mM FeNTA, then dialyse the holo-transferrin preparation completely against 100 mM HEPES, 10 mM NaHCO.sub.3 pH8.0 to remove remaining FeNTA before measuring the absorbance ratio at 470 nm:280 nm. Repeat the procedure using test sample, which should initially be free from iron, and compare final ratios to the control. Additionally, single or multiple heterologous fusions comprising any of the above; or single or multiple heterologous fusions to albumin, transferrin or immunoglobulins or a variant or fragment of any of these may be used. Such fusions include albumin N-terminal fusions, albumin C-terminal fusions and co-N-terminal and C-terminal albumin fusions as exemplified by WO 01/79271, and transferrin N-terminal fusions, transferrin C-terminal fusions, and co-N-terminal and C-terminal transferrin fusions.

[0311] Examples of transferrin fusions are given in US patent applications US2003/0221201 and US2003/0226155, Shin, et al., 1995, Proc Natl Acad Sci USA, 92, 2820, Ali, et al., 1999, J Biol Chem, 274, 24066, Mason, et al., 2002, Biochemistry, 41, 9448, the contents of which are incorporated herein by reference.

[0312] The skilled person will also appreciate that the open reading frame of any other gene or variant, or part or either, can be utilised as an open reading frame for use with the present invention. For example, the open reading frame may encode a protein comprising any sequence, be it a natural protein (including a zymogen), or a variant, or a fragment (which may or may not, for example, be a domain) of a natural protein; or a totally synthetic protein; or a single or multiple fusion of different proteins (natural or synthetic). Such proteins can be taken, but not exclusively, from the lists provided in WO 01/79258, WO 01/79271, WO 01/79442, WO 01/79443, WO 01/79444 and WO 01/79480, or a variant or fragment thereof; the disclosures of which are incorporated herein by reference. Although these patent applications present the list of proteins in the context of fusion partners for albumin, the present invention is not so limited and, for the purposes of the present invention, any of the proteins listed therein may be presented alone or as fusion partners for albumin, the Fc region of immunoglobulin, transferrin, lactoferrin or any other protein or fragment or variant of any of the above, as a desired polypeptide.

[0313] The protein product of choice may or may not be a therapeutically active protein. In other words, it may or may not have a recognised medical effect on individuals, such as humans. Many different types of therapeutically active protein are well known in the art.

[0314] As discussed above, the protein product of choice may or may not comprise a leader sequence effective to cause secretion in the host cell (such as in a yeast host cell).

[0315] Numerous natural or artificial polypeptide signal sequences (also called secretion pre regions) have been used or developed for secreting proteins from host cells. The signal sequence directs the nascent protein towards the machinery of the cell that exports proteins from the cell into the surrounding medium or, in some cases, into the periplasmic space. The signal sequence is usually, although not necessarily, located at the N-terminus of the primary translation product and is generally, although not necessarily, cleaved off the protein during the secretion process, to yield the "mature" protein.

[0316] In the case of some proteins the entity that is initially secreted, after the removal of the signal sequence, includes additional amino acids at its N-terminus called a "pro" sequence, the intermediate entity being called a "pro-protein". These pro sequences may assist the final protein to fold and become functional, and are usually then cleaved off. In other instances, the pro region simply provides a cleavage site for an enzyme to cleave off the pre-pro region and is not known to have another function.

[0317] The pro sequence can be removed either during the secretion of the protein from the cell or after export from the cell into the surrounding medium or periplasmic space.

[0318] Polypeptide sequences which direct the secretion of proteins, whether they resemble signal (i.e. pre) sequences or pre-pro secretion sequences, are referred to as leader sequences. The secretion of proteins is a dynamic process involving translation, translocation and post-translational processing, and one or more of these steps may not necessarily be completed before another is either initiated or completed.

[0319] For production of proteins in eukaryotic species such as the yeasts Saccharomyces cerevisiae, Zygosaccharomyces species, Kluyveromyces lactis and Pichia pastoris, known leader sequences include those from the S. cerevisiae acid phosphatase protein (Pho5p) (see EP 366 400), the invertase protein (Suc2p) (see Smith et al. (1985) Science, 229, 1219-1224) and heat-shock protein-150 (Hsp150p) (see WO 95/33833). Additionally, leader sequences from the S. cerevisiae mating factor alpha-1 protein (MF.alpha.-1) and from the human lysozyme and human serum albumin (HSA) protein have been used, the latter having been used especially, although not exclusively, for secreting human albumin. WO 90/01063 discloses a fusion of the MF.alpha.-1 and HSA leader sequences, which advantageously reduces the production of a contaminating fragment of human albumin relative to the use of the MF.alpha.-1 leader sequence. Modified leader sequences are also disclosed in the examples of this application and the reader will appreciate that those leader sequences can be used with proteins other than transferrin. In addition, the natural transferrin leader sequence may or may not be used to direct secretion of transferrin and other protein products of choice.

[0320] Where a helper protein is a chaperone involved in the formation of disulphide bonds, then in one embodiment the protein product of choice comprises disulphide bonds in its mature form. The disulphide bonds may be intramolecular and/or intermolecular.

[0321] The protein product of choice may or may not be a commercially useful protein. Some heterologously expressed proteins are intended to interact with the cell in which they are expressed in order to bring about a beneficial effect on the cell's activities. These proteins are not, in their own right, commercially useful. Commercially useful proteins are proteins that have a utility ex vivo of the cell in which they are expressed. Nevertheless, the skilled reader will appreciate that a commercially useful protein may or may not also have a biological effect on the host cell expressing it as a protein, but that that effect is not the main or sole reason for expressing the protein therein.

Suitable Host Cells for the Practice of the Present Invention

[0322] The host cell may be any type of cell. The host cell may or may not be an animal (such as mammalian, avian, insect, etc.), plant, fungal or bacterial cell. Bacterial and fungal, such as yeast, host cells may or may not be preferred.

[0323] Thus, the host cell may or may not be an animal (such as mammalian, avian, insect, etc.) cell. Suitable methods for transformation of animal cells are well known in the art and include, for example the use of retrovirus vectors (such as lentivirus vectors). Wolkowicz et al, 2004, Methods Mol. Biol., 246, 391-411 describes the use of lentivirus vectors for delivery of recombinant nucleic acid sequences to mammalian cells for use in cell culture techniques. Fassler, 2004, EMBO Rep., 5(1), 28-9 reviews lentiviral transgene vectors and their use in the production of transgenic systems.

[0324] In one embodiment the host cell is a yeast cell, such as a member of the Saccharomyces, Kluyveromyces, or Pichia genus, such as Saccharomyces cerevisiae, Kluyveromyces lactis, Pichia pastoris and Pichia membranaefaciens, or Zygosaccharomyces rouxii, Zygosaccharomyces bailii, Zygosaccharomyces fermentati, Hansenula polymorpha (also known as Pichia angusta) or Kluyveromyces drosophilarum are preferred.

[0325] It may be particularly advantageous to use a yeast deficient in one or more protein mannosyl transferases involved in O-glycosylation of proteins, for instance by disruption of the gene coding sequence.

[0326] Recombinantly expressed proteins can be subject to undesirable post-translational modifications by the producing host cell. For example, the albumin protein sequence does not contain any sites for N-linked glycosylation and has not been reported to be modified, in nature, by O-linked glycosylation. However, it has been found that recombinant human albumin ("rHA") produced in a number of yeast species can be modified by O-linked glycosylation, generally involving mannose. The mannosylated albumin is able to bind to the lectin Concanavalin A. The amount of mannosylated albumin produced by the yeast can be reduced by using a yeast strain deficient in one or more of the PMT genes (WO 94/04687). The most convenient way of achieving this is to create a yeast which has a defect in its genome such that a reduced level of one of the Pmt proteins is produced. For example, there may or may not be a deletion, insertion or transposition in the coding sequence or the regulatory regions (or in another gene regulating the expression of one of the PMT genes) such that little or no Pmt protein is produced. Alternatively, the yeast could be transformed to produce an anti-Pmt agent, such as an anti-Pmt antibody. Alternatively, the yeast could be cultured in the presence of a compound that inhibits the activity of one of the PMT genes (Duffy et al, "Inhibition of protein mannosyltransferase 1 (PMT1) activity in the pathogenic yeast Candida albicans", International Conference on Molecular Mechanisms of Fungal Cell Wall Biogenesis, 26-31 Aug. 2001, Monte Verita, Switzerland, Poster Abstract P38; the poster abstract may be viewed at http://www.micro.biol.ethz.ch/cellwall/).

[0327] If a yeast other than S. cerevisiae is used, disruption of one or more of the genes equivalent to the PMT genes of S. cerevisiae is also beneficial, e.g. in Pichia pastoris or Kluyveromyces lactis. The sequence of PMT1 (or any other PMT gene) isolated from S. cerevisiae may be used for the identification or disruption of genes encoding similar enzymatic activities in other fungal species. The cloning of the PMT1 homologue of Kluyveromyces lactis is described in WO 94/04687.

[0328] The yeast may or may not also have a deletion of the HSP150 and/or YAP3 genes as taught respectively in WO 95/33833 and WO 95/23857.

[0329] Where one or more of the helper protein(s) and/or protein product of choice are encoded by a plasmid-borne polynucleotide sequence, the host cell type may be selected for compatibility with the plasmid type being used.

[0330] The skilled person will appreciate that any suitable plasmid may be used, such as a centromeric plasmid. The examples provide suitable plasmids (centromeric YCplac33-based vectors) for use to transform yeast host cells of the present invention. Alternatively, any other suitable plasmid may be used, such as a yeast-compatible 2 .mu.m-based plasmid.

[0331] Plasmids obtained from one yeast type can be maintained in other yeast types (Irie et al, 1991, Gene, 108(1), 139-144; Irie et al, 1991, Mol. Gen. Genet., 225(2), 257-265). For example, pSR1 from Zygosaccharomyces rouxii can be maintained in Saccharomyces cerevisiae. In one embodiment the plasmid may or may not be a 2 .mu.m-family plasmid and the host cell will be compatible with the 2 .mu.m-family plasmid used (see below for a full description of the following plasmids). For example, where the plasmid is based on pSR1, pSB3 or pSB4 then a suitable yeast cell is Zygosaccharomyces rouxii; where the plasmid is based on pSB1 or pSB2 then a suitable yeast cell is Zygosaccharomyces bailli; where the plasmid is based on pSM1 then a suitable yeast cell is Zygosaccharomyces fermentati; where the plasmid is based on pKD1 then a suitable yeast cell is Kluyveromyces drosophilarum; where the plasmid is based on pPM1 then a suitable yeast cell is Pichia membranaefaciens; where the plasmid is based on the 2 .mu.m plasmid then a suitable yeast cell is Saccharomyces cerevisiae or Saccharomyces carlsbergensis. Thus, the plasmid may be based on the 2 .mu.m plasmid and the yeast cell may be Saccharomyces cerevisiae. A 2 .mu.m-family plasmid can be said to be "based on" a naturally occurring plasmid if it comprises one, two or preferably three of the genes FLP, REP1 and REP2 having sequences derived from that naturally occurring plasmid.

[0332] A plasmid as defined above, may be introduced into a host through standard techniques. With regard to transformation of prokaryotic host cells, see, for example, Cohen et al (1972) Proc. Natl. Acad. Sci. USA 69, 2110 and Sambrook et al (2001) Molecular Cloning, A Laboratory Manual, 3.sup.rd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. Transformation of yeast cells is described in Sherman et al (1986) Methods In Yeast Genetics, A Laboratory Manual, Cold Spring Harbor, N.Y. The method of Beggs (1978) Nature 275, 104-109 is also useful. Methods for the transformation of S. cerevisiae are taught generally in EP 251 744, EP 258 067 and WO 90/01063, all of which are incorporated herein by reference. With regard to vertebrate cells, reagents useful in transfecting such cells, for example calcium phosphate and DEAF-dextran or liposome formulations, are available from Stratagene Cloning Systems, or Life Technologies Inc., Gaithersburg, Md. 20877, USA.

[0333] Electroporation is also useful for transforming cells and is well known in the art for transforming fungal (including yeast) cell, plant cells, bacterial cells and animal (including vertebrate) cells. Methods for transformation of yeast by electroporation are disclosed in Becker & Guarente (1990) Methods Enzymol. 194, 182.

[0334] Generally, the plasmid will transform not all of the hosts and it will therefore be necessary to select for transformed host cells. Thus, a plasmid may comprise a selectable marker, including but not limited to bacterial selectable marker and/or a yeast selectable marker. A typical bacterial selectable marker is the .beta.-lactamase gene although many others are known in the art. Typical yeast selectable marker include LEU2, TRP1, HIS3, HIS4, URA3, URA5, SFA1, ADE2, MET15, LYS5, LYS2, ILV2, FBA1, PSE1, PDI1 and PGK1. Those skilled in the art will appreciate that any gene whose chromosomal deletion or inactivation results in an unviable host, so called essential genes, can be used as a selective marker if a functional gene is provided on the plasmid, as demonstrated for PGK1 in a pgk1 yeast strain (Piper and Curran, 1990, Curr. Genet. 17, 119). Suitable essential genes can be found within the Stanford Genome Database (SGD), (http:://db.yeastgenome.org). Any essential gene product (e.g. PDI1, PSE1, PGK1 or FBA1) which, when deleted or inactivated, does not result in an auxotrophic (biosynthetic) requirement, can be used as a selectable marker on a plasmid in a host cell that, in the absence of the plasmid, is unable to produce that gene product, to achieve increased plasmid stability without the disadvantage of requiring the cell to be cultured under specific selective conditions. By "auxotrophic (biosynthetic) requirement" we include a deficiency which can be complemented by additions or modifications to the growth medium. Therefore, preferred "essential marker genes" in the context of the present application are those that, when deleted or inactivated in a host cell, result in a deficiency which cannot be complemented by additions or modifications to the growth medium. Additionally, a plasmid may comprise more than one selectable marker.

[0335] One selection technique involves incorporating into the expression vector a DNA sequence marker, with any necessary control elements, that codes for a selectable trait in the transformed cell. These markers include dihydrofolate reductase, G418, neomycin or zeocin resistance for eukaryotic cell culture, and tetracycline, kanamycin, ampicillin (i.e. .beta.-lactamase) or zeocin resistance genes for culturing in E. coli and other bacteria. Zeocin resistance vectors are available from Invitrogen. Alternatively, the gene for such selectable trait can be on another vector, which is used to co-transform the desired host cell.

[0336] Another method of identifying successfully transformed cells involves growing the cells resulting from the introduction of a plasmid, optionally to allow the expression of a recombinant polypeptide (i.e. a polypeptide which is encoded by a polynucleotide sequence on the plasmid and is heterologous to the host cell, in the sense that that polypeptide is not naturally produced by the host). Cells can be harvested and lysed and their DNA or RNA content examined for the presence of the recombinant sequence using a method such as that described by Southern (1975) J. Mol. Biol. 98, 503 or Berent et al (1985) Biotech. 3, 208 or other methods of DNA and RNA analysis common in the art. Alternatively, the presence of a polypeptide in the supernatant of a culture of a transformed cell can be detected using antibodies.

[0337] In addition to directly assaying for the presence of recombinant DNA, successful transformation can be confirmed by well known immunological methods when the recombinant DNA is capable of directing the expression of the protein. For example, cells successfully transformed with an expression vector produce proteins displaying appropriate antigenicity. Samples of cells suspected of being transformed are harvested and assayed for the protein using suitable antibodies.

[0338] Thus, in addition to the transformed host cells themselves, the present invention also contemplates a culture of those cells, preferably a monoclonal (clonally homogeneous) culture, or a culture derived from a monoclonal culture, in a nutrient medium. Alternatively, transformed cells may represent an industrially/commercially or pharmaceutically useful product and can be used without further purification or can be purified from a culture medium and optionally formulated with a carrier or diluent in a manner appropriate to their intended industrial/commercial or pharmaceutical use, and optionally packaged and presented in a manner suitable for that use. For example, whole cells could be immobilised; or used to spray a cell culture directly on to/into a process, crop or other desired target. Similarly; whole cell, such as yeast cells can be used as capsules for a huge variety of applications, such as fragrances, flavours and pharmaceuticals.

[0339] Transformed host cells may be cultured for a sufficient time and under appropriate conditions known to those skilled in the art, and in view of the teachings disclosed herein, to permit the expression of the helper protein(s) and the protein product of choice.

[0340] The culture medium may be non-selective or place a selective pressure on the maintenance of a plasmid.

[0341] The thus produced protein product of choice may be present intracellularly or, if secreted, in the culture medium and/or periplasmic space of the host cell.

[0342] Accordingly, the present invention, also provides a method for producing a protein product of choice, the method comprising:

(a) providing a host cell of the invention comprising a polynucleotide encoding protein product of choice as defined above; and (b) growing the host cell (for example, culturing the host cell in a culture medium); thereby to produce a cell culture or recombinant organism comprising an increased level of the protein product of choice compared to the level of production of the protein product of choice achieved by growing (for example, culturing), under the same conditions, the same host cell that has not been genetically modified to cause over-expression of one or more helper proteins.

[0343] The step of growing the host cell may or may not involve allowing a host cell derived from a multicellular organism to be regrown into a multicellular recombinant organism (such as a plant or animal) and, optionally, producing one or more generations of progeny therefrom.

[0344] The method may or may not further comprise the step of purifying the thus expressed protein product of choice from the cultured host cell, recombinant organism or culture medium.

[0345] The step of "purifying the thus expressed protein product of choice from the cultured host cell, recombinant organism or culture medium" optionally comprises cell immobilisation, cell separation and/or cell breakage, but always comprises at least one other purification step different from the step or steps of cell immobilisation, separation and/or breakage.

[0346] Cell immobilisation techniques, such as encasing the cells using calcium alginate bead, are well known in the art. Similarly, cell separation techniques, such as centrifugation, filtration.(e.g. cross-flow filtration, expanded bed chromatography and the like) are well known in the art. Likewise, methods of cell breakage, including beadmilling, sonication, enzymatic exposure and the like are well known in the art.

[0347] The "at least one other purification step" may be any other step suitable for protein purification known in the art. For example purification techniques for the recovery of recombinantly expressed albumin have been disclosed in: WO 92/04367, removal of matrix-derived dye; EP 464 590, removal of yeast-derived colorants; EP 319 067, alkaline precipitation and subsequent application of the albumin to a lipophilic phase; and WO 96/37515, U.S. Pat. No. 5,728,553 and WO 00/44772, which describe complete purification processes; all of which are incorporated herein by reference.

[0348] Proteins other than albumin may be purified from the culture medium by any technique that has been found to be useful for purifying such proteins.

[0349] Suitable methods include ammonium sulphate or ethanol precipitation, acid or solvent extraction, anion or cation exchange chromatography, phosphocellulose chromatography, hydrophobic interaction chromatography, affinity chromatography, hydroxyapatite chromatography, lectin chromatography, concentration, dilution, pH adjustment, diafiltration, ultrafiltration, high performance liquid chromatography ("HPLC"), reverse phase HPLC, conductivity adjustment and the like.

[0350] In one embodiment, any one or more of the above mentioned techniques may or may not be used to further purifying the thus isolated protein to a commercially or industrially acceptable level of purity. By commercially or industrially acceptable level of purity, we include the provision of the protein at a concentration of at least 10.sup.4 gL.sup.-1, 10.sup.-3 gL.sup.-1, 0.01 gL.sup.-1, 0.02 gL.sup.-1, 0.03 gL.sup.-1, 0.04 gL.sup.-1, 0.05 gL.sup.-1, 0.06 gL.sup.-1, 0.07 gL.sup.-1, 0.08 gL.sup.-1, 0.09 gL.sup.-1, 0.1 gL.sup.-1, 0.2 gL.sup.-1, 0.3 gL.sup.-1, 0.4 gL.sup.-1, 0.5 gL.sup.-1, 0.6 gL.sup.-1, 0.7 gL.sup.-1, 0.8 gL.sup.-1, 0.9 gL.sup.-1, 1 gL.sup.-1, 2 gL.sup.-1, 3 gL.sup.-1, 4 gL.sup.-1, 5 gL.sup.-1, 6 gL.sup.-1, 7 gL.sup.-1, 8 gL.sup.-1, 9 gL.sup.-1, 10 gL.sup.-1, 15 gL.sup.-1, 20 gL.sup.-1, 25 gL.sup.-1, 30 gL.sup.-1, 40 gL.sup.-1, 50 gL.sup.-1, 60 gL.sup.-1, 70 gL.sup.-1, 70 gL.sup.-1, 90 gL.sup.-1, 100 gL.sup.-1, 150 gL.sup.-1, 200 gL.sup.-1, 250 gL.sup.-1, 300 gL.sup.-1, 350 gL.sup.-1, 400 gL.sup.-1, 500 gL.sup.-1, 600 gL.sup.-1, 700 gL.sup.-1, 800 gL.sup.-1, 900 gL.sup.-1, 1000 gL.sup.-1, or more.

[0351] A commercially or industrially acceptable level of purity may be obtained by a relatively crude purification method by which the protein product of choice is put into a form suitable for its intended purpose. A protein preparation that has been purified to a commercially or industrially acceptable level of purity may, in addition to the protein product of choice, also comprise, for example, cell culture components such as host cells or debris derived therefrom. Alternatively, high molecular weight components (such as host cells or debris derived therefrom) may or may not be removed (such as by filtration or centrifugation) to obtain a composition comprising the protein product of choice and, optionally, a functionally acceptable level of low molecular weight contaminants derived from the cell culture process.

[0352] The protein may or may not be purified to achieve a pharmaceutically acceptable level of purity. A protein has a pharmaceutically acceptable level of purity if it is essentially pyrogen free and can be administered in a pharmaceutically efficacious amount without causing medical effects not associated with the activity of the protein.

[0353] The resulting protein may be used for any of its known utilities, which, in the case of albumin, include i.v. administration to patients to treat severe burns, shock and blood loss, supplementing culture media, and as an excipient in formulations of other proteins.

[0354] A method of the present invention may or may not further comprise the step of formulating the purified protein product of choice with a carrier or diluent and optionally presenting the thus formulated protein in a unit dosage form.

[0355] Although it is possible for a therapeutically useful protein obtained by a process of the invention to be administered alone, it is preferable to present it as a pharmaceutical formulation, together with one or more acceptable carriers or diluents. The carrier(s) or diluent(s) must be "acceptable" in the sense of being compatible with the desired protein and not deleterious to the recipients thereof. Typically, the carriers or diluents will be water or saline which will be sterile and pyrogen free.

[0356] Optionally the thus formulated protein will be presented in a unit dosage form, such as in the form of a tablet, capsule, injectable solution or the like.

[0357] Alternatively, a method of the present invention may or may not further comprise the step of lyophilising the thus purified protein product of choice.

Detailed Description of Helper Proteins

[0358] JEM1 is one S. cerevisiae helper protein of interest for the present invention. It is also known as KAR8, and its gene is a non-essential gene located on chromosome X. It is a DnaJ-like chaperone and is thought to be required for nuclear membrane fusion during mating. It localises to the ER membrane and exhibits genetic interactions with Kar2p (described further below). A published protein sequence for the protein Jem1p is as follows:

TABLE-US-00001 MILISGYCLLVYSVILPVLISASKLCDLAELQRLNKNLKVDTESLPKYQWIAGQLEQNCM TADPASENMSDVIQLANQIYYKIGLIQLSNDQHLRAINTFEKIVFNETYKGSFGKLAEKR LQELYVDFGMWDKVHQKDDQYAKYLSLNETIRNKISSKDVSVEEDISELLRITPYDVNVL STHIDVLFHKLAEEIDVSLAAAIILDYETILDKHLASLSIDTRLSIHYVISVLQTFVLNS DASFNIRKCLSIDMDYDKCKKLSLTISKLNKVNPSKRQILDPATYAFENKKFRSWDRIIE FYLKDKKPFITPMKILNKDTNFKNNYFFLEEIIKQLIEDVQLSRPLAKNLFEDPPITDGF VKPKSYYHTDYLVYIDSILCQASSMSPDVKRAKLAAPFCKKSLRHSLTLETWKHYQDAKS EQKPLPETVLSDVWNSNPHLLMYMVNSILNKSRSKPHSQFKKQLYDQINKFFQDNGLSES TNPYVMKNFRLLQKQLQTYKEHKHRNFNQQYFQQQQQQQQHQRHQAPPAAPNYDPKKDYY KILGVSPSASSKEIRKAYLNLTKKYHPDKIKANHNDKQESIHETMSQINEAYETLSDDDK RKEYDLSRSNPRRNTFPQGPRQNNMFKNPGSGFPFGNGFKMNFGL*

[0359] The ORF of the JEM1 gene is 1.938 kbp in size. A published nucleotide coding sequence of JEM1 is as follows, although it will be appreciated that the sequence on be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00002 ATGATACTGATCTCGGGATACTGTCTTTTAGTGTATAGCGTTATTTTGCCAGTACTGATA TCGGCTTCTAAGTTATGTGATTTGGCTGAGTTACAACGATTGAACAAGAATTTAAAAGTA GACACTGAATCCTTGCCAAAATACCAATGGATCGCTGGGCAGTTGGAACAAAACTGCATG ACTGCGGATCCAGCAAGTGAAAATATGTCAGACGTAATTCAACTAGCCAATCAAATATAC TACAAAATTGGGCTGATCCAATTATCCAACGATCAACATCTAAGAGCTATTAACACATTT GAAAAAATCGTTTTTAATGAAACTTACAAAGGTTCTTTTGGGAAGCTGGCGGAAAAGAGG CTACAAGAGCTGTATGTCGATTTTGGGATGTGGGACAAGGTGCATCAGAAGGATGATCAG TATGCGAAATATCTGTCCTTGAATGAAACCATCAGAAACAAAATATCATCCAAAGACGTT TCTGTGGAGGAAGATATTTCTGAGCTGCTACGCATAACGCCGTACGATGTTAACGTCCTC TCCACGCACATCGATGTTCTTTTTCACAAACTAGCTGAAGAAATTGACGTTTCGTTAGCT GCTGCTATCATTTTGGATTACGAAACAATCCTCGACAAGCATTTGGCTAGCTTAAGCATA GATACAAGACTTTCGATTCATTATGTCATATCTGTTTTACAGACCTTTGTACTTAACTCA GATGCGTCGTTCAATATAAGAAAATGCCTTTCCATTGATATGGACTATGATAAATGTAAA AAACTAAGCCTGACTATTTCCAAATTGAACAAGGTGAATCCATCAAAAAGACAGATCCTG GATCCAGCAACATATGCATTTGAGAACAAAAAGTTTAGAAGTTGGGATAGAATTATTGAA TTTTATTTGAAGGATAAGAAGCCATTTATTACACCAATGAAAATTCTTAACAAAGATACA AACTTTAAAAACAACTACTTCTTTTTAGAGGAAATTATCAAACAATTGATAGAAGACGTT CAACTGTCGAGACCTTTGGCAAAAAATTTATTCGAAGATCCCCCAATAACCGATGGTTTT GTCAAACCAAAATCATACTATCATACCGATTATCTAGTATACATTGATTCCATTCTTTGT CAGGCTTCTAGCATGAGTCCGGACGTCAAGAGAGCTAAACTGGCTGCGCCGTTCTGTAAA AAGAGTTTGAGGCATTCACTAACACTAGAAACATGGAAACACTATCAGGATGCTAAGTCC GAGCAAAAACCTTTACCTGAGACGGTATTGAGTGATGTATGGAATTCCAATCCTCATTTG CTGATGTATATGGTAAACTCAATACTTAATAAAAGTAGGTCTAAACCTCATTCACAGTTC AAAAAGCAATTATATGACCAGATAAACAAATTTTTCCAAGATAACGGCCTCTCAGAGTCG ACCAATCCATACGTGATGAAGAACTTCCGATTATTACAGAAACAATTACAAACCTATAAA GAGCATAAACATCGGAATTTCAACCAGCAATATTTCCAACAACAACAACAGCAGCAACAA CACCAACGACATCAAGCACCCCCAGCAGCGCCTAACTACGACCCAAAAAAGGACTATTAT AAAATTCTTGGAGTATCGCCTAGTGCTAGTTCGAAAGAAATAAGGAAAGCATATTTAAAT TTAACCAAAAAATACCACCCAGACAAAATAAAGGCCAACCATAACGACAAACAAGAATCA ATTCACGAAACTATGTCACAAATCAATGAAGCGTACGAAACATTAAGTGATGACGATAAA AGGAAGGAATACGATCTTTCCAGATCAAACCCCCGCCGCAACACTTTTCCTCAGGGGCCT AGGCAAAATAACATGTTCAAAAATCCAGGAAGTGGCTTCCCATTCGGAAATGGCTTTAAA ATGAATTTTGGGCTTTGA

[0360] Further information concerning JEM1 can be seen at the following URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003609.

[0361] It will be appreciated that, by "JEM1", we include fragments or variants thereof having equivalent JEM1-like activity. Such variants may or may not include bacterial DnaJ proteins and/or may or may not include eukaryotic DnaJ type proteins, such as other members of the Hsp40 family. In one embodiment, a variant of JEM1 may not be SCJ1.

[0362] LHS1 is another S. cerevisiae helper protein of interest for the present invention. It is also known as CER1 or SSI1, is encoded by a non-essential gene which is located on chromosome XI. It is thought to be a molecular chaperone of the endoplasmic reticulum lumen, involved in polypeptide translocation and folding. It is a member of the HSP70 family, localizes to the lumen of the ER, and is thought to be regulated by the unfolded protein response pathway.

[0363] A published protein sequence for the protein Lhs1p is as follows:

TABLE-US-00003 MRNVLRLLFLTAFVAIGSLAAVLGVDYGQQNIKAIVVSPQAPLELVLTPEAKRKEISGLS IKRLPGYGKDDPNGIERIYGSAVGSLATRFPQNTLLHLKPLLGKSLEDETTVTLYSKQHP GLEMVSTNRSTIAFLVDNVEYPLEELVAMNVQEIANRANSLLKDRDARTEDFVNKMSFTI PDFFDQHQRKALLDASSITTGIEETYLVSEGMSVAVNFVLKQRQFPPGEQQHYIVYDMGS GSIKASMFSILQPEDTTQPVTIEFEGYGYNPHLGGAKFTMDIGSLIENKFLETHPAIRTD ELHANPKALAKINQAAEKAKLILSANSEASINIESLINDIDFRTSITRQEFEEFIADSLL DIVKPINDAVTKQFGGYGTNLPEINGVILAGGSSRIPIVQDQLIKLVSEEKVLRNVNADE SAVNGVVMRGIKLSNSFKTKPLNVVDRSVNTYSFKLSNESELYDVFTRGSAYPNKTSILT NTTDSIPNNFTIDLFENGKLFETITVNSGAIKNSYSSDKCSSGVAYNITFDLSSDRLFSI QEVNCICQSENDIGNSKQIKNKGSRLAFTSEDVEIKRLSPSERSRLHEHIKLLDKQDKER FQFQENLNVLESNLYDARNLLMDDEVMQNGPKSQVEELSEMVKVYLDWLEDASFDTDPED IVSRIREIGILKKKIELYMDSAKEPLNSQQFKGMLEEGHKLLQAIETHKNTVEEFLSQFE TEFADTIDNVREEFKKIKQPAYVSKALSTWEETLTSFKNSISEIEKFLAKNLFGEDLREH LFEIKLQFDMYRTKLEEKLRLIKSGDESRLNEIKKLHLRNFRLQKRKEEKLKRKLEQEKS RNNNETESTVINSADDKTTIVNDKTTESNPSSEEDILHDEL*

[0364] The ORF of the LHS1 gene is 2.646 kbp in size. A published nucleotide coding sequence of LHS1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00004 ATGCGAAACGTTTTAAGGCTTTTATTTTTAACAGCTTTTGTTGCTATAGGGTCTTTAGCA GCCGTTTTAGGTGTTGATTACGGTCAGCAAAATATCAAGGCCATTGTGGTTTCTCCGCAA GCCCCATTAGAACTTGTGCTCACACCAGAGGCAAAACGGAAGGAGATATCTGGTCTTTCG ATAAAAAGATTACCAGGTTATGGAAAGGATGATCCGAATGGGATTGAAAGAATCTACGGT TCCGCTGTTGGCAGTTTAGCAACAAGGTTTCCCCAAAACACATTGTTGCATTTGAAACCG CTACTTGGGAAATCACTAGAAGATGAAACCACTGTAACTTTGTATTCAAAACAACACCCC GGTTTAGAAATGGTATCAACAAATAGAAGTACCATAGCCTTTTTAGTTGATAATGTGGAA TATCCATTGGAAGAGTTAGTGGCAATGAATGTCCAAGAGATTGCCAATAGAGCCAATTCA CTGTTGAAGGATAGAGATGCAAGAACTGAGGACTTTGTAAACAAGATGAGTTTTACAATT CCTGACTTTTTTGACCAACATCAAAGGAAAGCACTTTTAGATGCCAGTTCAATAACCACA GGAATCGAAGAGACATATCTGGTTAGTGAAGGGATGTCTGTTGCAGTTAACTTTGTATTA AAGCAGCGCCAATTTCCACCAGGTGAACAGCAGCATTATATCGTATATGACATGGGGAGC GGTTCTATTAAGGCCTCAATGTTCTCTATATTGCAGCCGGAGGACACTACTCAGCCCGTT ACAATAGAATTTGAAGGATATGGGTATAATCCACATCTAGGTGGTGCAAAGTTTACAATG GATATTGGCAGTTTGATAGAGAATAAGTTTTTGGAAACACACCCAGCCATAAGAACTGAT GAATTGCACGCTAATCCCAAGGCCTTAGCAAAAATCAACCAAGCAGCAGAGAAGGCAAAG TTAATTTTAAGCGCCAATTCTGAGGCAAGTATTAACATAGAATCACTGATCAACGATATT GATTTCCGTACTTCTATAACTAGACAGGAATTCGAAGAATTTATTGCAGACTCGTTATTG GACATTGTCAAACCCATAAATGACGCTGTTACAAAACAATTCGGTGGCTATGGAACAAAT TTACCTGAGATAAATGGGGTCATTTTGGCGGGAGGCTCTTCCCGAATTCCCATTGTGCAG GATCAATTAATCAAACTCGTATCCGAAGAAAAAGTGTTGAGAAATGTCAATGCTGATGAA TCAGCTGTGAATGGTGTTGTTATGAGAGGGATCAAGTTATCTAATTCGTTTAAGACCAAG CCGTTAAATGTTGTTGACCGTTCTGTAAATACTTATTCATTCAAATTATCAAACGAATCT GAACTGTATGATGTGTTCACGCGCGGAAGTGCTTATCCAAACAAAACATCTATTTTGACA AACACGACTGATTCGATTCCTAATAATTTTACCATTGACTTATTTGAGAATGGTAAATTG TTCGAAACTATCACAGTTAATTCAGGAGCTATAAAGAATTCATATTCCTCTGATAAGTGC TCGTCAGGAGTTGCGTATAACATTACTTTCGACTTGTCCAGTGATAGATTATTCTCTATT CAAGAGGTTAACTGCATTTGTCAGAGCGAAAATGACATAGGTAACTCCAAGCAAATTAAG AACAAAGGCAGCCGTTTGGCTTTTACTTCTGAGGATGTTGAGATCAAAAGGCTTTCTCCT TCAGAACGTTCGCGTTTGCATGAGCATATCAAGTTGCTCGATAAACAGGATAAGGAAAGA TTTTCAATTCCAAGAAAATTTAAACGTTCTTGAAAGTAACTTGTATGATGCTAGAAACCTG CTAATGGATGATGAAGTTATGCAAAATGGACCAAAATCCCAAGTAGAAGAGTTATCGGAG ATGGTTAAAGTATATTTGGATTGGCTCGAAGATGCATCCTTTGATACTGACCCTGAGGAT ATAGTTAGCAGAATTAGAGAAATTGGAATATTAAAAAAGAAAATAGAACTTTACATGGAT TCTGCAAAGGAACCTTTGAACTCTCAACAATTTAAAGGAATGCTTGAAGAAGGCCATAAG TTACTTCAGGCTATAGAAACCCATAAGAATACCGTTGAAGAATTTTTGAGTCAATTTGAA ACCGAGTTTGCGGATACCATAGATAATGTTAGAGAAGAATTTAAAAAGATTAAGCAACCA GCGTATGTGTCGAAGGCGTTATCTACATGGGAGGAAACCTTAACCTCTTTTAAAAATTCC ATTAGCGAAATAGAGAAGTTCCTGGCAAAAAACCTATTTGGCGAAGACCTTCGTGAACAT TTATTTGAAATCAAATTACAATTTGATATGTATCGTACGAAACTAGAGGAAAAACTGCGT TTAATAAAAAGCGGTGATGAAAGTCGCTTAAATGAAATAAAGAAGTTACATTTAAGAAAC TTCCGCCTACAAAAGAGAAAGGAGGAAAAGTTGAAAAGAAAGCTTGAACAGGAAAAAAGC AGAAACAACAATGAAACAGAATCGACAGTAATCAACTCGGCTGACGATAAAACTACTATT GTCAATGACAAGACCACCGAGTCGAATCCAAGTTCTGAGGAAGACATTTTGCATGATGAA TTATAG

[0365] Further information on LHS1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000001556.

[0366] It will be appreciated that, by "LHS1", we include fragments or variants thereof having equivalent LHS1-like activity. Such variants may or may not include bacterial DnaK proteins and/or eukaryotic DnaK type proteins, such as other members of the Hsp70 family.

[0367] SCJ1 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of bacterial chaperone DnaJ, located in the ER lumen where it cooperates with Kar2p (described below) to mediate maturation of proteins.

[0368] A published protein sequence for the protein Scj1p is as follows:

TABLE-US-00005 MIPKLYIHLILSLLLLPLILAQDYYAILEIDKDATEKEIKSAYRQLSKKY HPDKNAGSEEAHQKFIEVGEAYDVLSDPEKKKIYDQFGADAVKNGGGGGG PGGPGAGGFHDPFDIFERMFQGGHGGPGGGFGQRQRQRGPMIKVQEKLSL KQFYSGSSIEFTLNLNDECDACHGSGSADGKLAQCPDCQGRGVIIQVLRM GIMTQQIQQMCGRCGGTGQIIKNECKTCHGKKVTKKNKFFHVDVPPGAPR NYMDTRVGEAEKGPDFDAGDLVIEFKEKDTENMGYRRRGDNLYRTEVLSA AEALYGGWQRTIEFLDENKPVKLSRPAHVVVSNGEVEVVKGFGMPKGSKG YGDLYIDYVVVMPKTFKSGQNMLKDEL*

[0369] SCJ1 is encoded by a non-essential gene comprising an ORF of 1.134 kbp. The gene is located on chromosome XIII. A published nucleotide coding sequence of SCJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00006 ATGATTCCAAAATTATATATACATTTGATACTATCTTTATTGTTGTTGCCGCTAATTTTG GCGCAGGATTATTATGCAATACTAGAGATAGACAAAGATGCCACTGAGAAGGAAATCAAA TCAGCGTACAGACAATTGTCTAAGAAGTACCATCCGGATAAAAATGCTGGGAGCGAAGAA GCCCATCAAAAATTCATTGAAGTCGGCGAGGCATACGATGTATTGAGCGATCCTGAAAAG AAAAAGATTTATGACCAGTTTGGTGCAGATGCTGTAAAGAATGGCGGTGGCGGTGGCGGT CCAGGAGGCCCTGGCGCAGGTGGATTCCACGATCCGTTTGACATATTCGAACGGATGTTT CAAGGAGGTCATGGAGGTCCTGGCGGCGGATTTGGCCAGAGACAGAGGCAGCGTGGTCCA ATGATCAAGGTCCAGGAAAAACTATCTTTAAAGCAGTTTTATTCCGGGTCCTCGATAGAA TTTACTTTAAACCTAAACGATGAATGTGATGCATGCCATGGTAGTGGCTCTGCAGATGGT AAGCTGGCCCAATGTCCCGATTGTCAAGGTCGTGGGGTTATAATACAAGTGCTGCGCATG GGTATTATGACGCAGCAGATTCAACAGATGTGTGGTAGGTGTGGTGGTACGGGACAAATT ATCAAAAATGAATGCAAAACATGTCACGGCAAAAAAGTTACCAAAAAGAACAAGTTCTTC CACGTTGACGTTCCACCAGGCGCACCAAGAAACTACATGGACACAAGAGTCGGCGAGGCT GAAAAAGGGCCTGACTTTGACGCCGGTGACTTGGTCATAGAATTCAAGGAAAAGGATACT GAGAACATGGGTTACAGAAGAAGAGGCGACAATCTGTACAGAACAGAAGTTCTTTCTGCT GCGGAAGCGCTATACGGCGGATGGCAAAGAACGATAGAATTCCTTGATGAGAACAAGCCC GTTAAGTTATCTAGACCCGCTCATGTAGTTGTCTCCAATGGCGAAGTTGAAGTCGTGAAG GGATTCGGCATGCCCAAGGGTAGCAAGGGTTACGGTGATTTGTACATAGACTACGTCGTT GTCATGCCAAAGACTTTCAAATCTGGGCAAAATATGCTCAAAGATGAGTTGTAG

[0370] Further information on SCJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S006004827.

[0371] It will be appreciated that, by "SCJ1", we include fragments or variants thereof having equivalent SCJ1-like activity.

[0372] KAR2 is another S. cerevisiae helper protein of interest for the present invention. KAR2 is also known as BIP or GRP78. Kar2p, is an ATPase involved in protein import into the ER. Kar2p also acts as a chaperone to mediate protein folding in the ER and may play a role in ER export of soluble proteins. It is also thought to regulate the unfolded protein response via interaction with kelp. A published protein sequence for the protein Kar2p is as follows:

TABLE-US-00007 MFFNRLSAGKLLVPLSVVLYALFVVILPLQNSFHSSNVLVRGADDVENYG TVIGIDLGTTYSCVAVMKNGKTEILANEQGNRITPSYVAFTDDERLIGDA AKNQVAANPQNTIFDIKRLIGLKYNDRSVQKDIKHLPFNVVNKDGKPAVE VSVKGEKKVFTPEEISGMILGKMKQIAEDYLGTKVTHAVVTVPAYFNDAQ RQATKDAGTIAGLNVLRIVNEPTAAAIAYGLDKSDKEHQIIVYDLGGGTF DVSLLSIENGVFEVQATSGDTHLGGEDFDYKIVRQLIKAFKKKHGIDVSD NNKALAKLKREAEKAKRALSSQMSTRIEIDSFVDGIDLSETLTRAKFEEL NLDLFKKTLKPVEKVLQDSGLEKKDVDDIVLVGGSTRIPKVQQLLESYFD GKKASKGINPDEAVAYGAAVQAGVLSGEEGVEDIVLLDVNALTLGIETTG GVMTPLIKRNTAIPTKKSQIFSTAVDNQPTVMIKVYEGERAMSKDNNLLG KFELTGIPPAPRGVPQIEVTFALDANGILKVSATDKGTGKSESITITNDK GRLTQEEIDRMVEEAEKFASEDASIKAKVESRNKLENYAHSLKNQVNGDL GEKLEEEDKETLLDAANDVLEWLDDNFETAIAEDFDEKFESLSKVAYPIT SKLYGGADGSGAADYDDEDEDDDGDYFEHDEL*

[0373] KAR2 is encoded by an essential gene comprising an ORF that is 2.049 kbp in size and located on chromosome X. A published nucleotide coding sequence of KAR2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00008 ATGTTTTTCAACAGACTAAGCGCTGGCAAGCTGCTGGTACCACTCTCCGTGGTCCTGTAC GCCCTTTTCGTGGTAATATTACCTTTACAGAATTCTTTCCACTCCTCCAATGTTTTAGTT AGAGGTGCCGATGATGTAGAAAACTACGGAACTGTTATCGGTATTGACTTAGGTACTACT TATTCCTGTGTTGCTGTGATGAAAAATGGTAAGACTGAAATTCTTGCTAATGAGCAAGGT AACAGAATCACCCCATCTTACGTGGCATTCACCGATGATGAAAGATTGATTGGTGATGCT GCAAAGAACCAAGTTGCTGCCAATCCTCAAAACACCATCTTCGACATTAAGAGATTGATC GGTTTGAAATATAACGACAGATCTGTTCAGAAGGATATCAAGCACTTGCCATTTAATGTG GTTAATAAAGATGGGAAGCCCGCTGTAGAAGTAAGTGTCAAAGGAGAAAAGAAGGTTTTT ACTCCAGAAGAAATTTCTGGTATGATCTTGGGTAAGATGAAACAAATTGCCGAAGATTAT TTAGGCACTAAGGTTACCCATGCTGTCGTTACTGTTCCTGCTTATTTCAATGACGCGCAA AGACAAGCCACCAAGGATGCTGGTACCATCGCTGGTTTGAACGTTTTGAGAATTGTTAAT GAACCAACCGCAGCCGCCATTGCCTACGGTTTGGATAAATCTGATAAGGAACATCAAATT ATTGTTTATGATTTGGGTGGTGGTACTTTCGATGTCTCTCTATTGTCTATTGAAAACGGT GTTTTCGAAGTCCAAGCCACTTCTGGTGATACTCATTTAGGTGGTGAAGATTTTGACTAT AAGATCGTTCGTCAATTGATAAAAGCTTTCAAGAAGAAGCATGGTATTGATGTGTCTGAC AACAACAAGGCCCTAGCTAAATTGAAGAGAGAAGCTGAAAAGGCTAAACGTGCCTTGTCC AGCCAAATGTCCACCCGTATTGAAATTGACTCCTTCGTTGATGGTATCGACTTAAGTGAA ACCTTGACCAGAGCTAAGTTTGAGGAATTAAACCTAGATCTATTCAAGAAGACCTTGAAG CCTGTCGAGAAGGTTTTGCAAGATTCTGGTTTGGAAAAGAAGGATGTTGATGATATCGTT TTGGTTGGTGGTTCTACTAGAATTCCAAAGGTCCAACAATTGTTAGAATCATACTTTGAT GGTAAGAAGGCCTCCAAGGGTATTAACCCAGATGAAGCTGTTGCATACGGTGCAGCCGTT CAAGCTGGTGTCTTATCCGGTGAAGAAGGTGTCGAAGATATTGTTTTATTGGATGTCAAC GCTTTGACTCTTGGTATTGAAACCACTGGTGGTGTCATGACTCCATTAATTAAGAGAAAT ACTGCTATTCCTACAAAGAAATCCCAAATTTTCTCTACTGCCGTTGACAACCAACCAACC GTTATGATCAAGGTATACGAGGGTGAAAGAGCCATGTCTAAGGACAACAATCTATTAGGT AAGTTTGAATTAACCGGCATTCCACCAGCACCAAGAGGTGTACCTCAAATTGAAGTCACA TTTGCACTTGACGCTAATGGTATTCTGAAGGTGTCTGCCACAGATAAGGGAACTGGTAAA TCCGAATCTATCACCATCACTAACGATAAAGGTAGATTAACCCAAGAAGAGATTGATAGA ATGGTTGAAGAGGCTGAAAAATTCGCTTCTGAAGACGCTTCTATCAAGGCCAAGGTTGAA TCTAGAAACAAATTAGAAAACTACGCTCACTCTTTGAAAAACCAAGTTAATGGTGACCTA GGTGAAAAATTGGAAGAAGAAGACAAGGAAACCTTATTAGATGCTGCTAACGATGTTTTA GAATGGTTAGATGATAACTTTGAAACCGCCATTGCTGAAGACTTTGATGAAAAGTTCGAA TCTTTGTCCAAGGTCGCTTATCCAATTACTTCTAAGTTGTACGGAGGTGCTGATGGTTCT GGTGCCGCTGATTATGACGACGAAGATGAAGATGACGATGGTGATTATTTCGAACACGAC GAATTGTAG

[0374] Further information on KAR2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003571.

[0375] It will be appreciated that, by "KAR2", we include fragments or variants thereof having equivalent KAR2-like activity.

[0376] SIL1 is another S. cerevisiae helper protein of interest for the present invention and is also known as SLS1. In particular, this helper protein was generally referred to as SLS1 in UK patent application no. 0512707.1, from which this application claims priority; it will be understood by the person skilled in the art that reference in UK patent application no. 0512707.1 to SLS1 and reference in this application to SIL1 should be taken to be reference to the same helper protein. SIL1p is an ER-localized protein required for protein translocation into the ER, which interacts with the ATPase domain of the Kar2p chaperone suggesting some role in modulating its activity. It is also thought to be a homolog of Yarrowia lipolytica SIL1 and a GrpE-like protein in the ER. A published protein sequence for the protein SIL1p is as follows:

TABLE-US-00009 MVRILPIILSALSSKLVASTILHSSIHSVPSGGEIISAEDLKELEISGNS ICVDNRCYPKIFEPRHDWQPILPGQELPGGLDIRINMDTGLKEAKLNDEK NVGDNGSHELIVSSEDMKASPGDYEFSSDFKEMRNIIDSNPTLSSQDIAR LEDSFDRIMEFAHDYKHGYKIITHEFALLANLSLNENLPLTLRELSTRVI TSCLRNNPPVVEFINESFPNFKSKIMAALSNLNDSNHRSSNILIKRYLSI LNELPVTSEDLPIYSTVVLQNVYERNNKDKQLQIKVLELISKILKADMYE NDDTNLILFKRNAENWSSNLQEWANEFQEMVQNKSIDELHTRTFFDTLYN LKKIEFSDITINKGFLNWLAQQCKARQSNLDNGLQERDTEQDSFDKKLID SRHLIFGNPMAHRIKNFRDEL*

[0377] SIL1 is encoded by a non-essential gene comprising an ORF that is 1.226 kbp in size and is located on chromosome XV. A published nucleotide coding sequence of SIL1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00010 ATGGTCCGGATTCTTCCCATAATTTTGAGCGCCCTATCTTCGAAATTAGTGGCGAGTACA ATATTGCATTCATCCATACACTCAGTGCCATCTGGAGGCGAAATCATATCTGCAGAAGAT CTTAAAGAACTTGAAATTTCAGGGAATTCGATCTGCGTTGATAATCGTTGCTATCCTAAG ATATTTGAACCAAGACACGATTGGCAGCCCATACTGCCAGGTCAAGAACTCCCCGGTGGT TTGGACATTAGAATAAACATGGACACAGGTTTAAAAGAGGCAAAACTAAATGATGAGAAG AATGTCGGTGATAATGGTAGCCATGAGTTAATTGTATCTTCAGAAGACATGAAAGCATCG CCTGGTGACTATGAATTTTCCAGTGATTTCAAAGAAATGAGAAACATCATAGATTCTAAC CCGACTTTATCTTCACAGGACATTGCCAGATTGGAGGATAGTTTTGATAGAATAATGGAA TTTGCGCATGATTACAAGCACGGCTACAAAATTATTACCCATGAATTCGCCCTCTTGGCC AACCTTAGTCTCAATGAAAATTTGCCGTTAACATTGAGAGAGCTCAGTACTAGAGTCATT ACCAGCTGCTTGAGAAACAATCCTCCTGTAGTCGAGTTCATTAATGAAAGTTTTCCAAAT TTTAAAAGCAAAATCATGGCCGCTCTGTCAAATTTGAATGATTCTAACCACAGATCCTCT AATATCCTAATAAAAAGATACTTGTCCATTTTAAACGAATTACCTGTCACATCCGAAGAT CTTCCTATATACTCTACGGTTGTTTTACAAAATGTATATGAAAGAAACAACAAGGACAAA CAGTTACAAATAAAAGTCCTGGAGTTGATCAGCAAAATTTTGAAGGCCGACATGTACGAA AATGACGATACAAATCTAATTTTGTTCAAAAGAAATGCTGAGAATTGGTCGTCAAATCTG CAAGAGTGGGCAAACGAGTTCCAAGAGATGGTCCAGAACAAAAGTATAGATGAACTACAT ACAAGAACGTTTTTTGACACCCTTTACAACTTGAAGAAAATTTTCAAAAGTGACATCACG ATCAACAAAGGGTTTTTGAATTGGTTAGCGCAACAATGTAAAGCCAGGCAATCTAACTTG GACAATGGGCTCCAAGAGAGAGATACTGAACAAGACTCATTTGATAAGAAACTTATCGAC AGCAGACACTTGATCTTTGGCAACCCCATGGCTCATAGAATAAAAAATTTCAGAGATGAA CTCTGA

[0378] Further information on SIL1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005391.

[0379] It will be appreciated that, by "SIL1", we include fragments or variants (including homologues) thereof having equivalent SIL1-like activity. In one embodiment, variants of SIL1 may or may not include bacterial GrpE type proteins and/or animal (such as mammalian) GrpE-like proteins. Variants of SIL1 may be a nucleotide exchange factor for an Hsp70 family protein, which nucleotide exchange factor is optionally not an Hsp70 family protein in itself. Suitable variants of SIL1 may or may not be FES1 and/or MGE1. A variant of SIL1 may or may not be localised to the lumen of the ER (such as SIL1 itself) to the mitochondria (such as MGE1) or to the cytosol (such as FES1). A variant of SIL1 may or may not include proteins such as members so of the mammalian GrpE-like protein family, the NEF family or BAG-1 (such as described in Hohfeld and Jentsch (1997) EMBO J. 16, 6209), mammalian BiP-associated protein (BAP) (Chung et al (2002) J. Biol. Chem. 277, 47557), a human GrpE-like protein (e.g. the protein defined by accession number AAG31605) (Choglay et al (2001) Gene 267, 125), an Arabidopsis thaliana GrpE-like protein (for example, accession numbers AAK68792 and BAB08589) (Sato et al (1998) DNA Res. 5, 41), a Chlamydia trachomatis Protein grpE (HSP-70 cofactor) (e.g. accession number P36424), a Pongo pygmaeus adenine nucleotide exchange factor (e.g. accession number CAH89792), a Mus musculus mitochondrial GrpE-like 2 protein (e.g. accession number NP.sub.--067271), a Mus musculus mitochondrial GrpE-like 1 protein (e.g. accession number NP.sub.--077798), a Gallus gallus GrpE protein homolog 2, mitochondrial precursor (Mt-GrpE#2) (e.g. accession number XP.sub.--425191), a Gallus gallus BiP-associated protein (e.g. accession number XP.sub.--414514), an Haemophilus influenzae 86-028NP GrpE protein (e.g. as defined by accession number YP.sub.--247735) (Harrison et al (2005) J. Bacteriol. 187, 4627), an Escherichia coli GrpE heat shock protein (e.g. as defined by accession number NP.sub.--417104) (Riley et al (1997) Science 277, 1453), a Streptococcus pneumoniae GrpE heat shock protein (e.g. as defined by accession number AAD23453), a Bacillus subtilis GrpE protein accession number (e.g. as defined by BAA12463) (Mizuno et al (1996) Microbiology (Reading, Engl.) 142, 3103) and/or a Nicotiana tabacum chaperone GrpE type 1 or GrpE type 2 protein (e.g. as defined by accession numbers AAC72386 or AAC72387) (Padidam et al (1999) Plant Mol. Biol. 39, 871).

[0380] Variants of SIL1 may have an activity equivalent to SIL1, when co-expressed with one or both of JEM1 and LHS1, for example in the manner as set out in the present examples. Thus, a host cell of the present invention, when genetically modified to cause simultaneous over-expression of a variant of SILT with one or both of JEM1 and LHS1, will provide at least substantially the same increase in the production of a protein product and/or at least substantially the same reduction of fragmentation of a protein product, as is observed in the same host cell when genetically modified to cause simultaneous over-expression of SIL1 with one or both of JEM1 and LHS1, the increase being compared to the level of production of the same protein product, and/or the level of fragmentation of the same protein product, in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1.

[0381] By "substantially the same increase in the production of a protein product", we mean at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, substantially 100% or greater than 100% of the increase in production of a protein product that is observed when the host cell is genetically modified to cause simultaneous over-expression of SIL1 with one or both of JEM1 and LHS1 (the increased being compared to the level of production of the same protein product in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1).

[0382] By "substantially the same reduction of fragmentation of a protein product", we mean at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, substantially 100% or greater than 100% of the reduction of fragmentation of a protein product that is observed when the host cell is genetically modified to cause simultaneous over-expression of SIL1 with one or both of JEM1 and LHS1 (the reduction of fragmentation of a protein product being compared to the level of fragmentation of the same protein product in the same host cell that has not been genetically modified to cause overexpression of any of LHS1, JEM1 or SIL1).

[0383] FKB2 is another S. cerevisiae helper protein of interest for the present invention and is also known as FPR2 and FKBP13. Fkb2p is a membrane bound peptidyl-prolyl cis-trans isomerase (PPIase) that binds to the drugs FK506 and rapamycin. The expression pattern of Fkb2p suggests possible involvement in ER protein trafficking. A published protein sequence for the protein Fkb2p is as follows:

TABLE-US-00011 MMFNIYLFVTFFSTILAGSLSDLEIGIIKRIPVEDCLIKAMPGDKVKVHY TGSLLESGTVFDSSYSRGSPIAFELGVGRVIKGWDQGVAGMCVGEKRKLQ IPSSLAYGERGVPGVIPPSADLVFDVELVDVKSAA*

[0384] FKB2 is encoded by a non-essential gene comprising an ORF that is 0.408 kbp in size and is located on chromosome IV. A published nucleotide coding sequence of FKB2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00012 ATGATGTTTAATATTTACCTTTTCGTCACTTTTTTTTCCACCATTCTTGC AGGTTCCCTGTCAGATTTGGAAATCGGTATTATCAAGAGAATACCGGTAG AAGATTGCTTAATTAAGGCAATGCCAGGTGATAAAGTTAAGGTTCATTAT ACAGGATCTTTATTAGAATCGGGAACTGTATTTGACTCAAGTTATTCAAG AGGCTCTCCTATCGCTTTTGAACTTGGCGTTGGCAGAGTAATTAAAGGTT GGGATCAAGGTGTTGCCGGCATGTGCGTTGGCGAAAAAAGAAAGCTGCAA ATTCCAAGTTCTTTGGCCTACGGAGAAAGAGGTGTCCCAGGCGTCATTCC TCCAAGTGCTGATTTGGTGTTTGATGTCGAATTGGTAGACGTGAAATCAG CCGCCTAG

[0385] Further information on FKB2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000002927.

[0386] It will be appreciated that, by "FKB2", we include fragments or variants thereof having equivalent FKB2-like activity.

[0387] SSA1 is another S. cerevisiae helper protein of interest for the present invention and is also known as YG100. Ssa1p is an ATPase that is involved in protein folding and nuclear localization signal (NLS)-directed nuclear transport. It is a member of heat shock protein 70 (HSP70) family. It forms a chaperone complex with Ydj1p and is localized to the nucleus, cytoplasm, and cell wall A published protein sequence for the protein Ssa1p is as follows:

TABLE-US-00013 MSKAVGIDLGTTYSCVAHFANDRVDIIANDQGNRTTPSFVAFTDTERLIG DAAKNQAAMNPSNTVFDAKRLIGRNFNDPEVQADMKHFPFKLIDVDGKPQ IQVEFKGETKNFTPEQISSMVLGKMKETAESYLGAKVNDAVVTVPAYFND SQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKGKEEHVLIFDLGGG TFDVSLLFIEDGIFEVKATAGDTHLGGEDFDNRLVNHFIQEFKRKNKKDL STNQRALRRLRTACERAKRTLSSSAQTSVEIDSLFEGIDFYTSITRARFE ELCADLERSTLDPVEKVLRDAKLDKSQVDEIVLVGGSTRIPKVQKLVTDY FNGKEPNRSINPDEAVAYGAAVQAAILTGDESSKTQDLLLLDVAPLSLGI ETAGGVMTKLIPRNSTISTKKFEIFSTYADNQPGVLIQVFEGERAKTKDN NLLGKFELSGIPPAPRGVPQIEVTEDVDSNGILNVSAVEKGTGKSNKITI TNDKGRLSKEDIEKMVAEAEKFKEEDEKESQRIASKNQLESIAYSLKNTI SEAGDKLEQADKDTVTKKAEETISWLDSNTTASKEEFDDKLKELQDIANP IMSKLYQAGGAPGGAAGGAPGGFPGGAPPAPEAEGPTVEEVD*

[0388] SSA1 is encoded by a non-essential gene comprising an ORF that is 1.929 kbp in size and is located on chromosome I. A published nucleotide coding sequence of SSA1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00014 ATGTCAAAAGCTGTCGGTATTGATTTAGGTACAACATACTCGTGTGTTGCTCACTTTGCT AATGATCGTGTGGACATTATTGCCAACGATCAAGGTAACAGAACCACTCCATCTTTTGTC GCTTTCACTGACACTGAAAGATTGATTGGTGATGCTGCTAAGAATCAAGCTGCTATGAAT CCTTCGAATACCGTTTTCGACGCTAAGCGTTTGATCGGTAGAAACTTCAACGACCCAGAA GTGCAGGCTGACATGAAGCACTTCCCATTCAAGTTGATCGATGTTGACGGTAAGCCTCAA ATTCAAGTTGAATTTAAGGGTGAAACCAAGAACTTTACCCCAGAACAAATCTCCTCCATG GTCTTGGGTAAGATGAAGGAAACTGCCGAATCTTACTTGGGAGCCAAGGTCAATGACGCT GTCGTCACTGTCCCAGCTTACTTCAACGATTCTCAAAGACAAGCTACCAAGGATGCTGGT ACCATTGCTGGTTTGAATGTCTTGCGTATTATTAACGAACCTACCGCCGCTGCCATTGCT TACGGTTTGGACAAGAAGGGTAAGGAAGAACACGTCTTGATTTTCGACTTGGGTGGTGGT ACTTTCGATGTCTCTTTGTTGTTCATTGAAGACGGTATCTTTGAAGTTAAGGCCACCGCT GGTGACACCCATTTGGGTGGTGAAGATTTTGACAACAGATTGGTCAACCACTTCATCCAA GAATTCAAGAGAAAGAACAAGAAGGACTTGTCTACCAACCAAAGAGCTTTGAGAAGATTA AGAACCGCTTGTGAAAGAGCCAAGAGAACTTTGTCTTCCTCCGCTCAAACTTCCGTTGAA ATTGACTCTTTGTTCGAAGGTATCGATTTCTACACTTCCATCACCAGAGCCAGATTCGAA GAATTGTGTGCTGACTTGTTCAGATCTACTTTGGACCCAGTTGAAAAGGTCTTGAGAGAT GCTAAATTGGACAAATCTCAAGTCGATGAAATTGTCTTGGTCGGTGGTTCTACCAGAATT CCAAAGGTCCAAAAATTGGTCACTGACTACTTCAACGGTAAGGAACCAAACAGATCTATC AACCCAGATGAAGCTGTTGCTTACGGTGCTGCTGTTCAAGCTGCTATTTTGACTGGTGAC GAATCTTCCAAGACTCAAGATCTATTGTTGTTGGATGTCGCTCCATTATCCTTGGGTATT GAAACTGCTGGTGGTGTCATGACCAAGTTGATTCCAAGAAACTCTACCATTTCAACAAAG AAGTTCGAGATCTTTTCCACTTATGCTGATAACCAACCAGGTGTCTTGATTCAAGTCTTT GAAGGTGAAAGAGCCAAGACTAAGGACAACAACTTGTTGGGTAAGTTCGAATTGAGTGGT ATTCCACCAGCTCCAAGAGGTGTCCCACAAATTGAAGTCACTTTCGATGTCGACTCTAAC GGTATTTTGAATGTTTCCGCCGTCGAAAAGGGTACTGGTAAGTCTAACAAGATCACTATT ACCAACGACAAGGGTAGATTGTCCAAGGAAGATATCGAAAAGATGGTTGCTGAAGCCGAA AAATTCAAGGAAGAAGATGAAAAGGAATCTCAAAGAATTGCTTCCAAGAACCAATTGGAA TCCATTGCTTACTCTTTGAAGAACACCATTTCTGAAGCTGGTGACAAATTGGAACAAGCT GACAAGGACACCGTCACCAAGAAGGCTGAAGAGACTATTTCTTGGTTAGACAGCAACACC ACTGCCAGCAAGGAAGAATTCGATGACAAGTTGAAGGAGTTGCAAGACATTGCCAACCCA ATCATGTCTAAGTTGTACCAAGCTGGTGGTGCTCCAGGTGGCGCTGCAGGTGGTGCTCCA GGCGGTTTCCCAGGTGGTGCTCCTCCAGCTCCAGAGGCTGAAGGTCCAACCGTTGAAGAA GTTGATTAA

[0389] Further information on SSA1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000004.

[0390] It will be appreciated that, by "SSA1", we include fragments or variants thereof having equivalent SSA1-like activity.

[0391] SSA2 is another S. cerevisiae helper protein of interest for the present invention. Ssa2p is an ATP binding protein that is involved in protein folding and vacuolar import of proteins; member of heat shock protein 70 (HSP70) family. It is associated with the chaperonin-containing T-complex. It is present in the cytoplasm, vacuolar membrane and cell wall. A published protein sequence for the protein Ssa2p is as follows:

TABLE-US-00015 MSKAVGIDLGTTYSCVAHFSNDRVDIIANDQGNRTTPSFVGFTDTERLIG DAAKNQAAMNPANTVFDAKRLIGRNFNDPEVQGDMKHFPFKLIDVDGKPQ IQVEFKGETKNFTPEQISSMVLGKMKETAESYLGAKVNDAVVTVPAYFND SQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKGKEEHVLIFDLGGG TFDVSLLSIEDGIFEVKATAGDTHLGGEDFDNRLVNHFIQEFKRKNKKDL STNQRALRRLRTACERAKRTLSSSAQTSVEIDSLFEGIDFYTSITRARFE ELCADLFRSTLDPVEKVLRDAKLDKSQVDEIVLVGGSTRIPKVQKLVTDY FNGKEPNRSINPDEAVAYGAAVQAAILTGDESSKTQDLLLLDVAPLSLGI ETAGGVMTKLIPRNSTIPTKKSEVFSTYADNQPGVLIQVFEGERAKTKDN NLLGKFELSGIPPAPRGVPQIEVTFDVDSNGILNVSAVEKGTGKSNKITI TNDKGRLSKEDIEKMVAEAEKFKEEDEKESQRIASKNQLESIAYSLKNTI SEAGDKLEQADKDAVTKKAEETIAWLDSNTTATKEEFDDQLKELQEVANP IMSKLYQAGGAPEGAAPGGFPGGAPPAPEAEGPTVEEVD*

[0392] SSA2 is encoded by a non-essential gene comprising an ORF that is 1.920 kbp in size and is located on chromosome XII. A published nucleotide coding sequence of SSA2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00016 ATGTCTAAAGCTGTCGGTATTGATTTAGGTACTACCTACTCCTGTGTTGCTCACTTCTCT AATGATCGTGTTGACATTATTGCCAACGACCAAGGTAACAGAACCACTCCATCTTTCGTT GGTTTCACTGATACTGAAAGATTGATTGGTGACGCTGCTAAGAACCAAGCTGCTATGAAC CCAGCTAACACTGTTTTCGACGCTAAGCGTTTGATCGGTAGAAACTTCAATGACCCAGAA GTCCAAGGTGATATGAAGCACTTCCCATTCAAGTTGATCGATGTTGACGGTAAGCCACAA ATTCAAGTTGAATTTAAGGGTGAAACCAAGAACTTTACCCCAGAACAAATCTCCTCCATG GTCTTGGGTAAGATGAAGGAAACTGCCGAATCTTACTTGGGTGCCAAGGTCAATGACGCT GTCGTCACTGTCCCAGCTTACTTCAACGATTCTCAAAGACAAGCTACCAAGGATGCTGGT ACCATTGCTGGTTTGAATGTCTTGCGTATTATTAACGAACCTACCGCCGCTGCCATTGCT TACGGTTTGGACAAGAAGGGTAAGGAAGAACACGTCTTGATTTTCGACTTGGGTGGTGGT ACTTTCGATGTCTCTTTGTTGTCCATTGAAGACGGTATCTTTGAAGTTAAGGCCACCGCT GGTGACACCCATTTGGGTGGTGAAGATTTTGACAACAGATTGGTCAACCACTTCATCCAA GAATTCAAGAGAAAGAACAAGAAGGACTTGTCTACCAACCAAAGAGCTTTGAGAAGATTA AGAACTGCTTGTGAAAGAGCCAAGAGAACTTTGTCTTCCTCCGCTCAAACTTCCGTTGAA ATTGACTCTTTGTTCGAAGGTATCGATTTCTACACTTCCATCACCAGAGCCAGATTCGAA GAATTGTGTGCTGACTTGTTCAGATCTACTTTGGACCCAGTTGAAAAGGTCTTGAGAGAT GCTAAATTGGATAAATCTCAAGTCGATGAAATTGTCTTGGTCGGTGGTTCTACCAGAATT CCAAAGGTCCAAAAATTGGTCACTGACTACTTCAACGGTAAGGAACCAAACAGATCTATC AACCCAGATGAAGCTGTTGCTTACGGTGCTGCTGTTCAAGCTGCTATTTTGACTGGTGAC GAATCTTCCAAGACTCAAGATCTATTGTTGTTGGATGTCGCTCCATTATCCTTGGGTATT GAAACTGCTGGTGGTGTCATGACCAAGTTGATTCCAAGAAACTCTACCATTCCAACTAAG AAATCCGAAGTTTTCTCTACTTATGCTGACAACCAACCAGGTGTCTTGATTCAAGTCTTT GAAGGTGAAAGAGCCAAGACTAAGGACAACAACTTGTTGGGTAAGTTCGAATTGAGTGGT ATTCCACCAGCTCCAAGAGGTGTCCCACAAATTGAAGTCACTTTCGATGTCGACTCTAAC GGTATTTTGAATGTTTCCGCCGTCGAAAAGGGTACTGGTAAGTCTAACAAGATCACTATT ACCAACGACAAGGGTAGATTGTCCAAGGAAGATATCGAAAAGATGGTTGCTGAAGCCGAA AAATTCAAGGAAGAAGATGAAAAGGAATCTCAAAGAATTGCTTCCAAGAACCAATTGGAA TCCATTGCTTACTCTTTGAAGAACACCATTTCTGAAGCTGGTGACAAGCTAGAGCAAGCT GACAAGGACGCTGTCACTAAGAAGGCTGAAGAAACTATTGCTTGGTTAGACAGCAACACC ACTGCTACCAAGGAAGAATTCGATGACCAATTGAAGGAATTGCAAGAGGTTGCCAACCCA ATCATGTCTAAATTGTACCAAGCTGGTGGTGCTCCAGAAGGCGCAGCTCCAGGTGGTTTC CCAGGTGGTGCTCCTCCAGCTCCAGAAGCTGAAGGTCCAACTGTCGAAGAAGTTGATTAA

[0393] Further information on SSA2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003947.

[0394] It will be appreciated that, by "SSA2", we include fragments or variants thereof having equivalent SSA2-like activity.

[0395] SSA3 is another S. cerevisiae helper protein of interest for the present invention, which is also known as HSP70. Ssa3p is an ATPase involved in protein folding and the response to stress. It plays a role in SRP-dependent cotranslational protein-membrane targeting and translocation and is a member of the heat shock protein 70 (HSP70) family. SSA3 is localized to the cytoplasm. A published protein sequence for the protein Ssa3p is as follows:

TABLE-US-00017 MSRAVGIDLGTTYSCVAHFSNDRVEIIANDQGNRTTPSYVAFTDTERLIG DAAKNQAAINPHNTVFDAKRLIGRKFDDPEVTTDAKHFPFKVISRDGKPV VQVEYKGETKTFTPEEISSMVLSKMKETAENYLGTTVNDAVVTVPAYFND SQRQATKDAGTIAGMNVLRIINEPTAAAIAYGLDKKGRAEHNVLIFDLGG GTFDVSLLSIDEGVFEVKATAGDTHLGGEDFDNRLVNHLATEFKRKTKKD ISNNQRSLRRLRTAAERAKRALSSSSQTSIEIDSLFEGMDFYTSLTRARF EELCADLFRSTLEPVEKVLKDSKLDKSQIDEIVLVGGSTRIPKIQKLVSD FFNGKEPNRSINPDEAVAYGAAVQAAILTGDQSTKTQDLLLLDVAPLSLG IETAGGIMTKLIPRNSTIPTKKSETFSTYADNQPGVLIQVFEGERTRTKD NNLLGKFELSGIPPAPRGVPQIDVTFDIDANGILNVSALEKGTGKSNKIT ITNDKGRLSKDDIDRMVSEAEKYRADDEREAERVQAKNQLESYAFTLKNT INEASFKEKVGEDDAKRLETASQETIDWLDASQAASTDEYKDRQKELEGI ANPIMTKFYGAGAGAGPGAGESGGFPGSMPNSGATGGGEDTGPTVEEVD*

[0396] SSA3 is encoded by a non-essential gene comprising an ORF that is 1.950 kbp in size and is located on chromosome II. A published nucleotide coding sequence of SSA3 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00018 ATGTCTAGAGCAGTTGGTATTGATTTGGGAACAACTTACTCGTGTGTTGCTCATTTTTCC AATGATAGGGTAGAGATAATTGCAAATGATCAAGGTAATAGGACCACTCCATCGTATGTG GCTTTCACAGACACCGAAAGATTAATTGGTGACGCCGCCAAAAATCAAGCTGCAATCAAT CCTCATAATACAGTTTTTGATGCAAAGCGGTTAATTGGTCGTAAATTTGATGATCCTGAA GTGACGACAGATGCCAAGCACTTCCCTTTCAAAGTTATATCCAGAGATGGTAAACCTGTA GTGCAAGTAGAATATAAGGGTGAAACGAAAACATTTACGCCTGAGGAAATTTCTTCCATG GTTTTAAGCAAAATGAAGGAAACTGCTGAGAACTATTTGGGAACTACGGTCAATGATGCT GTTGTAACTGTTCCTGCATATTTCAATGATTCTCAAAGACAAGCCACTAAGGATGCAGGA ACTATTGCAGGGATGAACGTTTTACGTATTATCAATGAACCCACTGCAGCAGCAATTGCT TATGGCTTGGATAAGAAAGGCAGGGCTGAGCACAATGTCCTGATTTTTGATTTGGGTGGT GGTACTTTTGACGTCTCTTTACTTTCAATTGATGAGGGTGTTTTTGAGGTTAAGGCTACC GCAGGAGACACTCATTTAGGTGGTGAAGATTTTGATAATAGGTTGGTGAACCATTTAGCC ACTGAATTCAAAAGGAAAACGAAAAAGGACATCTCTAATAATCAAAGATCGTTAAGAAGA TTGAGAACTGCGGCAGAAAGAGCTAAGAGAGCGCTTTCTTCCTCATCTCAAACCTCGATC GAGATCGATTCTTTATTTGAAGGTATGGATTTCTACACTTCGTTAACAAGGGCAAGGTTT GAAGAGCTATGTGCTGATTTATTCAGATCCACATTGGAACCAGTAGAAAAGGTTCTTAAA GATTCGAAGCTGGACAAGTCCCAAATTGATGAGATTGTGTTAGTCGGTGGATCTACCAGA ATCCCAAAGATTCAGAAATTAGTTTCTGACTTCTTCAATGGCAAAGAGCCTAATCGTTCT ATCAACCCGGATGAGGCTGTTGCTTATGGTGCAGCCGTTCAAGCTGCCATTTTAACCGGC GATCAATCAACAAAGACACAAGATTTACTATTATTGGATGTTGCGCCATTGTCCCTAGGA ATTGAAACTGCAGGCGGCATAATGACTAAGCTAATTCCTAGAAACTCAACGATTCCAACA AAGAAATCGGAAACCTTCTCTACCTATGCAGATAATCAACCTGGTGTTTTAATTCAAGTC TTTGAAGGTGAAAGAACAAGAACAAAGGATAATAACTTACTTGGTAAATTCGAATTAAGT GGCATTCCGCCTGCTCCCAGAGGTGTGCCTCAAATTGATGTTACCTTTGATATCGACGCT AATGGTATTCTTAATGTGTCTGCTTTGGAAAAGGGTACTGGTAAGAGTAACAAAATCACG ATCACTAACGATAAAGGTAGGCTCTCGAAGGATGATATTGATAGGATGGTTTCTGAAGCT GAAAAATATAGGGCTGACGATGAAAGGGAGGCAGAACGAGTTCAGGCTAAGAATCAGCTT GAATCGTATGCATTTACTTTGAAGAATACCATAAACGAAGCAAGTTTCAAAGAGAAAGTA GGTGAAGATGATGCAAAGAGATTAGAAACAGCGTCTCAGGAAACCATTGACTGGTTAGAT GCATCGCAGGCAGCCTCTACGGACGAATATAAGGATAGACAAAAGGAGTTGGAAGGCATT GCCAATCCAATAATGACGAAATTTTACGGTGCTGGTGCCGGCGCAGGTCCTGGAGCGGGG GAATCCGGTGGATTCCCCGGATCCATGCCCAACTCGGGTGCTACGGGAGGTGGAGAAGAT ACAGGTCCAACAGTGGAAGAGGTTGATTGA

[0397] Further information on SSA3 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000171.

[0398] It will be appreciated that, by "SSA3", we include fragments or variants thereof having equivalent SSA3-like activity.

[0399] SSA4 is another S. cerevisiae helper protein of interest for the present invention. Ssa4p is a heat shock protein that is highly induced upon stress. It plays a role in SRP-dependent cotranslational protein-membrane targeting and translocation; member of the HSP70 family. It is a cytoplasmic protein that concentrates in nuclei upon starvation. A published protein sequence for the protein Ssa4p is as follows:

TABLE-US-00019 MSKAVGIDLGTTYSCVAHFANDRVEIIANDQGNRTTPSYVAFTDTERLIG DAAKNQAAMNPHNTVFDAKRLIGRKFDDPEVTNDAKHYPFKVIDKGGKPV VQVEYKGETKTFTPEEISSMILTKMKETAENFLGTEVKDAVVTVPAYFND SQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKSQKEHNVLIFDLGG GTFDVSLLSIDEGVFEVKATAGDTHLGGEDFDSRLVNFLAEEFKRKNKKD LTTNQRSLRRLRTAAERAKRTLSSSAQTSIEIDSLFEGIDFYTSITRARF EELCADLFRSTLEPVEKVLADSKLDKSQIDEIVLVGGSTRIPKVQKLVSD FFNGKEPNRSINPDEAVAYGAAVQAAILTGDQSSTTQDLLLLDVAPLSLG IETAGGIMTKLIPRNSTIPTKKSEVFSTYADNQPGVLIQVFEGERTRTKD NNLLGKFELSGIPPAPRGVPQIEVTFDIDANGILNVSAVEKGTGKSNKIT ITNDKGRLSKEDIDKMVAEAEKFKAEDEQEAQRVQAKNQLESYAFTLKNS VSENNFKEKVGEEDARKLEAAAQDAINWLDASQAASTEEYKERQKELEGV ANPIMSKFYGAAGGAPGAGPVPGAGAGPTGAPDNGPTVEEVD*

[0400] SSA4 is encoded by a non-essential gene comprising an ORF that is 1.929 kbp in size and is located on chromosome V. A published nucleotide coding sequence of SSA4 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00020 ATGTCAAAAGCTGTTGGTATTGATTTAGGTACAACCTATTCATGTGTTGCTCATTTTGCA AACGATAGGGTTGAAATTATCGCTAACGATCAAGGTAATAGAACGACGCCTTCTTATGTG GCTTTTACTGACACAGAAAGGCTAATTGGTGACGCTGCGAAGAATCAAGCTGCGATGAAC CCACATAATACAGTATTCGATGCTAAGCGTCTGATCGGACGTAAATTCGATGATCCAGAA GTGACGAACGATGCTAAGCATTACCCATTCAAAGTGATTGACAAGGGAGGTAAACCGGTA GTGCAAGTGGAATATAAAGGCGAGACAAAGACATTTACTCCAGAAGAAATTTCCTCAATG ATCTTGACAAAGATGAAGGAGACTGCTGAGAACTTTTTAGGAACAGAAGTGAAAGATGCT GTAGTAACGGTTCCAGCCTATTTCAACGATTCACAAAGGCAAGCAACAAAAGATGCCGGT ACAATCGCGGGCTTGAACGTTCTTCGTATCATTAATGAACCTACAGCTGCCGCTATTGCG TATGGGCTGGACAAGAAATCGCAGAAGGAGCACAACGTCTTGATCTTTGATTTAGGTGGT GGTACTTTTGATGTCTCTCTGCTATCCATAGATGAAGGTGTCTTTGAGGTTAAGGCTACT GCTGGTGACACTCACTTGGGTGGTGAAGATTTCGATAGTAGGCTGGTTAACTTTCTAGCC GAGGAGTTCAAAAGAAAAAATAAAAAGGATCTAACAACTAACCAAAGGTCCCTAAGGAGG TTAAGGACCGCCGCTGAAAGGGCCAAGAGAACTCTGTCTTCGTCTGCTCAGACATCTATA GAAATAGATTCATTATTTGAGGGTATCGATTTCTATACTTCCATTACAAGGGCAAGATTT GAAGAATTATGTGCTGATTTGTTTAGATCTACATTGGAGCCAGTGGAAAAAGTTTTGGCT GATTCAAAATTAGATAAGTCACAAATTGATGAAATTGTACTTGTTGGTGGTTCAACAAGA ATTCCAAAAGTACAAAAACTGGTTTCTGATTTTTTCAATGGTAAAGAACCAAACCGTTCG ATTAACCCTGATGAGGCCGTCGCTTATGGTGCTGCCGTACAGGCTGCCATCTTAACGGGT GACCAGTCGTCGACGACCCAAGATTTACTGTTGCTGGATGTTGCACCATTATCTCTAGGT ATTGAAACTGCAGGTGGTATTATGACAAAGTTGATCCCAAGAAATTCGACTATCCCAACA AAAAAATCGGAAGTGTTTTCCACCTACGCTGACAACCAACCTGGTGTGTTGATACAAGTT TTTGAGGGTGAAAGGACAAGGACAAAAGACAACAATCTACTGGGTAAATTTGAGTTGAGC GGTATTCCACCCGCTCCAAGAGGCGTACCACAAATTGAAGTTACATTTGATATCGATGCA AATGGTATTCTGAACGTATCTGCCGTTGAAAAAGGTACTGGTAAATCTAACAAGATTACA ATTACTAACGATAAGGGAAGATTATCGAAGGAAGATATCGATAAAATGGTTGCTGAGGCA GAAAAGTTCAAGGCCGAAGATGAACAAGAAGCTCAACGTGTTCAAGCTAAGAATCAGCTA GAATCGTACGCGTTTACTTTGAAAAATTCTGTGAGCGAAAATAACTTCAAGGAGAAGGTG GGTGAAGAGGATGCCAGGAAATTGGAAGCCGCCGCCCAAGATGCTATAAATTGGTTAGAT GCTTCGCAAGCGGCCTCCACCGAGGAATACAAGGAAAGGCAAAAGGAACTAGAAGGTGTT GCAAACCCCATTATGAGTAAATTTTACGGAGCTGCAGGTGGTGCCCCAGGAGCAGGCCCA GTTCCGGGTGCTGGAGCAGGCCCCACTGGAGCACCAGACAACGGCCCAACGGTTGAAGAG GTTGATTAG

[0401] Further information on SSA4 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000905.

[0402] It will be appreciated that, by "SSA4", we include fragments or variants thereof having equivalent SSA4-like activity.

[0403] SSE1 is another S. cerevisiae helper protein of interest for the present invention and is also known as LPG3 and MSI3. Sse1p is an ATPase that is a component of the heat shock protein Hsp90 chaperone complex. It binds unfolded proteins and is a member of the heat shock protein 70 (HSP70) family. It is localized to the cytoplasm. A published protein sequence for the protein Sse1p is as follows:

TABLE-US-00021 MSTPFGLDLGNNNSVLAVARNRGIDIVVNEVSNRSTPSVVGFGPKNRYLGETGKNKQTSN IKNTVANLKRIIGLDYHHPDFEQESKHFTSKLVELDDKKTGAEVRFAGEKHVFSATQLAA MFIDKVKDTVKQDTKANITDVCIAVPPWYTEEQRYNIADAARIAGLNPVRIVNDVTAAGV SYGIFKTDLPEGEEKPRIVAFVDIGHSSYTCSIMAFKKGQLKVLGTACDKHFGGRDFDLA ITEHFADEFKTKYKIDIRENPKAYNRILTAAEKLKKVLSANTNAPFSVESVMNDVDVSSQ LSREELEELVKPLLERVTEPVTKALAQAKLSAEEVDFVEIIGGTTRIPTLKQSISEAFGK PLSTTLNQDEAIAKGAAFICAIHSPTLRVRPFKFEDIHPYSVSYSWDKQVEDEDHMEVFP AGSSFPSTKLITLNRTGDFSMAASYTDITQLPPNTPEQIANWEITGVQLPEGQDSVPVKL KLRCDPSGLHTIEEAYTIEDIEVEEPIPLPEDAPEDAEQEFKKVTKTVKKDDLTIVAHTF GLDAKKLNELIEKENEMLAQDKLVAETEDRKNTLEEYIYTLRGKLEEEYAPFASDAEKTK LQGMLNKAEEWLYDEGFDSIKAKYIAKYEELASLGNIIRGRYLAKEEEKKQAIRSKQEAS QMAAMAEKLAAQRKAEAEKKEEKKDTEGDVDMD*

[0404] SSE1 is encoded by a non-essential gene comprising an ORF that is 2.082 kbp in size and is located on chromosome XVI. A published nucleotide coding sequence of SSE1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00022 ATGAGTACTCCATTTGGTTTAGATTTAGGTAACAATAACTCTGTCCTTGCCGTTGCTAGA AACAGAGGTATCGACATTGTCGTTAATGAAGTCTCTAACCGTTCCACCCCATCTGTTGTT GGTTTTGGTCCAAAGAACAGATACTTGGGTGAAACTGGTAAGAACAAGCAGACTTCCAAC ATCAAGAACACTGTCGCCAACTTGAAAAGAATTATTGGTTTGGATTACCACCATCCAGAT TTCGAGCAAGAATCTAAGCACTTCACCTCTAAGTTGGTTGAATTGGATGACAAGAAGACT GGTGCCGAAGTTAGATTCGCTGGTGAGAAACATGTTTTTTCAGCTACTCAACTAGCTGCC ATGTTCATCGACAAAGTCAAGGACACCGTCAAGCAGGACACAAAGGCAAATATTACCGAT GTTTGTATTGCTGTCCCACCTTGGTACACCGAAGAACAACGTTACAACATTGCTGATGCT GCTAGAATTGCTGGTTTGAACCCTGTTAGAATTGTCAACGACGTTACTGCTGCCGGTGTT TCTTACGGTATCTTCAAGACTGATTTGCCTGAAGGCGAAGAAAAGCCAAGAATTGTTGCC TTTGTTGATATTGGTCACTCTTCCTACACCTGTTCTATCATGGCCTTCAAGAAGGGTCAA TTGAAAGTCTTAGGAACTGCCTGCGACAAGCATTTTGGTGGTAGGGACTTCGATTTGGCT ATAACAGAACATTTCGCCGATGAGTTCAAAACTAAATACAAGATTGACATCAGAGAAAAT CCAAAGGCTTACAACAGAATTCTAACTGCTGCTGAAAAGTTGAAGAAAGTTTTGTCTGCT AATACTAATGCCCCATTCTCTGTTGAATCCGTCATGAACGACGTTGATGTTTCCTCTCAA TTATCTCGTGAAGAATTAGAAGAATTGGTCAAGCCATTGTTGGAACGTGTTACTGAACCA GTTACCAAAGCTTTAGCTCAAGCCAAATTATCTGCTGAAGAAGTTGATTTTGTTGAAATT ATTGGTGGTACTACTCGTATCCCAACATTGAAACAATCCATTTCTGAAGCCTTCGGCAAG CCATTGTCCACCACTTTGAACCAAGATGAAGCCATCGCCAAGGGTGCCGCCTTTATTTGC GCCATTCACTCTCCAACTCTAAGAGTTAGACCATTCAAGTTTGAGGATATCCATCCTTAC TCTGTCTCTTACTCTTGGGACAAGCAAGTTGAGGACGAAGACCACATGGAAGTTTTCCCA GCTGGTTCATCCTTCCCATCTACTAAATTGATCACTTTGAACCGTACGGGTGACTTTTCA ATGGCTGCTAGCTACACTGACATCACACAGTTACCACCAAACACTCCAGAACAAATCGCT AACTGGGAGATCACTGGTGTTCAATTACCAGAAGGTCAAGACTCTGTTCCTGTTAAGTTA AAGTTGAGATGCGACCCCTCTGGTTTACACACAATTGAAGAGGCTTACACTATTGAAGAT ATTGAAGTTGAAGAACCTATTCCATTACCAGAAGATGCTCCAGAAGATGCTGAGCAAGAA TTTAAGAAGGTTACTAAAACTGTAAAGAAGGATGACTTAACCATCGTTGCACACACCTTT GGCCTAGACGCTAAAAAGTTGAATGAATTAATTGAAAAAGAAAATGAAATGCTTGCTCAA GATAAGCTAGTTGCTGAGACAGAAGACCGTAAGAACACTCTTGAAGAGTACATCTACACA TTGCGTGGTAAGTTGGAAGAAGAGTATGCTCCATTTGCTTCCGATGCTGAAAAGACGAAG TTACAAGGTATGTTAAACAAGGCCGAAGAGTGGTTATACGATGAAGGTTTCGATTCCATC AAAGCTAAGTACATTGCCAAATACGAAGAATTGGCTTCTCTAGGTAACATTATTAGAGGT AGATACTTGGCTAAAGAAGAAGAAAAGAAGCAAGCTATAAGATCTAAGCAAGAAGCATCC CAAATGGCTGCTATGGCTGAAAAGTTGGCTGCTCAAAGAAAGGCAGAAGCTGAAAAGAAG GAAGAAAAGAAGGACACTGAAGGTGATGTTGACATGGACTAA

[0405] Further information on SSE1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000006027.

[0406] It will be appreciated that, by "SSE1", we include fragments or variants thereof having equivalent SSE1-like activity.

[0407] SSE2 is another S. cerevisiae helper protein of interest for the present invention. Sse2p is a member of the heat shock protein 70 (HSP70) family. It may be involved in protein folding and is localised to the cytoplasm. It is highly homologous to the heat shock protein Sse1p. A published protein sequence for the protein Sse2p is as follows:

TABLE-US-00023 MSTPFGLDLGNNNSVLAVARNRGIDVVVNEVSNRSTPSLVGFGPRNRYLGESGKTKQTSN VKNTVENLKRIIGLKFKDPEFDIENKFFTSKLVQLKNGKVGVEVEFGGKTHVFSATQLTA MFIDKVKHTVQEETKSSITDVCLAVPVWYSEEQRYNIADAARIAGLNPVRIVNDVTAAAV SYGVFKNDLPGPEEKPRIIGLVDIGHSTYTCSIMAFRKGEMKVLGTAYDKHFGGRDFDRA ITEHFADQFKDKYKIDIRKNPKAYNRILIAAEKLKKVLSANTTAPFSVESVMDDIDVSSQ LSREELEELVEPLLKRVTYPITNALAQAKLTVNDIDFVEIIGGTTRIPVLKKSISDVFGK PLSSTLNQDEAVAKGAAFICAIHSPTLRVRPFKFEDIDPYSVSYTWDKQVDDEDRLEVFP ANSSYPSTKLITLHRTGDFSMKAVYTHPSKLPKGTSTTIAKWSFTGVKVPKDQDFIPVKV KLRCDPSGLHIIENAYTTEDITVQEPVPLPEDAPEDAEPQFKEVTKTIKKDVLGMTAKTF ALNPVELNDLIEKENELRNQDKLVAETEDRKNALEEYIYTLRAKLDDEYSDFASDAEKEK LKNMLATTENWLYGDGDDSTKAKYIAKYEELASLGNIIRGRYLAKEEEKRQALRANQETS KMNDIAEKLAEQRRARAASDDSDDNNDENMDLD*

[0408] SSE2 is encoded by a non-essential gene comprising an ORF that is 2.082 kbp in size and is located on chromosome II. A published nucleotide coding sequence of SSE2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00024 ATGAGCACTCCATTTGGCTTAGATTTAGGTAACAATAACTCAGTACTAGCAGTTGCCAGA AATAGGGGTATTGATGTCGTTGTCAATGAAGTTTCTAATAGGTCTACACCATCCTTGGTC GGCTTTGGCCCCAGAAATAGGTACTTAGGTGAATCTGGTAAAACTAAGCAAACATCGAAT GTTAAAAACACTGTGGAAAACTTGAAAAGAATCATTGGACTAAAGTTCAAAGACCCTGAA TTTGATATCGAGAATAAGTTCTTCACTTCGAAATTGGTACAGCTAAAAAATGGTAAAGTT GGTGTGGAAGTGGAGTTCGGCGGTAAAACACACGTATTTTCAGCTACTCAACTGACTGCT ATGTTCATTGATAAGGTGAAGCACACCGTTCAAGAGGAAACGAAGTCATCAATTACCGAT GTCTGCCTCGCAGTTCCTGTATGGTATTCGGAAGAACAACGTTATAACATAGCCGATGCT GCCAGAATTGCAGGATTAAATCCTGTAAGGATTGTCAACGATGTGACTGCAGCCGCCGTT TCGTACGGCGTCTTCAAGAATGATCTGCCAGGTCCTGAAGAAAAGCCAAGAATCATTGGC TTAGTGGACATTGGGCATTCTACCTACACCTGTTCTATTATGGCTTTCCGCAAAGGCGAA ATGAAAGTATTAGGTACTGCTTATGACAAGCACTTTGGTGGTAGAGATTTCGATCGCGCA ATCACAGAACATTTTGCTGATCAGTTTAAGGACAAGTACAAGATTGACATTAGGAAAAAT CCGAAAGCTTATAACAGAATTTTAATCGCTGCTGAAAAATTAAATAAAGTGCTTTCTGCG AACACTACTGCCCCCTTCTCCGTTGAATCTGTTATGGATGATATCGACGTTTCCTCTCAA TTGAGCCGTGAAGAGCTGGAAGAATTAGTAGAGCCCTTGTTGAAGCGTGTGACGTATCCA ATCACCAATGCATTGGCTCAAGCTAAATTAACTGTCAATGATATTGACTTCGTAGAAATA ATTGGTGGTACAACCCGTATCCCAGTTTTAAAGAAGTCAATTTCTGATGTTTTTGGAAAA CCTTTGTCATCTACTTTAAATCAAGACGAAGCTGTGGCCAAGGGGGCCGCTTTCATATGT GCCATTCACTCTCCAACTTTAAGGGTCAGGCCGTTTAAATTTGAAGATATTGATCCGTAT TCAGTGTCATACACTTGGGATAAGCAGGTCGATGACGAAGACCGTTTGGAAGTATTCCCT GCTAATTCATCATATCCATCAACTAAACTAATTACTTTACATCGTACTGGAGATTTCAGC ATGAAAGCGGTGTACACTCATCCTTCGAAACTGCCAAAAGGTACTTCCACCACTATTGCA AAATGGAGCTTCACTGGGGTCAAGGTTCCTAAAGATCAAGATTTTATTCCTGTAAAGGTC AAGTTAAGATGCGATCCTTCCGGCTTGCATATTATCGAGAACGCTTACACAACGGAAGAT ATTACGGTTCAAGAGCCAGTGCCTTTACCGGAAGACGCACCAGAAGATGCCGAGCCCCAG TTTAAAGAAGTTACTAAAACAATTAAGAAAGATGTGCTAGGTATGACTGCAAAAACATTC GCGCTAAACCCGGTTGAGTTGAACGATCTAATTGAAAAAGAGAATGAATTAAGAAACCAG GATAAGTTAGTTGCCGAAACCGAGGATCGCAAAAATGCCCTTGAAGAGTATATTTATACC CTTCGTGCCAAACTCGATGATGAATACTCCGATTTTGCGTCTGACGCAGAAAAAGAAAAG CTAAAAAACATGTTAGCCACTACTGAAAATTGGTTATATGGTGATGGTGACGATTCTACC AAGGCAAAATACATTGCTAAATATGAGGAGCTGGCATCGTTGGGGAATATTATTAGAGGT AGATATTTAGCAAAGGAGGAAGAAAAAAGACAAGCACTCAGAGCGAATCAAGAAACTTCT AAAATGAATGATATTGCTGAAAAATTGGCTGAGCAAAGAAGGGCACGCGCTGCAAGTGAT GATAGCGATGACAACAATGATGAAAACATGGACCTTGATTAA

[0409] Further information on SSE2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000373.

[0410] It will be appreciated that, by "SSE2", we include fragments or variants thereof having equivalent SSE2-like activity.

[0411] SSB1 is another S. cerevisiae helper protein of interest for the present invention and is also known as YG101. Ssb1p is a cytoplasmic ATPase that is a ribosome-associated molecular chaperone. It may be involved in the folding of newly-synthesized polypeptide chains and is a member of the heat shock protein 70 (HSP70) family. It interacts with the phosphatase subunit Reg1p. A published protein sequence for the protein Ssb1p is as follows:

TABLE-US-00025 MAEGVFQGAIGIDLGTTYSCVATYESSVEIIANEQGNRVTPSFVAFTPEERLIGDAAKNQ AALNPRNTVFDAKRLIGRRFDDESVQKDMKTWPFKVIDVDGNPVIEVQYLEETKTFSPQE ISAMVLTKMKEIAEAKIGKKVEKAVITVPAYFNDAQRQATKDAGAISGLNVLRIINEPTA AAIAYGLGAGKSEKERHVLIFDLGGGTFDVSLLHIAGGVYTVKSTSGNTHLGGQDFDTNL LEHFKAEFKKKTGLDISDDARALRRLRTAAERAKRTLSSVTQTTVEVDSLFDGEDFESSL TRARFEDLNAALFKSTLEPVEQVLKDAKISKSQIDEVVLVGGSTRIPKVQKLLSDFFDGK QLEKSINPDEAVAYGAAVQGAILTGQSTSDETKDLLLLDVAPLSLGVGMQGDMFGIVVPR NTTVPTIKRRTFTTCADNQTTVQFPVYQGERVNCKENTLLGEFDLKNIPMMPAGEPVLEA IFEVDANGILKVTAVEKSTGKSSNITISNAVGRLSSEEIEKMVNQAEEFKAADEAFAKKH EARQRLESYVASIEQTVTDPVLSSKLKRGSKSKIEAALSDALAALQIEDPSADELRKAEV GLKRVVTKAMSSR*

[0412] SSB1 is encoded by a non-essential gene comprising an ORF that is 1.842 kbp in size and is located on chromosome IV. A published nucleotide coding sequence of SSB1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00026 ATGGCTGAAGGTGTTTTCCAAGGTGCTATCGGTATCGATTTAGGTACAACCTACTCTTGT GTTGCTACTTACGAATCCTCCGTTGAAATTATTGCCAACGAACAAGGTAACAGAGTCACC CCATCTTTCGTTGCTTTCACTCCAGAAGAAAGATTGATTGGTGATGCTGCCAAGAACCAA GCTGCTTTGAACCCAAGAAACACTGTCTTCGATGCTAAGCGTTTGATTGGTAGAAGATTC GACGACGAATCTGTTCAAAAGGACATGAAGACCTGGCCTTTCAAGGTTATCGACGTCGAT GGTAACCCAGTCATCGAAGTCCAATACTTGGAAGAAACCAAGACTTTCTCCCCACAAGAA ATTTCCGCTATGGTTTTGACCAAGATGAAGGAAATTGCTGAAGCTAAGATTGGTAAGAAG GTTGAAAAGGCCGTCATTACTGTCCCAGCTTACTTTAACGACGCTCAAAGACAAGCTACC AAGGATGCCGGTGCCATTTCTGGTTTGAACGTTTTGCGTATCATCAACGAACCTACTGCC GCTGCTATTGCTTACGGTCTAGGTGCTGGTAAGTCCGAAAAGGAAAGACATGTTTTGATT TTCGATTTGGGTGGTGGTACTTTCGATGTTTCCTTGTTGCACATTGCTGGTGGTGTTTAC ACTGTTAAATCTACTTCCGGTAACACTCACTTGGGTGGTCAAGATTTCGACACCAACTTG TTGGAACACTTCAAGGCTGAATTCAAGAAGAAGACTGGTTTGGACATCTCCGACGATGCC AGAGCTTTGAGAAGATTGAGAACTGCTGCTGAAAGAGCTAAGAGAACCTTATCTTCTGTC ACTCAAACTACCGTTGAAGTTGACTCTTTGTTTGACGGTGAAGATTTCGAATCCTCTTTG ACTAGAGCTAGATTTGAAGACTTGAACGCCGCATTGTTCAAGTCTACTTTGGAACCTGTT GAACAAGTTTTGAAGGATGCTAAGATCTCTAAGTCTCAAATCGACGAAGTTGTCTTGGTT GGTGGTTCCACCAGAATTCCAAAGGTCCAAAAGTTGTTGTCTGACTTCTTTGACGGTAAG CAATTGGAAAAATCTATTAACCCAGATGAAGCTGTTGCTTACGGTGCTGCTGTTCAAGGT GCTATCTTGACCGGCCAATCCACATCTGACGAAACCAAGGACTTGTTGTTGTTAGATGTT GCTCCATTATCTCTAGGTGTTGGTATGCAAGGTGACATGTTCGGTATCGTTGTTCCAAGA AACACTACTGTTCCAACCATCAAGAGAAGAACCTTTACTACATGTGCTGACAACCAAACC ACCGTTCAATTCCCAGTCTACCAAGGTGAACGTGTTAACTGTAAAGAAAACACTTTGTTG GGTGAATTCGACTTGAAGAACATCCCAATGATGCCAGCTGGTGAACCAGTCTTGGAAGCT ATCTTCGAAGTTGATGCTAACGGTATCTTGAAGGTTACTGCCGTCGAAAAGTCTACCGGT AAGTCTTCTAACATCACTATCTCTAACGCTGTTGGTAGATTGTCTTCTGAAGAAATTGAA AAGATGGTTAACCAAGCTGAAGAGTTCAAGGCTGCCGATGAAGCTTTTGCCAAGAAGCAC GAAGCTAGACAAAGATTGGAATCCTACGTTGCCTCCATCGAACAAACTGTCACTGACCCA GTCTTGTCTTCTAAATTGAAGAGAGGTTCCAAGTCCAAGATTGAAGCTGCTTTGTCCGAT GCTTTGGCTGCTTTGCAAATCGAAGACCCATCTGCTGATGAATTGAGAAAGGCTGAAGTT GGTTTGAAGAGAGTTGTCACCAAGGCCATGTCTTCTCGTTAA

[0413] Further information on SSB1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000002388.

[0414] It will be appreciated that, by "SSB1", we include fragments or variants thereof having equivalent SSB1-like activity.

[0415] SSB2 is another S. cerevisiae helper protein of interest for the present invention. Ssb2p is a cytoplasmic ATPase that is a ribosome-associated molecular chaperone. It may be involved in the folding of newly-synthesized polypeptide chains. It is a member of the heat shock protein 70 (HSP70) family and is a homolog of SSB1. A published protein sequence for the protein Ssb2p is as follows:

TABLE-US-00027 MAEGVFQGAIGIDLGTTYSCVATYESSVEIIANEQGNRVTPSFVAFTPQERLIGDAAKNQ AALNPRNTVFDAKRLIGRRFDDESVQKDMKTWPFKVIDVDGNPVIEVQYLEETKTFSPQE ISAMVLTKMKEIAEAKIGKKVEKAVITVPAYFNDAQRQATKDAGAISGLNVLRIINEPTA AAIAYGLGAGKSEKERHVLIFDLGGGTFDVSLLHIAGGVYTVKSTSGNTHLGGQDFDTNL LEHFKAEFKKKTGLDISDDARALRRLRTAAERAKRTLSSVTQTTVEVDSLFDGEDFESSL TRARFEDLNAALFKSTLEPVEQVLKDAKISKSQIDEVVLVGGSTRIPKVQKLLSDFFDGK QLEKSINPDEAVAYGAAVQGAILTGQSTSDETKDLLLLDVAPLSLGVGMQGDIFGIVVPR NTTVPTIKRRTFTTVSDNQTTVQFPVYQGERVNCKENTLLGEFDLKNIPMMPAGEPVLEA IFEVDANGILKVTAVEKSTGKSSNITISNAVGRLSSEEIEKMVNQAEEFKAADEAFAKKH EARQRLESYVASIEQTVTDPVLSSKLKRGSKSKIEAALSDALAALQIEDPSADELRKAEV GLKRVVTKAMSSR*

[0416] SSB2 is encoded by a non-essential gene comprising an ORF that is 1.842 kbp in size and is located on chromosome XIV. A published nucleotide coding sequence of SSB2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00028 ATGGCTGAAGGTGTTTTCCAAGGTGCTATCGGTATCGATTTAGGTACAACATACTCTTGT GTTGCTACTTATGAATCTTCCGTTGAAATTATTGCCAACGAACAAGGTAACAGAGTTACT CCATCTTTCGTTGCCTTCACCCCACAGGAAAGATTGATCGGTGATGCTGCCAAGAACCAA GCTGCTTTGAACCCAAGAAACACTGTTTTTGATGCTAAGCGTTTGATTGGTAGAAGATTC GACGACGAGTCTGTCCAAAAGGACATGAAGACCTGGCCTTTCAAGGTTATCGACGTCGAT GGTAACCCAGTCATTGAAGTCCAATACTTGGAAGAAACCAAGACTTTCTCCCCACAAGAA ATTTCCGCTATGGTCTTGACCAAGATGAAGGAAATTGCTGAAGCTAAGATTGGTAAGAAG GTTGAAAAGGCTGTCATTACTGTCCCAGCTTACTTTAACGATGCCCAAAGACAAGCTACC AAGGATGCCGGTGCCATTTCTGGTTTGAACGTTTTGCGTATCATCAACGAACCTACTGCC GCTGCTATTGCTTACGGTCTAGGTGCTGGTAAGTCCGAAAAGGAAAGACATGTTTTGATT TTCGATTTGGGTGGTGGTACTTTCGATGTTTCCTTGTTGCACATTGCTGGTGGTGTTTAC ACTGTTAAATCTACTTCCGGTAACACTCACTTGGGTGGTCAAGATTTCGACACCAACTTG TTGGAACACTTCAAGGCTGAATTCAAGAAGAAGACTGGTTTGGACATCTCCGACGATGCC AGAGCTTTGAGAAGATTGAGAACTGCTGCTGAAAGAGCTAAGAGAACCTTATCTTCTGTC ACTCAAACTACCGTTGAAGTTGACTCTTTGTTTGACGGTGAAGATTTCGAATCCTCTTTG ACTAGAGCTAGATTTGAAGACTTGAACGCCGCATTGTTCAAGTCTACTTTGGAACCTGTT GAACAAGTTTTGAAGGATGCTAAGATCTCTAAGTCTCAAATCGACGAAGTTGTCTTGGTT GGTGGTTCTACCAGAATTCCAAAGGTCCAAAAGTTGTTGTCTGACTTCTTTGACGGTAAG CAATTGGAAAAATCTATTAACCCAGATGAAGCTGTTGCTTACGGTGCTGCTGTTCAAGGT GCTATCTTGACTGGCCAATCCACATCTGACGAAACCAAGGACTTGTTGTTGTTAGATGTT GCTCCATTATCTCTAGGTGTTGGTATGCAAGGTGACATTTTCGGTATTGTTGTCCCAAGA AACACAACTGTTCCAACCATCAAGAGAAGAACCTTCACAACTGTCAGTGACAACCAAACC ACCGTTCAATTCCCAGTCTACCAAGGTGAACGTGTCAACTGTAAAGAAAACACTTTGTTG GGTGAATTCGACTTGAAGAACATCCCAATGATGCCAGCTGGTGAACCAGTCTTGGAAGCT ATCTTCGAAGTTGATGCTAACGGTATCTTGAAGGTTACTGCCGTCGAAAAGTCTACCGGT AAGTCTTCTAACATCACTATCTCCAACGCTGTCGGTAGATTGTCTTCTGAAGAAATTGAA AAGATGGTTAACCAAGCCGAAGAGTTCAAGGCTGCTGATGAAGCTTTTGCTAAGAAGCAC GAAGCTAGACAAAGACTAGAATCCTACGTCGCTTCCATCGAACAAACCGTCACTGACCCA GTCTTGTCTTCTAAATTGAAGAGAGGTTCCAAGTCCAAGATCGAAGCTGCTTTGTCCGAT GCTTTGGCTGCTTTGCAAATCGAAGACCCATCCGCTGATGAGTTGAGAAAGGCAGAAGTT GGTTTGAAGAGAGTTGTCACCAAGGCCATGTCTTCTCGTTAA

[0417] Further information on SSB2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005153.

[0418] It will be appreciated that, by "SSB2", we include fragments or variants thereof having equivalent SSB2-like activity.

[0419] ECM10 is another S. cerevisiae helper protein of interest for the present invention and is also known as SSC3. Ecm10p is a heat shock protein of the Hsp70 family, which is localised in mitochondrial nucleoids. It is thought to play a role in protein translocation. It interacts with Mge1p in an ATP-dependent manner. Over-expression has been shown to induce extensive mitochondrial DNA aggregations. A published protein sequence for the protein Ecm10p is as follows:

TABLE-US-00029 MLPSWKAFKAHNILRILTRFQSTKIPDAVIGIDLGTTNSAVAIMEGKVPRIIENAEGSRT TPSVVAFTKDGERLVGEPAKRQSVINSENTLFATKRLIGRRFEDAEVQRDINQVPFKIVK HSNGDAWVEARNRTYSPAQIGGFILNKMKETAEAYLAKSVKNAVVTVPAYFNDAQRQATK DAGQIIGLNVLRVVNEPTAAALAYGLDKSEPKVIAVFDLGGGTFDISILDIDNGIFEVKS TNGDTHLGGEDFDIYLLQEIISHFKKETGIDLSNDRMAVQRIREAAEKAKIELSSTLSTE INLPFITADAAGPKHIRMPFSRVQLENITAPLIDRTVDPVKKALKDARITASDISDVLLV GGMSRMPKVADTVKKLFGKDASKAVNPDEAVALGAAIQAAVLSGEVTDVLLLDVTPLSLG IETLGGVFTKLIPRNSTIPNKKSQIFSTAASGQTSVEVKVFQGERELVKDNKLIGNFTLA GIPPAPKGTPQIEVTFDIDANGIINVSAKDLASHKDSSITVAGASGLSDTEIDRMVNEAE RYKNQDRARRNAIETANKADQLANDTENSIKEFEGKLDKTDSQRLKDQISSLRELVSRSQ AGDEVNDDDVGTKIDNLRTSSMKLFEQLYKNSDNPETKNGRENK*

[0420] ECM10 is encoded by a non-essential gene comprising an ORF that is 1.935 kbp in size and is located on chromosome V. A published nucleotide coding sequence of ECM10 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00030 ATGTTACCATCATGGAAAGCCTTTAAAGCACATAATATACTTCGTATTCTGACCCGTTTC CAGTCAACCAAAATTCCAGATGCAGTTATCGGTATTGATTTAGGTACTACCAATTCTGCG GTAGCTATTATGGAAGGTAAAGTTCCGAGAATTATCGAAAATGCAGAAGGCTCAAGAACT ACTCCGTCTGTAGTGGCTTTCACTAAAGACGGAGAACGTTTAGTTGGTGAGCCAGCCAAA CGACAATCCGTCATAAACTCAGAAAACACTTTGTTTGCTACTAAGCGTTTAATCGGCCGC CGTTTCGAGGACGCTGAAGTCCAAAGAGATATTAATCAGGTTCCTTTCAAAATCGTCAAG CATTCTAATGGAGATGCCTGGGTAGAGGCTAGAAACAGAACGTACTCCCCCGCCCAAATA GGAGGTTTTATCTTAAATAAAATGAAGGAAACAGCGGAGGCTTACTTAGCGAAGAGCGTC AAAAATGCTGTTGTCACCGTTCCTGCTTACTTCAATGATGCCCAAAGACAAGCTACTAAA GACGCAGGACAAATTATTGGGCTTAATGTATTACGTGTTGTCAACGAACCAACAGCTGCT GCCCTAGCTTACGGTCTAGATAAATCAGAGCCAAAAGTCATTGCTGTTTTCGACTTGGGC GGTGGTACTTTCGATATTTCAATCCTGGACATCGATAACGGTATCTTTGAGGTTAAATCT ACCAATGGTGACACCCATTTGGGTGGCGAAGATTTTGACATTTATTTGTTGCAAGAAATT ATTTCTCATTTCAAGAAAGAAACCGGTATCGATTTGAGTAATGACCGTATGGCTGTCCAA AGAATAAGAGAAGCCGCTGAAAAGGCTAAAATCGAACTGTCTTCTACACTCTCTACAGAA ATAAACTTGCCTTTCATAACTGCTGATGCTGCAGGCCCAAAGCATATTCGTATGCCCTTT TCTAGGGTTCAGCTTGAGAATATAACCGCCCCATTGATTGATAGAACGGTTGATCCTGTC AAAAAAGCACTGAAAGACGCAAGAATTACCGCCTCAGATATATCGGATGTTTTATTAGTT GGTGGTATGTCAAGGATGCCCAAGGTTGCAGATACTGTAAAGAAATTATTCGGTAAGGAT GCATCAAAAGCTGTTAACCCTGATGAAGCAGTCGCTTTAGGGGCCGCTATACAGGCTGCG GTCTTGTCTGGTGAAGTTACCGATGTTTTGTTGCTAGATGTCACTCCCCTATCATTGGGT ATTGAAACTTTAGGAGGAGTTTTTACAAAATTAATCCCAAGAAATTCTACAATTCCCAAT AAGAAATCTCAAATTTTTTCAACTGCGGCATCAGGTCAAACATCGGTGGAAGTTAAAGTT TTCCAAGGTGAGAGGGAGTTAGTCAAGGATAACAAATTAATAGGTAATTTTACTCTTGCG GGCATTCCTCCAGCTCCAAAAGGTACCCCACAAATTGAAGTCACTTTTGATATCGATGCG AACGGCATCATCAACGTTTCAGCAAAAGATCTCGCCAGCCACAAAGACTCTTCCATCACT GTTGCCGGAGCGTCTGGGCTATCTGATACGGAGATTGATCGAATGGTTAATGAAGCGGAA AGATATAAAAATCAGGATAGAGCCAGAAGGAATGCCATCGAAACCGCTAACAAAGCTGAC CAGCTAGCTAATGACACAGAAAATTCCATTAAGGAATTCGAAGGTAAGCTAGATAAAACT GATTCTCAAAGACTAAAAGATCAAATTTCATCCTTAAGGGAATTGGTTTCTCGGAGTCAA GCTGGAGATGAGGTTAATGATGACGATGTTGGAACAAAAATTGACAATTTGCGAACTTCA TCGATGAAACTTTTTGAACAGTTATACAAGAACAGTGACAATCCTGAAACTAAGAACGGG AGAGAAAATAAATAA

[0421] Further information on ECM10 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000756.

[0422] It will be appreciated that, by "ECM10", we include fragments or variants thereof having equivalent ECM10-like activity.

[0423] MDJ1 is another S. cerevisiae helper protein of interest for the present invention. Mdj1p is a protein involved in folding of mitochondrially synthesised proteins in the mitochondrial matrix. It localises to the mitochondrial inner membrane and is a member of the DnaJ family of molecular chaperones. A published protein sequence for the protein Mdj1p is as follows:

TABLE-US-00031 MAFQQGVLSRCSGVFRHHVGHSRHINNILYRHAIAFASIAPRIPKSSFHTSAIRNNEAFK DPYDTLGLKKSATGAEIKKAYYKLAKKYHPDINKEPDAEKKFHDLQNAYEILSDETKRQQ YDQFGPAAFGGGGAAGGAGGGSGSPFGSQFHDFSGFTSAGGSPFGGINFEDLFGAAFGGG GRGSGGASRSSSMFRQYRGDPIEIVHKVSFKDAVFGSKNVQLRFSALDPCSTCSGTGMKP NTHKVSCSTCHGTGTTVHIRGGFQMMSTCPTCNGEGTMKRPQDNCTKCHGEGVQVNRAKT ITVDLPHGLQDGDVVRIPGQGSYPDIAVEADLKDSVKLSRGDILVRIRVDKDPNFSIKNK YDIWYDKEIPITTAALGGTVTIPTVEGQKIRIKVAPGTQYNQVISIPNMGVPKTSTIRGD MKVQYKIVVKKPQSLAEKCLWEALADVTNDDMAKKTMQPGTAAGTAINEEILKKQKQEEE KHAKKDDDNTLKRLENFITNTFRKIKGDKKN*

[0424] MDJ1 is encoded by a non-essential gene comprising an ORF that is 1.536 kbp in size and is located on chromosome VI. A published nucleotide coding sequence of MDJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00032 ATGGCTTTCCAACAAGGTGTATTGTCAAGGTGTTCCGGTGTCTTTAGACACCATGTGGGA CATTCTCGCCATATCAATAATATTCTTTATAGACATGCCATCGCGTTTGCATCCATCGCT CCACGAATACCAAAATCTAGCTTCCATACTTCTGCAATCAGAAACAACGAAGCATTCAAG GACCCGTACGATACTTTAGGCTTGAAGAAATCTGCTACAGGTGCGGAAATCAAAAAAGCA TACTACAAACTGGCAAAGAAGTACCACCCGGATATCAACAAGGAACCGGATGCTGAGAAG AAATTCCACGATTTACAGAACGCTTATGAAATTCTGTCAGACGAAACGAAGAGGCAGCAG TACGATCAATTTGGGCCCGCTGCCTTCGGCGGCGGCGGTGCCGCTGGAGGTGCCGGTGGT GGTAGTGGCTCTCCCTTTGGTTCCCAATTTCATGATTTCTCAGGATTCACCAGTGCAGGC GGCTCGCCATTTGGCGGTATCAATTTTGAAGACCTGTTTGGTGCTGCATTTGGTGGTGGT GGCCGCGGTAGCGGTGGCGCAAGCAGGTCGTCATCTATGTTCAGACAATATAGGGGCGAC CCAATCGAGATTGTCCATAAAGTGTCTTTCAAGGACGCAGTGTTTGGGTCCAAGAACGTT CAGTTAAGATTCTCTGCGCTGGACCCTTGTAGTACCTGTTCAGGGACGGGAATGAAACCA AACACGCATAAGGTCAGTTGTAGCACTTGTCACGGAACAGGAACCACTGTTCACATTAGG GGCGGATTTCAGATGATGTCGACTTGTCCTACTTGCAACGGTGAAGGTACCATGAAACGG CCTCAGGACAATTGTACCAAGTGCCATGGTGAGGGTGTTCAGGTCAACAGGGCAAAGACA ATTACGGTGGACTTGCCACATGGATTACAGGACGGCGACGTGGTCAGGATCCCTGGCCAA GGCTCATACCCTGACATCGCTGTAGAGGCGGACTTGAAAGATTCAGTCAAGTTATCAAGA GGTGATATTTTGGTGAGAATTCGTGTCGACAAGGATCCCAACTTTTCGATAAAGAACAAG TACGATATTTGGTACGACAAGGAGATTCCTATAACCACAGCTGCACTTGGTGGTACTGTC ACTATCCCCACTGTGGAGGGACAAAAGATCAGGATAAAGGTCGCTCCAGGGACTCAATAC AATCAAGTGATATCCATTCCTAACATGGGTGTTCCTAAAACATCAACCATTCGCGGTGAT ATGAAAGTCCAGTACAAGATCGTTGTTAAGAAACCGCAATCGCTGGCAGAAAAATGCTTG TGGGAGGCACTGGCAGATGTCACCAACGATGACATGGCCAAGAAAACCATGCAACCGGGC ACAGCCGCGGGTACAGCCATTAATGAAGAGATACTGAAGAAACAAAAACAAGAAGAGGAA AAACACGCAAAAAAGGATGACGACAACACTTTGAAGAGACTAGAAAATTTCATTACCAAC ACATTCAGGAAGATCAAAGGTGACAAAAAAAATTAA

[0425] Further information on MDJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000001878.

[0426] It will be appreciated that, by "MDJ1", we include fragments or variants thereof having equivalent MDJ1-like activity.

[0427] MDJ2 is another S. cerevisiae helper protein of interest for the present invention. Mdj2p is a protein of the mitochondrial inner membrane. Its function partially overlaps that of Mdj1p, which is a chaperone involved in folding of mitochondrially synthesised proteins in the mitochondrial matrix. It is a member of the DnaJ family. A published protein sequence for the protein Mdj2p is as follows:

TABLE-US-00033 MVLPIIIGLGVTMVALSVKSGLNAWTVYKTLSPLTIAKLNNIRIENPTA GYRDALKFKSSLIDEELKNRLNQYQGGFAPRMTEPEALLILDISAREIN HLDEKLLKKKHRKAMVRNHPDRGGSPYMAAKINEAKEVLERSVLLRKR*

[0428] MDJ2 is encoded by a non-essential gene comprising an ORF that is 0.441 kbp in size and is located on chromosome XIV. A published nucleotide coding sequence of MDJ2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00034 ATGGTTTTGCCTATAATAATTGGTTTGGGCGTGACAATGGTTGCTCTAAGTGTCAAGTCT GGTCTCAATGCATGGACCGTCTACAAGACCCTGTCCCCTTTAACTATTGCAAAACTAAAT AACATTCGCATAGAAAACCCGACGGCGGGCTACCGCGATGCACTTAAGTTCAAAAGCTCA CTGATAGACGAAGAACTGAAAAATAGATTAAACCAGTACCAGGGAGGCTTTGCACCGCGA ATGACAGAGCCCGAAGCCTTGCTCATCTTGGATATCTCCGCCAGAGAGATTAATCACTTG GATGAAAAATTACTGAAAAAAAAGCACAGGAAGGCTATGGTTCGTAACCACCCAGACAGA GGAGGGAGTCCCTACATGGCGGCCAAGATAAATGAGGCGAAAGAAGTTCTCGAAAGAAGT GTTTTACTAAGAAAGAGATAA

[0429] Further information on MDJ2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005272.

[0430] It will be appreciated that, by "MDJ2", we include fragments or variants thereof having equivalent MDJ2-like activity.

[0431] ERO1 is another S. cerevisiae helper protein of interest for the present invention. EroIp is a glycoprotein required for oxidative protein folding in the endoplasmic reticulum. A published protein sequence for the protein Ero1p is as follows:

TABLE-US-00035 MRLRTAIATLCLTAFTSATSNNSYIATDQTQNAFNDTHFCKVDRNDHVSPSCNVTFNELN AINENIRDDLSALLKSDFFKYFRLDLYKQCSFWDANDGLCLNRACSVDVVEDWDTLPEYW QPEILGSFNNDTMKEADDSDDECKFLDQLCQTSKKPVDIEDTINYCDVNDFNGKNAVLID LTANPERFTGYGGKQAGQIWSTIYQDNCFTIGETGESLAKDAFYRLVSGFHASIGTHLSK EYLNTKTGKWEPNLDLFMARIGNFPDRVTNMYFNYAVVAKALWKIQPYLPEFSFCDLVNK EIKNKMDNVISQLDTKIFNEDLVFANDLSLTLKDEFRSRFKNVTKIMDCVQCDRCRLWGK IQTTGYATALKILFEINDADEFTKQHIVGKLTKYELIALLQTFGRLSESIESVNMFEKMY GKRLNGSENRLSSFFQNNFFNILKEAGKSIRYTIENINSTKEGKKKTNNSQSHVFDDLKM PKAEIVPRPSNGTVNKWKKAWNTEVNNVLEAFRFIYRSYLDLPRNIWELSLMKVYKFWNK FIGVADYVSEETREPISYKLDIQ*

[0432] ERO1 is encoded by an essential gene comprising an ORF that is 1.692 kbp in size and is located on chromosome XIII. A published nucleotide coding sequence of ERO1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00036 ATGAGATTAAGAACCGCCATTGCCACACTGTGCCTCACGGCTTTTACATCTGCAACTTCA AACAATAGCTACATCGCCACCGACCAAACACAAAATGCCTTTAATGACACTCACTTTTGT AAGGTCGACAGGAATGATCACGTTAGTCCCAGTTGTAACGTAACATTCAATGAATTAAAT GCCATAAATGAAAACATTAGAGATGATCTTTCGGCGTTATTAAAATCTGATTTCTTCAAA TACTTTCGGCTGGATTTATACAAGCAATGTTCATTTTGGGACGCCAACGATGGTCTGTGC TTAAACCGCGCTTGCTCTGTTGATGTCGTAGAGGACTGGGATACACTGCCTGAGTACTGG CAGCCTGAGATCTTGGGTAGTTTCAATAATGATACAATGAAGGAAGCGGATGATAGCGAT GACGAATGTAAGTTCTTAGATCAACTATGTCAAACCAGTAAAAAACCTGTAGATATCGAA GACACCATCAACTACTGTGATGTAAATGACTTTAACGGTAAAAACGCCGTTCTGATTGAT TTAACAGCAAATCCGGAACGATTTACAGGTTATGGTGGTAAGCAAGCTGGTCAAATTTGG TCTACTATCTACCAAGACAACTGTTTTACAATTGGCGAAACTGGTGAATCATTGGCCAAA GATGCATTTTATAGACTTGTATCCGGTTTCCATGCCTCTATCGGTACTCACTTATCAAAG GAATATTTGAACACGAAAACTGGTAAATGGGAGCCCAATCTGGATTTGTTTATGGCAAGA ATCGGGAACTTTCCTGATAGAGTGACAAACATGTATTTCAATTATGCTGTTGTAGCTAAG GCTCTCTGGAAAATTCAACCATATTTACCAGAATTTTCATTCTGTGATCTAGTCAATAAA GAAATCAAAAACAAAATGGATAACGTTATTTCCCAGCTGGACACAAAAATTTTTAACGAA GACTTAGTTTTTGCCAACGACCTAAGTTTGACTTTGAAGGACGAATTCAGATCTCGCTTC AAGAATGTCACGAAGATTATGGATTGTGTGCAATGTGATAGATGTAGATTGTGGGGCAAA ATTCAAACTACCGGTTACGCAACTGCCTTGAAAATTTTGTTTGAAATCAACGACGCTGAT GAATTCACCAAACAACATATTGTTGGTAAGTTAACCAAATATGAGTTGATTGCACTATTA CAGACTTTCGGTAGATTATCTGAATCTATTGAATCTGTTAACATGTTCGAAAAAATGTAC GGGAAAAGGTTAAACGGTTCTGAAAACAGGTTAAGCTCATTCTTCCAAAATAACTTCTTC AACATTTTGAAGGAGGCAGGCAAATCGATTCGTTACACCATAGAGAACATCAATTCCACT AAAGAAGGAAAGAAAAAGACTAACAATTCTCAATCACATGTATTTGATGATTTAAAAATG CCCAAAGCAGAAATAGTTCCAAGGCCCTCTAACGGTACAGTAAATAAATGGAAGAAAGCT TGGAATACTGAAGTTAACAACGTTTTAGAAGCATTCAGATTTATTTATAGAAGCTATTTG GATTTACCCAGGAACATCTGGGAATTATCTTTGATGAAGGTATACAAATTTTGGAATAAA TTCATCGGTGTTGCTGATTACGTTAGTGAGGAGACACGAGAGCCTATTTCCTATAAGCTA GATATACAATAA

[0433] Further information on ERO1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000004599.

[0434] It will be appreciated that, by "ERO1", we include fragments or variants thereof having equivalent ERO1-like activity.

[0435] ERV2 is another S. cerevisiae helper protein of interest for the present invention. Erv2p is a flavin-linked sulfhydryl oxidase localised to the endoplasmic reticulum lumen, involved in disulphide bond formation within the ER. A published protein sequence for the protein Erv2p is as follows:

TABLE-US-00037 MKQIVKRSHAIRIVAALGIIGLWMFFSSNELSIATPGLIKAKSGIDEVQG AAAEKNDARLKEIEKQTIMPLMGDDKVKKEVGRASWKYFHTLLARFPDEP TPEEREKLHTFIGLYAELYPCGECSYHFVKLIEKYPVQTSSRTAAMWA GCHIHNKVNEYLKKDIYDCATILEDYDCGCSDSDGKRVSLEKEAKQHG*

[0436] ERV2 is encoded by a non-essential gene comprising an ORF that is 0.591 kbp in size, located on chromosome XVI. A published nucleotide coding sequence of ERV2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00038 ATGAAACAGATAGTCAAAAGAAGCCATGCCATCAGAATAGTTGCAGCATTAGGAATCATA GGCCTGTGGATGTTTTTCTCGTCTAATGAACTATCCATCGCTACGCCGGGCCTAATCAAG GCGAAGTCTGGTATAGATGAAGTGCAAGGGGCGGCTGCTGAGAAGAACGACGCTCGGTTG AAAGAGATCGAGAAGCAAACCATTATGCCATTGATGGGCGATGACAAGGTGAAGAAGGAA GTGGGCAGGGCGTCGTGGAAGTACTTCCATACCCTGCTGGCCCGTTTTCCGGACGAGCCT ACTCCTGAAGAAAGAGAGAAACTGCACACGTTTATTGGGTTGTATGCAGAACTCTATCCA TGCGGGGAATGTTCATATCACTTTGTAAAGTTGATTGAGAAGTATCCCGTACAGACATCT AGCAGGACGGCTGCCGCAATGTGGGGATGCCACATTCACAACAAGGTGAACGAATACCTA AAGAAAGACATATATGACTGTGCTACCATCCTGGAGGACTACGATTGTGGATGTAGTGAC AGCGACGGTAAACGCGTGTCTCTCGAGAAGGAGGCTAAACAGCACGGTTGA

[0437] Further information on ERV2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000006241.

[0438] It will be appreciated that, by "ERV2", we include fragments or variants thereof having equivalent ERV2-like activity.

[0439] EUG1 is another S. cerevisiae helper protein of interest for the present invention. Eug1p is a protein disulphide isomerase of the endoplasmic reticulum lumen, with an overlapping function with Pdi1p. It may interact with nascent polypeptides in the ER. A published protein sequence for the protein Eug1p is as follows:

TABLE-US-00039 MQVTTRFISAIVSFCLFASFTLAENSARATPGSDLLVLTEKKFKSFIESHPLVLVEFFAP WCLHSQILRPHLEEAASILKEHNVPVVQIDCEANSMVCLQQTINTYPTLKIFKNGRIFDG QVYRGVKITDEITQYMIQLYEASVIYLNSEDEIQPYLENATLPVVINRGLTGLNETYQEV ALDLAEDYVFLSLLDSEDKSLSIHLPNTTEPILFDGNVDSLVGNSVALTQWLKVVILPYF TDIEPDLFPKYISSNLPLAYFFYTSEEELEDYTDLFTQLGKENRGQINFIALNSTMFPHH VRFLNMREQFPLFAIHNMINNLKYGLPQLPEEEYAKLEKPQPLDRDMIVQLVKDYREGTA KPIVKSEEIPKEQKSNVYKIVGKTHDDIVHDDDKDVLVKYYATWCIHSKRFAPIYEEIAN VLASDESVRDKILIAEVDSGANDILSFPVTGYPTIALYPAGNNSKPIIFNKIRNLEDVFE FIKESGTHHIDGQAIYDKLHQAKDSEVSTEDTVHDEL*

[0440] EUG1 is encoded by a non-essential gene comprising an ORF that is 1.554 kbp in size and is located on chromosome IV. A published nucleotide coding sequence of EUG1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00040 ATGCAAGTGACCACAAGATTTATATCTGCGATAGTCTCGTTTTGCCTGTTTGCTTCTTTC ACGTTGGCTGAAAACAGCGCAAGAGCTACGCCGGGATCAGATTTACTCGTTCTAACAGAG AAGAAATTTAAATCATTCATCGAATCTCATCCGTTAGTCCTCGTCGAGTTTTTTGCTCCA TGGTGTTTGCATTCTCAGATCTTACGCCCTCACTTAGAAGAGGCCGCCTCTATTTTAAAG GAGCATAACGTCCCAGTTGTTCAAATTGATTGTGAGGCTAACAGTATGGTTTGCCTGCAA CAAACTATAAATACCTACCCAACCTTGAAAATCTTTAAAAATGGTCGTATTTTTGATGGT CAAGTCTATCGCGGTGTCAAGATCACCGATGAAATCACTCAGTACATGATTCAGCTATAC GAGGCTTCTGTCATTTATTTAAATTCCGAAGATGAAATCCAACCATACTTGGAAAATGCA ACTTTACCAGTAGTAATAAACAGAGGCTTGACAGGCTTGAATGAAACGTATCAAGAAGTC GCACTGGACCTTGCTGAGGATTACGTCTTTTTATCCCTTCTAGATTCAGAAGATAAGTCA TTATCAATCCACTTGCCAAACACTACAGAACCAATTCTGTTTGATGGAAATGTAGACTCT TTGGTCGGAAATTCCGTTGCTCTAACTCAGTGGTTAAAAGTGGTAATTTTACCTTACTTT ACCGACATCGAACCTGATCTCTTCCCCAAGTACATTTCTAGCAATTTGCCGTTGGCTTAC TTCTTTTATACTTCTGAGGAAGAATTGGAAGATTACACTGATCTTTTCACGCAGTTAGGT AAGGAAAATCGTGGCCAAATAAATTTCATTGCATTAAACTCTACAATGTTCCCACACCAC GTTAGATTCCTAAATATGAGAGAACAGTTCCCATTATTTGCTATCCATAATATGATCAAT AATCTGAAATATGGTTTACCACAACTACCAGAAGAAGAGTACGCGAAATTAGAAAAACCA CAACCACTAGACAGAGATATGATCGTTCAGTTGGTAAAAGATTACCGTGAAGGTACTGCC AAGCCAATTGTTAAGTCAGAAGAGATTCCAAAAGAACAAAAGTCCAATGTTTATAAAATA GTTGGGAAGACACATGACGACATTGTTCATGATGATGACAAGGATGTCCTTGTCAAATAT TACGCGACATGGTGTATTCATAGTAAAAGGTTTGCGCCTATTTACGAAGAAATTGCAAAT GTCTTAGCATCTGATGAATCTGTTCGCGATAAAATCTTGATCGCCGAAGTAGATTCAGGG GCAAATGATATCTTAAGTTTTCCTGTGACAGGATATCCAACCATTGCTTTGTATCCTGCC GGAAATAACTCTAAGCCTATTATCTTCAATAAAATTAGAAATTTGGAAGATGTTTTCGAA TTTATCAAGGAATCAGGTACACATCACATTGACGGCCAGGCAATTTATGATAAATTGCAC CAGGCCAAGGATTCTGAAGTGTCTACTGAAGATACCGTACATGATGAATTATAA

[0441] Further information on EUG1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000002926.

[0442] It will be appreciated that, by "EUG1", we include fragments or variants thereof having equivalent EUG1-like activity.

[0443] MPD1 is another S. cerevisiae helper protein of interest for the present invention. Mpd1p is a member of the protein disulphide isomerase (PDI) family. Its over-expression suppresses the defect in maturation of carboxypeptidase Y, and defects in other essential Pdi1p functions that can be caused by PDI1 deletion. A published protein sequence for the protein Mpd1p is as follows:

TABLE-US-00041 MLFLNIIKLLLGLFIMNEVKAQNFYDSDPHISELTPKSFDKAIHNTNYTS LVEFYAPWCGHCKKLSSTFRKAAKRLDGVVQVAAVNCDLNKNKALCAKYD VNGFPTLMVFRPPKIDLSKPIDNAKKSFSAHANEVYSGARTLAPIVDFSL SRIRSYVKKFVRIDTLGSLLRKSPKLSVVLFSKQDKISPVYKSIALDWLG KFDFYSISNKKLKQLTDMNPTYEKTPEIFKYLQKVIPEQRQSDKSKLVVF DADKDKFWEYEGNSINKNDISKFLRDTFSITPNEGPFSRRSEYIAYLKTG KKPIKKNHSSSGNKHDEL*

[0444] MPD1 is encoded by a non-essential gene comprising an ORF that is 0.957 kbp in size and is located on chromosome XV. A published nucleotide coding sequence of MPD1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00042 ATGTTATTTCTTAATATTATTAAGCTCCTTTTGGGACTTTTTATTATGAATGAAGTAAAG GCGCAAAACTTTTACGATTCCGATCCTCATATATCAGAGTTAACGCCAAAAAGCTTCGAT AAAGCGATCCATAACACAAATTACACATCATTAGTGGAATTTTATGCTCCGTGGTGCGGC CATTGTAAGAAGCTCTCTAGTACGTTCCGCAAGGCAGCAAAAAGATTGGATGGTGTAGTC CAAGTTGCTGCTGTAAACTGTGACCTTAACAAGAATAAGGCTTTGTGTGCTAAATACGAC GTAAACGGATTTCCCACGTTAATGGTATTTAGGCCCCCAAAAATTGACCTATCTAAGCCA ATAGATAACGCCAAAAAAAGTTTCAGCGCTCATGCCAATGAAGTGTACTCAGGTGCAAGA ACTCTCGCGCCTATTGTTGATTTTTCTCTTTCAAGAATAAGGTCATATGTCAAAAAGTTT GTCCGTATAGATACACTTGGCTCTTTACTTAGAAAGTCACCCAAACTTTCCGTGGTGTTG TTTTCCAAACAAGACAAAATTTCACCGGTTTATAAAAGCATTGCCCTTGATTGGTTAGGA AAGTTCGATTTTTATTCAATTTCAAACAAAAAACTCAAGCAACTAACCGATATGAACCCA ACATATGAAAAAACTCCTGAGATTTTCAAATATTTGCAGAAGGTCATTCCTGAACAGCGA CAGAGCGATAAAAGTAAGCTTGTCGTTTTTGATGCAGACAAAGATAAATTTTGGGAGTAT GAAGGGAACTCAATCAACAAAAATGACATTTCCAAATTTCTGCGGGACACTTTTAGTATT ACCCCCAATGAGGGTCCTTTTAGTAGACGTTCTGAATATATTGCTTACTTAAAAACTGGC AAGAAGCCAATTAAAAAGAACCATTCCTCCTCAGGAAACAAGCACGACGAATTGTAG

[0445] Further information on MPD1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005814.

[0446] It will be appreciated that, by "MPD1", we include fragments or variants thereof having equivalent MPD1-like activity.

[0447] MPD2 is another S. cerevisiae helper protein of interest for the present invention. Mpd2p is a member of the protein disulphide isomerase (PDI) family. It exhibits chaperone activity. Its overexpression suppresses the lethality of a PDI1 deletion but does not complement all Pdi1p functions. It undergoes oxidation by Ero1p. A published protein sequence for the protein Mpd2p is as follows:

TABLE-US-00043 MKLHGFLFSVLSTCVVILPALAYSEAVTMVKSIEQYFDICNRNDSYTMIK YYTSWCQHCKTLAPVYEELGELYAKKANKDDTPINFLEVNCEFFGPTLCT DLPGFPIIELVKPRTKPLVLPKLDWSSMKFHERLWQRIKTWFNNPKYQLD TSRVVRFEGSRNLKSLSNFIDTVRSKDTEERFIEHIFDDSRNCNEELRSQ QLLCKAGKEYYSDTLSKLYGDVNGLEKERRRLEALIKQNGDDLSKEVKEK LKIIRLQLSLLSHIEDQLEDTSSHDEL*

[0448] MPD2 is encoded by a non-essential gene comprising an ORF that is 0.834 kbp in size and is located on chromosome XV. A published nucleotide coding sequence of MPD2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00044 ATGAAATTGCACGGCTTTTTATTTTCCGTATTATCAACATGCGTCGTCATTTTACCAGCG TTGGCCTACAGTGAAGCTGTCACGATGGTCAAGTCGATTGAGCAGTACTTCGATATCTGC AATAGGAATGATTCTTACACAATGATAAAATACTACACTTCTTGGTGCCAACATTGTAAA ACTCTGGCCCCAGTATACGAAGAGCTTGGTGAGCTATACGCCAAAAAAGCTAATAAAGAT GATACCCCAATTAACTTCCTTGAAGTTAACTGTGAATTCTTCGGGCCAACTTTATGTACC GACTTGCCTGGATTTCCAATAATTGAACTGGTCAAACCTCGTACTAAGCCCTTAGTTCTT CCGAAGCTCGATTGGTCGTCTATGAAATTTCATGAAAGACTATGGCAAAGAATCAAGACG TGGTTCAACAATCCTAAGTACCAACTGGATACGTCTAGGGTTGTTCGTTTTGAAGGGAGT AGGAACCTAAAGAGTTTAAGCAACTTTATCGATACTGTAAGAAGTAAAGATACAGAAGAA AGATTCATAGAACATATTTTCGATGATTCTAGGAATTGCAATGAAGAATTACGTTCTCAA CAGCTTCTGTGTAAAGCTGGTAAAGAATACTACTCTGATACTTTATCTAAATTATACGGT GACGTGAATGGGCTGGAAAAGGAAAGGCGAAGACTAGAAGCTTTAATTAAGCAAAATGGA GATGACTTGAGTAAAGAAGTTAAAGAAAAACTGAAAATCATTCGTCTACAATTGAGCCTA TTATCACACATAGAAGACCAGTTAGAAGATACCAGTAGTCATGACGAGCTTTGA

[0449] Further information on MPD2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005448.

[0450] It will be appreciated that, by "MPD2", we include fragments or variants thereof having equivalent MPD2-like activity.

[0451] EPS1 is another S. cerevisiae helper protein of interest for the present invention. Eps1p is a Pdi1p (protein disulphide isomerase)-related protein involved in endoplasmic reticulum retention of resident ER proteins. A published protein sequence for the protein Eps1p is as follows:

TABLE-US-00045 MKMNLKRLVVTFFSCITFLLKFTIAAAEPPEGFPEPLNPTNFKEELSKGLHIIDFYSPYC PHCKHLAPVWMETWEEFKEESKTLNITFSQVNCIESADLCGDENIEYFPEIRLYNPSGYI KSFTETPRTKESLIAFARRESMDPNNLDTDLDSAKSESQYLEGFDFLELIAGKATRPHLV SFWPTKDMKNSDDSLEFKNCDKCHEFQRTWKIISRQLAVDDINTGHVNCESNPTICEELG FGDLVKITNHRADREPKVALVLPNKTSNNLFDYPNGYSAKSDGYVDFARRTFTNSKFPNI TEGELEKKANRDIDFLQERGRVTNNDIHLVFSYDPETVVIEDFDILEYLIEPLSKIPNIY LHQIDKNLINLSRNLFGRMYEKINYDASQTQKVFNKEYFTMNTVTQLPTFFMFKDGDPIS YVFPGYSTTEMRNIDAIMDWVKKYSNPLVTEVDSSNLKKLISFQTKSYSDLAIQLISSTD HKHIKGSNKLIKNLLLASWEYEHIRMENNFEEINERRARKADGIKKIKEKKAPANKIVDK MREEIPHMDQKKLLLGYLDISKEKNFFRKYGITGEYKIGDVIIIDKSNNYYYNKDNFGNS LTSNNPQLLREAFVSLNIPSKALYSSKLKGRLINSPFHNVLSFLDIIHGNGMPGYLIVIV LFIAILKGPSIYRRYKVRKHYRAKRNAVGILGNMEKKKNQD*

[0452] EPS1 is a non-essential gene comprising an ORF that is 2.106 kbp in size and is located on chromosome IX. A published nucleotide coding sequence of EPS1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00046 ATGAAAATGAATCTGAAAAGGCTCGTAGTTACCTTCTTCTCATGCATCACCTTTCTGCTG AAATTCACTATAGCCGCCGCTGAACCACCAGAGGGCTTTCCAGAGCCCTTAAATCCAACA AACTTCAAAGAAGAGCTATCTAAGGGGCTGCATATTATTGACTTCTATAGTCCATACTGT CCGCACTGCAAACATTTAGCACCTGTTTGGATGGAAACATGGGAGGAGTTTAAAGAGGAG AGCAAAACACTGAACATAACATTTTCACAGGTTAACTGCATCGAGAGCGCCGATTTGTGT GGAGATGAAAATATTGAATACTTCCCTGAAATTAGACTTTATAACCCCTCAGGATACATC AAATCGTTCACTGAAACACCGAGGACCAAAGAATCATTAATTGCATTTGCACGCAGGGAG TCTATGGACCCAAATAACCTCGATACTGATCTGGATTCTGCTAAAAGTGAGAGCCAGTAT CTCGAAGGCTTTGATTTTCTCGAGCTGATCGCTGGTAAGGCGACTAGGCCACATTTGGTT TCCTTCTGGCCAACAAAAGATATGAAAAATAGCGATGATTCACTAGAATTCAAAAACTGT GACAAATGCCATGAATTCCAAAGGACTTGGAAGATCATTTCAAGACAGTTAGCCGTGGAT GATATCAACACGGGCCACGTTAATTGCGAATCTAATCCAACAATCTGTGAAGAACTGGGC TTTGGCGACTTGGTGAAAATAACCAACCACAGAGCCGATAGAGAACCCAAGGTAGCATTA GTCCTACCCAATAAAACCTCAAATAATTTGTTCGACTATCCCAATGGCTACTCAGCGAAG TCAGATGGCTATGTAGATTTTGCCAGGAGGACTTTTACAAACAGTAAATTTCCCAATATA ACAGAAGGGGAGCTCGAAAAAAAAGCAAACAGAGACATTGATTTTCTGCAAGAAAGGGGA CGAGTAACTAATAATGATATCCATTTAGTTTTTTCATATGACCCCGAAACTGTTGTTATT GAAGATTTTGACATTTTGGAGTATTTAATCGAGCCTTTGTCAAAAATTCCAAACATATAT TTGCACCAAATTGACAAGAATCTAATAAATTTGTCACGTAATCTTTTTGGAAGAATGTAT GAAAAGATCAACTACGACGCCAGCCAAACTCAAAAGGTTTTTAACAAAGAATACTTTACT ATGAATACGGTTACGCAACTCCCAACTTTTTTCATGTTTAAAGATGGTGATCCCATATCC TATGTTTTCCCCGGATACTCCACAACAGAAATGAGAAATATTGATGCCATTATGGATTGG GTAAAAAAGTATTCTAATCCCTTAGTTACCGAAGTTGACTCTTCTAATTTGAAAAAATTA ATTTCCTTCCAAACCAAGAGCTACAGTGATTTAGCAATTCAGTTAATAAGTAGCACTGAC CACAAACATATCAAAGGAAGCAACAAGCTTATTAAAAACTTGCTCCTCGCAAGTTGGGAG TATGAACATATTCGGATGGAAAATAACTTCGAAGAAATTAATGAGAGAAGGGCAAGGAAA GCAGACGGGATCAAGAAAATAAAGGAAAAAAAGGCTCCGGCTAACAAAATTGTTGATAAA ATGCGTGAAGAGATTCCCCATATGGATCAAAAAAAATTGTTATTAGGATATTTAGATATT TCAAAGGAGAAGAATTTTTTTAGAAAATATGGTATTACTGGAGAATATAAAATTGGTGAT GTGATTATCATTGATAAATCAAATAATTACTACTACAATAAAGATAATTTTGGCAACTCC TTGACTTCTAACAACCCTCAATTGCTGAGAGAAGCATTCGTGTCCTTAAATATTCCATCA AAAGCTCTATACAGCTCTAAGTTGAAGGGGAGATTGATAAATTCTCCATTCCATAATGTC CTCAGTTTCCTAGACATAATCCACGGGAACGGCATGCCCGGTTACTTAATTGTTATTGTT TTGTTTATCGCAATACTCAAAGGTCCATCTATTTACAGAAGATACAAAGTAAGGAAACAC TATAGGGCGAAAAGGAACGCTGTCGGTATCCTAGGAAATATGGAGAAAAAAAAAAATCAA GATTAA

[0453] Further information on EPS1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000001267.

[0454] It will be appreciated that, by "EPS1", we include fragments or variants thereof having equivalent EPS1-like activity.

[0455] PDI, or a fragment or variant thereof having an equivalent ability to catalyse the formation of disulphide bonds within the lumen of the endoplasmic reticulum (ER), is another S. cerevisiae helper protein of interest for the present invention. By "PDI" we include any protein having the ability to reactivate the ribonuclease activity against RNA of scrambled ribonuclease as described in EP 0 746 611 and Hillson et al, 1984, Methods Enzymol., 107, 281-292.

[0456] PDI is an enzyme which typically catalyses thiol:disulphide interchange reactions, and is a major resident protein component of the ER lumen in secretory cells. A body of evidence suggests that it plays a role in secretory protein biosynthesis (Freedman, 1984, Trends Biochem. Sci., 9, 438-41) and this is supported by direct cross-linking studies in situ (Roth and Pierce, 1987, Biochemistry, 26, 4179-82). The finding that microsomal membranes deficient in PDI show a specific defect in cotranslational protein disulphide (Bulleid and Freedman, 1988, Nature, 335, 649-51) implies that the enzyme functions as a catalyst of native disulphide bond formation during the biosynthesis of secretory and cell surface proteins. This role is consistent with what is known of the enzyme's catalytic properties in vitro; it catalyzes thiol: disulphide interchange reactions leading to net protein disulphide formation, breakage or isomerisation, and can typically catalyze protein folding and the formation of native disulphide bonds in a wide variety of reduced, unfolded protein substrates (Freedman et al., 1989, Biochem. Soc. Symp., 55, 167-192). PDI also functions as a chaperone since mutant PDI lacking isomerase activity accelerates protein folding (Hayano et al, 1995, FEBS Letters, 377, 505-511). Recently, sulphydryl oxidation, not disulphide isomerisation was reported to be the principal function of Protein Disulphide Isomerase in S. cerevisiae (Solovyov et al., 2004, J. Biol. Chem., 279 (33) 34095-34100). The DNA and amino acid sequence of the enzyme is known for several species (Scherens et al, 1991, Yeast, 7, 185-193; Farquhar et al, 1991, Gene, 108, 81-89; EP074661; EP0293793; EP0509841) and there is increasing information on the mechanism of action of the enzyme purified to homogeneity from mammalian liver (Creighton et al, 1980, J. Mol. Biol., 142, 43-62; Freedman et al, 1988, Biochem. Soc. Trans., 16, 96-9; Gilbert, 1989, Biochemistry, 28, 7298-7305; Lundstrom and Holmgren, 1990, J. Biol. Chem., 265, 9114-9120; Hawkins and Freedman, 1990, Biochem. J., 275, 335-339). Of the many protein factors currently implicated as mediators of protein folding, assembly and translocation in the cell (Rothman, 1989, Cell, 59, 591-601), PDI has a well-defined catalytic activity.

[0457] The deletion or inactivation of the endogenous PDI gene in a host results in the production of an inviable host. In other words, the endogenous PDI gene is an "essential" gene.

[0458] PDI is readily isolated from mammalian tissues and the homogeneous enzyme is a homodimer (2.times.57 kD) with characteristically acidic pI (4.0-4.5) (Hinson et al, 1984, op. cit.). The enzyme has also been purified from wheat and from the alga Chlamydomonas reinhardii (Kaska et al, 1990, Biochem. J., 268, 63-68), rat (Edman et al, 1985, Nature, 317, 267-270), bovine (Yamauchi et al, 1987, Biochem. Biophys. Res. Comm., 146, 1485-1492), human (Pihlajaniemi et al, 1987, EMBO J., 6, 643-9), yeast (Scherens et al, supra; Farquhar et al, op. cit.) and chick (Parkkonen et al, 1988, Biochem. J., 256, 1005-1011). The proteins from these vertebrate species show a high degree of sequence conservation throughout and all show several overall features first noted in the rat PDI sequence (Edman et al., 1985, op. cit.).

[0459] Preferred PDI sequences include those from humans and those from yeast species, such as S. cerevisiae.

[0460] A yeast protein disulphide isomerase precursor, PDI1, can be found as Genbank accession no. CAA42373 or BAA00723. It has the following sequence of 522 amino acids:

TABLE-US-00047 1 mkfsagavls wsslllassv faqqeavape dsavvklatd sfneyiqshd lvlaeffapw 61 cghcknmape yvkaaetlve knitlaqidc tenqdlcmeh nipgfpslki fknsdvnnsi 121 dyegprtaea ivqfmikqsq pavavvadlp aylanetfvt pvivqsgkid adfnatfysm 181 ankhfndydf vsaenadddf klsiylpsam depvvyngkk adiadadvfe kwlqvealpy 241 fgeidgsvfa qyvesglplg ylfyndeeel eeykplftel akknrglmnf vsidarkfgr 301 hagnlnmkeq fplfaihdmt edlkyglpql seeafdelsd kivleskaie slvkdflkgd 361 aspivksqei fenqdssvfq lvgknhdeiv ndpkkdvlvl yyapwcghck rlaptyqela 421 dtyanatsdv liakldhten dvrgvviegy ptivlypggk ksesvvyqgs rsldslfdfi 481 kenghfdvdg kalyeeaqek aaeeadadae ladeedaihd el

[0461] An alternative yeast protein disulphide isomerase sequence can be found as Genbank accession no. CAA38402. It has the following sequence of 530 amino acids

TABLE-US-00048 1 mkfsagavls wsslllassv faqqeavape dsavvklatd sfneyiqshd lvlaeffapw 61 cghcknmape yvkaaetlve knitlaqidc tenqdlcmeh nipgfpslki fknrdvnnsi 121 dyegprtaea ivqfmikqsq pavavvadlp aylanetfvt pvivqsgkid adfnatfysm 181 ankhfndydf vsaenadddf klsiylpsam depvvyngkk adiadadvfe kwlqvealpy 241 fgeidgsvfa qyvesglplg ylfyndeeel eeykplftel akknrglmnf vsidarkfgr 301 hagnlnmkeq fplfaihdmt edlkyglpql seeafdelsd kivleskaie slvkdflkgd 361 aspivksqei fenqdssvfq lvgknhdeiv ndpkkdvlvl yyapwcghck rlaptyqela 421 dtyanatsdv liakldhten dvrgvviegy ptivlypggk ksesvvyqgs rsldslfdfi 481 kenghfdvdg kalyeeaqek aaeeaeadae aeadadaela deedaihdel

[0462] The following alignment of these sequences (the sequence of Genbank accession no. CAA42373 or BAA00723 first, the sequence of Genbank accession no. CAA38402 second) shows that the differences between these two sequences are a single amino acid difference at position 114 (highlighted in bold) and that the sequence defined by Genbank accession no. CAA38402 contains the additional amino acids EADAEAEA at positions 506-513.

TABLE-US-00049 1 mkfsagavls wsslllassv faqqeavape dsavvklatd sfneyiqshd lvlaeffapw 1 mkfsagavls wsslllassv faqqeavape dsavvklatd sfneyiqshd lvlaeffapw 61 cghcknmape yvkaaetlve knitlaqidc tenqdlcmeh nipgfpslki fknsdvnnsi 61 cghcknmape yvkaaetlve knitlaqidc tenqdlcmeh nipgfpslki fknrdvnnsi 121 dyegprtaea ivqfmikqsq pavavvadlp aylanetfvt pvivqsgkid adfnatfysm 181 dyegprtaea ivqfmikqsq pavavvadlp aylanetfvt pvivqsgkid adfnatfysm 181 ankhfndydf vsaenadddf klsiylpsam depvvyngkk adiadadvfe kwlqvealpy 181 ankhfndydf vsaenadddf klsiylpsam depvvyngkk adiadadvfe kwlqvealpy 241 fgeidgsvfa qyvesglplg ylfyndeeel eeykplftel akknrglmnf vsidarkfgr 241 fgeidgsvfa qyvesglplg ylfyndeeel eeykplftel akknrglmnf vsidarkfgr 301 hagnlnmkeq fplfaihdmt edlkyglpql seeafdelsd kivleskaie slvkdflkgd 301 hagnlnmkeq fplfaihdmt edlkyglpql seeafdelsd kivleskaie slvkdflkgd 361 aspivksqei fenqdssvfq lvgknhdeiv ndpkkdvlvl yyapwcghck rlaptyqela 361 aspivksqei fenqdssvfq lvgknhdeiv ndpkkdvlvl yyapwcghck rlaptyqela 421 dtyanatsdv liakldhten dvrgvviegy ptivlypggk ksesvvyqgs rsldslfdfi 421 dtyanatsdv liakldhten dvrgvviegy ptivlypggk ksesvvyqgs rsldslfdfi 481 kenghfdvdg kalyeeaqek aaeea***** ***dadaela deedaihdel 481 kenghfdvdg kalyeeaqek aaeeaeadae aeadadaela deedaihdel

[0463] It will be appreciated that, by "PDI" and "PDI1", we include fragments or variants thereof having equivalent PDI-like activity and PDI1-like activity, respectively.

[0464] DER1 is another S. cerevisiae helper protein of interest for the present invention. Der1p is an endoplasmic reticulum membrane protein, required for the protein degradation process associated with the ER, and is involved in the retrograde transport of misfolded or unassembled proteins. A published protein sequence for the protein Der1p is as follows:

TABLE-US-00050 MDAVILNLLGDIPLVTRLWTIGCLVLSGLTSLRIVDPGKVVYSYDLVF KKGQYGRLLYSIFDYGAFNWISMINIFVSANHLSTLENSFNLRRKFC WIIFLLLVILVKMTSIEQPAASLGVLLHENLVYYELKKNGNQMNVRFF GAIDVSPSIFPIYMNAVMYFVYKRSWLEIAMNFMPGHVIYYMDDIIGKIY GIDLCKSPYDWFRNTETP*

[0465] DER1 is encoded by a non-essential gene comprising an ORF that is 0.636 kbp in size and is located on chromosome II. A published nucleotide coding sequence of DER1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00051 ATGGATGCTGTAATACTGAATCTCTTAGGCGACATTCCTTTGGTCACA AGATTATGGACAATTGGCTGTCTTGTACTATCAGGTCTCACAAGTCTCC GGATTGTGGATCCAGGGAAGGTAGTGTACAGTTATGATTTAGTATTCAA AAAGGGACAATATGGAAGACTACTTTATTCGATATTCGATTACGGCGCA TTTAATTGGATATCCATGATAAACATCTTTGTCAGCGCTAATCACTTATC AACTTTGGAAAACTCATTCAATCTGAGAAGAAAATTCTGTTGGATAATAT TTTTACTGTTGGTGATACTGGTAAAGATGACCAGCATTGAACAACCTGC AGCATCACTCGGTGTGTTATTGCATGAGAATCTCGTGTACTACGAACTG AAAAAGAACGGAAACCAAATGAACGTACGATTCTTCGGTGCCATTGAT GTTTCACCATCTATATTCCCAATCTACATGAATGCAGTAATGTATTTTGT ATATAAGCGTAGCTGGTTAGAAATTGCCATGAATTTCATGCCAGGTCAC GTAATTTACTACATGGATGATATAATAGGGAAGATTTATGGCATCGATTT GTGTAAATCTCCGTACGACTGGTTCCGCAACACTGAAACACCCTAA

[0466] Further information on DER1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000405.

[0467] It will be appreciated that, by "DER1", we include fragments or variants thereof having equivalent DER1-like activity.

[0468] DER3 is another S. cerevisiae helper protein of interest for the present invention and is also known as HRD1. Der3p is a ubiquitin-protein ligase required for endoplasmic reticulum-associated degradation (BRAD) of misfolded proteins. It is genetically linked to the unfolded protein response (UPR) and is thought to be regulated through association with Hrd3p. It contains an H2 ring finger. A published protein sequence for the protein Der3p is as follows:

TABLE-US-00052 MVPENRRKQLAIFVVVTYLLTFYCVYSATKTSVSFLQVTLKLNEGF NLMVLSIFILLNSTLLWQLLTKLLFGELRLIEHEHIFERLPFTIINTLFM SSLFHERYFFTVAFFGLLLLYLKVFHWILKDRLEALLQSINDSTTMK TLIFSRFSFNLVLLAVVDYQIITRCISSIYTNQKSDIESTSLYLIQVME FTMLLIDLLNLFLQTCLNFWEFYRSQQSLSNENNHIVHGDPTDENTVE SDQSQPVLNDDDDDDDDDRQFTGLEGKFMYEKAIDVFTRFLKTAL HLSMLIPFRMPMMLLKDVVWDILALYQSGTSLWKIWRNNKQLDDTL VTVTVEQLQNSANDDNICIICMDELIHSPNQQTWKNKNKKPKRLPCG HILHLSCLKNWMERSQTCPICRLPVFDEKGNVVQTTFTSNSDITTQTT VTDSTGIATDQQGFANEVDLLPTRTTSPDIRIVPTQNIDTLAMRTRSTS TPSPTWYTFPLHKTGDNSVGSSRSAYEFLITNSDEKENGIPVKLTIEN HEVNSLHGDGGEQIAKKIVIPDKFIQHI*

[0469] DER3 is encoded by a non-essential gene comprising an ORF that is 1.656 kbp in size and is located on chromosome XV. A published nucleotide coding sequence of DER3 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00053 ATGGTGCCAGAAAATAGAAGGAAACAGTTGGCAATTTTTGTAGTTGTCACATATTTGCTC ACATTTTATTGCGTGTATTCAGCCACCAAGACAAGCGTTTCCTTTTTGCAAGTAACACTG AAGCTAAATGAAGGCTTCAATCTAATGGTTTTGTCGATATTCATCTTATTAAATTCTACC TTACTATGGCAACTCCTAACGAAACTATTATTTGGTGAACTGAGGCTTATTGAGCATGAG CACATTTTTGAAAGGTTACCATTTACCATTATAAACACCTTGTTTATGTCCTCACTGTTC CACGAACGGTATTTTTTCACAGTGGCATTTTTTGGACTATTACTACTCTATCTGAAAGTT TTCCATTGGATTTTAAAGGATAGGCTGGAGGCCTTATTACAGTCAATAAATGATTCCACC ACAATGAAAACCCTTATCTTTAGTAGATTCTCATTTAACCTCGTACTATTGGCGGTTGTA GACTACCAGATAATAACACGATGCATCTCCTCCATATATACAAACCAAAAGAGTGATATT GAATCCACATCCCTTTACCTGATACAAGTAATGGAGTTTACCATGCTTTTGATTGATTTG CTAAATTTATTCCTACAGACTTGTTTGAATTTCTGGGAATTTTATCGCTCACAACAAAGT CTGTCTAATGAGAACAACCATATTGTCCATGGCGATCCTACAGATGAAAACACGGTTGAG TCTGATCAATCTCAGCCAGTGCTGAATGACGACGACGATGACGACGATGATGATAGACAA TTTACCGGCCTGGAGGGTAAATTCATGTATGAAAAAGCAATTGACGTATTCACAAGATTC TTAAAAACGGCACTTCATTTGTCTATGCTAATACCATTTAGGATGCCTATGATGCTTTTG AAAGATGTGGTGTGGGATATCTTGGCACTATATCAAAGTGGCACAAGTTTGTGGAAAATC TGGAGAAATAACAAACAGCTCGACGACACTCTTGTCACTGTCACCGTAGAACAGCTACAA AATTCTGCAAATGATGACAATATTTGTATCATTTGTATGGATGAGTTAATACATTCTCCA AACCAGCAGACGTGGAAGAATAAAAACAAGAAACCCAAAAGGTTACCTTGTGGCCACATA CTTCATTTGTCGTGTTTAAAGAATTGGATGGAACGTTCTCAGACTTGTCCTATTTGTAGA TTGCCTGTCTTTGATGAAAAAGGTAATGTTGTGCAAACGACTTTCACTTCCAATAGTGAT ATCACGACACAGACCACCGTAACAGATAGCACTGGGATAGCGACAGATCAACAAGGTTTC GCAAACGAAGTAGATCTACTTCCCACAAGAACAACTTCCCCTGATATAAGGATAGTGCCT ACTCAAAATATAGACACATTAGCAATGAGAACAAGGTCAACCTCTACACCATCTCCTACG TGGTATACGTTCCCATTACATAAAACTGGTGATAATTCTGTTGGGTCAAGCCGATCAGCC TACGAATTTTTGATCACAAATTCAGATGAGAAAGAAAATGGTATTCCTGTCAAATTAACA ATAGAAAATCACGAAGTAAATTCTCTGCATGGAGACGGGGGCGAGCAAATTGCCAAGAAA ATTGTCATACCAGATAAATTTATCCAGCATATCTAG

[0470] Further information on DER3 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005373.

[0471] It will be appreciated that, by "DER3", we include fragments or variants thereof having equivalent DER3-like activity.

[0472] HRD3 is another S. cerevisiae helper protein of interest for the present invention. Hrd3p is a resident protein of the ER membrane that plays a central role in ER-associated protein degradation (ERAD). It forms an HRD complex with Hrd1p and ERAD determinants that engage in lumen to cytosol communication and coordination of ERAD events. A published protein sequence for the protein Hrd3p is as follows:

TABLE-US-00054 MITLLLYLCVICNAIVLIRADSIADPWPEARHLLNTIAKSRDPMKEAAMEPNADEFVGFY VPMDYSPRNEEKNYQSIWQNEITDSQRHIYELLVQSSEQFNNSEATYTLSQIHLWSQYNF PHNMTLAHKYLEKFNDLTHFTNHSAIFDLAVMYATGGCASGNDQTVIPQDSAKALLYYQR AAQLGNLKAKQVLAYKYYSGFNVPRNFHKSLVLYRDIAEQLRKSYSRDEWDIVFPYWESY NVRISDFESGLLGKGLNSVPSSTVRKRTTRPDIGSPFIAQVNGVQMTLQIEPMGRFAFNG NDGNINGDEDDEDASERRIIRIYYAALNDYKGTYSQSRNCERAKNLLELTYKEFQPHVDN LDPLQVFYYVRCLQLLGHMYFTGEGSSKPNIHMAEEILTTSLEISRRAQGPIGRACIDLG LINQYITNNISQAISYYMKAMKTQANNGIVEFQLSKLATSFPEEKIGDPFNLMETAYLNG FIPAIYEFAVMIESGMNSKSSVENTAYLFKTFVDKNEAIMAPKLRTAFAALINDRSEVAL WAYSQLAEQGYETAQVSAAYLMYQLPYEFEDPPRTTDQRKTLAISYYTRAFKQGNIDAGV VAGDIYFQMQNYSKAMALYQGAALKYSIQAIWNLGYMHEHGLGVNRDFHLAKRYYDQVSE HDHRFYLASKLSVLKLHLKSWLTWITREKVNYWKPSSPLNPNEDTQHSKTSWYKQLTKIL QRMRHKEDSDKAAEDSHKHRTVVQNGANHRGDDQEEASEILGFQMEDLVTMGCILGIFLL SILMSTLAARRGWNVRFNGAQLNANGNRQQEQQQQQQAQGPPGWDFNVQIFAI*

[0473] HRD3 is encoded by a non-essential gene comprising an ORF that is 2.502 kbp in size and is located on chromosome XII. A published nucleotide coding sequence of HRD3 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00055 ATGATAACACTCTTATTATACCTGTGCGTAATATGTAACGCAATAGTGTTAATAAGGGCT GATTCGATAGCGGACCCTTGGCCTGAAGCGCGACATCTACTAAATACCATAGCTAAGTCC AGAGACCCAATGAAAGAAGCTGCTATGGAACCCAATGCAGATGAATTTGTTGGATTCTAT GTACCGATGGATTATTCCCCACGTAATGAGGAAAAAAACTACCAGAGCATTTGGCAAAAC GAAATCACAGATTCTCAACGTCATATTTATGAATTACTTGTACAATCAAGTGAACAATTC AACAACTCAGAAGCAACATATACACTTAGCCAGATTCACCTTTGGAGTCAATATAATTTC CCGCATAATATGACTTTGGCACACAAATACTTAGAAAAATTCAATGATCTAACCCACTTC ACCAATCATTCGGCCATCTTCGACTTAGCTGTGATGTATGCCACTGGGGGATGTGCTTCT GGTAATGATCAAACCGTGATCCCTCAGGATTCTGCTAAAGCACTGCTATATTACCAAAGG GCTGCCCAACTAGGGAATTTAAAGGCTAAGCAAGTGCTAGCTTATAAATACTATTCTGGC TTCAATGTCCCACGAAATTTTCATAAATCTTTAGTATTGTACAGGGACATTGCTGAACAG CTGAGAAAGTCGTACTCCAGGGACGAATGGGATATTGTCTTCCCCTATTGGGAAAGTTAC AACGTGAGAATATCGGATTTTGAGAGTGGCCTATTAGGTAAAGGTTTGAATTCCGTTCCA TCTTCTACAGTAAGGAAAAGAACTACGAGACCAGATATTGGTTCACCCTTTATTGCGCAA GTTAACGGTGTACAGATGACCTTGCAAATCGAACCGATGGGTAGGTTCGCTTTCAACGGT AACGATGGCAACATAAATGGCGACGAAGATGACGAGGATGCCAGTGAAAGACGAATCATT CGGATATATTATGCAGCTTTGAATGATTATAAAGGAACATATTCACAAAGCAGAAATTGT GAGCGCGCCAAAAACTTGTTGGAATTAACGTACAAGGAATTTCAGCCTCATGTCGACAAT TTGGATCCTTTGCAAGTATTTTACTACGTCCGTTGCTTACAATTATTGGGGCACATGTAT TTCACCGGCGAAGGCTCCTCGAAGCCTAATATTCATATGGCCGAAGAGATCCTGACCACG TCGCTAGAAATAAGCAGAAGGGCACAGGGACCTATAGGTAGAGCGTGCATAGATCTGGGC TTAATAAATCAATACATCACAAACAATATTTCTCAAGCAATTTCGTATTATATGAAAGCT ATGAAAACACAAGCTAACAATGGAATCGTAGAATTCCAATTATCCAAATTGGCCACTTCA TTCCCTGAAGAAAAAATCGGCGACCCATTTAACTTAATGGAAACTGCCTACTTGAATGGA TTCATTCCAGCCATATATGAGTTTGCAGTAATGATCGAATCTGGAATGAACAGTAAGAGT AGTGTGGAAAACACTGCTTACCTGTTCAAAACATTCGTTGACAAAAACGAAGCTATTATG GCACCTAAACTGAGGACAGCATTTGCCGCATTAATCAACGATCGTTCAGAAGTGGCTTTA TGGGCTTATTCCCAACTAGCCGAGCAAGGCTACGAGACTGCTCAAGTCTCTGCCGCCTAC TTAATGTACCAGTTGCCATATGAGTTTGAGGATCCTCCAAGAACCACAGATCAGAGAAAA ACTTTGGCAATTTCCTACTATACAAGAGCGTTTAAACAGGGAAATATAGATGCTGGTGTT GTCGCGGGAGATATCTATTTTCAGATGCAGAATTACAGTAAAGCTATGGCTCTTTATCAG GGTGCAGCTTTGAAGTACTCTATACAGGCTATCTGGAACTTAGGGTACATGCATGAGCAT GGGCTAGGTGTAAACAGAGATTTCCATCTTGCTAAACGTTACTACGACCAAGTTTCAGAA CACGATCATAGATTTTACTTGGCTTCCAAATTGAGTGTTTTAAAATTACACCTAAAGTCA TGGTTGACTTGGATCACCAGAGAAAAAGTAAACTACTGGAAACCTTCCTCGCCACTTAAC CCTAACGAAGATACTCAGCACTCGAAGACTTCATGGTACAAGCAATTGACGAAGATTCTA CAAAGAATGAGACATAAGGAGGATAGTGACAAAGCTGCGGAAGATTCTCACAAACACAGA ACTGTAGTGCAGAATGGAGCTAACCATAGGGGTGACGACCAAGAGGAGGCTTCCGAGATT TTGGGCTTCCAAATGGAGGATCTTGTTACGATGGGATGTATCTTGGGGATATTCCTATTA AGTATATTAATGAGTACACTGGCGGCCCGTAGAGGCTGGAATGTCCGTTTCAATGGAGCA CAATTAAATGCAAATGGTAACCGGCAGCAAGAGCAACAACAACAACAACAAGCACAAGGT CCCCCGGGCTGGGACTTCAATGTTCAGATATTCGCCATATGA

[0474] Further information on HRD3 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000004197.

[0475] It will be appreciated that, by "HRD3", we include fragments or variants thereof having equivalent HRD3-like activity.

[0476] UBC7 is another S. cerevisiae helper protein of interest for the present invention and is also known as QRI8. Ubc7p is a ubiquitin conjugating enzyme, involved in the ER-associated protein degradation pathway. It requires Cue1p for recruitment to the ER membrane and is proposed to be involved in chromatin assembly. A published protein sequence for the protein Ubc7p is as follows:

TABLE-US-00056 MSKTAQKRLLKELQQLIKDSPPGIVAGPKSENNIFIWDCLIQGPPDTP YADGVFNAKLEFPKDYPLSPPKLTFTPSILHPNIYPNGEVCISILHSPG DDPNMYELAEERWSPVQSVEKILLSVMSMLSEPNIESGANIDACILW RDNRPEFERQVKLSILKSLGF*

[0477] UBC7 is encoded by a non-essential gene comprising an ORF that is 0.498 kbp in size and is located on chromosome XIII. A published nucleotide coding sequence of UBC7 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00057 ATGTCGAAAACCGCTCAGAAACGTCTCCTCAAGGAGCTTCAACAGTTA ATTAAAGATTCTCCACCTGGTATAGTGGCTGGTCCCAAATCGGAGAATA ACATATTCATTTGGGACTGCCTAATTCAAGGGCCTCCAGATACGCCATA CGCTGATGGTGTTTTTAATGCTAAGCTAGAGTTTCCTAAAGACTATCCGT TATCTCCACCTAAACTTACTTTCACACCCAGCATACTACATCCAAATATT TATCCAAATGGGGAAGTGTGCATATCCATTCTACACTCCCCTGGTGATG ATCCTAACATGTACGAATTAGCGGAAGAAAGATGGTCGCCAGTGCAAA GTGTAGAAAAAATTCTATTAAGTGTTATGAGCATGTTGAGTGAGCCCAAT ATCGAAAGTGGTGCCAACATTGATGCTTGCATCTTGTGGAGAGATAATA GACCTGAATTTGAGAGACAGGTAAAGTTATCCATTTTGAAATCATTAGGA TTCTGA

[0478] Further information on UBC7 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000004624.

[0479] It will be appreciated that, by "UBC7", we include fragments or variants thereof having equivalent UBC7-like activity.

[0480] DOA4 is another S. cerevisiae helper protein of interest for the present invention and is also known as DOS1, MUT4, NPI2, SSV7, and UBP4. Doa4p is a ubiquitin hydrolase, required for recycling ubiquitin from proteasome-bound ubiquitinated intermediates, which acts at the late endosome/prevacuolar compartment to recover ubiquitin from ubiquitinated membrane proteins en route to the vacuole. A published protein sequence for the protein Doa4p is as follows:

TABLE-US-00058 MEQNIISTIRDECIRHRSKYLTIAQLTAIAEAKINEFIITGKAKDQDLSSLLDKCIDILS IYKKNSKDIKNIISCKNKGAMISSNSVMIIQLNYVYYKVIHIIVTTNIPHLSEFAKIKLH KSTSDEGNGNNNNNEFQLMNIYNTLLETLLKDENIAKIKSFIKSSIKQTKLNHEQEECNL MRTGSYITSNQLNSLISSSANSASSQMEILLIDIRSRLEFNKSHIDTKNIICLEPISFKM SYSDHDLEKKSLITSPNSEIKMFQSRNLFKFIILYTDANEYNVKQQSVLLDILVNHSFEK PISDDFTKIFILESGFPGWLKSNYGRQVSSSFPSNNNIKDDSVYINGNTSGLSLQHLPKM SPSIRHSMDDSMKEMLVAPTPLNHLQQQQQQQSDNDHVLKRSSSFKKLFSNYTSPNPKNS NSNLYSISSLSISSSPSPLPLHSPDPVKGNSLPINYPETPHLWKNSETDFMTNQREQLNH NSFAHIAPINTKAITSPSRTATPKLQRFPQTISMNLNMNSNGHSSATSTIQPSCLSLSNN DSLDHTDVTPTSSHNYDLDFAVGLENLGNSCYMNCIIQCILGTHELTQIFLDDSYAKHIN INSKLGSKGILAKYFARLVHMMYKEQVDGSKKISISPIKFKLACGSVNSLFKTASQQDCQ EFCQFLLDGLHEDLNQCGSNPPLKELSQEAEARREKLSLRIASSIEWERFLTTDFSVIVD LFQGQYASRLKCKVCSHTSTTYQPFTVLSIPIPKKNSRNNITIEDCFREFTKCENLEVDE QWLCPHCEKRQPSTKQLTITRLPRNLIVHLKRFDNLLNKNNDFVIYPFLLDLTPFWANDF DGVFPPGVNDDELPIRGQIPPFKYELYGVACHFGTLYGGHYTAYVKKGLKKGWLYFDDTK YKPVKNKADAINSNAYVLFYHRVYGV*

[0481] DOA4 is encoded by a non-essential gene comprising an ORF that is 2.781 kbp in size and is located on chromosome IV. A published nucleotide coding sequence of DOA4 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00059 ATGGAGCAGAATATTATTAGTACCATAAGGGATGAGTGTATTCGTCACCGGTCGAAGTAC CTTACGATAGCACAACTAACCGCTATTGCAGAGGCTAAAATTAACGAATTCATCATAACT GGTAAGGCAAAAGATCAAGATTTGAGCAGTCTTCTAGATAAATGCATCGATATTTTATCT ATTTACAAGAAGAACTCGAAAGATATCAAAAATATTATATCGTGCAAAAATAAGGGTGCA ATGATTAGTTCAAATTCCGTAATGATTATTCAATTAAATTATGTTTACTACAAGGTAATT CACATTATTGTAACAACCAATATTCCTCATTTAAGTGAATTCGCCAAGATTAAATTACAT AAGAGCACGAGTGATGAGGGCAACGGTAATAACAACAATAATGAATTTCAACTCATGAAC ATTTACAACACTTTGCTGGAAACCTTATTAAAAGATGAAAACATTGCAAAAATAAAAAGT TTCATTAAGTCTTCCATAAAACAAACAAAATTGAACCATGAGCAAGAAGAATGTAACCTG ATGAGAACGGGTTCCTATATCACTTCCAATCAATTAAACTCCCTAATAAGTTCATCAGCA AATTCTGCTTCCTCCCAAATGGAGATACTACTGATAGATATACGATCAAGGTTGGAATTC AACAAGTCACATATTGATACAAAAAATATTATATGCCTGGAGCCTATTTCTTTTAAAATG TCATATTCAGATCATGATTTGGAGAAAAAATCATTAATTACTTCTCCTAATAGTGAGATT AAAATGTTTCAAAGTAGAAATCTTTTCAAGTTTATCATTCTCTATACAGACGCAAACGAA TACAATGTTAAACAGCAGTCTGTCCTGTTGGACATTCTGGTGAATCATTCCTTTGAAAAA CCAATATCCGATGACTTTACCAAAATTTTCATTCTGGAATCTGGTTTTCCAGGTTGGCTT AAGTCAAATTATGGGAGGCAAGTATCATCATCTTTTCCATCAAATAACAATATTAAAGAT GATAGTGTTTATATTAATGGTAACACTTCTGGCCTAAGTTTACAACATTTACCTAAGATG TCTCCCAGTATAAGACATTCAATGGACGACTCTATGAAAGAAATGCTAGTTGCGCCTACT CCATTAAATCATCTTCAACAACAGCAACAACAGCAATCAGACAATGATCATGTGCTAAAA AGATCTTCAAGTTTCAAAAAATTATTCTCAAATTATACGTCTCCTAATCCGAAGAATTCA AATTCAAACTTATATTCTATATCTTCGTTGTCCATATCTAGTTCACCATCGCCTTTACCT CTACATTCGCCTGACCCAGTTAAGGGCAATTCATTGCCAATCAATTATCCGGAAACGCCA CATCTTTGGAAAAACAGTGAGACAGATTTTATGACAAATCAAAGAGAACAGTTGAATCAC AACTCTTTTGCTCACATAGCTCCTATCAACACGAAGGCCATCACTTCTCCATCAAGAACT GCCACACCGAAGTTACAACGCTTCCCGCAAACAATTAGTATGAACCTTAATATGAACTCC AATGGACACAGTTCTGCCACCTCTACCATTCAACCTTCGTGTCTATCCTTGTCTAATAAT GACTCTTTAGATCATACAGATGTTACACCAACTTCTTCTCATAATTATGACCTTGATTTC GCGGTTGGTTTGGAAAATCTAGGAAATTCGTGTTACATGAACTGTATCATTCAGTGTATC TTAGGTACACACGAATTAACCCAAATCTTTTTGGACGATTCATATGCTAAACACATCAAT ATTAATAGTAAGTTGGGATCGAAAGGTATTCTGGCAAAATATTTTGCAAGGTTGGTTCAT ATGATGTATAAGGAACAGGTTGATGGTTCAAAGAAAATTTCCATATCACCGATAAAATTT AAATTGGCATGTGGATCTGTTAACTCATTATTTAAGACTGCATCCCAACAGGACTGCCAA GAGTTTTGCCAATTCCTTCTAGATGGTCTTCATGAAGACTTGAACCAATGCGGTTCAAAC CCACCTTTGAAGGAGCTTTCTCAAGAAGCTGAGGCGAGAAGAGAAAAACTGTCTTTGCGA ATTGCCTCGTCAATTGAGTGGGAACGATTCTTGACTACTGATTTCAGTGTTATTGTCGAC TTATTTCAGGGACAATACGCCTCACGACTAAAATGTAAAGTCTGTAGTCATACCTCGACA ACATACCAACCTTTTACGGTGCTGTCAATCCCTATTCCTAAAAAAAATTCCCGAAATAAT ATTACCATTGAAGATTGTTTCAGAGAGTTCACCAAATGTGAGAACTTGGAAGTGGATGAG CAATGGTTGTGCCCACATTGTGAAAAAAGGCAGCCCTCCACGAAACAATTGACAATAACG AGATTACCGAGGAATCTGATAGTCCATTTAAAGAGATTTGATAATTTATTAAACAAAAAT AATGACTTCGTCATATACCCTTTTTTGTTGGACTTGACTCCATTTTGGGCCAATGATTTT GACGGGGTTTTTCCTCCAGGTGTTAATGACGATGAACTACCAATAAGGGGACAAATACCA CCTTTTAAGTATGAATTATATGGTGTAGCATGCCACTTTGGTACTTTGTATGGTGGTCAT TATACAGCCTATGTGAAAAAGGGATTAAAGAAGGGATGGCTATATTTTGATGATACCAAA TATAAACCTGTCAAAAACAAAGCCGATGCAATTAACTCTAATGCATACGTTTTGTTTTAT CACCGCGTCTACGGTGTTTGA

[0482] Further information on DOA4 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000002476.

[0483] It will be appreciated that, by "DOA4", we include fragments or variants thereof having equivalent DOA4-like activity.

[0484] HAC1 is another S. cerevisiae helper protein of interest for the present invention, and is also known as ERN4 and IRE15. Hac1p, is a bZIP transcription factor (ATF/CREB1 homolog) that regulates the unfolded protein response, via UPRE binding, and membrane biogenesis. ER stress-induced splicing pathway utilising Ire1p, Trl1p and Ada5p facilitates efficient Hac1p synthesis. A published protein sequence for the protein Hac1p is as follows:

TABLE-US-00060 MEMTDFELTSNSQSNLAIPTNFKSTLPPRKRAKTKEEKEQRRIERILRNR RAAHQSREKKRLHLQYLERKCSLLENLLNSVNLEKLADHEDALTCSHD AFVASLDEYRDFQSTRGASLDTRASSHSSSDTFTPSPLNCTMEPATLS PKSMRDSASDQETSWELQMFKTENVPESTTLPAVDNNNLFDAVASPL ADPLCDDIAGNSLPFDNSIDLDNWRNPEAQSGLNSFELNDFFITS*

[0485] HAC1 is encoded by a non-essential gene that is located on chromosome VI. A published nucleotide coding sequence of HAC1, that has been processed to remove introns, is 0.717 kbp in size and is as follows (although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product):

TABLE-US-00061 ATGGAAATGACTGATTTTGAACTAACTAGTAATTCGCAATCGAACTTGGCTATCCCTACC AACTTCAAGTCGACTCTGCCTCCAAGGAAAAGAGCCAAGACAAAAGAGGAAAAGGAACAG CGAAGGATCGAGCGTATTTTGAGAAACAGAAGAGCTGCTCACCAGAGCAGAGAGAAAAAA AGACTACATCTGCAGTATCTCGAGAGAAAATGTTCTCTTTTGGAAAATTTACTGAACAGC GTCAACCTTGAAAAACTGGCTGACCACGAAGACGCGTTGACTTGCAGCCACGACGCTTTT GTTGCTTCTCTTGACGAGTACAGGGATTTCCAGAGCACGAGGGGCGCTTCACTGGACACC AGGGCCAGTTCGCACTCGTCGTCTGATACGTTCACACCTTCACCTCTGAACTGTACAATG GAGCCTGCGACTTTGTCGCCCAAGAGTATGCGCGATTCCGCGTCGGACCAAGAGACTTCA TGGGAGCTGCAGATGTTTAAGACGGAAAATGTACCAGAGTCGACGACGCTACCTGCCGTA GACAACAACAATTTGTTTGATGCGGTGGCCTCGCCGTTGGCAGACCCACTCTGCGACGAT ATAGCGGGAAACAGTCTACCCTTTGACAATTCAATTGATCTTGACAATTGGCGTAATCCA GAAGCGCAGTCAGGTTTGAATTCATTTGAATTGAATGATTTCTTCATCACTTCATGA

[0486] Further information on HAC1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000001863.

[0487] It will be appreciated that, by "HAC1", we include fragments or variants thereof having equivalent HAC1-like activity.

[0488] SEC63 is another S. cerevisiae helper protein of interest for the present invention. It is also known as PTL1. It is an essential subunit of the Sec63 complex (Sec63p, Sec62p, Sec66p and Sec72p); with Sec61 complex, Kar2p/BiP and Lhs1p it forms a channel competent for SRP-dependent and post-translational SRP-independent protein targeting and import into the ER. A published protein sequence for the protein Sec63p is as follows:

TABLE-US-00062 MPTNYEYDEASETWPSFILTGLLMVVGPMTLLQIYQIFFGANAEDGNSGKSKEFNEEVFK NLNEEYTSDEIKQFRRKFDKNSNKKSKIWSRRNIIIIVGWILVAILLQRINSNDAIKDAA TKLFDPYEILGISTSASDRDIKSAYRKLSVKFHPDKLAKGLTPDEKSVMEETYVQITKAY ESLTDELVRQNYLKYGHPDGPQSTSHGIALPRFLVDGSASPLLVVCYVALLGLILPYFVS RWWARTQSYTKKGIHNVTASNFVSNLVNYKPSEIVTTDLILHWLSFAHEFKQFFPDLQPT DFEKLLQDHINRRDSGKLNNAKFRIVAKCHSLLHGLLDIACGFRNLDIALGAINTFKCIV QAVPLTPNCQILQLPNVDKEHFITKTGDIHTLGKLFTLEDAKIGEVLGIKDQAKLNETLR VASHIPNLKIIKADFLVPGENQVTPSSTPYISLKVLVRSAKQPLIPTSLIPEENLTEPQD FESQRDPFAMMSKQPLVPYSFAPFFPTKRRGSWCCLVSSQKDGKILQTPIIIEKLSYKNL NDDKDFFDKRIKMDLTKHEKFDINDWEIGTIKIPLGQPAPETVGDFFFRVIVKSTDYFTT DLDITMNMKVRDSPAVEQVEVYSEEDDEYSTDDDETESDDESDASDYTDIDTDTEAEDDE SPE*

[0489] SEC63 is encoded by an essential gene comprising an ORF that is 1.192 kbp in size and is located on chromosome XV. A published nucleotide coding sequence of SEC63 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00063 ATGCCTACAAATTACGAGTATGATGAGGCTAGTGAGACGTGGCCGTCCTTCATTTTAACG GGGCTCTTGATGGTCGTCGGGCCTATGACACTGCTTCAAATATACCAAATTTTTTTTGGG GCCAATGCTGAAGATGGGAATTCAGGGAAGAGTAAGGAGTTTAATGAGGAAGTTTTCAAG AACTTGAATGAAGAATACACCAGTGATGAAATCAAACAATTTAGAAGGAAGTTTGATAAA AATAGTAATAAGAAGTCCAAAATATGGAGCAGGAGAAATATTATAATTATTGTGGGTTGG ATCTTAGTTGCAATTCTTCTGCAAAGGATTAATAGTAATGACGCGATTAAAGACGCTGCT ACAAAATTATTTGATCCTTATGAAATCCTTGGTATCTCTACTAGTGCTTCCGATAGAGAC ATCAAATCTGCTTATAGAAAATTATCTGTTAAATTTCATCCAGATAAATTAGCAAAGGGC CTAACACCTGATGAGAAAAGTGTGATGGAAGAAACTTATGTTCAGATTACGAAGGCTTAC GAATCCCTTACTGACGAATTGGTTAGGCAAAACTATTTGAAATACGGTCATCCAGATGGC CCACAATCTACTTCACATGGTATCGCTCTACCAAGATTTTTGGTAGATGGAAGTGCATCT CCATTATTAGTGGTTTGTTATGTTGCGCTACTAGGTTTAATCTTGCCATATTTTGTTAGT AGATGGTGGGCAAGAACACAATCGTATACTAAGAAGGGAATACATAATGTGACGGCTTCT AATTTTGTTAGTAACTTAGTCAATTACAAGCCATCTGAGATTGTCACCACAGATTTGATC TTACACTGGTTATCATTTGCTCATGAATTTAAACAATTCTTCCCGGATTTGCAACCAACG GATTTTGAAAAACTTTTGCAAGATCATATTAACCGCAGAGATAGTGGTAAACTTAACAAT GCGAAATTTAGAATAGTGGCCAAATGTCACTCTTTGTTACACGGTTTATTGGATATTGCT TGTGGATTCAGAAATTTAGATATTGCATTGGGTGCAATCAATACTTTCAAGTGTATTGTT CAGGCTGTACCATTAACACCAAACTGTCAAATCCTTCAATTGCCGAACGTAGATAAAGAG CACTTTATTACCAAAACCGGAGATATTCATACATTAGGTAAATTGTTTACTTTAGAAGAT GCCAAGATTGGTGAGGTTCTTGGAATAAAGGATCAAGCAAAGTTAAACGAAACTTTGAGA GTTGCATCGCATATTCCAAATCTAAAGATCATCAAGGCAGACTTCCTTGTCCCAGGTGAG AACCAAGTAACACCATCATCTACCCCATACATTTCTTTGAAAGTACTGGTTCGTTCTGCT AAACAGCCATTGATACCAACTAGCTTAATTCCTGAAGAAAATTTAACAGAACCTCAAGAT TTTGAATCTCAAAGAGATCCATTTGCTATGATGAGTAAACAGCCACTCGTCCCATATTCC TTTGCACCATTTTTCCCTACAAAGAGACGTGGGAGTTGGTGCTGTCTGGTAAGTTCTCAA AAAGATGGTAAAATACTTCAAACGCCAATTATCATTGAAAAGCTATCTTACAAGAACTTG AACGATGACAAAGATTTCTTTGATAAGAGGATAAAAATGGATTTAACCAAACACGAAAAA TTCGATATAAATGATTGGGAAATCGGGACCATAAAAATTCCATTAGGTCAGCCTGCACCT GAAACTGTTGGTGATTTCTTTTTTAGAGTAATCGTTAAATCCACAGATTATTTCACTACA GATTTGGATATTACCATGAATATGAAAGTTCGTGATTCTCCTGCAGTGGAACAAGTAGAG GTGTATTCTGAGGAGGATGATGAGTACTCTACTGATGACGACGAAACCGAAAGTGATGAT GAAAGTGATGCTAGCGATTATACTGATATCGATACGGATACAGAAGCTGAAGATGATGAA TCACCAGAATAG

[0490] Further information on SEC63 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005780

[0491] It will be appreciated that, by "SEC63", we include fragments or variants thereof having equivalent SEC63-like activity.

[0492] YDJ1 is another S. cerevisiae helper protein of interest for the present invention. It is also known as MASS and HSP40. It is a protein chaperone involved in regulation of the HSP90 and HSP70 functions; involved in protein translocation across membranes; member of the DnaJ family, and is located in the cytoplasm. A published protein sequence for the protein Ydj1p is as follows:

TABLE-US-00064 MVKETKFYDILGVPVTATDVEIKKAYRKCALKYHPDKNPSEEAAEKFK EASAAYEILSDPEKRDIYDQFGEDGLSGAGGAGGFPGGGFGFGDDIF SQFFGAGGAQRPRGPQRGKDIKHEISASLEELYKGRTAKLALNKQILC KECEGRGGKKGAVKKCTSCNGQGIKFVTRQMGPMIQRFQTECDVCH GTGDIIDPKDRCKSCNGKKVENERKILEVHVEPGMKDGQRIVFKGEAD QAPDVIPGDVVFIVSERPHKSFKRDGDDLVYEAEIDLLTAIAGGEFALE HVSGDWLKVGIVPGEVIAPGMRKVIEGKGMPIPKYGGYGNLIIKFTIKFP ENHFTSEENLKKLEEILPPRIVPAIPKKATVDECVLADFDPAKYNRTRA SRGGANYDSDEEEQGGEGVQCASQ*

[0493] YDJ1 is encoded by a non-essential gene comprising an ORF that is 1.230 kbp in size and is located on chromosome XIV. A published nucleotide coding sequence of YDJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00065 ATGGTTAAAGAAACTAAGTTTTACGATATTCTAGGTGTTCCAGTAACTGCCACTGATGTC GAAATTAAGAAAGCTTATAGAAAATGCGCCTTAAAATACCATCCAGATAAGAATCCAAGT GAGGAAGCTGCAGAAAAGTTCAAAGAAGCTTCAGCAGCCTATGAAATTTTATCAGATCCT GAAAAGAGAGATATATATGACCAATTTGGTGAAGATGGTCTAAGTGGTGCTGGTGGCGCT GGCGGATTCCCAGGTGGTGGATTCGGTTTTGGTGACGATATCTTTTCCCAATTCTTTGGT GCTGGTGGCGCACAAAGACCAAGAGGTCCCCAAAGAGGTAAAGATATCAAGCATGAAATT TCTGCCTCACTTGAAGAATTATATAAGGGTAGGACAGCTAAGTTAGCCCTTAACAAACAG ATCCTATGTAAAGAATGTGAAGGTCGTGGTGGTAAGAAAGGCGCCGTCAAGAAGTGTACC AGCTGTAATGGTCAAGGTATTAAATTTGTAACAAGACAAATGGGTCCAATGATCCAAAGA TTCCAAACAGAGTGTGATGTCTGTCACGGTACTGGTGATATCATTGATCCTAAGGATCGT TGTAAATCTTGTAACGGTAAGAAAGTTGAAAACGAAAGGAAGATCCTAGAAGTCCATGTC GAACCAGGTATGAAAGATGGTCAAAGAATCGTTTTCAAAGGTGAAGCTGACCAAGCCCCA GATGTCATTCCAGGTGATGTTGTCTTCATAGTTTCTGAGAGACCACACAAGAGCTTCAAG AGAGATGGTGATGATTTAGTATATGAGGCTGAAATTGATCTATTGACTGCTATCGCTGGT GGTGAATTTGCATTGGAACATGTTTCTGGTGATTGGTTAAAGGTCGGTATTGTTCCAGGT GAAGTTATTGCCCCAGGTATGCGTAAGGTCATCGAAGGTAAAGGTATGCCAATTCCAAAA TACGGTGGCTATGGTAATTTAATCATCAAATTTACTATCAAGTTCCCAGAAAACCATTTC ACATCAGAAGAAAACTTGAAGAAGTTAGAAGAAATTTTGCCTCCAAGAATTGTCCCAGCC ATTCCAAAGAAAGCTACTGTGGACGAATGTGTACTCGCAGACTTTGACCCAGCCAAATAC AACAGAACACGGGCCTCCAGGGGTGGTGCAAACTATGATTCCGATGAAGAAGAACAAGGT GGCGAAGGTGTTCAATGTGCATCTCAATGA

[0494] Further information on YDJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005008

[0495] It will be appreciated that, by "YDJ1", we include fragments or variants thereof having equivalent YDJ1-like activity.

[0496] XDJ1 is another S. cerevisiae helper protein of interest for the present invention. It is a putative chaperone, a homolog of E. coli DnaJ, and is closely related to Ydj1p. A published protein sequence for the protein Xdj1p is as follows:

TABLE-US-00066 MSGSDRGDRLYDVLGVTRDATVQEIKTAYRKLALKHHPDKYVDQDSKEVN EIKFKEITAAYEILSDPEKKSHYDLYGDDNGAASSGGANGFGDEDFMNFF NNFFNNGSHDGNNFPGEYDAYEEGNSTSSKDIDIDISLTLKDLYMGKKLK FDLKRQVICIKCHGSGWKPKRKIHVTHDVECESCAGKGSKERLKRFGPGL VASQWVVCEKCNGKGKYTKRPKNPKNFCPDCAGLGLLSKKEIITVNVAPG HHFNDVITVKGMADEEIDKTTCGDLKFHLTEKQENLEQKQIFLKNFDDGA GEDLYTSITISLSEALTGFEKFLTKTFDDRLLTLSVKPGRVVRPGDTIKI ANEGWPILDNPHGRCGDLYVFVHIEFPPDNWFNEKSELLAIKTNLPSSSS CASHATVNTEDDSNLTNNETISNFRIIHTDDLPEGIRPFKPEAQDSAHQK ARSSYCCIQ*

[0497] XDJ1 is encoded by a non-essential gene comprising an ORF that is 1.380 kbp in size and is located on chromosome XII. A published nucleotide coding sequence of XDJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00067 ATGAGTGGCAGTGATAGAGGAGACCGGTTATACGATGTGTTGGGGGTGACGAGAGATGCG ACCGTGCAAGAGATTAAAACTGCTTACAGAAAGCTTGCCCTGAAACATCATCCGGACAAG TATGTGGATCAAGACTCAAAGGAGGTAAATGAAATCAAATTCAAAGAGATCACTGCCGCT TACGAGATCTTGAGCGATCCGGAGAAGAAATCACATTACGACTTGTATGGTGATGATAAT GGTGCCGCTAGCAGCGGTGGCGCTAATGGCTTTGGAGATGAAGATTTTATGAACTTCTTT AACAATTTCTTCAATAATGGAAGTCACGATGGAAATAATTTCCCTGGCGAGTATGATGCG TACGAAGAGGGCAACTCTACAAGCTCTAAGGATATCGATATCGATATATCTCTTACTTTG AAGGATTTGTACATGGGCAAGAAGCTGAAGTTTGATTTAAAGAGACAGGTCATCTGTATA AAGTGCCACGGTTCTGGCTGGAAACCAAAGAGGAAAATTCACGTTACACACGATGTGGAA TGTGAATCATGCGCTGGAAAGGGTTCAAAGGAACGTCTGAAGAGGTTTGGTCCCGGTTTG GTAGCTTCGCAATGGGTGGTCTGTGAGAAATGTAATGGTAAGGGGAAGTACACTAAAAGA CCCAAGAATCCAAAGAACTTTTGCCCCGATTGCGCAGGCTTGGGGCTCCTGTCAAAGAAG GAAATCATCACAGTGAACGTGGCTCCGGGACACCACTTTAACGACGTAATTACAGTCAAG GGGATGGCGGACGAGGAAATCGATAAGACCACATGTGGTGATTTAAAGTTCCATCTCACT GAAAAACAAGAAAACTTGGAGCAGAAGCAAATCTTTTTGAAGAACTTTGACGACGGCGCC GGGGAAGATTTGTATACAAGCATTACCATATCGTTAAGCGAGGCCTTGACGGGATTTGAG AAATTTTTGACAAAAACCTTCGACGACAGGTTACTAACATTGAGCGTTAAACCTGGCAGA GTAGTAAGACCTGGTGACACCATCAAAATCGCCAATGAAGGTTGGCCCATTTTAGATAAC CCTCATGGCCGGTGCGGCGATCTGTATGTTTTCGTTCATATTGAATTTCCACCAGATAAC TGGTTCAATGAAAAATCAGAACTACTAGCAATAAAAACGAATCTGCCGTCATCTTCATCT TGTGCCTCACATGCGACTGTAAATACTGAAGATGACAGCAACCTGACTAACAACGAAACT ATATCAAATTTCCGGATCATTCACACGGACGATCTTCCAGAAGGGATAAGGCCGTTCAAG CCAGAAGCACAGGATTCAGCGCATCAGAAAGCAAGAAGTTCGTACTGCTGTATCCAATGA

[0498] Further information on XDJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000004080

[0499] It will be appreciated that, by "XDJ1", we include fragments or variants thereof having equivalent XDJ1-like activity.

[0500] APJ1 is another S. cerevisiae helper protein of interest for the present invention. It is a putative chaperone of the HSP40 (DnaJ) family; over expression of which interferes with propagation of the [Psi+] prion. A published protein sequence for the protein Apj1p is as follows:

TABLE-US-00068 MQQNTSLYDSLNVTAAASTSEIKKAYRNAALKYHPDKNNHTEESKRKFQEICQAYEILKD NRLRALYDQYGTTDEVLIQEQQAQAQRQQAGPFSSSSNFDTEAMSFPDLSPGDLFAQFFN SSATPSSNGSKSSFNFSFNNSSTPSFSFVNGSGVNNLYSSSAKYNSNDEDHHLDRGPDIK HNLKCTLKELYMGKTAKLGLNRTRICSVCDGHGGLKKCTCKTCKGQGIQTQTRRMGPLVQ SWSQTCADCGGAGVFVKNKDICQQCQGLGFIKERKILQVTVQPGSCHNQLIVLTGEGDEV ISTKGGGHEKVIPGDVVITILRLKDPNFQVINYSNLICKKCKIDFMTSLCGGVVYIEGHP SGKLIKLDIIPGEILKPGCFKTVEDMGMPKFINGVRSGFGHLYVKFDVTYPERLEPENAK KIQNILANDKYIKAERSTMETADSDCYCDLEKSYDSVEEHVLSSFEAPNLNNEVIEDDDL GDLINERDSRKRNNRRFDESNINNNNETKRNKYSSPVSGFYDHDINGY*

[0501] APJ1 is encoded by a non-essential gene comprising an ORF that is 1.587 kbp in size and is located on chromosome XIV. A published nucleotide coding sequence of APJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00069 ATGCAACAAAACACGTCTTTATATGACTCTTTGAACGTTACTGCCGCTGCATCCACATCT GAGATTAAGAAAGCTTACAGGAACGCTGCATTAAAATATCATCCTGATAAAAACAATCAT ACAGAAGAATCCAAGCGAAAGTTTCAAGAGATATGCCAGGCATACGAAATACTTAAAGAC AATCGTTTAAGAGCTTTGTATGACCAGTACGGTACCACAGATGAAGTCCTGATTCAAGAG CAGCAGGCGCAGGCGCAACGCCAACAAGCCGGGCCGTTCAGTTCATCCTCAAATTTCGAT ACGGAAGCAATGTCATTCCCGGATCTATCTCCAGGTGATCTTTTCGCGCAGTTTTTTAAT AGTTCTGCTACCCCCTCTTCTAATGGCTCCAAAAGCAGTTTTAATTTTAGCTTCAATAAT AGCTCTACGCCGAGCTTCTCCTTTGTTAATGGCAGTGGCGTGAACAATCTGTACTCCTCG TCAGCAAAATACAACTCCAACGATGAGGACCATCATTTGGATAGAGGCCCTGATATCAAA CATAATCTAAAGTGCACATTGAAGGAACTCTACATGGGTAAGACTGCAAAGTTGGGTTTG AATAGGACAAGGATTTGCAGTGTTTGTGATGGGCACGGTGGTCTAAAGAAATGCACTTGT AAAACATGCAAAGGGCAAGGTATTCAAACCCAAACTAGGCGTATGGGACCTCTAGTACAA AGTTGGTCTCAAACTTGTGCAGATTGCGGGGGTGCCGGGGTTTTTGTCAAAAATAAAGAT ATTTGCCAACAGTGCCAAGGTCTTGGCTTCATTAAGGAGAGGAAGATTCTACAAGTCACC GTTCAACCGGGATCGTGTCATAACCAACTTATAGTACTTACGGGCGAAGGTGACGAAGTT ATTAGTACTAAGGGAGGCGGTCACGAAAAGGTAATACCTGGTGACGTCGTTATCACCATT TTACGTTTAAAAGATCCGAATTTCCAGGTTATCAACTACTCCAATTTGATATGTAAGAAG TGCAAAATCGACTTCATGACCAGTTTATGTGGAGGCGTAGTTTATATTGAAGGGCACCCT AGCGGTAAGTTGATCAAACTTGATATTATACCTGGCGAGATACTGAAGCCTGGTTGTTTC AAGACTGTTGAGGACATGGGGATGCCCAAGTTTATCAACGGTGTTCGGAGCGGTTTCGGT CATCTATATGTCAAATTCGATGTGACGTATCCAGAGAGACTGGAACCTGAAAATGCTAAG AAAATACAAAATATTCTGGCTAATGATAAATACATTAAAGCAGAACGTTCCACCATGGAA ACCGCAGATTCAGACTGCTATTGCGATTTGGAGAAGTCATATGACAGTGTGGAAGAGCAT GTGTTAAGTAGCTTTGAGGCCCCTAATTTAAACAATGAAGTTATTGAAGACGACGACCTT GGTGATTTGATTAATGAAAGAGATTCTCGGAAAAGGAACAACCGTCGATTCGACGAAAGT AATATTAATAATAATAATGAAACGAAACGAAATAAATATTCTTCACCGGTAAGCGGTTTT TATGACCATGATATTAATGGATATTGA

[0502] Further information on APJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005021

[0503] It will be appreciated that, by "APJ1", we include fragments or variants thereof having equivalent APJ1-like activity.

[0504] SIS1 is another S. cerevisiae helper protein of interest for the present invention. It is a type II HSP40 co-chaperone that interacts with the HSP70 protein Ssa1p; not functionally redundant with Ydj1p due to due to substrate specificity; shares similarity with bacterial DnaJ proteins. A published protein sequence for the protein Sis1p is as follows:

TABLE-US-00070 MVKETKLYDLLGVSPSANEQELKKGYRKAALKYHPDKPTGDTEKFKEISE AFEILNDPQKREIYDQYGLEAARSGGPSFGPGGPGGAGGAGGFPGGAGGF SGGHAFSNEDAFNIFSQFFGGSSPFGGADDSGFSFSSYPSGGGAGMGGMP GGMGGMHGGMGGMPGGFRSASSSPTYPEEETVQVNLPVSLEDLFVGKKKS FKIGRKGPHGASEKTQIDIQLKPGWKAGTKITYKNQGDYNPQTGRRKTLQ FVIQEKSHPNFKRDGDDLIYTLPLSFKESLLGFSKTIQTIDGRTLPLSRV QPVQPSQTSTYPGQGMPTPKNPSQRGNLIVKYKVDYPISLNDAQKRAI DENF*

[0505] SIS1 is encoded by a non-essential gene comprising an ORF that is 1.059 kbp in size and is located on chromosome XIV. A published nucleotide coding sequence of SIS1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00071 ATGGTCAAGGAGACAAAACTTTATGATTTACTTGGAGTATCTCCAAGTGCTAATGAGCAA GAACTGAAAAAGGGTTATAGAAAAGCAGCTCTAAAATATCATCCAGATAAGCCAACAGGT GACACAGAAAAGTTTAAGGAGATATCAGAGGCCTTTGAAATTTTAAATGATCCTCAAAAA AGGGAAATATATGATCAATACGGTCTCGAGGCTGCTAGATCTGGTGGTCCAAGCTTTGGT CCTGGTGGTCCTGGCGGTGCTGGAGGTGCTGGAGGCTTCCCTGGCGGTGCGGGCGGATTC TCCGGAGGACATGCGTTCAGTAATGAGGATGCTTTCAATATTTTTTCACAATTCTTTGGC GGCAGTTCCCCATTCGGTGGTGCTGATGACAGTGGCTTCAGTTTCTCTAGTTATCCATCT GGCGGCGGTGCTGGTATGGGAGGTATGCCTGGAGGAATGGGAGGAATGCATGGCGGCATG GGAGGTATGCCTGGCGGCTTTAGATCAGCATCAAGCTCTCCCACGTATCCAGAGGAAGAA ACAGTTCAAGTTAATTTACCAGTTAGTCTAGAAGATTTGTTTGTTGGTAAAAAGAAGTCA TTTAAAATTGGAAGAAAGGGCCCACATGGGGCCTCTGAAAAGACACAAATTGACATTCAA TTAAAACCGGGTTGGAAAGCTGGTACCAAAATAACATACAAGAACCAGGGTGATTACAAT CCTCAAACGGGCCGTAGAAAGACTTTGCAGTTTGTCATCCAGGAAAAGAGCCATCCAAAC TTTAAAAGAGACGGTGATGACCTAATTTACACTCTGCCACTATCTTTCAAGGAATCATTG TTAGGTTTTTCAAAAACTATCCAAACAATTGATGGCAGAACCTTACCTTTGTCGAGAGTA CAGCCTGTCCAACCCTCACAAACTTCTACTTATCCTGGTCAAGGTATGCCAACTCCAAAG AACCCATCTCAGAGAGGTAATTTGATTGTAAAATATAAAGTGGACTATCCAATATCACTA AACGACGCTCAAAAACGTGCTATAGATGAAAATTTTTAA

[0506] Further information on SIS1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000004952

[0507] It will be appreciated that, by "SIS1", we include fragments or variants thereof having equivalent SIS1-like activity.

[0508] DJP1 is another S. cerevisiae helper protein of interest for the present invention. It is also known as ICS1 and PAS22. It is a J-domain-containing protein, required for peroxisomal protein import and involved in peroxisome assembly, homologous to E. coli DnaJ and is located in the cytoplasm. A published protein sequence for the protein Djp1p is as follows:

TABLE-US-00072 MVVDTEYYDLLGVSTTASSIEIKKAYRKKSIQEHPDKNPNDPTATERFQAISEAYQVLGD DDLRAKYDKYGRKEAIPQGGFEDAAEQFSVIFGGDAFASYIGELMLLKNLQKTEELNAED EAEKEKENVETMEESPADGKTNGTTNAVDAALGNTNEKDDKNKARTTSGNLTVHDGNKKN EQVGAEAKKKKTKLEQFEEEQEVEKQKRVDQLSKTLIERLSILTESVYDDACKDSFKKKF EEEANLLKMESFGLDILHTIGDVYYEKAEIFLASQNLFGMGGIFHSMKAKGGVFMDTLRT VSAAIDAQNTMKELEKMKEASTNNEPLFDKDGNEQIKPTTEELAQQEQLLMGKVLSAAWH GSKYEITSTLRGVCKKVLEDDSVSKKTLIRRAEAMKLLGEVFKKTFRTKVEQEEAQIFEE LVAEATKKKRHT*

[0509] DJP1 is encoded by a non-essential gene comprising an ORF that is 1.299 kbp in size and is located on chromosome IX. A published nucleotide coding sequence of DJP1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00073 ATGGTTGTTGATACTGAGTATTACGATTTGTTAGGTGTGTCTACCACTGCATCTTCCATT GAAATAAAAAAGGCCTATAGAAAGAAATCTATTCAAGAGCATCCTGATAAGAATCCCAAT GACCCCACGGCTACCGAAAGGTTTCAAGCAATATCCGAAGCTTATCAAGTTTTAGGTGAC GATGATCTTCGCGCAAAGTATGATAAGTATGGAAGAAAAGAAGCTATTCCTCAGGGCGGC TTTGAAGATGCAGCTGAACAGTTCTCTGTCATCTTTGGTGGAGATGCGTTTGCCTCATAT ATTGGCGAACTGATGCTATTAAAGAACCTACAGAAAACTGAGGAGCTAAATGCTGAAGAC GAAGCTGAAAAGGAGAAGGAGAATGTGGAAACAATGGAAGAATCACCTGCAGACGGTAAG ACGAATGGCACCACTAACGCTGTTGATGCAGCATTGGGCAATACTAACGAAAAAGATGAC AAAAATAAGGCGAGGACAACTTCTGGTAATTTAACTGTACACGATGGAAACAAGAAAAAT GAGCAGGTAGGAGCAGAAGCTAAGAAGAAGAAGACAAAATTAGAGCAGTTTGAGGAAGAA CAAGAGGTAGAAAAGCAAAAAAGAGTAGACCAATTAAGCAAAACATTGATTGAAAGATTA TCGATATTAACAGAAAGTGTCTATGATGATGCATGTAAAGATTCCTTTAAAAAAAAGTTC GAAGAGGAAGCCAATCTTTTAAAGATGGAATCATTTGGTCTGGACATATTACACACAATA GGCGACGTTTACTACGAAAAAGCTGAAATTTTTCTTGCATCCCAGAACCTGTTCGGAATG GGTGGTATATTTCATTCTATGAAGGCTAAAGGGGGAGTATTTATGGATACACTAAGAACT GTTTCGGCAGCCATAGACGCTCAGAATACTATGAAGGAGCTTGAAAAAATGAAAGAAGCT AGCACGAATAATGAGCCTTTGTTTGACAAAGACGGAAATGAGCAAATTAAGCCAACCACT GAGGAACTGGCGCAGCAAGAGCAGCTATTGATGGGCAAAGTATTGTCGGCTGCTTGGCAT GGTTCTAAATATGAAATAACATCCACTTTACGTGGCGTTTGTAAAAAAGTACTAGAAGAT GACTCGGTAAGTAAGAAAACGCTTATCAGAAGAGCTGAAGCAATGAAACTATTGGGTGAA GTCTTTAAGAAAACTTTCAGAACCAAAGTCGAACAAGAAGAGGCACAGATCTTTGAAGAA CTTGTAGCAGAAGCTACAAAAAAGAAGAGACATACATGA

[0510] Further information on DJP1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000001443

[0511] It will be appreciated that, by "DJP1", we include fragments or variants thereof having equivalent DJP1-like activity.

[0512] ZUO1 is another S. cerevisiae helper protein of interest for the present invention. It is a cytosolic ribosome-associated chaperone that acts, together with Ssz1p and the Ssb proteins, as a chaperone for nascent polypeptide chains; contains a DnaJ domain and functions as a J-protein partner for Ssb1p and Ssb2p. A published protein sequence for the protein Zuo1p is as follows:

TABLE-US-00074 MFSLPTLTSDITVEVNSSATKTPFVRRPVEPVGKFFLQHAQRTLRNHTWSEFERIEAEKN VKTVDESNVDPDELLFDTELADEDLLTHDARDWKTADLYAAMGLSKLRFRATESQIIKAH RKQVVKYHPDKQSAAGGSLDQDGFFKIIQKAFETLTDSNKRAQYDSCDFVADVPPPKKGT DYDFYEAWGPVFEAEARFSKKTPIPSLGNKDSSKKEVEQFYAFWHRFDSWRTFEFLDEDV PDDSSNRDHKRYIERKNKAARDKKKTADNARLVKLVERAVSEDPRIKMFKEEEKKEKERR KWEREAGARAEAEAKAKAEAEAKAKAESEAKANASAKADKKKAKEAAKAAKKKNKRAIRN SAKEADYFGDADKATTIDEQVGLIVDSLNDEELVSTADKIKANAAGAKEVLKESAKTIVD SGKLPSSLLSYFV*

[0513] ZUO1 is encoded by a non-essential gene comprising an ORF that is 1.302 kbp in size and is located on chromosome VII. A published nucleotide coding sequence of ZUO1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00075 ATGTTTTCTTTACCTACCCTAACCTCAGACATCACTGTTGAAGTCAACAGTTCCGCTACC AAAACCCCATTCGTCCGTCGTCCGGTCGAACCGGTTGGTAAGTTCTTTTTGCAACATGCT CAAAGAACTTTGAGAAACCACACCTGGTCTGAATTTGAAAGAATTGAAGCTGAAAAGAAC GTCAAAACCGTTGATGAATCCAATGTCGACCCAGATGAGTTGTTATTCGACACTGAATTG GCCGATGAAGATTTACTGACTCATGATGCTAGAGACTGGAAAACTGCCGATTTGTATGCT GCTATGGGTTTGTCTAAGTTGCGTTTCAGAGCTACTGAAAGTCAAATCATCAAGGCTCAC AGAAAACAAGTTGTCAAGTACCATCCAGACAAGCAATCTGCTGCTGGTGGTAGTTTGGAC CAAGATGGCTTTTTCAAGATTATTCAAAAGGCCTTTGAAACTTTGACTGATTCCAACAAG AGAGCTCAGTACGACTCATGTGATTTTGTTGCCGATGTTCCTCCTCCAAAGAAGGGTACC GATTATGACTTTTATGAAGCTTGGGGCCCCGTTTTCGAAGCTGAAGCTCGTTTTTCTAAG AAGACTCCTATTCCTTCTCTAGGTAACAAAGATTCTTCCAAGAAGGAAGTTGAACAATTC TATGCTTTCTGGCACAGATTTGACTCCTGGAGAACCTTTGAGTTCTTGGACGAAGATGTC CCAGATGACTCTTCTAACAGAGACCACAAGCGTTACATTGAAAGAAAGAACAAGGCCGCA AGAGACAAGAAGAAGACTGCTGATAACGCTAGATTGGTCAAACTTGTTGAAAGAGCTGTC AGTGAAGATCCCCGTATCAAAATGTTCAAAGAAGAAGAGAAGAAGGAAAAGGAAAGAAGA AAATGGGAAAGAGAAGCCGGTGCCAGAGCTGAAGCTGAAGCTAAGGCCAAGGCCGAAGCT GAAGCGAAGGCTAAAGCTGAATCTGAAGCCAAGGCTAACGCCTCCGCAAAAGCTGACAAA AAGAAGGCTAAGGAAGCTGCTAAGGCCGCCAAGAAAAAGAACAAGAGAGCCATCCGTAAC TCTGCTAAGGAAGCTGACTACTTTGGTGATGCTGACAAGGCCACCACGATTGACGAACAA GTTGGTTTGATCGTTGACAGTTTGAATGACGAAGAGTTAGTGTCCACCGCCGATAAGATC AAGGCCAATGCTGCTGGTGCCAAGGAAGTTTTGAAGGAATCTGCAAAGACTATTGTCGAT TCTGGCAAACTACCATCCAGCTTGTTGTCCTACTTCGTGTGA

[0514] Further information on ZUO1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003517

[0515] It will be appreciated that, by "ZUO1", we include fragments or variants thereof having equivalent ZUO1-like activity.

[0516] SWA2 is another S. cerevisiae helper protein of interest for the present invention. It is also known as AUX1 and BUD24. It is an auxilin-like protein involved in vesicular transport; clathrin-binding protein required for uncoating of clathrin-coated vesicles. A published protein sequence for the protein Swa2p is as follows:

TABLE-US-00076 MSDPFAHLLTSLKNKDSASASKETTPQSSNSPSITGSAVADVARTDKSPNDSLHSISAPP LIPSPKVDFSAPPLVPTNSTTKSNTANNTPPSALANTDDDFNQLFGMGTVTTTDTIQKPD EDYYGSKEDHLYNGDDALVDEVKDMEIARLMSLGLSIEEATEFYENDVTYERYLEILKSK QKERNDLAIRKKESGIKMEKSGLSNIVGTDSNNLFSMATDFFNKGKKLVDQWTSFPPEAN DRLNNYSKTHDKVEDYDLPQVNDSPNRILFEDNEVVENLPPADNPDQDLLTDFETKIDIT KRTAPDVSHSSSPTSGILIEENSRRNEPLIEDSLLDFSEGNLTNSKSNEDSTLFNENSNT DSTIPISDIELSGYNEFKAKGTSLFKNGDYINSLQEYEKSLNTLPLNHPLRIIALSNIIA SQLKIGEYSKSIENSSMALELFPSSKAKWKNKISNSDPERSFNDIWPKIMIRRAESFEHL ESFKKALETYQELIKKNFFDDKIMQGKRRCQDFINPPPVKKSMPVKKKTTTTSPATKKQN LTASSSNSPISVDSTSEIKKRELENAKLALYDKVFEKISSWKDGKDDDIRHLLANLSSLL TWCNWKDVSMQDLVMPKRVKITYMKAVAKTHPDKIPESLSLENKMIAENIFSTLSIAWDK FKLQNDIN*

[0517] SWA2 is encoded by a non-essential gene comprising an ORF that is 2.007 kbp in size and is located on chromosome IV. A published nucleotide coding sequence of SWA2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00077 ATGTCAGATCCATTTGCACATTTACTGACTTCTTTGAAGAATAAGGACTCTGCATCTGCA TCCAAGGAAACAACTCCTCAGAGCAGCAATTCGCCTTCCATTACTGGTTCCGCTGTTGCA GATGTTGCAAGGACGGATAAAAGCCCCAATGATAGTCTGCATTCAATTTCAGCTCCTCCG CTGATACCGTCACCGAAGGTAGATTTTTCTGCACCTCCTTTGGTCCCAACTAATAGCACC ACTAAATCTAATACTGCCAACAACACACCTCCCTCGGCTCTTGCCAATACCGATGACGAC TTCAATCAACTATTTGGTATGGGCACAGTAACTACAACGGATACGATCCAAAAACCGGAT GAGGATTACTATGGAAGCAAGGAAGACCACCTTTACAATGGTGATGACGCCTTAGTTGAT GAAGTTAAGGATATGGAAATAGCAAGATTGATGTCTCTAGGTTTATCAATTGAAGAAGCC ACTGAGTTTTACGAAAATGACGTAACTTATGAAAGATATTTGGAGATTTTAAAGTCAAAG CAAAAGGAGCGCAACGATCTAGCTATAAGAAAGAAAGAAAGTGGTATAAAAATGGAAAAG TCAGGATTATCCAACATTGTTGGTACAGATAGCAATAATTTATTCAGCATGGCCACTGAT TTTTTCAATAAGGGTAAGAAACTGGTAGACCAATGGACCTCCTTCCCACCTGAGGCAAAT GATAGACTGAATAATTACTCAAAAACTCATGATAAGGTTGAGGATTATGATTTGCCTCAA GTAAACGACTCACCCAATAGAATTTTGTTTGAAGATAATGAAGTCGTAGAGAACTTACCA CCTGCCGATAATCCGGATCAAGATCTTTTAACTGATTTCGAAACAAAGATTGATATAACA AAGAGGACAGCGCCTGATGTCTCCCACTCCTCCTCACCGACTTCTGGTATACTAATTGAA GAAAATTCGCGAAGAAATGAGCCCCTGATAGAGGATAGTCTTCTCGACTTTTCAGAAGGA AATCTCACCAATAGTAAAAGCAATGAAGATAGCACCCTCTTCAATGAAAACAGCAACACT GACTCTACAATACCCATCTCAGATATTGAATTATCGGGGTATAACGAATTTAAGGCGAAA GGTACTAGTTTGTTCAAGAACGGGGATTATATTAACTCATTACAAGAATATGAAAAGTCT TTAAATACATTGCCTTTAAATCATCCATTGAGGATCATTGCATTATCAAACATTATTGCC TCGCAACTGAAAATCGGTGAGTACTCTAAGTCCATAGAAAACTCCAGCATGGCTTTGGAA TTATTCCCATCAAGCAAAGCTAAGTGGAAGAATAAAATCTCAAATAGTGACCCTGAAAGA TCATTTAACGACATCTGGCCAAAGATTATGATTAGGCGTGCTGAGTCTTTTGAACATTTA GAAAGTTTCAAAAAAGCACTAGAAACATACCAAGAGCTGATTAAGAAGAATTTTTTTGAT GATAAAATCATGCAGGGAAAAAGAAGATGCCAAGACTTTATTAATCCTCCCCCTGTTAAA AAATCCATGCCCGTTAAGAAGAAGACAACGACAACCTCGCCTGCAACAAAAAAACAGAAC TTAACCGCTTCTTCTTCAAATTCTCCAATTTCTGTTGATAGCACTTCAGAAATAAAAAAA CGGGAGCTAGAAAACGCTAAACTGGCGCTATATGATAAAGTATTTGAGAAAATTAGCTCC TGGAAGGATGGCAAAGACGATGACATTCGTCATCTGTTAGCAAATTTATCCAGCTTACTA ACATGGTGCAATTGGAAGGATGTCTCTATGCAAGATTTGGTTATGCCTAAGAGGGTCAAA ATTACATACATGAAAGCTGTAGCCAAGACACATCCTGATAAGATACCAGAGTCCTTGTCC CTGGAAAATAAGATGATTGCAGAGAATATTTTCAGTACTTTAAGTATTGCTTGGGATAAG TTCAAACTGCAGAATGACATTAACTGA

[0518] Further information on SWA2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000002728

[0519] It will be appreciated that, by "SWA2", we include fragments or variants thereof having equivalent SWA2-like activity.

[0520] JJJ1 is another S. cerevisiae helper protein of interest for the present invention. It contains a 70 amino acid J-domain, may function as a co-chaperone to recruit Hsp70-like activity to specific sites; mutation of it causes defects in fluid-phase endocytosis. A published protein sequence for the protein Jjj1p is as follows:

TABLE-US-00078 MKTCYYELLGVETHASDLELKKAYRKKALQYHPDKNPDNVEEATQKFAVIRAAYEVLSDP QERAWYDSHKEQILNDTPPSTDDYYDYEVDATVTGVTTDELLLFFNSALYTKIDNSAAGI YQIAGKIFAKLAKDEILSGKRLGKFSEYQDDVFEQDINSIGYLKACDNFINKTDKLLYPL FGYSPTDYEYLKHFYKTWSAFNTLKSFSWKDEYMYSKNYDRRTKREVNRRNEKARQQARN EYNKTVKRFVVFIKKLDKRMKEGAKIAEEQRKLKEQQRKNELNNRRKFGNDNNDEEKFHL QSWQTVKEENWDELEKVYDNFGEFENSKNDKEGEVLIYECFICNKTFKSEKQLKNHINTK LHKKNMEEIRKEMEEENITLGLDNLSDLEKFDSADESVKEKEDIDLQALQAELAEIERKL AESSSEDESEDDNLNIEMDIEVEDVSSDENVHVNTKNKKKRKKKKKAKVDTETEESESFD DTKDKRSNELDDLLASLGDKGLQTDDDEDWSTKAKKKKGKQPKKNSKSTKSTPSLSTLPS SMSPTSAIEVCTTCGESFDSRNKLFNHVKIAGHAAVKNVVKRKKVKTKRI*

[0521] JJJ1 is encoded by a non-essential gene comprising an ORF that is 1.773 kbp in size and is located on chromosome XIV. A published nucleotide coding sequence of JJJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00079 ATGAAGACCTGCTACTATGAGCTTTTAGGGGTCGAAACGCATGCTTCTGATCTTGAGTTA AAAAAAGCTTACCGTAAAAAGGCCCTACAATATCACCCAGATAAAAACCCAGATAATGTT GAAGAAGCCACACAAAAATTTGCTGTGATTCGAGCCGCTTATGAAGTACTGTCTGACCCC CAGGAAAGAGCATGGTATGACTCACATAAGGAACAAATTTTAAATGATACTCCACCAAGC ACTGATGATTACTATGATTATGAGGTAGACGCTACAGTCACAGGTGTCACAACTGATGAA TTACTCTTATTTTTTAACTCTGCTCTTTATACTAAAATAGACAACTCAGCTGCTGGGATA TATCAAATTGCAGGAAAAATATTTGCCAAGTTAGCTAAAGATGAGATTTTAAGTGGTAAG CGACTGGGGAAATTTTCCGAGTATCAAGATGATGTATTCGAACAGGATATTAATAGTATT GGCTATTTGAAAGCCTGCGATAACTTTATTAACAAGACGGATAAACTTTTATATCCTTTA TTTGGATATTCGCCAACGGATTATGAATATTTGAAACATTTCTATAAGACTTGGTCAGCG TTCAATACCTTGAAAAGTTTTAGCTGGAAAGACGAGTACATGTACTCTAAAAACTATGAC AGAAGAACCAAGAGGGAAGTTAATAGAAGAAATGAGAAGGCTAGGCAACAAGCTCGAAAT GAATACAACAAAACCGTGAAAAGGTTTGTAGTTTTCATAAAAAAGCTCGATAAAAGAATG AAAGAAGGTGCAAAAATTGCAGAAGAACAGCGTAAACTAAAAGAACAACAGAGGAAAAAT GAGTTAAATAACAGAAGAAAGTTTGGGAACGACAACAATGACGAAGAAAAATTTCATTTA CAAAGCTGGCAAACGGTAAAAGAAGAAAACTGGGATGAACTGGAAAAGGTATATGATAAT TTTGGAGAATTCGAAAATTCTAAGAATGATAAGGAAGGTGAAGTATTGATTTACGAGTGT TTTATCTGCAACAAGACATTTAAGTCGGAAAAGCAATTGAAAAACCACATAAACACTAAA CTGCATAAGAAAAATATGGAAGAGATACGGAAAGAAATGGAAGAGGAAAACATAACGCTT GGGTTGGATAATCTCTCCGATCTCGAGAAATTTGATTCAGCAGATGAAAGTGTTAAAGAA AAAGAAGATATTGATCTGCAAGCATTGCAAGCTGAACTCGCTGAAATTGAAAGAAAACTG GCAGAATCGTCTTCTGAAGACGAAAGTGAAGATGACAATCTCAACATAGAAATGGATATA GAGGTAGAAGACGTCAGTTCGGATGAAAATGTACATGTGAATACGAAGAATAAAAAGAAA AGAAAAAAGAAAAAAAAAGCAAAGGTTGACACAGAAACAGAGGAATCTGAATCGTTCGAT GATACTAAAGACAAACGGAGTAATGAGTTGGATGATCTTTTGGCATCACTAGGAGACAAG GGCTTACAAACGGATGACGATGAAGATTGGTCTACTAAAGCGAAAAAGAAAAAGGGCAAA CAACCTAAAAAGAATTCTAAATCCACAAAAAGCACTCCGTCCTTGTCGACTCTACCGTCC TCTATGTCTCCAACCTCCGCGATCGAGGTGTGCACTACATGCGGAGAATCATTTGATAGT CGAAATAAGCTATTCAACCACGTGAAGATAGCAGGGCATGCGGCAGTGAAAAACGTAGTG AAAAGAAAGAAAGTCAAGACCAAAAGAATATAG

[0522] Further information on JJJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005171

[0523] It will be appreciated that, by "JJJ1", we include fragments or variants thereof having equivalent JJJ1-like activity.

[0524] JJJ2 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the cytoplasm. A published protein sequence for the protein Jjj2p is as follows:

TABLE-US-00080 MSQVIEPQLDRTTYYSILGLTSNATSSEVHKSYLKLARLLHPDKTKSDKSEELFKAVVHA HSILTDEDQKLRYDRDLKIKGLHTYQPKKNCHIFKTKAKESQGASPTLGQSEAYHRQNKP YEQQPYGFGVGKKMTSSSKSKVPIFKSFNLKSYQRNHYYSSKKERKHGSPDIDSLFHETN GASKVRMTDAGKMDTNSQFQEIWEILGKNAYTHKSYSEDPNSCLGSALSDHEEEEEAGKQ QQQQQQQQQQQQHYGMTSKSSSPDEEKKNNKEPKRESRVSPEENGEEETGHKQFKLPKTS TFSSGSHDSNLQSPFYNHEYRHYARSKFECKNQFRKSVSPIKEIPATTSANEGWNILRDI IEKLNISNVDDRNKDLLFRRDEIGDKNHSDSIDIENLSIKEPKGMKRRKKDDISLEELFQ SLPREKDYFMMDAINDSLESINLFKKPKTTQSHEQGGTFAQAESNRAKFKPLLEQCGITP EILDLEIPEIPEFDAVADLETLKLNVQLFNNQCNKLKETIHQVSLQRLRADTQFSDMLTQ KQSIMVWKTYLEFDKSLMDKLNILQERQMQVIKIFSERCDGKV*

[0525] JJJ2 is encoded by a non-essential gene comprising an ORF that is 1.752 kbp in size and is located on chromosome 10. A published nucleotide coding sequence of JJJ2 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00081 ATGTCACAGGTAATAGAACCACAATTAGATAGAACAACCTATTATTCCATATTAGGCTTG ACATCAAATGCGACTTCCTCCGAAGTACATAAATCATATCTAAAACTGGCCAGATTACTT CACCCAGATAAAACAAAATCTGATAAGTCTGAGGAATTATTCAAAGCTGTGGTGCATGCA CATTCAATTTTAACTGATGAAGATCAAAAACTTCGATATGATCGAGATTTGAAAATCAAA GGTTTACACACTTACCAGCCGAAGAAAAACTGTCATATTTTCAAGACCAAGGCAAAGGAA TCACAAGGGGCTAGTCCCACACTTGGTCAATCAGAAGCTTATCATAGGCAAAATAAACCT TATGAGCAACAGCCCTACGGTTTCGGTGTAGGCAAAAAAATGACCTCAAGCTCTAAGAGT AAGGTTCCGATATTCAAGTCCTTCAATTTAAAAAGCTACCAACGAAACCACTATTATTCA TCCAAAAAGGAAAGGAAACATGGAAGTCCTGATATTGATTCTTTGTTCCATGAAACCAAT GGAGCCTCAAAAGTAAGAATGACTGATGCCGGTAAAATGGATACGAACTCTCAGTTCCAA GAAATATGGGAAATATTGGGTAAAAATGCGTACACACATAAATCTTACTCTGAAGATCCA AATTCATGTTTGGGATCAGCACTAAGCGATCATGAAGAAGAAGAAGAAGCAGGAAAACAA CAACAGCAACAGCAGCAACAACAGCAACAGCAGCAACATTATGGAATGACGTCGAAGTCT AGCAGTCCTGATGAAGAAAAAAAAAATAATAAAGAACCGAAAAGGGAAAGCAGAGTCTCT CCAGAGGAAAATGGCGAAGAAGAAACGGGACACAAACAATTTAAATTGCCCAAGACCAGT ACTTTTTCTAGTGGATCCCATGATTCAAATTTGCAATCTCCTTTTTACAATCATGAGTAT CGACATTACGCAAGAAGTAAATTCGAATGCAAGAATCAGTTTAGAAAGTCAGTTTCTCCC ATTAAAGAGATACCTGCAACAACTAGTGCCAATGAAGGATGGAACATTTTGAGAGACATT ATTGAAAAACTCAATATAAGCAATGTAGACGATCGAAATAAAGACTTGCTGTTTCGTCGG GATGAAATAGGTGATAAAAATCACAGCGACTCAATCGACATAGAAAATTTATCTATCAAA GAACCTAAAGGGATGAAAAGGAGAAAGAAAGATGATATATCTTTAGAAGAATTGTTCCAA TCTTTACCAAGAGAAAAAGATTATTTTATGATGGATGCAATTAATGACTCGTTAGAATCA ATCAATCTTTTTAAAAAGCCGAAGACCACTCAGAGTCACGAACAAGGTGGAACTTTTGCC CAAGCAGAAAGTAATCGTGCAAAATTCAAACCGTTACTAGAACAGTGTGGAATTACACCC GAGATCTTAGATTTGGAAATACCAGAGATTCCGGAATTTGATGCAGTGGCTGACCTTGAA ACATTGAAGCTTAACGTGCAGCTGTTTAATAACCAATGTAACAAACTTAAAGAAACAATA CATCAAGTATCATTACAGCGCCTGAGAGCAGATACGCAGTTCAGTGATATGTTAACCCAA AAGCAAAGTATTATGGTTTGGAAAACATACCTAGAATTTGATAAAAGTTTAATGGACAAA TTGAACATCTTACAAGAAAGACAGATGCAGGTCATTAAAATTTTTTCCGAAAGATGTGAC GGTAAAGTATAA

[0526] Further information on JJJ2 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003698

[0527] It will be appreciated that, by "JJJ2", we include fragments or variants thereof having equivalent JJJ2-like activity.

[0528] JJJ3 is another S. cerevisiae helper protein of interest for the present invention and is also known as DPH4. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the cytoplasm. A published protein sequence for the protein Jjj3p is as follows:

TABLE-US-00082 MSLVNSLTHYEILRIPSDATQDEIKKAYRNRLLNTHPDKLSKSIHDTVSN VTINKIQDAYKILSNIKTRREYDRLILENYKRQGFHNCGDGLDEFSLDDF SFDEDKLEFMMNCPRCQFVGGFHFSESLLDECIDNVDAMERSHSGYQ LLTQCSACSLWLKVNFDIEEEQEGQ

[0529] JJJ3 is encoded by a non-essential gene comprising an ORF that is 0.519 kbp in size and is located on chromosome X. A published nucleotide coding sequence of JJJ3 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00083 ATGTCATTGGTGAATTCGTTAACACACTACGAAATTTTAAGAATTCCATCGGATGCAACA CAAGATGAAATCAAAAAGGCATATAGGAATCGGTTACTAAATACGCACCCCGATAAACTT TCTAAAAGCATACATGATACGGTTAGCAACGTCACAATCAATAAGATTCAAGATGCTTAT AAAATACTATCGAATATAAAAACTCGTCGCGAATATGATAGGTTGATCCTTGAAAACTAT AAACGCCAAGGATTTCATAATTGTGGTGATGGGCTGGATGAATTTTCCTTAGACGATTTC TCATTTGATGAAGATAAGCTGGAGTTTATGATGAATTGTCCTCGCTGTCAATTTGTTGGT GGTTTTCATTTTAGTGAGAGTTTGTTAGATGAATGCATTGATAATGTAGACGCTATGGAA CGGAGTCATTCTGGTTATCAATTATTAACCCAATGTAGCGCATGCAGCTTATGGCTGAAG GTTAATTTTGACATCGAGGAAGAGCAAGAAGGACAATAA

[0530] Further information on JJJ3 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003858

[0531] It will be appreciated that, by "JJJ3", we include fragments or variants thereof having equivalent JJJ3-like activity.

[0532] CAJ1 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the nucleus. A published protein sequence for the protein Caj1p is as follows:

TABLE-US-00084 MVKETEYYDILGIKPEATPTEIKKAYRRKAMETHPDKHPDDPDAQAKFQA VGEAYQVLSDPGLRSKYDQFGKEDAVPQQGFEDASEYFTAIFGGDGFKDW IGEFSLFKELNEATEMFGKEDEEGTAATETEKADESTDGGMVKHDTNKAE SLKKDKLSKEQREKLMEMEKKRREDMMKQVDELAEKLNEKISRYLIAVK SNNLEEFTRKLDQEIEDLKLESFGLELLYLLARVYKTKANNFIMSKKTY GISKIFTGTRDNARSVKSAYNLLSTGLEAQKAMEKMSEVNTDELDQYERA KFESTMAGKALGVMWAMSKFELERKLKDVCNKILNDKKVPSKERIAKAK AMLFIAHKFASARRSPEEAEEARVFEELILGEQEKEHKKHTVAR

[0533] CAJ1 is encoded by a non-essential gene comprising an ORF that is 1.176 kbp in size and is located on chromosome V. A published nucleotide coding sequence of CAJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00085 ATGGTAAAGGAGACGGAGTATTATGATATTTTGGGCATCAAGCCTGAGGCCACGCCCACT GAAATCAAAAAGGCCTATCGTAGAAAGGCTATGGAAACACATCCGGACAAGCATCCTGAT GACCCAGATGCTCAAGCAAAGTTTCAAGCCGTAGGCGAGGCCTACCAAGTCTTAAGTGAT CCAGGGCTTCGTTCCAAGTATGACCAGTTTGGTAAGGAGGATGCTGTTCCTCAGCAAGGA TTTGAAGATGCTTCTGAATACTTTACAGCAATATTCGGTGGTGATGGCTTCAAAGATTGG ATTGGAGAATTTTCTTTGTTCAAAGAGCTAAACGAGGCAACAGAAATGTTTGGAAAGGAA GATGAGGAGGGTACAGCAGCCACTGAAACCGAAAAAGCAGATGAGAGCACTGATGGTGGA ATGGTTAAGCATGACACTAATAAAGCTGAATCTTTGAAAAAAGATAAATTATCGAAGGAG CAAAGAGAGAAGCTAATGGAAATGGAGAAAAAAAGACGGGAAGATATGATGAAACAAGTC GACGAGTTGGCAGAAAAACTGAACGAAAAAATCTCTAGGTACTTAATTGCTGTGAAGTCC AATAACTTGGAGGAATTTACGCGAAAACTAGATCAAGAAATCGAGGATTTGAAATTAGAA AGTTTTGGTCTAGAGTTATTGTATTTATTGGCCAGGGTTTACAAGACAAAAGCGAATAAT TTTATCATGTCCAAGAAGACTTACGGAATTTCTAAAATATTCACTGGTACACGCGACAAT GCTAGATCTGTTAAATCAGCATACAATTTATTGTCTACAGGCTTAGAAGCTCAAAAAGCC ATGGAAAAAATGAGTGAAGTCAATACTGACGAACTAGACCAATATGAACGTGCCAAATTT GAGTCCACAATGGCTGGTAAGGCACTTGGTGTCATGTGGGCTATGTCGAAATTTGAACTG GAAAGAAAACTAAAAGACGTTTGCAATAAGATTCTAAACGATAAAAAGGTCCCTTCCAAG GAACGTATTGCAAAGGCAAAAGCAATGCTGTTTATTGCCCACAAGTTTGCCAGTGCTAGA AGGTCACCAGAAGAAGCTGAAGAAGCTAGAGTTTTTGAAGAGCTAATCCTAGGTGAGCAG GAGAAGGAACACAAAAAACATACTGTGGCCAGATAA

[0534] Further information on CAJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000850

[0535] It will be appreciated that, by "CAJ1", we include fragments or variants thereof having equivalent CAJ1-like activity.

[0536] CWC23 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the nucleus. A published protein sequence for the protein Cwc23p is as follows:

TABLE-US-00086 MPGHELEDVINQRLNLYDVLELPTPLDVHTIYDDLPQIKRKYRTLALKYH PDKHPDNPSIIHKFHLLSTATNILTNADVRPHYDRWLIEFLRKTNDIERN KLIQKLEESESSTIPTTTPHPDLLQIQRHGELLRKLKHFNLPYGDWKHLN TQDQENASQHPYYDCSTLRIVLDNFLQSNNKSNCLSHLRNQVFITLSANE IYDIYFSERNNYSKDDSIIIYTVFDTPITAQHVFRNWSSGNLIPTVKDIS PLIPLHYYSDFNLETELNDDIARLVSNEPILLD

[0537] CWC23 is encoded by an essential gene comprising an ORF that is 0.852 kbp in size and is located on chromosome VII. A published nucleotide coding sequence of CWC23 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00087 ATGCCAGGACACGAATTGGAAGACGTAATAAATCAACGTTTGAACCTATATGATGTATTA GAATTACCGACCCCCCTGGACGTCCATACCATCTACGATGATTTGCCCCAAATTAAACGC AAATACAGGACCCTTGCCCTGAAGTATCATCCTGACAAACACCCGGACAATCCATCAATT ATACACAAATTCCACTTATTATCGACCGCAACTAATATCCTCACCAATGCAGACGTGAGA CCCCATTACGACCGCTGGTTAATTGAGTTCCTACGGAAAACAAACGACATTGAAAGAAAT AAACTTATACAAAAGCTGGAAGAATCTGAATCGAGTACGATACCCACCACCACACCACAT CCTGATTTATTGCAAATCCAACGCCACGGCGAGCTACTCAGGAAACTAAAACATTTCAAC TTGCCCTATGGTGACTGGAAACATCTCAACACACAAGACCAAGAAAATGCTTCGCAACAT CCGTATTACGATTGCTCTACTTTGAGAATTGTCCTTGACAACTTCCTGCAATCAAATAAT AAATCAAACTGCTTATCTCATTTGCGCAATCAAGTATTCATCACGCTAAGTGCTAATGAA ATCTACGACATCTACTTCTCTGAAAGAAACAACTACTCGAAGGATGATTCAATCATCATA TATACTGTATTCGATACTCCCATCACAGCGCAGCACGTATTCCGAAACTGGTCAAGTGGG AACCTCATACCCACGGTCAAGGATATTTCGCCCTTGATCCCGCTACATTACTACTCTGAT TTTAATTTGGAGACGGAACTGAATGACGATATTGCAAGACTGGTCTCTAATGAACCTATC CTACTCGACTAG

[0538] Further information on CWC23 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003096

[0539] It will be appreciated that, by "CWC23", we include fragments or variants thereof having equivalent CWC23-like activity.

[0540] PAM18 is another S. cerevisiae helper protein of interest for the present invention and is also known as TIM14. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the mitochondria. A published protein sequence for the protein Pam18p is as follows:

TABLE-US-00088 MSSQSNTGNSIEAPQLPIPGQTNGSANVTVDGAGVNVGIQNGSQGQKTGM DLYFDQALNYMGEHPVITGFGAFLTLYFTAGAYKSISKGLNGGKSTTAFL KGGFDPKMNSKEALQILNLTENTLTKKKLKEVHRKIMLANHPDKGGSPFL ATKINEAKDFLEKRGISK

[0541] PAM18 is encoded by an essential gene comprising an ORF that is 0.507 kbp in size and is located on chromosome XII. A published nucleotide coding sequence of PAM18 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00089 ATGAGTTCTCAAAGTAATACTGGTAATTCTATTGAGGCACCACAACTACCCATTCCTGGT CAAACTAATGGCTCTGCGAACGTTACTGTTGATGGAGCTGGTGTTAATGTCGGTATCCAG AATGGTTCGCAGGGTCAAAAGACCGGAATGGACCTTTATTTTGATCAAGCTTTGAACTAC ATGGGAGAACATCCTGTGATAACAGGTTTTGGGGCCTTTTTAACTTTATATTTTACAGCC GGTGCATATAAATCAATATCGAAGGGACTTAACGGTGGAAAATCCACTACTGCCTTCTTG AAAGGCGGATTTGACCCGAAAATGAATTCTAAAGAGGCTCTACAGATTTTGAATTTGACA GAAAATACATTGACTAAAAAAAAGTTGAAAGAGGTTCATAGGAAAATTATGTTAGCTAAT CATCCTGACAAAGGTGGTTCTCCATTTTTGGCCACTAAGATAAACGAAGCTAAGGACTTT TTGGAAAAAAGGGGTATTAGCAAATAA

[0542] Further information on PAM18 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000003998

[0543] It will be appreciated that, by "PAM18", we include fragments or variants thereof having equivalent PAM18-like activity.

[0544] JAC1 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the mitochondria. A published protein sequence for the protein Jac1p is as follows:

TABLE-US-00090 MLKYLVQRRFTSTFYELFPKTFPKKLPIWTIDQSRLRKEYRQLQAQHHPD MAQQGSEQSSTLNQAYHTLKDPLRRSQYMLKLLRNIDLTQEQTSNEVTTS DPQLLLKVLDIHDELSQMDDEAGVKLLEKQNKERIQDIEAQLGQCYNDKD YAAAVKLTVELKYWYNLAKAFKDWAPGKQLEMNH

[0545] JAC1 is encoded by an essential gene comprising an ORF that is 0.555 kbp in size and is located on chromosome VII. A published nucleotide coding sequence of JAC1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00091 ATGTTGAAATACTTGGTTCAACGAAGATTCACTTCTACATTTTACGAGCTGTTCCCAAAG ACCTTCCCCAAAAAGCTACCCATTTGGACTATCGATCAATCCAGATTAAGGAAGGAGTAT AGGCAATTACAAGCACAGCACCATCCAGACATGGCCCAACAAGGTAGTGAACAGTCATCA ACTCTTAATCAAGCTTACCATACTCTCAAAGATCCCCTTAGAAGGTCACAATATATGCTA AAACTCTTGCGCAATATCGATTTGACGCAAGAACAGACCTCAAATGAAGTAACTACCAGT GATCCACAGTTACTATTGAAAGTTCTAGACATCCATGATGAATTATCCCAGATGGACGAC GAAGCTGGTGTGAAGCTGCTTGAAAAGCAAAACAAGGAAAGAATTCAAGATATTGAAGCC CAGTTGGGACAATGCTACAATGACAAGGATTACGCCGCCGCAGTGAAGTTGACCGTGGAG CTAAAGTACTGGTACAACTTGGCCAAGGCATTCAAAGACTGGGCTCCAGGAAAACAATTG GAAATGAATCACTAA

[0546] Further information on JAC1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S0000002986

[0547] It will be appreciated that, by "JAC1", we include fragments or variants thereof having equivalent JAC1-like activity.

[0548] JID1 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the mitochondria. A published protein sequence for the protein Jid1p is as follows:

TABLE-US-00092 MLHHKFVYPFLFKWHLSCVEKCPPQITFIAKYATANDKNGNRKLTIRDEQ WPELADPTPYDIFGIPKAGSGNPKLDKKSLKKKYHRYVKLYHPDHSDNIQ IFSSEKVTNSDSKSPLLLTSSEKLHRFKVISQAYDILCDPKKKIVYDTTR QGWTTSYSPRSNVNTENYQYAGSYGYHSNAQYEYWNAGTWEDANSMKN ERIQENINPWTVIGIICGLAICIEGTALLAKIQESLSKAEFTHDESGLHL IQSYTNYGLDTDKFSRLRRFLWFRTWGLYKSKEDLDREAKINEEMIRKLK AAK

[0549] JID1 is encoded by a non-essential gene comprising an ORF that is 0.906 kbp in size and is located on chromosome XVI. A published nucleotide coding sequence of JID1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00093 ATGCTACACCATAAGTTCGTATACCCATTTTTATTCAAGTGGCACTTATCATGTGTAGAA AAGTGTCCCCCACAAATCACTTTTATAGCTAAGTATGCTACAGCGAACGATAAAAATGGC AATAGAAAACTTACGATAAGGGATGAACAATGGCCTGAGTTGGCAGATCCAACTCCCTAT GATATTTTTGGCATTCCAAAGGCCGGATCTGGAAATCCTAAACTGGACAAGAAGTCGTTA AAAAAAAAATATCATCGTTATGTAAAATTGTACCACCCTGACCATTCCGATAACATTCAA ATATTTAGCTCAGAAAAGGTTACCAACAGTGATAGTAAATCACCGCTGCTGCTAACATCA AGCGAAAAACTACATAGATTTAAAGTCATCTCTCAAGCATATGATATTCTTTGTGACCCA AAGAAAAAGATCGTATATGACACAACGAGGCAAGGCTGGACCACATCGTATTCACCACGT TCTAACGTTAATACTGAAAATTACCAATATGCCGGCTCTTATGGCTACCACTCTAACGCG CAGTATGAATACTGGAACGCTGGGACTTGGGAAGACGCAAATAGCATGAAAAACGAAAGA ATTCAAGAAAACATCAACCCATGGACCGTTATTGGCATAATTTGTGGCCTAGCTATATGC ATCGAAGGGACTGCGTTGTTAGCCAAAATCCAGGAGTCTCTGAGCAAGGCCGAATTTACT CATGACGAAAGTGGATTACATTTGATTCAGTCATACACGAATTATGGTCTTGATACTGAC AAATTTTCCAGATTGAGGCGGTTCTTATGGTTTAGAACTTGGGGACTTTACAAGTCGAAA GAGGATTTAGATAGAGAAGCCAAGATCAATGAAGAAATGATACGCAAACTGAAAGCAGCT AAATGA

[0550] Further information on JID1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000006265

[0551] It will be appreciated that, by "JID1", we include fragments or variants thereof having equivalent JID1-like activity.

[0552] HLJ1 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the endoplasmic reticulum membrane. A published protein sequence for the protein Hlj1p is as follows:

TABLE-US-00094 MSFTEDQEKIALEILSKDKHEFYEILKVDRKATDSEIKKAYRKLAIKLHP DKNSHPKAGEAFKVINRAFEVLSNEEKRSIYDRIGRDPDDRQMPSRGAAS GFRGSAGGSPMGGGFEDMFFNSRFGGQRAGPPEDIFDFLFNAGGSPFGA SPFGPSASTFSFGGPGGFRVYTNNRGGSPFMRQQPRSRQQQQQAEENA VNSQLKNMLVLFIIFIVLPMIKDYLFS

[0553] HLJ1 is encoded by a non-essential gene comprising an ORF that is 0.675 kbp in size and is located on chromosome XIII. A published nucleotide coding sequence of HLJ1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00095 ATGTCTTTCACTGAGGATCAAGAAAAAATCGCGCTAGAAATACTGTCAAA AGACAAGCATGAGTTTTACGAAATTTTGAAGGTAGATAGGAAAGCCACAG ATAGTGAGATCAAGAAGGCATACAGAAAACTAGCAATCAAATTGCATCCT GATAAAAACTCTCATCCAAAAGCGGGAGAAGCTTTCAAAGTAATTAATAG GGCATTTGAAGTACTAAGCAATGAGGAAAAGCGCAGTATTTATGACAGGA TAGGTAGGGATCCTGACGATAGACAAATGCCATCCAGAGGTGCTGCTTCA GGGTTCCGAGGAAGTGCAGGTGGGTCTCCAATGGGTGGCGGATTTGAAGA CATGTTTTTCAATTCACGTTTCGGTGGTCAAAGAGCTGGACCACCAGAGG ACATATTCGACTTTTTGTTCAACGCAGGCGGCAGCCCATTCGGCGCTTCA CCATTTGGGCCTTCTGCTTCCACTTTTTCATTTGGAGGCCCCGGTGGTTT CAGAGTTTATACTAATAATCGTGGTGGCTCACCGTTCATGCGTCAACAAC CCCGCTCAAGACAGCAGCAACAACAAGCAGAAGAAAATGCAGTGAATTCG CAATTAAAAAATATGCTCGTTCTTTTCATCATCTTTATTGTTCTTCCTAT GATTAAAGATTACCTGTTTAGTTAA

[0554] Further information HLJ1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000004771

[0555] It will be appreciated that, by "HLJ1", we include fragments or variants thereof having equivalent HLJ1-like activity.

[0556] ERJ5 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial chaperone DnaJ, and is located in the endoplasmic reticulum. A published protein sequence for the protein Erj5p is as follows:

TABLE-US-00096 MNGYWKPALVVLGLVSLSYAFTTIETEIFQLQNEISTKYGPDMNFYKFLK LPKLQNSSTKEITKNLRKLSKKYHPDKNPKYRKLYERLNLATQILSNSSN RKIYDYYLQNGFPNYDFHKGGFYFSRMKPKTWFLLAFIWIVVNIGQYIIS IIQYRSQRSRIENFISQCKQQDDTNGLGVKQLTFKQHEKDEGKSLVVRFS DVYVVEPDGSETLISPDTLDKPSVKNCLFWRIPASVWNMTFGKSVGSAGK EEIITDSKKYDGNQTKKGNKVKKGSAKKGQKKMELPNGKVIYSRK

[0557] ERJ5 is encoded by a non-essential gene comprising an ORF that is 0.888 kbp in size and is located on chromosome VI. A published nucleotide coding sequence of ERJ5 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00097 ATGAACGGTTACTGGAAACCTGCGTTGGTTGTCCTGGGATTGGTATCTCT ATCATATGCTTTTACCACCATTGAAACAGAAATTTTCCAATTACAAAATG AAATAAGTACGAAATATGGCCCAGATATGAACTTCTACAAGTTCTTGAAG TTACCTAAACTGCAGAATTCTAGTACAAAGGAGATTACAAAAAACTTAAG AAAGCTATCCAAGAAGTACCATCCGGATAAGAACCCTAAATACCGTAAAT TGTATGAAAGGTTAAACCTCGCTACTCAAATTCTTTCAAACAGCTCTAAT CGTAAGATTTATGATTATTATCTACAGAATGGCTTTCCAAACTATGATTT CCATAAGGGTGGTTTTTATTTTTCCAGAATGAAGCCTAAGACTTGGTTCC TGCTGGCCTTTATTTGGATAGTCGTTAATATTGGGCAGTATATCATTTCT ATTATTCAATATCGTTCTCAAAGATCAAGAATTGAAAACTTCATCAGTCA GTGTAAACAACAGGATGATACCAATGGACTAGGCGTAAAACAACTAACGT TTAAACAACATGAAAAGGATGAGGGTAAAAGTTTGGTTGTAAGGTTTAGC GATGTCTATGTTGTAGAGCCTGATGGAAGTGAAACACTAATTTCGCCAGA TACCTTGGATAAACCTTCAGTAAAGAACTGTTTGTTTTGGAGAATACCTG CTTCGGTTTGGAACATGACGTTTGGCAAATCTGTTGGTAGCGCAGGAAAA GAAGAAATAATAACGGATAGTAAAAAGTATGATGGTAACCAAACAAAAAA GGGGAACAAAGTAAAAAAGGGTTCTGCAAAGAAAGGCCAAAAGAAAATGG AATTGCCTAACGGTAAAGTGATCTATTCACGTAAATGA

[0558] Further information ERJ5 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000001937

[0559] It will be appreciated that, by "ERJ5", we include fragments or variants thereof having equivalent ERJ5-like activity.

[0560] MGE1 is another S. cerevisiae helper protein of interest for the present invention and is also known as YGE1. It is one of several homologs of the bacterial GrpE and is located in the mitochondria. A published protein sequence for the protein Mge1p is as follows:

TABLE-US-00098 MRAFSAATVRATTRKSFIPMAPRTPFVTPSFTKNVGSMRRMRFYSDEAKS EESKENNEDLTEEQSEIKKLESQLSAKTKEASELKDRLLRSVADFRNLQQ VTKKDIQKAKDFALQKFAKDLLESVDNFGHALNAFKEEDLQKSKEISDLY TGVRMTRDVFENTLRKHGIEKLDPLGEPFDPNKHEATFELPQPDKEPGTV FHVQQLGFTLNDRVIRPAKVGIVKGEEN

[0561] MGE1 is encoded by an essential gene comprising an ORF that is 0.687 kbp in size and is located on chromosome XV. A published nucleotide coding sequence of MGE1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00099 ATGAGAGCTTTTTCAGCAGCCACCGTTAGGGCCACAACTAGGAAGTCGTT CATCCCAATGGCACCAAGAACTCCTTTTGTGACTCCATCATTTACAAAGA ATGTAGGCTCAATGAGAAGAATGAGATTTTATTCTGATGAAGCCAAAAGT GAAGAATCCAAAGAAAACAATGAAGATTTGACTGAAGAGCAATCAGAAAT CAAGAAATTAGAGAGCCAGTTAAGCGCGAAGACTAAAGAAGCTTCTGAAC TCAAGGACAGATTATTAAGATCTGTGGCAGATTTCAGAAATTTACAACAA GTCACAAAGAAGGATATTCAGAAAGCTAAGGACTTTGCTTTACAGAAGTT TGCAAAGGATTTATTGGAATCTGTAGATAACTTTGGTCATGCTTTGAATG CTTTTAAAGAGGAAGACTTACAAAAGTCCAAGGAAATTAGTGATTTGTAT ACAGGGGTTAGAATGACAAGAGATGTTTTTGAAAACACCCTAAGAAAGCA CGGTATTGAAAAATTAGACCCATTGGGAGAACCATTTGATCCAAATAAAC ACGAAGCAACGTTCGAGTTGCCACAACCTGATAAGGAACCGGGTACTGTT TTCCATGTACAACAATTAGGTTTCACCTTGAATGACAGAGTTATCAGACC AGCAAAAGTCGGAATTGTTAAGGGCGAAGAGAACTAA

[0562] Further information MGE1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000005758

[0563] It will be appreciated that, by "MGE1", we include fragments or variants thereof having equivalent MGE1-like activity.

[0564] FES1 is another S. cerevisiae helper protein of interest for the present invention. It is one of several homologs of the bacterial GrpE and is located in the cytoplasm. A published protein sequence for the protein Fes1p is as follows:

TABLE-US-00100 MEKLLQWSIANSQGDKEAMARAGQPDPKLLQQLFGGGGPDDPTLMKESMA VIMNPEVDLETKLVAFDNFEMLIENLDNANNIENLKLWEPLLDVLVQTKD EELRAAALSIIGTAVQNNLDSQNNFMKYDNGLRSLIEIASDKTKPLDVRT KAFYALSNLIRNHKDISEKFFKLNGLDCIAPVLSDNTAKPKLKMRAIALL TAYLSSVKIDENIISVLRKDGVIESTIECLSDESNLNIIDRVLSFLSHLI SSGIKFNEQELHKLNEGYKHIEPLKDRLNEDDYLAVKYVL

[0565] FES1 is encoded by a non-essential gene comprising an ORF that is 0.873 kbp in size and is located on chromosome II. A published nucleotide coding sequence of FES1 is as follows, although it will be appreciated that the sequence can be modified by degenerate substitutions to obtain alternative nucleotide sequences which encode an identical protein product:

TABLE-US-00101 ATGGAAAAGCTATTACAGTGGTCTATTGCGAATTCTCAAGGGGACAAAGA AGCTATGGCTAGGGCCGGCCAACCTGATCCTAAATTGCTACAGCAGTTAT TCGGTGGTGGTGGTCCTGACGATCCAACCTTAATGAAAGAATCCATGGCT GTTATTATGAATCCGGAGGTTGACTTAGAAACAAAACTCGTTGCATTTGA CAACTTTGAAATGTTGATTGAGAACTTAGATAATGCTAATAATATCGAAA ATTTAAAACTGTGGGAGCCATTGTTGGATGTTCTTGTTCAGACGAAGGAT GAAGAACTACGTGCTGCTGCTTTATCCATTATTGGAACGGCTGTGCAAAA CAACTTGGATTCGCAAAATAATTTCATGAAATACGACAATGGTCTGCGAA GCCTTATCGAAATAGCTAGTGACAAGACAAAGCCACTCGACGTGAGAACA AAAGCTTTTTACGCACTATCTAATCTAATAAGAAACCACAAAGATATCTC AGAAAAGTTTTTCAAATTAAATGGGCTCGACTGCATAGCACCTGTATTAA GTGATAACACCGCCAAACCAAAACTGAAAATGAGAGCCATTGCCTTATTG ACCGCATATTTGTCATCTGTTAAGATTGATGAAAATATAATCAGTGTGCT GAGAAAGGATGGAGTAATTGAAAGTACGATTGAGTGCTTGTCTGACGAGA GTAACTTGAACATCATAGATAGAGTTCTGTCTTTTCTCTCTCACCTGATA TCTTCCGGAATAAAATTTAATGAACAGGAATTGCACAAATTGAACGAAGG TTACAAACATATCGAGCCTCTAAAGGACAGACTTAATGAAGACGATTATT TAGCCGTAAAGTATGTATTATGA

[0566] Further information FES1 can be obtained from the URL address http://db.yeastgenome.org/cgi-bin/singlepageformat?sgdid=S000000305

[0567] It will be appreciated that, by "FES1", we include fragments or variants thereof having equivalent FES1-like activity.

[0568] Variants and fragments of the above JEM1, LHS1, SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1, MDJ2, ERO1, ERV2, EUG1, MPD1, MPD2, EPS1, PDI1, DER1, DER3, HRD3, UBC7, DOA4, HAC1, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, HLJ1, ERJ5, MGE1 and FES1 proteins and encoding polynucleotide sequences, and variants of other naturally occurring JEM1, LHS1, SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1, MDJ2, ERO1, ERV2, EUG1, MPD1, MPD2, EPS1, PDI1, DER1, DER3, HRD3, UBC7, DOA4, HAC1, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, HLJ1, ERJ5, MGE1 and FES1 proteins and encoding polynucleotide sequences are also included in the present invention.

[0569] A "variant", in the context of a JEM1, LHS1, SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1, MDJ2, ERV2, EUG1, MPD1, MPD2, EPS1, PDI1, DER1, DER3, HRD3, UBC7, DOA4, HAC1, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, HLJ1, ERJ5, MGE1 or FES1 protein, refers to a protein having a sequence as defined above by the present application wherein at one or more positions there have been amino acid insertions, deletions, or substitutions, either conservative or non-conservative, provided that such changes result in a protein whose basic properties, for example enzymatic activity (type of and specific activity), thermostability, activity in a certain pH-range (pH-stability) have not significantly been changed. "Significantly" in this context means that one skilled in the art would say that the properties of the variant may still be different but would not be unobvious over the ones of the original protein.

[0570] By "conservative substitutions" is intended combinations such as Val, Ile, Leu, Ala, Met; Asp, Glu; Asn, Gln; Ser, Thr, Gly, Ala; Lys, Arg, His; and Phe, Tyr, Trp. Preferred conservative substitutions include Gly, Ala; Val, Ile, Leu; Asp, Glu; Asn, Gln; Ser, Thr; Lys, Arg; and Phe, Tyr.

[0571] A "variant" typically has at least 25%, at least 50%, at least 60% or at least 70%, preferably at least 80%, more preferably at least 90%, even more preferably at least 95%, yet more preferably at least 99%, most preferably at least 99.5% sequence identity to the polypeptide from which it is derived.

[0572] The percent sequence identity between two polypeptides may be determined using suitable computer programs, as discussed below. Such variants may be natural or made using the methods of protein engineering and site-directed mutagenesis as are well known in the art.

[0573] A "fragment", in the context of JEM1, LHS1, SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1, MDJ2, ERO1, ERV2, EUG1, MPD1, MPD2, EPS1, PDI1, DER1, DER3, HRD3, UBC7, DOA4, HAC1, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, HLJ1, ERJ5, MGE1 and FES1 proteins, refers to a protein wherein at one or more positions there have been deletions. Thus the fragment may comprise at most 5, 10, 20, 30, 40 or 50%, typically up to 60%, more typically up to 70%, preferably up to 80%, more preferably up to 90%, even more preferably up to 95%, yet more preferably up to 99% of the complete sequence of the full mature protein as defined above. Particularly preferred fragments of a protein comprise one or more whole domains of the desired protein.

[0574] A fragment or variant of a JEM1, LHS1, SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1, MDJ2, ERO1, ERV2, EUG1, MPD1, MPD2, EPS1, PDI1, DER1, DER3, HRD3, UBC7, DOA4, HAC1, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, HLJ1, ERJ5, MGE1 or FES1 protein may be a protein that, when expressed recombinantly in a host cell, can complement the deletion of the same endogenously encoded gene in the host cell, such as S. cerevisiae, and may or may not, for example, be a naturally occurring homolog of the protein upon which it is based, such as a homolog encoded by another organism, such as another yeast or other fungi, or another eukaryote such as a human or other vertebrate, or animal or by a plant.

[0575] A fragment or a variant of a polynucleotide encoding a JEM1, LHS1, SCJ1, KAR2, SIL1, FKB2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2, ECM10, MDJ1, MDJ2, ERO1, ERV2, EUG1, MPD1, MPD2, EPS1, PDI1, DER1, DER3, HRD3, UBC7, DOA4, HAC1, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, HLJ1, ERJ5, MGE1 or FES1 protein may be a polynucleotide that comprises a sequence that encodes a fragment or variant of the protein as defined above.

[0576] The present invention will now be exemplified with reference to the following non-limiting examples and figures.

BRIEF DESCRIPTION OF FIGURES

[0577] FIGS. 1 to 9, 11 to 16, 21, 23-25 and 28 show various plasmid maps as described in the following examples.

[0578] FIG. 10 shows analysis of HAC1 splicing at log phase by qRT-PCR in the strain AH22 (ura3) [pAYE329]. Helper protein overexpression plasmids are shown on the x-axis. Data are normalised to ACT1 transcript levels and presented as fold changes from AH22 (ura3) [pAYE329, YCplac33]. All values shown represent duplicate analysis of mRNA levels from single experimental cultures.

[0579] FIG. 17 shows SDS-PAGE gels for quantification of rHA production in overexpression strains. Sample labels shown indicate overexpression plasmids transformed into the strain AH22 (ura3) [pAYE329]. Duplicate samples represent two independent shake flasks from the same transformant.

[0580] FIG. 18 shows quantification of main rHA band in transformed and control strains, by analysis of SDS-PAGE gel of FIG. 17 using densitometry. Values are normalised (based on culture optical density readings) to account for different growth rates observed between strains.

[0581] FIG. 19 shows quantification of main rHA band in transformed and control strains, by analysis of SDS-PAGE gel of FIG. 17 using densitometry, expressed as a percentage of determined rHA production by the negative control YCplac33. Values are normalised (based on culture optical density readings) to account for different growth rates observed between strains.

[0582] FIG. 20 shows quantification of rHA fragments relative to total rHA, by analysis of SDS-PAGE gel of FIG. 17 using densitometry, expressed as a percentage of detected rHA fragments relative to total rHA levels detected (total rHA=full length rHA+degradation products). Values are normalised (based on culture optical density readings) to account for different growth rates observed between strains.

[0583] FIG. 22 shows a comparison of recombinant transferrin titres by rocket immunoelectrophoresis. A=Control Strain [pDB3213]; B=Control Strain (ura3). [pTPC17 pDB3213]. Duplicate 10 mL shake flasks cultures were inoculated with yeast and incubated with shaking at 200 rpm for 4-days at 30.degree. C. 5 .mu.L culture supernatant loaded per well of a rocket immunoelectrophoresis gel. Plasma Tf standards concentrations are in .mu.g/mL. 20 .mu.L goat anti-Tf/50 mL agarose. Precipin was stained with Coomassie blue.

[0584] FIG. 26 shows the effect of LHS1, JEM1 and SIL1 co-expression on rHA production, when rHA is fused to different leader sequences. Two separate transformants for each strain were inoculated into 50 mL shake flasks containing 10 mL BMMD and incubated with shaking at 200 rpm for 4-days at 30.degree. C. 20 .mu.L of culture supernatant was loaded per well of a 4-12% SDS-PAGE gel and run for 50 mins in MOPS buffer. Gel A shows the results obtained with plasmid pDB2244, which encodes a HSA/MF.alpha.-1 fusion leader sequence (A=AH22 (ura3) [pDB2244 YCplac33]; B=AH22 (ura3) [pDB2244 pTPC17]). Gel B shows the results obtained with plasmid pDB2286, which encodes an invertase leader sequence (C=AH22 (ura3) [pDB2286 YCplac33]; D=AH22 (ura3) [pDB2286 pTPC17]). Gel C shows the results obtained with plasmid pDB2287, which encodes the MF.alpha.-1 leader sequence (E=AH22 (ura3) [pDB2287 YCplac33]; F=AH22 (ura3) [pDB2287 pTPC17]).

[0585] FIG. 26, part D, shows densitometric quantification of rHA secretion. Gels shown in FIG. 26 A-C were analysed by densitometry and comparison to rHA standard curves. Data presented above represents quantification of single rHA bands. For each strain two transformants were analysed (samples A and B in FIG. 26D).

[0586] FIG. 27 shows the DNA sequence of the human GM-CSF cDNA with an incorporated N-terminal Met codon.

[0587] FIG. 29 A shows an SDS-PAGE gel for quantification of GM-CSF production. Lanes 2-5 show GM-CSF production in the control strain (ura3) [pDB2109 YCplac33]. Lanes 6-9 show GM-CSF production in the control strain (ura3) [pDB2109 pTPC17.

[0588] FIG. 29 B shows the results of densitometric analysis of the SDS-PAGE gel shown in FIG. 29 A, as further given in Table 9, below.

EXAMPLE 1

[0589] A strain of S. cerevisiae that possesses increased production of a recombinant protein was produced by the following methodology.

[0590] Strains. The S. cerevisiae strain used was a histidine revertant of AH22 (cir.sup.o a leu2-3 leu2-112 his4 canR). AH22 is further described in Mead at al, 1986, Mol. Gen. Genet., 205, 417-421. A polynucleotide encoding a recombinant heterologous protein expression cassette was introduced by S. cerevisiae transformation performed according to Ito, H., at al. (Transformation of intact yeast cells treated with alkali cations. J. Bacterial. 153, 163-168, (1983)).

[0591] Media. Yeast strains were grown in rich broth medium, YEP (1% yeast extract 2% w/v Bactopeptone).

[0592] Protein assays. Yeast cells were grown in 10 ml cultures for 72 hours to a density of 5.times.10.sup.7 cells/mL at 30.degree. C. in YEP 2% (w/v) sucrose. In order to analyse the soluble heterologous protein fraction of yeast, cells were harvested by centrifugation and disrupted in phosphate buffered saline by vortexing with 40 mesh glass beads. The soluble fraction was collected as the supernatant of a 10,000.times.g centrifugation. The fraction was assayed for the presence of heterologous protein by polyacrylamide gel electrophoresis and Western blot, using appropriate commercially available antibodies.

[0593] Mutagenesis. Yeast cells to be mutated were grown in 100 ml defined medium (0.65% (w/v) YNB; 2% (w/v) sucrose; Na.sub.2HPO.sub.4/citric acid pH 6.5) to OD.sub.650=0.5. Cells were harvested by centrifugation and resuspended in 100 ml defined medium. To 2 ml of washed cells was added 10 microlitres, 20 microlitres, 40 microlitres, 80 microlitres or 160 microlitres of the mutagen stock solution. The cells were then incubated at 30.degree. C., 200 rpm for 30 rain. One ml of mutated cells was washed twice with 1 ml sterile distilled water and finally resuspended in 1 ml YEP. The percentage of cells that survived the mutagenic treatment was assessed by spreading an aliquot of each mutagenic reaction onto YEP, 2% (w/v) sucrose plates. Mutagen stock solutions were prepared as follows. N-methyl-N-nitro-N-nitrosoguanidine (NTG) was dissolved in ethanol at 5 mg/mL; 4 nitroquinoline N-oxide (NQO) was resuspended in acetone at 10 mg/mL and then diluted 1 in 100 to 0.1 mg/mL with K.sub.2HPO.sub.4/KH.sub.2PO.sub.4 (pH 7.0); 1,2,7,8-diepoxyoctane (DEO) and ethyl methanesulphonate (EMS) were both supplied as liquids (Sigma) and were used without dilution.

[0594] After mutagenesis, a S. cerevisiae strain was identified with a higher level of production of a recombinant protein, compared to its ancestral strain (data not shown).

EXAMPLE 2

[0595] The expression of genes in the strain identified in Example 1 was compared to the expression of genes in the ancestral strain from which it was derived (i.e. the ancestral strain displays lower levels of production of a recombinant protein).

[0596] The comparison was made by using microarray analysis. Yeast cells to be analysed were grown in 100 ml defined medium (0.65% (w/v) YNB; 2% (w/v) dextrose; Na.sub.2HPO.sub.4/citric acid pH 6.5) to OD.sub.600=2.0. The cells were immediately harvested by centrifugation and frozen by immersion in liquid nitrogen. RNA suitable for microarray analysis was prepared by disruption of the cells using a micro dismembrator (Braun Melsungen, Germany) all as described by Jones et al, 2003, Physiol. Genomics, 16, 107-118. cDNA synthesis, labelling, hybridisation to high-density oligonucleotide arrays (Affymetrix-Yeast S98) and scanning were carried out as described by protocols provided by the manufacturer (Affymetrix Inc, USA). The subsequent data was analysed using the MAS 5.1 and DTM 3.0 software programs (Affymetrix Inc, USA).

[0597] Genes identified as being up-regulated in the strain identified in Example 1, compared to the ancestral strain, include--

TABLE-US-00102 TABLE 1 Gene Fold change Gene Fold change JEM1 2.63 EUG1 3.68 LHS1 2.40 MPD1 2.37 SCJ1 1.81 MPD2 1.51 KAR2 1.24 EPS1 1.10 SIL1 4.5 PDI1 1.22 FKB2 1.62 DER1 2.64 SSA3 2.61 DER3 1.67 SSA4 1.83 HRD3 1.82 SSE2 2.31 UBC7 1.33 ECM10 5.65 DOA4 1.91 ERO1 2.66 HAC1 2.05 ERV2 1.73

[0598] It will be recognised that none of SSA1, SSA2, SSE1, SSB1, SSB2, MDJ1 or MDJ2 were identified as being over-expressed in the strain identified in Example 1. However, these helper proteins have been included in the present invention as a result of their functional association to the helper proteins whose genes have been identified as being upregulated in the strain isolated in Example 1. For example, the genes encoding SSA3, SSA4 and SSB2 have all been identified as being over-expressed; SSA1, SSA2, SSE1, SSB1 and SSB2 are functional equivalents of these helper proteins and so it is anticipated that over-expression of the genes encoding any of SSA1, SSA2, SSE1, SSB1 or SSB2 would cause the same phenotype as the over-expression of the genes encoding any of SSA3, SSA4 or SSB2. Similarly the gene encoding ECM10 has been identified as being over-expressed; MDJ1 and MDJ2 are functional equivalents of ECM10 and so it is anticipated that the over-expression of either of the genes encoding MDJ1 or MDJ2 would cause the same phenotype as the over-expression of the gene encoding ECM10.

EXAMPLE 3

[0599] The example describes the vector construction and yeast transformation for the overexpression of the representative helper proteins LHS1, SLS1, JEM1 and SCJ1.

TABLE-US-00103 TABLE 2 Primers used Primer name Sequence (5'-3') HO 5' ForNotIBbsI GCATGCGGCCGCCCGAAGACCCTACACAGGGCTTAAGGGC HO 5' RevBsiWIMluI CCACGCGTCGTACGGGATTGCTGCTTATGAGGATA HO 3' ForMluIEcoRI ACGCGTGAATTCAAAAAGGGAACCCGTATATTTCAGC HO 3' RevBbsIClaI TATCGATAGTCTTCCTAATATACACATTTTAGCAGATGC pBST HO Poly For GCATGCATACGCGTCACGCATGTGCCTCAGCGGCCGGCCGGCGCCGGGCCCC GGACCGCCTGCAGGCTCGAGTTAATTAAGTTTAAACGAATTCGCATGCAT pBST HO Poly Rev ATGCATGCGAATTCGTTTAAACTTAATTAACTCGAGCCTGCAGGCGGTCCGG GGCCCGGCGCCGGCCGGCCGCTGAGGCACATGCGTGACGCGTATGCATGC Ycplac33 Poly For CTAGATTGGATCCCTAGTCTAGGTTTAAACTAGCGATTCACCTAGGTGCTAG GAATTCTAGC Ycplac33 Poly Rev GCTAGAATTCCTAGCACCTAGGTGAATCGCTAGTTTAAACCTAGACTAGGGA TCCAATCTAG LHS1forOverlap CACAATATTTCAAGCTATACCAAGCATACAATCAACTATCTCATATA CAATGCGAAACGTTTTAAGGCT LHS1revBbvCI GCATGCTGAGGGTGCCACTATAATATTAATGTGC SLS1forOverlap CACCAACACACACAAAAAACAGTACTTCACTAAATTTACACACAAA ACAAAATGGTCCGGATTCTTCCCAT SLS1revNarI GCATGGCGCCCCACGGCAGGGCAGTTGGCAC JEM1forOverlap CAGATCATCAAGGAAGTAATTATCTACTTTTTACAACAAATATAAAA CAATGATACTGATCTCGGGATAC JEM1revRsrII CGATCGGTCCGAGGGAAATAAGGCAGATCAAAG SCJ1forOverlap CACGCTTACTGCTTTTTTCTTCCCAAGATCGAAAATTTACTGAATTAA CAATGATTCCAAAATTATATATAC SCJ1revXhoI GCATCTCGAGGACTTTGAGACCTGTGATC ADH1promForAleI CGATCACCGATGTGGTTGTTTCCGGGTGTACAATATGG ADH1promRevOverlap CCTATAGCAACAAAAGCTGTTAAAAATAAAAGCCTTAAAACGTTTCG CATTGTATATGAGATAGTTGATTG PGK1promForPspOMI GCATGGGCCCAGATTCCTGACTTCAACTCAAG PGK1promRevOverlap GGCAAAATAACGCTATACACTAAAAGACAGTATCCCGAGATCAGTAT CATTGTTTTATATTTGTTGTAAAAAC TDH1promForFseI GCATGGCCGGCCACCATATGGAGGATAAGTTGG TDH1promRevOverlap CTAATTTCGAAGATAGGGCGCTCAAAATTATGGGAAGAATCCGGACC ATTTTGTTTTGTGTGTTTTAAATC TEF1promForSbfI CGGTAGTACCTGCAGGAAGCAACAGGCGCGTTGGAC TEF1promRevOverlap GGCAACAACAATAAAGATAGTATCAAATGTATATATAATTTTGGAAT CATTTTGTAATTAAAACTTAGATTAGATTGC URA3forPac1 CTAGAGTTAATTAAGTTTCAATTCAATTCATC URA3revPme1 GCCTGAGTTTAAACGTTTTCTTTCCAATTTTT

[0600] pBST HO regions: HO regions were amplified by PCR from BY4741 (Brachmann et al., 1998, Yeast, 30; 14(2):115-32) genomic DNA using the primers shown in Table 2. Fast Start High Fidelity PCR system (Roche) was used with the conditions as recommended: 50 .mu.L final volume containing 0.2 mM dNTPs, 1.8 mM MgCl.sub.2, 0.4 .mu.M forward and reverse primers, 100 ng template genomic DNA, 2.5 U polymerase and H.sub.2O to volume. Cycling conditions: 95.degree. C. for 2 mins followed by 35 cycles of 95.degree. C. 30 s, 60.degree. C. 30 s, 72.degree. C. 1 min and 72.degree. C. 7 reins for final elongation.

[0601] Fragments were gel extracted from a 1% (w/v) agarose TAE gel using the GeneClean III kit (Q-bio Gene). Purified DNA was digested with the appropriate enzymes, NotI and MluI for HO 5' region, MluI and ClaI for HO 3' region. pBST+ (WO99/00504) was digested with NotI and ClaI. Fragments were purified as above. A three way ligation was performed using a Rapid Ligation Kit (Roche) as per manufacturers instructions. Ligations were transformed into the E. coli strain DH5.alpha.. Diagnostic restriction digests were performed on mini-prep DNA to confirm the ligation was successful. The plasmid map is shown in FIG. 1.

[0602] Polylinkers: To facilitate the cloning of the helper genes a polynucleotide linkers were incorporated into pBST+HO regions (FIG. 1) and into YCplac33 (Gietz and Sugino, 1988, Gene, 74, 527-534).

[0603] Complementary single stranded oligonucleotides were annealed as follows: 1 .mu.L of a 100 .mu.M solution of each oligo (Poly For and Poly Rev, Table 2) was added into a 50 .mu.L total volume containing 10.times. restriction buffer (Roche Buffer H for pBST HO polylinker, Buffer B for YCplac33 polylinker). Samples were placed into a PCR machine and heated to 98.degree. C. for 4 mins. Samples were then held for 1 min with the temperature dropping 1.degree. C. every cycle down to 30.degree. C. The annealed polylinkers were then digested by addition of the appropriate restriction enzyme (MluI, EcoRI for pBST HO polylinker, BamHI, EcoRI for YCplac33 polylinker). Digested polylinkers were gel extracted as previously and ligated into the corresponding vector digests. Incorporation of polylinkers was confirmed by linearising plasmids with all restriction sites present in polylinkers. Vectors produced are shown as FIGS. 2 and 3 respectively.

[0604] Production of promoter/open reading frame constructs: All four open reading frames (ORFs) and promoters were amplified by PCR, from the genomic DNA of an AH22 derivative, using Vent polymerase (NEB). Reactions were setup as per manufacturers instructions with an annealing temperature of 50.degree. C. All fragments were gel extracted and resuspended in 5 .mu.L of water. 1 .mu.L was run on gel to check fragment presence and quantity.

[0605] Promoters and ORFs were joined according to the method of Shevchuk et al. (Nucleic Acids Res., 2004, 32(2), e19.). 100 ng of ORF and an equimolar amount of promoter was used in the first PCR stage. 10 .mu.L from this was used in the second PCR stage. Primers were added to a final concentration of 0.4 .mu.M.

[0606] Second stage PCRs were run on a 1% (w/v) agarose TAE gel and bands extracted of the expected size (promoter+ORF length). Extracted fragments were A-tailed using Fast Start High Fidelity polymerase (Roche) and cloned into the Topo pCR2.1 vector (Invitrogen). Plasmid DNA was restriction digested to confirm the correct insert and subsequently sequenced.

[0607] Assembly of overexpression constructs: Restriction digests were performed to release promoter/ORF constructs from Topo pCR2.1 vectors. Fragments were gel extracted and ligated into the pBST HO polylinker vector, digested accordingly. In the first instance, constructs were produced containing each individual promoter/ORF and containing all four. This required subsequent rounds of plasmid transformation, digestion and ligation. The vector containing all four promoter/ORFs is shown in FIG. 4.

[0608] For insertion of promoter/ORF constructs into the centromeric vector, YCplac33 polylinker, a PmeI/AleI digest was performed on pBST HO POLY (FIG. 4) containing the required promoter/ORFs, and YCplac33 polylinker. The fragment released from pBST HO POLY was ligated with the digested YCplac33 polylinker vector. The vector containing all four promoter/ORFs is shown in FIG. 5.

[0609] Insertion of URA3 marker into pBST HO POLY: The URA3 marker was amplified by PCR from the vector YCp50 (Rose et al., 1987, Gene, 60, 237-243) using Fast Start High Fidelity polymerase (Roche) with an annealing temperature of 50.degree. C. The fragment was gel extracted, digested with PacI/PmeI and ligated into each pBST HO POLY vector containing the required promoter/ORFs (also PacI/PmeI digested). It is important the URA3 fragment be introduced last as it contains sites for restriction enzymes used elsewhere in construction of the plasmid. The vector produced containing all four promoter/ORFs is shown in FIG. 6.

[0610] Chromosomal integration: The helper gene constructs were integrated into the genome of a S. cerevisiae host cell as follows. The vector pBST HO POLY URA3 COMP (FIG. 6) was digested with NotI and SacII. Approximately 2-3 .mu.g of the required fragment was gel extracted and used to transform a ura3 derivative of AH22 [pAYE329] using a yeast transformation kit (Sigma). Transformations were plated onto minimal media and incubated at 30.degree. C. until colonies appeared. The construction of plasmid pAYE329 is described in Sleep et al., 1990, Gene, 101, 89-96. A ura3 auxotrophic mutant of the AH22 derivative was created by 5-fluoro-orotic acid selection as described by Boeke et al, 1987, Methods Enzymol., 154, 164-175.

[0611] Alternatively, the helper gene constructs may be introduced on a centromeric vector. For the YCplac33 based-vectors, 500 ng of plasmid DNA may be used to transform a S. cerevisiae host cell as above.

EXAMPLE 4

[0612] This example describes a modified protocol for vector construction and yeast transformation for the overexpression of the representative helper proteins LHS1, SIL1; JEM1 and SCJ1.

TABLE-US-00104 TABLE 3 Primers used Primer Sequence (5'-3') - Regions underlined indicate restriction enzyme name Product cleavage sites and are followed by the name of the cleaving enzyme. A01 H0 5' region GCATGCGGCCGC(NotI)CCGAAGAC(BbsI)CCTACACAGGGCTTAAGGGC A02 CCACGCGT(MluI)CGTACG(BsiWI)GGATTGCTGCTTATGAGGATA A03 HO 3' region ACGCGT(MluI)GAATTC(EcoRI)AAAAAGGGAACCCGTATATTTCAGC A04 TATCGAT(ClaI)AGTCTTC(BbsI)CTAATATACACATTTTAGCAGATGC A05 pTPA02 GCATGCATACGCGT(MluI)CACGCATGTGCCTCAGC(BbvCI)GGCCGGCC poly-linker (FseI)GGCGCC(NarI)GGGCCC(PspOMI)CGGACCG(RsrII)CCTGCAGG(SbfI) CTCGAG(XhoI)TTAATTAA(PacI)GTTTAAAC(PmeI)GAATTC(EcoRI)GCA TGCAT A06 ATGCATGCGAATTC(EcoRI)GTTTAAAC(PmeI)TTAATTAA(PacI)CTCGA G(XhoI)CCTGCAGG(SbfI)CGGTCCG(RsrII)GGGCCC(PspOMI)GGCGCC(NarI) GGCCGGCC(FseI)GCTGAGG(BbvCI)CACATGCGTGACGCGT(MluI)AT GCATGC A07 ACT1 CTAGGTAACTTAATTAA(PacI)GGGTAAGCTGCCACAGCA A08 promoter CTACGTACTCTAGA(XbaI)TGTTAATTCAGTAAATTTTC A09 ACT1 CTAGACTCTAGA(XbaI)TCTCTGCTTTTGTGCGCG A10 terminator CATGCTACGTTTAAAC(PmeI)GATGATCATATGATACAC A11 URA3 region CTAGAGTTAATTAA(PacI)GTTTCAATTCAATTCATC A12 GCCTGAGTTTAAAC(PmeI)GTTTTCTTTCCAATTTTT A13 pTPA05 CTAGATTGGATCCCTAGTCTAGGTTTAAACTAGCGATTCACCTAGGTG poly-linker (AleI)CTAGGAATTCTAGC A14 GCTAGAATTCCTAGCACCTAGGTG(AleI)AATCGCTAGTTTAAACCTAG ACTAGGGATCCAATCTAG C01 LHS1 ORF/ CACAATATTTCAAGCTATACCAAGCATACAATCAACTATCTCATATAC terminator AATGCGAAACGTTTTAAGGCT C02 GCATGCTGAGG(BbvCI)GTGCCACTATAATATTAATGTGC C03 SIL1 ORF/ CTAGATCTCTAGA(XbaI)ATGGTCCGGATTCTTCC C04 terminator GCATGGCGCC(NarI)CCACGGCAGGGCAGTTGGCAC C05 JEM1 ORF/ CTAGATCTCTAGA(XbaI)ATGATACTGATCTCGGG C06 terminator CGATCGGTCCG(RsrII)AGGGAAATAAGGCAGATCAAAG C07 SCJ1 ORF/ CACGCTTACTGCTTTTTTCTTCCCAAGATCGAAAATTTACTGAATTAA terminator CAATGATTCCAAAATTATATATAC C08 GCATCTCGAG(XhoI)GACTTTGAGACCTGTGATC C09 ADH1 CGATCACCGATGTG(AleI)GTTGTTTCCGGGTGTACAATATGG C10 promoter CCTATAGCAACAAAAGCTGTTAAAAATAAAAGCCTTAAAACGTTTCG CATTGTATATGAGATAGTTGATTG C11 PGK1 GCATGGGCCC(PspOMI)AGATTCCTGACTTCAACTCAAG C12 promoter GATCTAGTCTAGA(XbaI)TGTTTTATATTTGTTGTAA C13 TDH1 GCATGGCCGGCC(FseI)ACCATATGGAGGATAAGTTGG C14 promoter ACCTAGTCTAGA(XbaI)TTTGTTTTGTGTGTAAATTTAG C15 TEF1 CGGTAGTACCTGCAGG(SbfI)AAGCAACAGGCGCGTTGGAC C16 promoter GGCAACAACAATAAAGATAGTATCAAATGTATATATAATTTTGGAAT CATTTTGTAATTAAAACTTAGATTAGATTGC C17 HAC1 ORF CTAGTCTCTAGA(XbaI)ATGGAAATGACTGATTTTGAAC C18 CTAGTCTAGA(XbaI)TCATGAAGTGATGAAGAAATC

[0613] Construction of pTPA01: 5' and 3' regions of the HO open reading frame were amplified by PCR from BY4741 (Brachmann et al., 1998, Yeast, 30; 14(2):115-32) genomic DNA using the primers A01-02 (5') and A03-04 (3'). Fast Start High Fidelity PCR system (Roche) was used with the conditions as recommended, as defined in Example 3, above.

[0614] Fragments were gel extracted from a 1% (w/v) agarose TAE gel using the GeneClean III kit (Q-bio Gene). Purified DNA was digested with the appropriate enzymes, NotI and MluI for HO 5' region, MluI and ClaI for HO 3' region. pBST+ (WO99/00504) was digested with NotI and ClaI. Fragments were purified as above. A three-way ligation was performed using a Rapid Ligation Kit (Roche) as per manufacturers instructions. Ligations were transformed into the E. coli strain DH5.alpha.. Diagnostic restriction digests were performed on mini-prep DNA to confirm the ligation was successful. The plasmid map of TPA01 is shown in FIG. 7.

[0615] Polylinkers: To facilitate the cloning of the helper genes a polynucleotide linker was incorporated into pTPA01 (FIG. 7) and into YCplac33 (Gietz and Sugino, 1988, Gene, 74, 527-534).

[0616] Complementary single stranded oligonucleotides were annealed as follows: 1 .mu.L of a 100 .mu.M solution of each oligo (A05-06 and A13-14) was added into a 50 .mu.L, total volume containing 10.times. restriction buffer (Roche Buffer H for pTPA01 polylinker, Buffer B for YCplac33 polylinker). Samples were placed into a PCR machine and heated to 98.degree. C. for 4 mins. Samples were then held for 1 min with the temperature dropping 1.degree. C. every cycle down to 30.degree. C. The annealed polylinkers were then digested by addition of the appropriate restriction enzyme (MluI, EcoRI for pTPA01 polylinker, BamHI, EcoRI for YCplac33 polylinker). Digested polylinkers were gel extracted as previously and ligated into the corresponding vector digests. Incorporation of polylinkers was confirmed by linearising plasmids with all restriction sites present in polylinkers. Vectors produced are shown as FIGS. 8 and 11 respectively.

[0617] Production of promoter/oven reading frame constructs: LHS1, SIL1, JEM1 and SCJ1 open reading frames (ORFs) plus approximately 300 bp of terminator sequence (3' of ORF) and promoters were amplified by PCR, from the genomic DNA of an AH22 derivative, using Vent polymerase (NEB) (see Table 3 for primers used). Reactions were setup as per manufacturers instructions with an annealing temperature of 50.degree. C. All fragments were gel extracted and resuspended in 5 .mu.L of water. 1 .mu.L was run on a gel to check fragment presence and quantity.

[0618] Promoters and ORFs for LHS1 and SCJ1 were joined according to the method of Shevchuk et al. (Nucleic Acids Res., 2004, 32(2), e19.). 100 ng of the ORF fragment and an equimolar amount of promoter fragment was used in the first PCR stage. 10 .mu.L from this was used in the second PCR stage. Primers were added to a final concentration of 0.4 .mu.M.

[0619] Second stage PCRs were run on a 1% (w/v) agarose TAE gel and bands extracted of the expected size (promoter+ORF+terminator). Extracted fragments were A-tailed using Fast Start High Fidelity polymerase (Roche) and cloned into the TOPO pCR2.1 vector (Invitrogen). Plasmid DNA was restriction digested to confirm the correct insert.

[0620] Promoters and ORFs for SIL1 and JEM1 were digested with restriction enzymes corresponding to sites incorporated into primers used for PCR (see Table 3). Promoter and ORF fragments were then joined by three way ligation with digested pTPA02.

[0621] The ACT1 promoter and terminator were amplified by PCR from the genomic DNA of an AH22 derivative and gel extracted. Purified fragments were digested with restriction enzymes corresponding to sites incorporated into primers used for PCR and ligated in a three way ligation with PacI/PmeI digested pTPA02 to create pTPA03 (FIG. 9).

[0622] The HAC1 ORF was amplified by PCR from cDNA derived from RNA from an AH22 derivative treated with the reducing agent dithiothreitol (DTT). The spliced form of HAC1 (HAC1.sup.i) was identified as a 717 bp fragment and gel extracted. The extracted fragment was then digested with XbaI and ligated into pTPA03 digested with the same enzyme. Diagnostic restriction digests were used to confirm that the HAC1 ORF was present in the correct orientation relative to the ACT1 promoter and terminator sequences. The resultant plasmid pTPC01 is shown in FIG. 13.

[0623] All ORFs were sequenced and, with exception of LHS1, were shown to contain the same sequence as that published for the strain S288C. Repeat sequencing of multiple cloned PCR products for LHS1 confirmed that the AH22 derived clones contained a single base change from the S288C sequence. The base change at position 1215 (relative to the first base of the start codon) results in a change from A to C, which produces a Lys to Asn substitution at position 405.

[0624] Assembly of overexpression constructs: Restriction digests (see Table 3) were performed to release promoter/ORF constructs from TOPO pCR2.1 vectors. Fragments were gel extracted and ligated into the pTPA02 vector, digested accordingly. In the first instance, constructs were produced containing each individual promoter/ORF and then containing all four. This required subsequent rounds of plasmid transformation, digestion and ligation. The vector containing all four promoter/ORFs is shown in FIG. 12.

[0625] For insertion of the various promoter/ORF constructs (with the exception of HAC1) into the centromeric vector, pTPA05 (FIG. 11), an AleI/XhoI digest was performed on the various pTPA02 based vectors containing the required promoter/ORFs (e.g. pTPC08 (FIG. 12) for LHS1, SIL1, JEM1 and SCJ1), and an AleI/SalI digest on pTPA05 (FIG. 11). The various promoter/ORF fragments released were ligated into AleI/Sa/I digested pTPA05 to create a series of vectors including pTPC18 (FIG. 14) containing all four promoter/ORFs.

[0626] Plasmid pTPC17 (Example 4, FIG. 15) contained the LHS1, SIL1 and JEM1 ORFs expressed from YCplac33. pTPC17 was constructed by cloning an approximately 9.0-kb AleI-XhoI DNA fragment from pTPC07 (FIG. 16) that contained the expression cassette for the LHS1, SIL1 and JEM1 ORFs, into pTPA05 (FIG. 11) which had been digested with AleI and SalI. The expression cassette for the LHS1, SIL1 and JEM1 ORFs was assembled in pTPA05 in a similar method to that described for pTPC08 (FIG. 12), but using the promoter/ORF constructs from TOPO pCR2.1 vectors for LHS1, SIL1 and JEM1 expression.

[0627] For insertion of the HAC1 promoter/ORF (FIG. 13) into the centromeric vector pTPA05, an AleI/BclI digest was performed on pTPC01 (FIG. 13) and an AleI/BamHI digest was performed on pTPA05 (FIG. 11). The HAC1 AleI/BclI fragment released from pTPC01 was ligated into the AleI/BamHI digested pTPA05.

[0628] The various promoter/ORF constructs comprising the YCplac33 based plasmids pTPC11, pTPC12, pTPC13, pTPC14, pTPC15, pTPC17 and pTPC18 are shown in Table 4.

TABLE-US-00105 TABLE 4 Plasmid compositions Name Helper genes overexpressed Promoter used YCplac33 -- -- pTPC11 HAC1.sup.i ACT1 pTPC12 SIL1 TDH1 pTPC13 LHS1 ADH1 pTPC14 JEM1 PGK1 pTPC15 SCJ1 TEF1 pTPC17 LHS1, JEM1, SIL1 As shown individually above pTPC18 LHS1, JEM1, SIL1, SCJ1 As shown individually above

[0629] Insertion of URA3 marker into pTPA02: The URA3 marker was amplified by PCR from the vector YCp50 as described above in Example 3. The fragment was gel extracted, digested with PacI/PmeI and ligated into each pTPA02 based vector containing the required promoter/ORFs (also PacI/PmeI digested). It is important the URA3 fragment be introduced last as it contains sites for restriction enzymes used elsewhere in construction of the plasmid.

[0630] Chromosomal integration: The helper gene constructs were integrated into the genome of a S. cerevisiae host cell by digestion of the vector pTPC08 (FIG. 12) with Nod and SacII and transformation of a ura3 derivative of AH22 [pAYE329] as described in Example 3, above.

[0631] Alternatively, the helper gene constructs may be introduced on a centromeric vector. For the YCplac33 based-vectors, 500 ng of plasmid DNA may be used to transform a S. cerevisiae host cell as above.

EXAMPLE 5

[0632] Plasmids constructs were produced for the overexpression of the genes LHS1, JEM1, SCJ1 and SIL1 as described in Example 4, above.

[0633] The spliced form of the transcription factor HAC1 (referred to as HAC1.sup.i) was also overexpressed using the vector series produced. Due to the regulatory role of HAC1 within the unfolded protein response, HAC1s was overexpressed alone, not in conjunction with the other chaperone genes described here.

[0634] All genes were overexpressed from YCplac33 based vectors (Table 4) and transformed into the ura3 auxotrophic mutant of the ancestral S. cerevisiae strain (a histidine revertant of AH22) [pAYE329] defined in Example 4, above.

[0635] Overexpression was confirmed using real time PCR. Taqman hybridisation probes were designed to bind specifically to each gene under investigation plus ACT1, used here as an endogenous control. An additional probe was designed for the gene HAC1 to bind across the exon-exon junction--resulting in binding only to the spliced form. The proportion of HAC1.sup.i relative to total HAC1 can thus be determined.

TABLE-US-00106 TABLE 5 Taqman probe/primer sequences and binding co-ordinates Gene Name Feature Sequence/Coordinates ACT1 Forward primer (5'-3') CCCAGAAGCTTTGTTCCATCCTT Reverse primer (5'-3') ATGATGGAGTTGTAAGTAGTTTGGTCAA Probe (5'-3') CAGATTCCAAACCCAAAACA Coordinates* 795-814 LHS1 Forward primer (5'-3') ACACTACTCAGCCCGTTACAATAGA Reverse primer (5'-3') GTAAACTTTGCACCACCTAGATGTG Probe (5'-3') ATTTGAAGGATATGGGTATAATC Coordinates* 789-811 SIL1 Forward primer (5'-3') GACATGTACGAAAATGACGATACAAATCT Reverse primer (5'-3') TCGTTTGCCCACTCTTGCA Probe (5'-3') TTTGACGACCAATTCTC Coordinates* 940-956 SCJ1 Forward primer (5'-3') GGCGCAGGTGGATTCCA Reverse primer (5'-3') CGCCAGGACCTCCATGAC Probe (5'-3') CATATTCGAACGGATGTTTC Coordinates* 342-361 JEM1 Forward primer (5'-3') CCTCTCCACGCACATCGA Reverse primer (5'-3') TGCTTGTCGAGGATTGTTTCGTAAT Probe (5'-3') TCGTTAGCTGCTGCTATCA Coordinates* 592-610 HAC1 Forward primer (5'-3') GAAGACGCGTTGACTTGCA Reverse primer (5'-3') GAAATCCCTGTACTCGTCAAGAGAA Probe (5'-3') CCACGACGCTTTTGTTGC Coordinates* 288-305 HAC1.sup.i Forward primer (5'-3') ACAATTCAATTGATCTTGACAATTGG Reverse primer (5'-3') TCAATTCAAATGAATCAAACCTGAC Probe (5'-3') CGTAATCCAGAAGCGCA Coordinates* 652-668 *means probe binding coordinates, relative to start codon

[0636] The relative standard curve method of transcript quantification was used as described by Applied Biosystems in the `ABI PRISM 770 Sequence Detection System: User Bulletin #2` document. This can be downloaded from the Applied Biosystems' website (www.appliedbiosystems.com). Equivalent technical disclosure of a suitable quantitative RT-PCR method can be found in Bustin, 2000, Journal of Molecular Endocrinology, 25, 169-193. This method allows quantification of the gene of interest relative to an endogenous control gene that is known to exhibit constant expression across experimental conditions.

[0637] All real time PCR was carried out on cDNA derived from RNA extracted from log phase (OD.sub.600=2) BMMD yeast cultures. Overexpression was assessed by comparison of strains with a control yeast strain transformed with the base vector YCplac33 and are expressed as fold changes.

TABLE-US-00107 TABLE 6 Summary of overexpression levels achieved Overexpression in single gene construct Overexpression in multiple gene (Fold change vs. construct pTPC18 Gene YCplac33 control) (Fold change vs. YCplac33 control) HAC1.sup.i 3.51 -- LHS1 22.63 23.52 JEM1 10.16 11.48 SIL1 2.03 2.36 SCJ1 15.81 16.71

[0638] As shown below in Table 6, overexpression levels vary between the different constructs. Levels achieved range from 2.03 fold for SIL1 to 22.63 fold for LHS1.

[0639] The effect of overexpression of HAC1.sup.i, LHS1, JEM1, SIL1 and SCJ1 on the induction of the stress-related unfolded protein response (UPR) in a host cell was investigated by measuring the levels of HAC1.sup.i and total HAC1 transcript levels in AH22 (ura3) [pAYE329] host cells transformed with Ycplac33 (as a negative control), pTPC11, pTPC12, pTPC13, pTPC14, pTPC15 or pTPC18. Total HAC1 transcript levels are the sum of HAC1.sup.i transcript levels and unspliced HAC1 transcript levels. A reduced proportion of the level of HAC1.sup.i transcript levels compared to total HAC1 transcript levels is indicative of reduced stress and reduced UPR signalling.

[0640] FIG. 10 shows that individual over-expression of LHS1 (pTPC13) or JEW (pTPC14) or simultaneous over-expression of all of LHS1, JEM1, SIL1 and SCJ1 (pTPC18) resulted a reduced proportion of the level of HAC1.sup.i transcript levels (compared to total HAC1 transcript levels) compared to the control. This indicates that over-expression of the above-identified helper proteins can help to reduce stress in cultured cells and avoid the unnecessary induction of the UPR.

EXAMPLE 6

[0641] The levels of recombinant protein production achieved by the transformed strains described in Examples 4 and 5 (see Table 4), above, were analysed. In this case, the recombinant protein was recombinant human albumin ("rHA") expressed from the plasmid pAYE329, described in Sleep et al.; 1990, Gene, 101, 89-96.

[0642] All analysis was performed on cultures grown for 5 days at 30.degree. C., 200 rpm.

[0643] Culture supernatants were run immediately on gels to prevent any rHA proteolysis/degradation that could otherwise occur during freezing and overnight storage at -20.degree. C. Each of the three bands (main rHA band plus two degradation products) were quantified by densitometry. This gives an indication of rHA production levels and the level of proteolysis occurring in each strain. The mutagenised strain identified in Example 1 was also included as a positive control.

[0644] Results of the analysis are shown in FIG. 17. It is apparent from a comparison of the results for the ancestral strain expressing recombinant albumin from pAYE329/YCplac33 ("YCplac33") and the mutagenised strain identified in. Example 1 as possessing increased recombinant protein production ("+ve control") that the mutagenised strain is not only capable of producing increased levels of rHA, but additionally displays reduced levels of rHA degradation compared to the ancestral strain. Moreover, FIG. 17 is particularly clear in demonstrating that strain transformed with pTPC17 (i.e. the ancestral strain transformed to over-express LHS1, JEM1 and SIL1) also displays reduced levels of rHA degradation compared to the untransformed ancestral strain.

[0645] Further characterisation of the effect of the defined transformations is possible in view of the analysis of the SDS-PAGE gel by densitometry, the results of which are present in Table 7, below, and FIGS. 18 and 19.

TABLE-US-00108 TABLE 7 Comparison of rHA levels, as percentage of YCplac33 control production levels. In the third column, the rHA production levels have been normalised (based on culture optical density readings) to account for different growth rates observed between transformants. rHA production, Overexpression as % of YCplac33 control plasmid Not normalised by OD Normalised by OD pTPC11 164.26 139.2 pTPC12 102.51 101.7 pTPC13 122.42 115.1 pTPC14 177.85 170.4 pTPC15 86.37 103.4 pTPC17 132.85 116.3 pTPC18 102.65 96.0 +ve control 383.44 369.0

[0646] Table 7, above, and FIGS. 18 and 19, show that the individual overexpression of HAC1, LHS7, JEM1, SIL1 and SCJ1 results in an increase in rHA production, on a per cell basis (i.e. when results are normalised by culture OD). However, the negative growth effect of SCJ1 overexpression resulted in an overall reduction of rHA production on a per culture basis (i.e. when results are not normalised by culture OD).

[0647] The overexpression of JEM1 alone had the largest measured effect on rHA production.

[0648] However, as will be apparent from FIG. 17, the strains that individually expressed HAC1, LHS1, JEM1, SIL1 and SCJ1 still demonstrated relatively high levels of rHA degradation, comparable to the ancestral strain and higher than the to mutagenised strain identified in Example 1. By contrast, cells that simultaneously over-express LHS1, JEM1 and SIL1 demonstrate increased rHA productivity and a concomitant reduction in rHA degradation, comparable with the mutagenised strain identified in Example 1. This is further demonstrated in FIG. 20. In fact, FIG. 20 shows that several of the strains tested show lower levels of degradation compared to the ancestral strain, but this reduction is particularly pronounced in strain transformed with pTPC17.

EXAMPLE 7

[0649] This example describes the increased secretion of a recombinant transferrin mutant by over-expression of LHS1, JEM1 and SIL1 from the centromeric vector pTPC17 in a Saccharomyces cerevisiae strain containing a 2-micron plasmid encoding the PDI1 gene.

[0650] A S. cerevisiae strain, the "control strain" as used in WO 2005/061718 and WO 2005/061719 was used to generate a ura3 mutant derivative, referred to herein as "control strain (ura3)" by random mutagenesis and selection on 5-fluoro-orotic acid plates (Boeke et al., 1984, op. cit.).

[0651] The S. cerevisiae control strain was transformed to leucine prototrophy with pDB3213 (FIG. 21) and the control strain (ura3) was co-transformed to both leucine and uracil prototrophy with plasmids pTPC17 (FIG. 15) and pDB3213. Transformation was by a modified lithium acetate method (Sigma yeast transformation kit, YEAST-1, protocol 2 (Elble, R, 1992, Biotechniques, 13, 18-20; Ito et al., 1983, op. cit.). Transformants were selected on BMMD-agar plates, and subsequently patched out on BMMD-agar plates.

[0652] The construction of pTPC17 is described in Example 4.

[0653] Plasmid pDB3213 is similar to pDB2929 (WO 2005/061718, Example 1 and FIG. 12), and contains a NotI expression cassette for a non-glycosylated transferrin cloned into pDB2690 (WO 2005/061718, Example 1 and FIG. 6). The NotI expression cassette of pDB3213 contains an alternative codon for Leucine-505 in mature transferrin that is the CTG codon (11% codon usage in S. cerevisiae) compared to the CTG codon (6% codon usage in S. cerevisiae) present in pDB2929, a KEX2-independent leader sequence (derived from the HSA-pre leader sequence) and mutations within the N-linked glycosylation sites (-N-X-S/T-) that prevent glycosylation of residues N413 and N611.

[0654] Transformants of each strain were inoculated into 10 mL BMMD and 10 mL YEPD in 50 mL shake flasks and incubated in an orbital shaker at 30.degree. C., 200 rpm for 4-days. Culture supernatants were harvested and the recombinant transferrin titres compared by rocket immunoelectrophoresis (FIG. 22). The results indicated that the recombinant transferrin titres in supernatants of both the YEPD and BMMD shake flask cultures were higher when pTPC17 was present. Furthermore, in high cell density fed batch fermentation the recombinant transferrin titres from control strain (ura3) [pTPC17 pDB3213] was 1.7 g/L compared to only 0.9 g/L for control strain [pDB3213]. Therefore, over-expression of LHS1, JEM1 and SIL1 from the centromeric plasmid pTPC17 had approximately doubled the quantity of the recombinant transferrin product secreted from the S. cerevisiae strain during fermentation.

[0655] It is to be noted that pDB3213 encodes an additional copy of PDI1, and these results suggest that over-expression of PDI1 (and variants thereof) in conjunction with one, two or all three of LHS1, JEM1, and SIL1 (e.g. LHS1 alone; JEM1 alone; SIL1 alone; LHS1 and JEM1; LHS1, and SIL1; JEM1, and SIL1; or LHS1, JEM1, and SIL1) provide unexpected benefits to the production of a desired protein product.

EXAMPLE 8

[0656] This example shows increased secretion of recombinant albumin ("rHA") by over-expression of LHS1, JEM1 and SIL1 from the centromeric vector pTPC17 in a Saccharomyces cerevisiae strain.

[0657] Construction of plasmid pDB2243 containing the NotI rHA expression cassette, incorporating the HSA/MF.alpha.-1 fusion leader sequence, as taught in WO 90/01063, is described in WO 00/44772 (see WO 00/44772, FIG. 6). The rHA expression disintegration vector pDB2244 (FIG. 23) was created by ligating the NotI expression cassette from pDB2243 into NotI cut pSAC35 (Sleep et al, 1991, Bio/Technology 9, 183-187 and EP 431 880) to generate the plasmid pDB2244 in which the direction of rHA transcription is in the same orientation as that of the LEU2 gene as described in WO 00/44772.

[0658] Construction of plasmid pDB2283 containing a NotI rHA expression cassette, incorporating the invertase leader sequence, was accomplished by replacing the 1.21-kb BfrI-XbaI fragment in pDB2243, comprising the HSA/MF.alpha.-1 fusion leader sequence and part of the human albumin cDNA, with a 1.07-kb blunt end-XbaI fragment from mp 19.7 (EP-A-248 637) and a synthetic double stranded oligonucleotide linker of the following structure--

TABLE-US-00109 1 gagtccaatt agcttcatcg ccaataaaaa aacaagctaa acctaattct ctcaggttaa tcgaagtagc ggttattttt ttgttcgatt tggattaaga HindIII -+---- 51 aacaagcaaa gatgaagtgg gtaagcttaa cctaattcta acaagcaaag ttgttcgttt ctacttcacc cattcgaatt ggattaagat tgttcgtttc 101 atgcttttgc aagccttcct tttccttttg gctggttttg cagccaaaat tacgaaaacg ttcggaagga aaaggaaaac cgaccaaaac gtcggtttta >>......................Invertase......................> m l l q a f l f l l a g f a a k 151 atctgca tagacgt >....>> Invertase i s a

which was formed by annealing two complementary single stranded oligonucleotides with the sequences

TABLE-US-00110 5'TTAAGAGTCCAATTAGCTTCATCGCCAATAAAAAAACAAGCTAAACCT AATTCTAACAAGCAAAGATGAAGTGGGTAAGCTTAACCTAATTCTAACAA GCAAAGATGCTTTTGCAAGCCTTCCTTTTCCTTTTGGCTGGTTTTGCAGC CAAAATATCTGCA3'; and 5'TGCAGATATTTTGGCTGCAAAACCAGCCAAAAGGAAAAGGAAGGCTTG CAAAAGCATCTTTGCTTGTTAGAATTAGGTTAAGCTTACCCACTTCATCT TTGCTTGTTAGAATTAGGTTTAGCTTGTTTTTTTATTGGCGATGAAGCTA ATTGGACTC3'.

[0659] Plasmid mp 19.7 (EP-A-248 637) was digested to completion with XhoI, phenol/chloroform extracted and ethanol precipitated. The recovered DNA was then blunt ended with the Klenow fragment of E. coli DNA polymerase I to remove the XhoI overhang, phenol/chloroform extracted, and ethanol precipitated. The recovered DNA was digested to completion with XbaI. The digestion products were resolved by agarose gel electrophoresis and the 1.07-kb blunt end-XbaI mp 19.7 fragment recovered using the GeneClean III kit (Q-bio Gene).

[0660] The rHA expression disintegration vector pDB2286 (FIG. 24) was created by ligating the Nod expression cassette from pDB2283 into NotI cut pSAC35 (Sleep et al, 1991, Bio/Technology 9, 183-187 and EP 431 880).

[0661] Construction of plasmid pDB2284 containing a Nod rHA expression cassette, incorporating the MF.alpha.-1 leader sequence, was accomplished by replacing the 1.21-kb BrfI-XbaI fragment in pDB2243, comprising the HSA/MF.alpha.-1 fusion leader sequence and part of the human albumin cDNA, with a 1.07-kb blunt end-XbaI fragment from mp 19.7 (EP-A-248 637) and a synthetic double stranded phosphorylated oligonucleotide linker of the structure--

TABLE-US-00111 1 ttaagagtcc aattagcttc atcgccaata aaaaaacaaa ctaaacctaa ctcagg ttaatcgaag tagcggttat ttttttgttt gatttggatt PstI ------+ 51 ttctaacaag caaagatgag atttccttca atttttactg cagttttatt aagattgttc gtttctactc taaaggaagt taaaaatgac gtcaaaataa >>.............MFalpha..............> m r f p s i f t a v l 101 cgcagcatcc tccgcattag ctgctccagt caacactaca acagaagatg gcgtcgtagg aggcgtaatc gacgaggtca gttgtgatgt tgtcttctac > MFalpha > f a a s s a l a a p v n t t t e d 151 aaacggcaca aattccggct gaagctgtca tcggttactc agatttagaa tttgccgtgt ttaaggccga cttcgacagt agccaatgag tctaaatctt > MFalpha > e t a q i p a e a v i g y s d l e 201 ggggatttcg atgttgctgt tttgccattt tccaacagca caaataacgg cccctaaagc tacaacgaca aaacggtaaa aggttgtcgt gtttattgcc > MFalpha > g d f d v a v l p f s n s t n n 251 gttattgttt ataaatacta ctattgccag cattgctgct aaagaagaag caataacaaa tatttatgat gataacggtc gtaacgacga tttcttcttc > MFalpha > g l l f i n t t i a s i a a k e e HindIII -+---- 301 gggtaagctt ggataaaaga cccattcgaa cctattttct >......MFalpha.....>> g v s l d k r

formed by annealing complementary six single stranded oligonucleotides with the sequences

TABLE-US-00112 5'TTAAGAGTCCAATTAGCTTCATCGCCAATAAAAAAACAAACTAAACCT AATTCTAACAAGCAAAGATGAGATTTCCTTCAATTTTTACTGCAGTTTTA 3'; 5'TTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACAACAGAA GATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTT AGAAGGGGATTT3'; 5'CGATGTTGCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATT GTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGTAA GCTTGGATAAAAGA3'; 5'TCTTTTATCCAAGCTTACCCCTTCTTCTTTAGCAGCAATGCTGGCAAT AGTAGTATTTATAAACAATAACCCGTTATTTGTGCTGTTGGAAAATGGCA AAAC3'; 5'AGCAACATCGAAATCCCCTTCTAAATCTGAGTAACCGATGACAGCTTC AGCCGGAATTTGTGCCGTTTCATCTTCTGTTGTAGTGTTGACTGGAGCAG CTAATGCGGAGG3'; and 5'ATGCTGCGAATAAAACTGCAGTAAAAATTGAAGGAAATCTCATCTTTG CTTGTTAGAATTAGGTTTAGTTTGTTTTTTTATTGGCGATGAAGCTAATT GGACTC3'.

[0662] Plasmid mp 19.7 (EP-A-248 637) was digested to completion with XhoI, phenol/chloroform extracted and ethanol precipitated. The recovered DNA was then blunt ended with the Klenow fragment of E. coli DNA polymerase I to remove the XhoI overhang, phenol/chloroform extracted, and ethanol precipitated. The recovered DNA was digested to completion with XbaI. The digestion products were resolved by agarose gel electrophoresis and the 1.07-kb blunt end-XbaI mp 19.7 fragment recovered using the GeneClean III kit (Q-bio Gene).

[0663] The rHA expression disintegration vector pDB2287 (FIG. 25) was created by ligating the NotI expression cassette from pDB2284 into NotI cut pSAC35 (Sleep et al, 1991, Bio/Technology 9, 183-187 and EP 431 880).

[0664] The ura3 auxotrophic mutant of the AH22 histidine revertant described in Example 4 was co-transformed to both leucine and uracil prototrophy with plasmids pDB2244 and YCplac33, or pDB2244 and pTPC17, or pDB2286 and YCplac33, or pDB2286 and pTPC17, or pDB2287 and YCplac33, or pDB2287 and pTPC17. Transformation was by a modified lithium acetate method (Sigma yeast transformation kit, YEAST-1, protocol 2 (Elble, 1992, op. cit.; Ito et al, 1983, op. cit.). Transformants were selected on BMMD-agar plates, and subsequently patched out on BMMD-agar plates.

[0665] Two transformants for each strain were inoculated into 10 mL BMMD in 50 mL shake flasks and incubated in an orbital shaker at 30.degree. C., 200 rpm for 4-days. Culture supernatants were harvested and the recombinant human albumin (rHA) titres compared by SDS-PAGE (FIG. 26 A-C) and densitometric analysis (FIG. 26 D). The results are summarised in Table 8, below.

TABLE-US-00113 TABLE 8 Increased rHA secretion by overexpression of SIL1, LHS1 and JEM1 (pTPC17) from three distinct leader sequences. Average percentage increase in rHA secretion by pTPC17 Expression plasmid versus YCplac33 transformation pDB2244 29.1 pDB2286 16.7 pDB2287 14.5

[0666] The results indicated that the rHA titres were increased by transformation with pTPC017 relative to the control plasmid YCplac33. Increases in rHA titres varied between the different expression constructs in the range of 14.5-29.1% demonstrating the beneficial effect of LHS1, JEM1 and SIL1 on rHA secretion was not restricted to a specific secretory leader sequence. Thus, for example, it is clear that the beneficial effect of LHS1, JEM1 and SIL1 on rHA secretion was not restricted by features of the leader sequence at the amino acid or DNA sequence level, or by configuration (pre or pre-pro) or whether or not the secretory leader sequence contained N-linked glycosylation sites.

EXAMPLE 9

[0667] This example describes the increased secretion of recombinant granulocyte macrophage colony stimulating factor (GM-CSF) from a 2-micron based plasmid by over-expression of LHS1, JEM1 and SIL1 from the centromeric vector pTPC17.

[0668] A cDNA for human GM-CSF was obtained from plasmid pBBG12 (R&D Systems Europe Ltd.) cloned between the HindIII and EcoRI sites of the pUC18 polylinker. The DNA sequence of the human GM-CSF cDNA (FIG. 27) incorporated an N-terminal Met codon.

[0669] Oligonucleotides SINK1 and SINK 2 were synthesised to construct a linker which would reconstruct the HSA/MF.alpha.-1 fusion leader as taught in WO 90/01063, coupled to GM-CSF up to the BstEII site.

TABLE-US-00114 SINK1: 5'GTACCAAGCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGC TTATTCCAGGAGCTTGGATAAAAGAGCACCCGCCCG3' SINK2: 5'GTGACCGGGCGGGTGCTCTTTTATCCAAGCTCCTGGAATAA GCCGAGCTAAAGAGAAAAAGAAGGGAAATAAAGCTTG3'

[0670] A 380 bp BstEII/BamHI GMCSF fragment was isolated from pBBG12 and ligated into pUC19 Asp718/BstEII along with the Asp718/BstEII SINK1/2 linker above, to create pDB2095. Accordingly, the GM-CSF cDNA, linked to the HSA/MF.alpha.-1 fusion secretion leader, was available on a HindIII fragment suitable for subcloning into pAYE441 (as described in WO 2004/009819, Example 1 and FIG. 5) to create pDB2102 in which the GM-CSF cDNA was now present on a NotI expression cassette, comprising the PRB1 promoter, the HSA/MF.alpha.-1 fusion secretion leader and the ADH1 terminator. The GM-CSF NotI expression cassette was isolated and subcloned into pSAC35 (Sleep et al, 1991; Biotechnology (NY), 9, 13 and EP 431 880) linearised with NotI to create plasmid pDB2109 (FIG. 28).

[0671] The S. cerevisiae Control Strain (ura3), as described above in Example 7, was co-transformed to both leucine and uracil prototrophy with plasmids pDB2109 (FIG. 28) and either YCplac33 or pTPC17 (FIG. 15). Transformation was by a modified lithium acetate method (Sigma yeast transformation kit, YEAST-1, protocol 2 (Elble, 1992, op. cit.; Ito et al., 1983, op. cit.). Transformants were selected on BMMD-agar plates, and subsequently patched out on BMMD-agar plates.

[0672] Transformants of each strain were inoculated into 10 mL BMMD in 50 mL shake flasks and incubated in an orbital shaker at 30.degree. C., 200 rpm for 4-days. Culture supernatants were harvested and the recombinant GM-CSF titres compared by SDS-PAGE and densitometric analysis (FIGS. 29 A and B). The results of the densitometric analysis are also provided in Table 9, below.

TABLE-US-00115 TABLE 9 Increased GM-CSF production as determined by SDS-PAGE and densitometric analysis Control strain Control strain (ura3) [pDB2109 YCplac33] (ura3) [pDB2109 pTPC17] Integrated optical Integrated optical Gel lane density Gel lane density 2 45.20 6 108.36 3 72.14 7 108.41 4 71.54 8 111.73 5 74.21 9 111.30 Average 65.77 Average 109.95

[0673] The results indicated that the recombinant GM-CSF titres in supernatants of BMMD shake flask cultures were greater than 50% higher when pTPC17 was present.

Sequence CWU 1

1

1951645PRTSaccharomyces cerevisiae 1Met Ile Leu Ile Ser Gly Tyr Cys Leu Leu Val Tyr Ser Val Ile Leu1 5 10 15Pro Val Leu Ile Ser Ala Ser Lys Leu Cys Asp Leu Ala Glu Leu Gln 20 25 30Arg Leu Asn Lys Asn Leu Lys Val Asp Thr Glu Ser Leu Pro Lys Tyr 35 40 45Gln Trp Ile Ala Gly Gln Leu Glu Gln Asn Cys Met Thr Ala Asp Pro 50 55 60Ala Ser Glu Asn Met Ser Asp Val Ile Gln Leu Ala Asn Gln Ile Tyr65 70 75 80Tyr Lys Ile Gly Leu Ile Gln Leu Ser Asn Asp Gln His Leu Arg Ala 85 90 95Ile Asn Thr Phe Glu Lys Ile Val Phe Asn Glu Thr Tyr Lys Gly Ser 100 105 110Phe Gly Lys Leu Ala Glu Lys Arg Leu Gln Glu Leu Tyr Val Asp Phe 115 120 125Gly Met Trp Asp Lys Val His Gln Lys Asp Asp Gln Tyr Ala Lys Tyr 130 135 140Leu Ser Leu Asn Glu Thr Ile Arg Asn Lys Ile Ser Ser Lys Asp Val145 150 155 160Ser Val Glu Glu Asp Ile Ser Glu Leu Leu Arg Ile Thr Pro Tyr Asp 165 170 175Val Asn Val Leu Ser Thr His Ile Asp Val Leu Phe His Lys Leu Ala 180 185 190Glu Glu Ile Asp Val Ser Leu Ala Ala Ala Ile Ile Leu Asp Tyr Glu 195 200 205Thr Ile Leu Asp Lys His Leu Ala Ser Leu Ser Ile Asp Thr Arg Leu 210 215 220Ser Ile His Tyr Val Ile Ser Val Leu Gln Thr Phe Val Leu Asn Ser225 230 235 240Asp Ala Ser Phe Asn Ile Arg Lys Cys Leu Ser Ile Asp Met Asp Tyr 245 250 255Asp Lys Cys Lys Lys Leu Ser Leu Thr Ile Ser Lys Leu Asn Lys Val 260 265 270Asn Pro Ser Lys Arg Gln Ile Leu Asp Pro Ala Thr Tyr Ala Phe Glu 275 280 285Asn Lys Lys Phe Arg Ser Trp Asp Arg Ile Ile Glu Phe Tyr Leu Lys 290 295 300Asp Lys Lys Pro Phe Ile Thr Pro Met Lys Ile Leu Asn Lys Asp Thr305 310 315 320Asn Phe Lys Asn Asn Tyr Phe Phe Leu Glu Glu Ile Ile Lys Gln Leu 325 330 335Ile Glu Asp Val Gln Leu Ser Arg Pro Leu Ala Lys Asn Leu Phe Glu 340 345 350Asp Pro Pro Ile Thr Asp Gly Phe Val Lys Pro Lys Ser Tyr Tyr His 355 360 365Thr Asp Tyr Leu Val Tyr Ile Asp Ser Ile Leu Cys Gln Ala Ser Ser 370 375 380Met Ser Pro Asp Val Lys Arg Ala Lys Leu Ala Ala Pro Phe Cys Lys385 390 395 400Lys Ser Leu Arg His Ser Leu Thr Leu Glu Thr Trp Lys His Tyr Gln 405 410 415Asp Ala Lys Ser Glu Gln Lys Pro Leu Pro Glu Thr Val Leu Ser Asp 420 425 430Val Trp Asn Ser Asn Pro His Leu Leu Met Tyr Met Val Asn Ser Ile 435 440 445Leu Asn Lys Ser Arg Ser Lys Pro His Ser Gln Phe Lys Lys Gln Leu 450 455 460Tyr Asp Gln Ile Asn Lys Phe Phe Gln Asp Asn Gly Leu Ser Glu Ser465 470 475 480Thr Asn Pro Tyr Val Met Lys Asn Phe Arg Leu Leu Gln Lys Gln Leu 485 490 495Gln Thr Tyr Lys Glu His Lys His Arg Asn Phe Asn Gln Gln Tyr Phe 500 505 510Gln Gln Gln Gln Gln Gln Gln Gln His Gln Arg His Gln Ala Pro Pro 515 520 525Ala Ala Pro Asn Tyr Asp Pro Lys Lys Asp Tyr Tyr Lys Ile Leu Gly 530 535 540Val Ser Pro Ser Ala Ser Ser Lys Glu Ile Arg Lys Ala Tyr Leu Asn545 550 555 560Leu Thr Lys Lys Tyr His Pro Asp Lys Ile Lys Ala Asn His Asn Asp 565 570 575Lys Gln Glu Ser Ile His Glu Thr Met Ser Gln Ile Asn Glu Ala Tyr 580 585 590Glu Thr Leu Ser Asp Asp Asp Lys Arg Lys Glu Tyr Asp Leu Ser Arg 595 600 605Ser Asn Pro Arg Arg Asn Thr Phe Pro Gln Gly Pro Arg Gln Asn Asn 610 615 620Met Phe Lys Asn Pro Gly Ser Gly Phe Pro Phe Gly Asn Gly Phe Lys625 630 635 640Met Asn Phe Gly Leu 64521938DNASaccharomyces cerevisiae 2atgatactga tctcgggata ctgtctttta gtgtatagcg ttattttgcc agtactgata 60tcggcttcta agttatgtga tttggctgag ttacaacgat tgaacaagaa tttaaaagta 120gacactgaat ccttgccaaa ataccaatgg atcgctgggc agttggaaca aaactgcatg 180actgcggatc cagcaagtga aaatatgtca gacgtaattc aactagccaa tcaaatatac 240tacaaaattg ggctgatcca attatccaac gatcaacatc taagagctat taacacattt 300gaaaaaatcg tttttaatga aacttacaaa ggttcttttg ggaagctggc ggaaaagagg 360ctacaagagc tgtatgtcga ttttgggatg tgggacaagg tgcatcagaa ggatgatcag 420tatgcgaaat atctgtcctt gaatgaaacc atcagaaaca aaatatcatc caaagacgtt 480tctgtggagg aagatatttc tgagctgcta cgcataacgc cgtacgatgt taacgtcctc 540tccacgcaca tcgatgttct ttttcacaaa ctagctgaag aaattgacgt ttcgttagct 600gctgctatca ttttggatta cgaaacaatc ctcgacaagc atttggctag cttaagcata 660gatacaagac tttcgattca ttatgtcata tctgttttac agacctttgt acttaactca 720gatgcgtcgt tcaatataag aaaatgcctt tccattgata tggactatga taaatgtaaa 780aaactaagcc tgactatttc caaattgaac aaggtgaatc catcaaaaag acagatcctg 840gatccagcaa catatgcatt tgagaacaaa aagtttagaa gttgggatag aattattgaa 900ttttatttga aggataagaa gccatttatt acaccaatga aaattcttaa caaagataca 960aactttaaaa acaactactt ctttttagag gaaattatca aacaattgat agaagacgtt 1020caactgtcga gacctttggc aaaaaattta ttcgaagatc ccccaataac cgatggtttt 1080gtcaaaccaa aatcatacta tcataccgat tatctagtat acattgattc cattctttgt 1140caggcttcta gcatgagtcc ggacgtcaag agagctaaac tggctgcgcc gttctgtaaa 1200aagagtttga ggcattcact aacactagaa acatggaaac actatcagga tgctaagtcc 1260gagcaaaaac ctttacctga gacggtattg agtgatgtat ggaattccaa tcctcatttg 1320ctgatgtata tggtaaactc aatacttaat aaaagtaggt ctaaacctca ttcacagttc 1380aaaaagcaat tatatgacca gataaacaaa tttttccaag ataacggcct ctcagagtcg 1440accaatccat acgtgatgaa gaacttccga ttattacaga aacaattaca aacctataaa 1500gagcataaac atcggaattt caaccagcaa tatttccaac aacaacaaca gcagcaacaa 1560caccaacgac atcaagcacc cccagcagcg cctaactacg acccaaaaaa ggactattat 1620aaaattcttg gagtatcgcc tagtgctagt tcgaaagaaa taaggaaagc atatttaaat 1680ttaaccaaaa aataccaccc agacaaaata aaggccaacc ataacgacaa acaagaatca 1740attcacgaaa ctatgtcaca aatcaatgaa gcgtacgaaa cattaagtga tgacgataaa 1800aggaaggaat acgatctttc cagatcaaac ccccgccgca acacttttcc tcaggggcct 1860aggcaaaata acatgttcaa aaatccagga agtggcttcc cattcggaaa tggctttaaa 1920atgaattttg ggctttga 19383881PRTSaccharomyces cerevisiae 3Met Arg Asn Val Leu Arg Leu Leu Phe Leu Thr Ala Phe Val Ala Ile1 5 10 15Gly Ser Leu Ala Ala Val Leu Gly Val Asp Tyr Gly Gln Gln Asn Ile 20 25 30Lys Ala Ile Val Val Ser Pro Gln Ala Pro Leu Glu Leu Val Leu Thr 35 40 45Pro Glu Ala Lys Arg Lys Glu Ile Ser Gly Leu Ser Ile Lys Arg Leu 50 55 60Pro Gly Tyr Gly Lys Asp Asp Pro Asn Gly Ile Glu Arg Ile Tyr Gly65 70 75 80Ser Ala Val Gly Ser Leu Ala Thr Arg Phe Pro Gln Asn Thr Leu Leu 85 90 95His Leu Lys Pro Leu Leu Gly Lys Ser Leu Glu Asp Glu Thr Thr Val 100 105 110Thr Leu Tyr Ser Lys Gln His Pro Gly Leu Glu Met Val Ser Thr Asn 115 120 125Arg Ser Thr Ile Ala Phe Leu Val Asp Asn Val Glu Tyr Pro Leu Glu 130 135 140Glu Leu Val Ala Met Asn Val Gln Glu Ile Ala Asn Arg Ala Asn Ser145 150 155 160Leu Leu Lys Asp Arg Asp Ala Arg Thr Glu Asp Phe Val Asn Lys Met 165 170 175Ser Phe Thr Ile Pro Asp Phe Phe Asp Gln His Gln Arg Lys Ala Leu 180 185 190Leu Asp Ala Ser Ser Ile Thr Thr Gly Ile Glu Glu Thr Tyr Leu Val 195 200 205Ser Glu Gly Met Ser Val Ala Val Asn Phe Val Leu Lys Gln Arg Gln 210 215 220Phe Pro Pro Gly Glu Gln Gln His Tyr Ile Val Tyr Asp Met Gly Ser225 230 235 240Gly Ser Ile Lys Ala Ser Met Phe Ser Ile Leu Gln Pro Glu Asp Thr 245 250 255Thr Gln Pro Val Thr Ile Glu Phe Glu Gly Tyr Gly Tyr Asn Pro His 260 265 270Leu Gly Gly Ala Lys Phe Thr Met Asp Ile Gly Ser Leu Ile Glu Asn 275 280 285Lys Phe Leu Glu Thr His Pro Ala Ile Arg Thr Asp Glu Leu His Ala 290 295 300Asn Pro Lys Ala Leu Ala Lys Ile Asn Gln Ala Ala Glu Lys Ala Lys305 310 315 320Leu Ile Leu Ser Ala Asn Ser Glu Ala Ser Ile Asn Ile Glu Ser Leu 325 330 335Ile Asn Asp Ile Asp Phe Arg Thr Ser Ile Thr Arg Gln Glu Phe Glu 340 345 350Glu Phe Ile Ala Asp Ser Leu Leu Asp Ile Val Lys Pro Ile Asn Asp 355 360 365Ala Val Thr Lys Gln Phe Gly Gly Tyr Gly Thr Asn Leu Pro Glu Ile 370 375 380Asn Gly Val Ile Leu Ala Gly Gly Ser Ser Arg Ile Pro Ile Val Gln385 390 395 400Asp Gln Leu Ile Lys Leu Val Ser Glu Glu Lys Val Leu Arg Asn Val 405 410 415Asn Ala Asp Glu Ser Ala Val Asn Gly Val Val Met Arg Gly Ile Lys 420 425 430Leu Ser Asn Ser Phe Lys Thr Lys Pro Leu Asn Val Val Asp Arg Ser 435 440 445Val Asn Thr Tyr Ser Phe Lys Leu Ser Asn Glu Ser Glu Leu Tyr Asp 450 455 460Val Phe Thr Arg Gly Ser Ala Tyr Pro Asn Lys Thr Ser Ile Leu Thr465 470 475 480Asn Thr Thr Asp Ser Ile Pro Asn Asn Phe Thr Ile Asp Leu Phe Glu 485 490 495Asn Gly Lys Leu Phe Glu Thr Ile Thr Val Asn Ser Gly Ala Ile Lys 500 505 510Asn Ser Tyr Ser Ser Asp Lys Cys Ser Ser Gly Val Ala Tyr Asn Ile 515 520 525Thr Phe Asp Leu Ser Ser Asp Arg Leu Phe Ser Ile Gln Glu Val Asn 530 535 540Cys Ile Cys Gln Ser Glu Asn Asp Ile Gly Asn Ser Lys Gln Ile Lys545 550 555 560Asn Lys Gly Ser Arg Leu Ala Phe Thr Ser Glu Asp Val Glu Ile Lys 565 570 575Arg Leu Ser Pro Ser Glu Arg Ser Arg Leu His Glu His Ile Lys Leu 580 585 590Leu Asp Lys Gln Asp Lys Glu Arg Phe Gln Phe Gln Glu Asn Leu Asn 595 600 605Val Leu Glu Ser Asn Leu Tyr Asp Ala Arg Asn Leu Leu Met Asp Asp 610 615 620Glu Val Met Gln Asn Gly Pro Lys Ser Gln Val Glu Glu Leu Ser Glu625 630 635 640Met Val Lys Val Tyr Leu Asp Trp Leu Glu Asp Ala Ser Phe Asp Thr 645 650 655Asp Pro Glu Asp Ile Val Ser Arg Ile Arg Glu Ile Gly Ile Leu Lys 660 665 670Lys Lys Ile Glu Leu Tyr Met Asp Ser Ala Lys Glu Pro Leu Asn Ser 675 680 685Gln Gln Phe Lys Gly Met Leu Glu Glu Gly His Lys Leu Leu Gln Ala 690 695 700Ile Glu Thr His Lys Asn Thr Val Glu Glu Phe Leu Ser Gln Phe Glu705 710 715 720Thr Glu Phe Ala Asp Thr Ile Asp Asn Val Arg Glu Glu Phe Lys Lys 725 730 735Ile Lys Gln Pro Ala Tyr Val Ser Lys Ala Leu Ser Thr Trp Glu Glu 740 745 750Thr Leu Thr Ser Phe Lys Asn Ser Ile Ser Glu Ile Glu Lys Phe Leu 755 760 765Ala Lys Asn Leu Phe Gly Glu Asp Leu Arg Glu His Leu Phe Glu Ile 770 775 780Lys Leu Gln Phe Asp Met Tyr Arg Thr Lys Leu Glu Glu Lys Leu Arg785 790 795 800Leu Ile Lys Ser Gly Asp Glu Ser Arg Leu Asn Glu Ile Lys Lys Leu 805 810 815His Leu Arg Asn Phe Arg Leu Gln Lys Arg Lys Glu Glu Lys Leu Lys 820 825 830Arg Lys Leu Glu Gln Glu Lys Ser Arg Asn Asn Asn Glu Thr Glu Ser 835 840 845Thr Val Ile Asn Ser Ala Asp Asp Lys Thr Thr Ile Val Asn Asp Lys 850 855 860Thr Thr Glu Ser Asn Pro Ser Ser Glu Glu Asp Ile Leu His Asp Glu865 870 875 880Leu42646DNASaccharomyces cerevisiae 4atgcgaaacg ttttaaggct tttattttta acagcttttg ttgctatagg gtctttagca 60gccgttttag gtgttgatta cggtcagcaa aatatcaagg ccattgtggt ttctccgcaa 120gccccattag aacttgtgct cacaccagag gcaaaacgga aggagatatc tggtctttcg 180ataaaaagat taccaggtta tggaaaggat gatccgaatg ggattgaaag aatctacggt 240tccgctgttg gcagtttagc aacaaggttt ccccaaaaca cattgttgca tttgaaaccg 300ctacttggga aatcactaga agatgaaacc actgtaactt tgtattcaaa acaacacccc 360ggtttagaaa tggtatcaac aaatagaagt accatagcct ttttagttga taatgtggaa 420tatccattgg aagagttagt ggcaatgaat gtccaagaga ttgccaatag agccaattca 480ctgttgaagg atagagatgc aagaactgag gactttgtaa acaagatgag ttttacaatt 540cctgactttt ttgaccaaca tcaaaggaaa gcacttttag atgccagttc aataaccaca 600ggaatcgaag agacatatct ggttagtgaa gggatgtctg ttgcagttaa ctttgtatta 660aagcagcgcc aatttccacc aggtgaacag cagcattata tcgtatatga catggggagc 720ggttctatta aggcctcaat gttctctata ttgcagccgg aggacactac tcagcccgtt 780acaatagaat ttgaaggata tgggtataat ccacatctag gtggtgcaaa gtttacaatg 840gatattggca gtttgataga gaataagttt ttggaaacac acccagccat aagaactgat 900gaattgcacg ctaatcccaa ggccttagca aaaatcaacc aagcagcaga gaaggcaaag 960ttaattttaa gcgccaattc tgaggcaagt attaacatag aatcactgat caacgatatt 1020gatttccgta cttctataac tagacaggaa ttcgaagaat ttattgcaga ctcgttattg 1080gacattgtca aacccataaa tgacgctgtt acaaaacaat tcggtggcta tggaacaaat 1140ttacctgaga taaatggggt cattttggcg ggaggctctt cccgaattcc cattgtgcag 1200gatcaattaa tcaaactcgt atccgaagaa aaagtgttga gaaatgtcaa tgctgatgaa 1260tcagctgtga atggtgttgt tatgagaggg atcaagttat ctaattcgtt taagaccaag 1320ccgttaaatg ttgttgaccg ttctgtaaat acttattcat tcaaattatc aaacgaatct 1380gaactgtatg atgtgttcac gcgcggaagt gcttatccaa acaaaacatc tattttgaca 1440aacacgactg attcgattcc taataatttt accattgact tatttgagaa tggtaaattg 1500ttcgaaacta tcacagttaa ttcaggagct ataaagaatt catattcctc tgataagtgc 1560tcgtcaggag ttgcgtataa cattactttc gacttgtcca gtgatagatt attctctatt 1620caagaggtta actgcatttg tcagagcgaa aatgacatag gtaactccaa gcaaattaag 1680aacaaaggca gccgtttggc ttttacttct gaggatgttg agatcaaaag gctttctcct 1740tcagaacgtt cgcgtttgca tgagcatatc aagttgctcg ataaacagga taaggaaaga 1800tttcaattcc aagaaaattt aaacgttctt gaaagtaact tgtatgatgc tagaaacctg 1860ctaatggatg atgaagttat gcaaaatgga ccaaaatccc aagtagaaga gttatcggag 1920atggttaaag tatatttgga ttggctcgaa gatgcatcct ttgatactga ccctgaggat 1980atagttagca gaattagaga aattggaata ttaaaaaaga aaatagaact ttacatggat 2040tctgcaaagg aacctttgaa ctctcaacaa tttaaaggaa tgcttgaaga aggccataag 2100ttacttcagg ctatagaaac ccataagaat accgttgaag aatttttgag tcaatttgaa 2160accgagtttg cggataccat agataatgtt agagaagaat ttaaaaagat taagcaacca 2220gcgtatgtgt cgaaggcgtt atctacatgg gaggaaacct taacctcttt taaaaattcc 2280attagcgaaa tagagaagtt cctggcaaaa aacctatttg gcgaagacct tcgtgaacat 2340ttatttgaaa tcaaattaca atttgatatg tatcgtacga aactagagga aaaactgcgt 2400ttaataaaaa gcggtgatga aagtcgctta aatgaaataa agaagttaca tttaagaaac 2460ttccgcctac aaaagagaaa ggaggaaaag ttgaaaagaa agcttgaaca ggaaaaaagc 2520agaaacaaca atgaaacaga atcgacagta atcaactcgg ctgacgataa aactactatt 2580gtcaatgaca agaccaccga gtcgaatcca agttctgagg aagacatttt gcatgatgaa 2640ttatag 26465377PRTSaccharomyces cerevisiae 5Met Ile Pro Lys Leu Tyr Ile His Leu Ile Leu Ser Leu Leu Leu Leu1 5 10 15Pro Leu Ile Leu Ala Gln Asp Tyr Tyr Ala Ile Leu Glu Ile Asp Lys 20 25 30Asp Ala Thr Glu Lys Glu Ile Lys Ser Ala Tyr Arg Gln Leu Ser Lys 35 40 45Lys Tyr His Pro Asp Lys Asn Ala Gly Ser Glu Glu Ala His Gln Lys 50 55 60Phe Ile Glu Val Gly Glu Ala Tyr Asp Val Leu Ser Asp Pro Glu Lys65 70 75 80Lys Lys Ile Tyr Asp Gln Phe Gly Ala Asp Ala Val Lys Asn Gly Gly 85 90 95Gly Gly Gly Gly Pro Gly Gly Pro Gly Ala Gly Gly Phe His Asp Pro 100 105 110Phe Asp Ile Phe Glu Arg Met Phe Gln Gly Gly His Gly Gly Pro Gly 115 120 125Gly Gly Phe Gly Gln Arg Gln Arg Gln Arg Gly Pro Met Ile Lys Val 130 135 140Gln Glu Lys Leu Ser Leu Lys Gln Phe Tyr Ser Gly Ser Ser Ile Glu145 150

155 160Phe Thr Leu Asn Leu Asn Asp Glu Cys Asp Ala Cys His Gly Ser Gly 165 170 175Ser Ala Asp Gly Lys Leu Ala Gln Cys Pro Asp Cys Gln Gly Arg Gly 180 185 190Val Ile Ile Gln Val Leu Arg Met Gly Ile Met Thr Gln Gln Ile Gln 195 200 205Gln Met Cys Gly Arg Cys Gly Gly Thr Gly Gln Ile Ile Lys Asn Glu 210 215 220Cys Lys Thr Cys His Gly Lys Lys Val Thr Lys Lys Asn Lys Phe Phe225 230 235 240His Val Asp Val Pro Pro Gly Ala Pro Arg Asn Tyr Met Asp Thr Arg 245 250 255Val Gly Glu Ala Glu Lys Gly Pro Asp Phe Asp Ala Gly Asp Leu Val 260 265 270Ile Glu Phe Lys Glu Lys Asp Thr Glu Asn Met Gly Tyr Arg Arg Arg 275 280 285Gly Asp Asn Leu Tyr Arg Thr Glu Val Leu Ser Ala Ala Glu Ala Leu 290 295 300Tyr Gly Gly Trp Gln Arg Thr Ile Glu Phe Leu Asp Glu Asn Lys Pro305 310 315 320Val Lys Leu Ser Arg Pro Ala His Val Val Val Ser Asn Gly Glu Val 325 330 335Glu Val Val Lys Gly Phe Gly Met Pro Lys Gly Ser Lys Gly Tyr Gly 340 345 350Asp Leu Tyr Ile Asp Tyr Val Val Val Met Pro Lys Thr Phe Lys Ser 355 360 365Gly Gln Asn Met Leu Lys Asp Glu Leu 370 37561134DNASaccharomyces cerevisiae 6atgattccaa aattatatat acatttgata ctatctttat tgttgttgcc gctaattttg 60gcgcaggatt attatgcaat actagagata gacaaagatg ccactgagaa ggaaatcaaa 120tcagcgtaca gacaattgtc taagaagtac catccggata aaaatgctgg gagcgaagaa 180gcccatcaaa aattcattga agtcggcgag gcatacgatg tattgagcga tcctgaaaag 240aaaaagattt atgaccagtt tggtgcagat gctgtaaaga atggcggtgg cggtggcggt 300ccaggaggcc ctggcgcagg tggattccac gatccgtttg acatattcga acggatgttt 360caaggaggtc atggaggtcc tggcggcgga tttggccaga gacagaggca gcgtggtcca 420atgatcaagg tccaggaaaa actatcttta aagcagtttt attccgggtc ctcgatagaa 480tttactttaa acctaaacga tgaatgtgat gcatgccatg gtagtggctc tgcagatggt 540aagctggccc aatgtcccga ttgtcaaggt cgtggggtta taatacaagt gctgcgcatg 600ggtattatga cgcagcagat tcaacagatg tgtggtaggt gtggtggtac gggacaaatt 660atcaaaaatg aatgcaaaac atgtcacggc aaaaaagtta ccaaaaagaa caagttcttc 720cacgttgacg ttccaccagg cgcaccaaga aactacatgg acacaagagt cggcgaggct 780gaaaaagggc ctgactttga cgccggtgac ttggtcatag aattcaagga aaaggatact 840gagaacatgg gttacagaag aagaggcgac aatctgtaca gaacagaagt tctttctgct 900gcggaagcgc tatacggcgg atggcaaaga acgatagaat tccttgatga gaacaagccc 960gttaagttat ctagacccgc tcatgtagtt gtctccaatg gcgaagttga agtcgtgaag 1020ggattcggca tgcccaaggg tagcaagggt tacggtgatt tgtacataga ctacgtcgtt 1080gtcatgccaa agactttcaa atctgggcaa aatatgctca aagatgagtt gtag 11347682PRTSaccharomyces cerevisiae 7Met Phe Phe Asn Arg Leu Ser Ala Gly Lys Leu Leu Val Pro Leu Ser1 5 10 15Val Val Leu Tyr Ala Leu Phe Val Val Ile Leu Pro Leu Gln Asn Ser 20 25 30Phe His Ser Ser Asn Val Leu Val Arg Gly Ala Asp Asp Val Glu Asn 35 40 45Tyr Gly Thr Val Ile Gly Ile Asp Leu Gly Thr Thr Tyr Ser Cys Val 50 55 60Ala Val Met Lys Asn Gly Lys Thr Glu Ile Leu Ala Asn Glu Gln Gly65 70 75 80Asn Arg Ile Thr Pro Ser Tyr Val Ala Phe Thr Asp Asp Glu Arg Leu 85 90 95Ile Gly Asp Ala Ala Lys Asn Gln Val Ala Ala Asn Pro Gln Asn Thr 100 105 110Ile Phe Asp Ile Lys Arg Leu Ile Gly Leu Lys Tyr Asn Asp Arg Ser 115 120 125Val Gln Lys Asp Ile Lys His Leu Pro Phe Asn Val Val Asn Lys Asp 130 135 140Gly Lys Pro Ala Val Glu Val Ser Val Lys Gly Glu Lys Lys Val Phe145 150 155 160Thr Pro Glu Glu Ile Ser Gly Met Ile Leu Gly Lys Met Lys Gln Ile 165 170 175Ala Glu Asp Tyr Leu Gly Thr Lys Val Thr His Ala Val Val Thr Val 180 185 190Pro Ala Tyr Phe Asn Asp Ala Gln Arg Gln Ala Thr Lys Asp Ala Gly 195 200 205Thr Ile Ala Gly Leu Asn Val Leu Arg Ile Val Asn Glu Pro Thr Ala 210 215 220Ala Ala Ile Ala Tyr Gly Leu Asp Lys Ser Asp Lys Glu His Gln Ile225 230 235 240Ile Val Tyr Asp Leu Gly Gly Gly Thr Phe Asp Val Ser Leu Leu Ser 245 250 255Ile Glu Asn Gly Val Phe Glu Val Gln Ala Thr Ser Gly Asp Thr His 260 265 270Leu Gly Gly Glu Asp Phe Asp Tyr Lys Ile Val Arg Gln Leu Ile Lys 275 280 285Ala Phe Lys Lys Lys His Gly Ile Asp Val Ser Asp Asn Asn Lys Ala 290 295 300Leu Ala Lys Leu Lys Arg Glu Ala Glu Lys Ala Lys Arg Ala Leu Ser305 310 315 320Ser Gln Met Ser Thr Arg Ile Glu Ile Asp Ser Phe Val Asp Gly Ile 325 330 335Asp Leu Ser Glu Thr Leu Thr Arg Ala Lys Phe Glu Glu Leu Asn Leu 340 345 350Asp Leu Phe Lys Lys Thr Leu Lys Pro Val Glu Lys Val Leu Gln Asp 355 360 365Ser Gly Leu Glu Lys Lys Asp Val Asp Asp Ile Val Leu Val Gly Gly 370 375 380Ser Thr Arg Ile Pro Lys Val Gln Gln Leu Leu Glu Ser Tyr Phe Asp385 390 395 400Gly Lys Lys Ala Ser Lys Gly Ile Asn Pro Asp Glu Ala Val Ala Tyr 405 410 415Gly Ala Ala Val Gln Ala Gly Val Leu Ser Gly Glu Glu Gly Val Glu 420 425 430Asp Ile Val Leu Leu Asp Val Asn Ala Leu Thr Leu Gly Ile Glu Thr 435 440 445Thr Gly Gly Val Met Thr Pro Leu Ile Lys Arg Asn Thr Ala Ile Pro 450 455 460Thr Lys Lys Ser Gln Ile Phe Ser Thr Ala Val Asp Asn Gln Pro Thr465 470 475 480Val Met Ile Lys Val Tyr Glu Gly Glu Arg Ala Met Ser Lys Asp Asn 485 490 495Asn Leu Leu Gly Lys Phe Glu Leu Thr Gly Ile Pro Pro Ala Pro Arg 500 505 510Gly Val Pro Gln Ile Glu Val Thr Phe Ala Leu Asp Ala Asn Gly Ile 515 520 525Leu Lys Val Ser Ala Thr Asp Lys Gly Thr Gly Lys Ser Glu Ser Ile 530 535 540Thr Ile Thr Asn Asp Lys Gly Arg Leu Thr Gln Glu Glu Ile Asp Arg545 550 555 560Met Val Glu Glu Ala Glu Lys Phe Ala Ser Glu Asp Ala Ser Ile Lys 565 570 575Ala Lys Val Glu Ser Arg Asn Lys Leu Glu Asn Tyr Ala His Ser Leu 580 585 590Lys Asn Gln Val Asn Gly Asp Leu Gly Glu Lys Leu Glu Glu Glu Asp 595 600 605Lys Glu Thr Leu Leu Asp Ala Ala Asn Asp Val Leu Glu Trp Leu Asp 610 615 620Asp Asn Phe Glu Thr Ala Ile Ala Glu Asp Phe Asp Glu Lys Phe Glu625 630 635 640Ser Leu Ser Lys Val Ala Tyr Pro Ile Thr Ser Lys Leu Tyr Gly Gly 645 650 655Ala Asp Gly Ser Gly Ala Ala Asp Tyr Asp Asp Glu Asp Glu Asp Asp 660 665 670Asp Gly Asp Tyr Phe Glu His Asp Glu Leu 675 68082049DNASaccharomyces cerevisiae 8atgtttttca acagactaag cgctggcaag ctgctggtac cactctccgt ggtcctgtac 60gcccttttcg tggtaatatt acctttacag aattctttcc actcctccaa tgttttagtt 120agaggtgccg atgatgtaga aaactacgga actgttatcg gtattgactt aggtactact 180tattcctgtg ttgctgtgat gaaaaatggt aagactgaaa ttcttgctaa tgagcaaggt 240aacagaatca ccccatctta cgtggcattc accgatgatg aaagattgat tggtgatgct 300gcaaagaacc aagttgctgc caatcctcaa aacaccatct tcgacattaa gagattgatc 360ggtttgaaat ataacgacag atctgttcag aaggatatca agcacttgcc atttaatgtg 420gttaataaag atgggaagcc cgctgtagaa gtaagtgtca aaggagaaaa gaaggttttt 480actccagaag aaatttctgg tatgatcttg ggtaagatga aacaaattgc cgaagattat 540ttaggcacta aggttaccca tgctgtcgtt actgttcctg cttatttcaa tgacgcgcaa 600agacaagcca ccaaggatgc tggtaccatc gctggtttga acgttttgag aattgttaat 660gaaccaaccg cagccgccat tgcctacggt ttggataaat ctgataagga acatcaaatt 720attgtttatg atttgggtgg tggtactttc gatgtctctc tattgtctat tgaaaacggt 780gttttcgaag tccaagccac ttctggtgat actcatttag gtggtgaaga ttttgactat 840aagatcgttc gtcaattgat aaaagctttc aagaagaagc atggtattga tgtgtctgac 900aacaacaagg ccctagctaa attgaagaga gaagctgaaa aggctaaacg tgccttgtcc 960agccaaatgt ccacccgtat tgaaattgac tccttcgttg atggtatcga cttaagtgaa 1020accttgacca gagctaagtt tgaggaatta aacctagatc tattcaagaa gaccttgaag 1080cctgtcgaga aggttttgca agattctggt ttggaaaaga aggatgttga tgatatcgtt 1140ttggttggtg gttctactag aattccaaag gtccaacaat tgttagaatc atactttgat 1200ggtaagaagg cctccaaggg tattaaccca gatgaagctg ttgcatacgg tgcagccgtt 1260caagctggtg tcttatccgg tgaagaaggt gtcgaagata ttgttttatt ggatgtcaac 1320gctttgactc ttggtattga aaccactggt ggtgtcatga ctccattaat taagagaaat 1380actgctattc ctacaaagaa atcccaaatt ttctctactg ccgttgacaa ccaaccaacc 1440gttatgatca aggtatacga gggtgaaaga gccatgtcta aggacaacaa tctattaggt 1500aagtttgaat taaccggcat tccaccagca ccaagaggtg tacctcaaat tgaagtcaca 1560tttgcacttg acgctaatgg tattctgaag gtgtctgcca cagataaggg aactggtaaa 1620tccgaatcta tcaccatcac taacgataaa ggtagattaa cccaagaaga gattgataga 1680atggttgaag aggctgaaaa attcgcttct gaagacgctt ctatcaaggc caaggttgaa 1740tctagaaaca aattagaaaa ctacgctcac tctttgaaaa accaagttaa tggtgaccta 1800ggtgaaaaat tggaagaaga agacaaggaa accttattag atgctgctaa cgatgtttta 1860gaatggttag atgataactt tgaaaccgcc attgctgaag actttgatga aaagttcgaa 1920tctttgtcca aggtcgctta tccaattact tctaagttgt acggaggtgc tgatggttct 1980ggtgccgctg attatgacga cgaagatgaa gatgacgatg gtgattattt cgaacacgac 2040gaattgtag 20499421PRTSaccharomyces cerevisiae 9Met Val Arg Ile Leu Pro Ile Ile Leu Ser Ala Leu Ser Ser Lys Leu1 5 10 15Val Ala Ser Thr Ile Leu His Ser Ser Ile His Ser Val Pro Ser Gly 20 25 30Gly Glu Ile Ile Ser Ala Glu Asp Leu Lys Glu Leu Glu Ile Ser Gly 35 40 45Asn Ser Ile Cys Val Asp Asn Arg Cys Tyr Pro Lys Ile Phe Glu Pro 50 55 60Arg His Asp Trp Gln Pro Ile Leu Pro Gly Gln Glu Leu Pro Gly Gly65 70 75 80Leu Asp Ile Arg Ile Asn Met Asp Thr Gly Leu Lys Glu Ala Lys Leu 85 90 95Asn Asp Glu Lys Asn Val Gly Asp Asn Gly Ser His Glu Leu Ile Val 100 105 110Ser Ser Glu Asp Met Lys Ala Ser Pro Gly Asp Tyr Glu Phe Ser Ser 115 120 125Asp Phe Lys Glu Met Arg Asn Ile Ile Asp Ser Asn Pro Thr Leu Ser 130 135 140Ser Gln Asp Ile Ala Arg Leu Glu Asp Ser Phe Asp Arg Ile Met Glu145 150 155 160Phe Ala His Asp Tyr Lys His Gly Tyr Lys Ile Ile Thr His Glu Phe 165 170 175Ala Leu Leu Ala Asn Leu Ser Leu Asn Glu Asn Leu Pro Leu Thr Leu 180 185 190Arg Glu Leu Ser Thr Arg Val Ile Thr Ser Cys Leu Arg Asn Asn Pro 195 200 205Pro Val Val Glu Phe Ile Asn Glu Ser Phe Pro Asn Phe Lys Ser Lys 210 215 220Ile Met Ala Ala Leu Ser Asn Leu Asn Asp Ser Asn His Arg Ser Ser225 230 235 240Asn Ile Leu Ile Lys Arg Tyr Leu Ser Ile Leu Asn Glu Leu Pro Val 245 250 255Thr Ser Glu Asp Leu Pro Ile Tyr Ser Thr Val Val Leu Gln Asn Val 260 265 270Tyr Glu Arg Asn Asn Lys Asp Lys Gln Leu Gln Ile Lys Val Leu Glu 275 280 285Leu Ile Ser Lys Ile Leu Lys Ala Asp Met Tyr Glu Asn Asp Asp Thr 290 295 300Asn Leu Ile Leu Phe Lys Arg Asn Ala Glu Asn Trp Ser Ser Asn Leu305 310 315 320Gln Glu Trp Ala Asn Glu Phe Gln Glu Met Val Gln Asn Lys Ser Ile 325 330 335Asp Glu Leu His Thr Arg Thr Phe Phe Asp Thr Leu Tyr Asn Leu Lys 340 345 350Lys Ile Phe Lys Ser Asp Ile Thr Ile Asn Lys Gly Phe Leu Asn Trp 355 360 365Leu Ala Gln Gln Cys Lys Ala Arg Gln Ser Asn Leu Asp Asn Gly Leu 370 375 380Gln Glu Arg Asp Thr Glu Gln Asp Ser Phe Asp Lys Lys Leu Ile Asp385 390 395 400Ser Arg His Leu Ile Phe Gly Asn Pro Met Ala His Arg Ile Lys Asn 405 410 415Phe Arg Asp Glu Leu 420101266DNASaccharomyces cerevisiae 10atggtccgga ttcttcccat aattttgagc gccctatctt cgaaattagt ggcgagtaca 60atattgcatt catccataca ctcagtgcca tctggaggcg aaatcatatc tgcagaagat 120cttaaagaac ttgaaatttc agggaattcg atctgcgttg ataatcgttg ctatcctaag 180atatttgaac caagacacga ttggcagccc atactgccag gtcaagaact ccccggtggt 240ttggacatta gaataaacat ggacacaggt ttaaaagagg caaaactaaa tgatgagaag 300aatgtcggtg ataatggtag ccatgagtta attgtatctt cagaagacat gaaagcatcg 360cctggtgact atgaattttc cagtgatttc aaagaaatga gaaacatcat agattctaac 420ccgactttat cttcacagga cattgccaga ttggaggata gttttgatag aataatggaa 480tttgcgcatg attacaagca cggctacaaa attattaccc atgaattcgc cctcttggcc 540aaccttagtc tcaatgaaaa tttgccgtta acattgagag agctcagtac tagagtcatt 600accagctgct tgagaaacaa tcctcctgta gtcgagttca ttaatgaaag ttttccaaat 660tttaaaagca aaatcatggc cgctctgtca aatttgaatg attctaacca cagatcctct 720aatatcctaa taaaaagata cttgtccatt ttaaacgaat tacctgtcac atccgaagat 780cttcctatat actctacggt tgttttacaa aatgtatatg aaagaaacaa caaggacaaa 840cagttacaaa taaaagtcct ggagttgatc agcaaaattt tgaaggccga catgtacgaa 900aatgacgata caaatctaat tttgttcaaa agaaatgctg agaattggtc gtcaaatctg 960caagagtggg caaacgagtt ccaagagatg gtccagaaca aaagtataga tgaactacat 1020acaagaacgt tttttgacac cctttacaac ttgaagaaaa ttttcaaaag tgacatcacg 1080atcaacaaag ggtttttgaa ttggttagcg caacaatgta aagccaggca atctaacttg 1140gacaatgggc tccaagagag agatactgaa caagactcat ttgataagaa acttatcgac 1200agcagacact tgatctttgg caaccccatg gctcatagaa taaaaaattt cagagatgaa 1260ctctga 126611135PRTSaccharomyces cerevisiae 11Met Met Phe Asn Ile Tyr Leu Phe Val Thr Phe Phe Ser Thr Ile Leu1 5 10 15Ala Gly Ser Leu Ser Asp Leu Glu Ile Gly Ile Ile Lys Arg Ile Pro 20 25 30Val Glu Asp Cys Leu Ile Lys Ala Met Pro Gly Asp Lys Val Lys Val 35 40 45His Tyr Thr Gly Ser Leu Leu Glu Ser Gly Thr Val Phe Asp Ser Ser 50 55 60Tyr Ser Arg Gly Ser Pro Ile Ala Phe Glu Leu Gly Val Gly Arg Val65 70 75 80Ile Lys Gly Trp Asp Gln Gly Val Ala Gly Met Cys Val Gly Glu Lys 85 90 95Arg Lys Leu Gln Ile Pro Ser Ser Leu Ala Tyr Gly Glu Arg Gly Val 100 105 110Pro Gly Val Ile Pro Pro Ser Ala Asp Leu Val Phe Asp Val Glu Leu 115 120 125Val Asp Val Lys Ser Ala Ala 130 13512408DNASaccharomyces cerevisiae 12atgatgttta atatttacct tttcgtcact tttttttcca ccattcttgc aggttccctg 60tcagatttgg aaatcggtat tatcaagaga ataccggtag aagattgctt aattaaggca 120atgccaggtg ataaagttaa ggttcattat acaggatctt tattagaatc gggaactgta 180tttgactcaa gttattcaag aggctctcct atcgcttttg aacttggcgt tggcagagta 240attaaaggtt gggatcaagg tgttgccggc atgtgcgttg gcgaaaaaag aaagctgcaa 300attccaagtt ctttggccta cggagaaaga ggtgtcccag gcgtcattcc tccaagtgct 360gatttggtgt ttgatgtcga attggtagac gtgaaatcag ccgcctag 40813642PRTSaccharomyces cerevisiae 13Met Ser Lys Ala Val Gly Ile Asp Leu Gly Thr Thr Tyr Ser Cys Val1 5 10 15Ala His Phe Ala Asn Asp Arg Val Asp Ile Ile Ala Asn Asp Gln Gly 20 25 30Asn Arg Thr Thr Pro Ser Phe Val Ala Phe Thr Asp Thr Glu Arg Leu 35 40 45Ile Gly Asp Ala Ala Lys Asn Gln Ala Ala Met Asn Pro Ser Asn Thr 50 55 60Val Phe Asp Ala Lys Arg Leu Ile Gly Arg Asn Phe Asn Asp Pro Glu65 70 75 80Val Gln Ala Asp Met Lys His Phe Pro Phe Lys Leu Ile Asp Val Asp 85 90 95Gly Lys Pro Gln Ile Gln Val Glu Phe Lys Gly Glu Thr Lys Asn Phe 100 105 110Thr Pro Glu Gln Ile Ser Ser Met Val Leu Gly Lys Met Lys Glu Thr 115 120 125Ala Glu Ser Tyr Leu Gly Ala Lys Val Asn Asp Ala Val Val Thr Val 130 135 140Pro Ala Tyr Phe Asn Asp Ser Gln Arg Gln Ala Thr Lys Asp Ala Gly145 150

155 160Thr Ile Ala Gly Leu Asn Val Leu Arg Ile Ile Asn Glu Pro Thr Ala 165 170 175Ala Ala Ile Ala Tyr Gly Leu Asp Lys Lys Gly Lys Glu Glu His Val 180 185 190Leu Ile Phe Asp Leu Gly Gly Gly Thr Phe Asp Val Ser Leu Leu Phe 195 200 205Ile Glu Asp Gly Ile Phe Glu Val Lys Ala Thr Ala Gly Asp Thr His 210 215 220Leu Gly Gly Glu Asp Phe Asp Asn Arg Leu Val Asn His Phe Ile Gln225 230 235 240Glu Phe Lys Arg Lys Asn Lys Lys Asp Leu Ser Thr Asn Gln Arg Ala 245 250 255Leu Arg Arg Leu Arg Thr Ala Cys Glu Arg Ala Lys Arg Thr Leu Ser 260 265 270Ser Ser Ala Gln Thr Ser Val Glu Ile Asp Ser Leu Phe Glu Gly Ile 275 280 285Asp Phe Tyr Thr Ser Ile Thr Arg Ala Arg Phe Glu Glu Leu Cys Ala 290 295 300Asp Leu Phe Arg Ser Thr Leu Asp Pro Val Glu Lys Val Leu Arg Asp305 310 315 320Ala Lys Leu Asp Lys Ser Gln Val Asp Glu Ile Val Leu Val Gly Gly 325 330 335Ser Thr Arg Ile Pro Lys Val Gln Lys Leu Val Thr Asp Tyr Phe Asn 340 345 350Gly Lys Glu Pro Asn Arg Ser Ile Asn Pro Asp Glu Ala Val Ala Tyr 355 360 365Gly Ala Ala Val Gln Ala Ala Ile Leu Thr Gly Asp Glu Ser Ser Lys 370 375 380Thr Gln Asp Leu Leu Leu Leu Asp Val Ala Pro Leu Ser Leu Gly Ile385 390 395 400Glu Thr Ala Gly Gly Val Met Thr Lys Leu Ile Pro Arg Asn Ser Thr 405 410 415Ile Ser Thr Lys Lys Phe Glu Ile Phe Ser Thr Tyr Ala Asp Asn Gln 420 425 430Pro Gly Val Leu Ile Gln Val Phe Glu Gly Glu Arg Ala Lys Thr Lys 435 440 445Asp Asn Asn Leu Leu Gly Lys Phe Glu Leu Ser Gly Ile Pro Pro Ala 450 455 460Pro Arg Gly Val Pro Gln Ile Glu Val Thr Phe Asp Val Asp Ser Asn465 470 475 480Gly Ile Leu Asn Val Ser Ala Val Glu Lys Gly Thr Gly Lys Ser Asn 485 490 495Lys Ile Thr Ile Thr Asn Asp Lys Gly Arg Leu Ser Lys Glu Asp Ile 500 505 510Glu Lys Met Val Ala Glu Ala Glu Lys Phe Lys Glu Glu Asp Glu Lys 515 520 525Glu Ser Gln Arg Ile Ala Ser Lys Asn Gln Leu Glu Ser Ile Ala Tyr 530 535 540Ser Leu Lys Asn Thr Ile Ser Glu Ala Gly Asp Lys Leu Glu Gln Ala545 550 555 560Asp Lys Asp Thr Val Thr Lys Lys Ala Glu Glu Thr Ile Ser Trp Leu 565 570 575Asp Ser Asn Thr Thr Ala Ser Lys Glu Glu Phe Asp Asp Lys Leu Lys 580 585 590Glu Leu Gln Asp Ile Ala Asn Pro Ile Met Ser Lys Leu Tyr Gln Ala 595 600 605Gly Gly Ala Pro Gly Gly Ala Ala Gly Gly Ala Pro Gly Gly Phe Pro 610 615 620Gly Gly Ala Pro Pro Ala Pro Glu Ala Glu Gly Pro Thr Val Glu Glu625 630 635 640Val Asp141929DNASaccharomyces cerevisiae 14atgtcaaaag ctgtcggtat tgatttaggt acaacatact cgtgtgttgc tcactttgct 60aatgatcgtg tggacattat tgccaacgat caaggtaaca gaaccactcc atcttttgtc 120gctttcactg acactgaaag attgattggt gatgctgcta agaatcaagc tgctatgaat 180ccttcgaata ccgttttcga cgctaagcgt ttgatcggta gaaacttcaa cgacccagaa 240gtgcaggctg acatgaagca cttcccattc aagttgatcg atgttgacgg taagcctcaa 300attcaagttg aatttaaggg tgaaaccaag aactttaccc cagaacaaat ctcctccatg 360gtcttgggta agatgaagga aactgccgaa tcttacttgg gagccaaggt caatgacgct 420gtcgtcactg tcccagctta cttcaacgat tctcaaagac aagctaccaa ggatgctggt 480accattgctg gtttgaatgt cttgcgtatt attaacgaac ctaccgccgc tgccattgct 540tacggtttgg acaagaaggg taaggaagaa cacgtcttga ttttcgactt gggtggtggt 600actttcgatg tctctttgtt gttcattgaa gacggtatct ttgaagttaa ggccaccgct 660ggtgacaccc atttgggtgg tgaagatttt gacaacagat tggtcaacca cttcatccaa 720gaattcaaga gaaagaacaa gaaggacttg tctaccaacc aaagagcttt gagaagatta 780agaaccgctt gtgaaagagc caagagaact ttgtcttcct ccgctcaaac ttccgttgaa 840attgactctt tgttcgaagg tatcgatttc tacacttcca tcaccagagc cagattcgaa 900gaattgtgtg ctgacttgtt cagatctact ttggacccag ttgaaaaggt cttgagagat 960gctaaattgg acaaatctca agtcgatgaa attgtcttgg tcggtggttc taccagaatt 1020ccaaaggtcc aaaaattggt cactgactac ttcaacggta aggaaccaaa cagatctatc 1080aacccagatg aagctgttgc ttacggtgct gctgttcaag ctgctatttt gactggtgac 1140gaatcttcca agactcaaga tctattgttg ttggatgtcg ctccattatc cttgggtatt 1200gaaactgctg gtggtgtcat gaccaagttg attccaagaa actctaccat ttcaacaaag 1260aagttcgaga tcttttccac ttatgctgat aaccaaccag gtgtcttgat tcaagtcttt 1320gaaggtgaaa gagccaagac taaggacaac aacttgttgg gtaagttcga attgagtggt 1380attccaccag ctccaagagg tgtcccacaa attgaagtca ctttcgatgt cgactctaac 1440ggtattttga atgtttccgc cgtcgaaaag ggtactggta agtctaacaa gatcactatt 1500accaacgaca agggtagatt gtccaaggaa gatatcgaaa agatggttgc tgaagccgaa 1560aaattcaagg aagaagatga aaaggaatct caaagaattg cttccaagaa ccaattggaa 1620tccattgctt actctttgaa gaacaccatt tctgaagctg gtgacaaatt ggaacaagct 1680gacaaggaca ccgtcaccaa gaaggctgaa gagactattt cttggttaga cagcaacacc 1740actgccagca aggaagaatt cgatgacaag ttgaaggagt tgcaagacat tgccaaccca 1800atcatgtcta agttgtacca agctggtggt gctccaggtg gcgctgcagg tggtgctcca 1860ggcggtttcc caggtggtgc tcctccagct ccagaggctg aaggtccaac cgttgaagaa 1920gttgattaa 192915639PRTSaccharomyces cerevisiae 15Met Ser Lys Ala Val Gly Ile Asp Leu Gly Thr Thr Tyr Ser Cys Val1 5 10 15Ala His Phe Ser Asn Asp Arg Val Asp Ile Ile Ala Asn Asp Gln Gly 20 25 30Asn Arg Thr Thr Pro Ser Phe Val Gly Phe Thr Asp Thr Glu Arg Leu 35 40 45Ile Gly Asp Ala Ala Lys Asn Gln Ala Ala Met Asn Pro Ala Asn Thr 50 55 60Val Phe Asp Ala Lys Arg Leu Ile Gly Arg Asn Phe Asn Asp Pro Glu65 70 75 80Val Gln Gly Asp Met Lys His Phe Pro Phe Lys Leu Ile Asp Val Asp 85 90 95Gly Lys Pro Gln Ile Gln Val Glu Phe Lys Gly Glu Thr Lys Asn Phe 100 105 110Thr Pro Glu Gln Ile Ser Ser Met Val Leu Gly Lys Met Lys Glu Thr 115 120 125Ala Glu Ser Tyr Leu Gly Ala Lys Val Asn Asp Ala Val Val Thr Val 130 135 140Pro Ala Tyr Phe Asn Asp Ser Gln Arg Gln Ala Thr Lys Asp Ala Gly145 150 155 160Thr Ile Ala Gly Leu Asn Val Leu Arg Ile Ile Asn Glu Pro Thr Ala 165 170 175Ala Ala Ile Ala Tyr Gly Leu Asp Lys Lys Gly Lys Glu Glu His Val 180 185 190Leu Ile Phe Asp Leu Gly Gly Gly Thr Phe Asp Val Ser Leu Leu Ser 195 200 205Ile Glu Asp Gly Ile Phe Glu Val Lys Ala Thr Ala Gly Asp Thr His 210 215 220Leu Gly Gly Glu Asp Phe Asp Asn Arg Leu Val Asn His Phe Ile Gln225 230 235 240Glu Phe Lys Arg Lys Asn Lys Lys Asp Leu Ser Thr Asn Gln Arg Ala 245 250 255Leu Arg Arg Leu Arg Thr Ala Cys Glu Arg Ala Lys Arg Thr Leu Ser 260 265 270Ser Ser Ala Gln Thr Ser Val Glu Ile Asp Ser Leu Phe Glu Gly Ile 275 280 285Asp Phe Tyr Thr Ser Ile Thr Arg Ala Arg Phe Glu Glu Leu Cys Ala 290 295 300Asp Leu Phe Arg Ser Thr Leu Asp Pro Val Glu Lys Val Leu Arg Asp305 310 315 320Ala Lys Leu Asp Lys Ser Gln Val Asp Glu Ile Val Leu Val Gly Gly 325 330 335Ser Thr Arg Ile Pro Lys Val Gln Lys Leu Val Thr Asp Tyr Phe Asn 340 345 350Gly Lys Glu Pro Asn Arg Ser Ile Asn Pro Asp Glu Ala Val Ala Tyr 355 360 365Gly Ala Ala Val Gln Ala Ala Ile Leu Thr Gly Asp Glu Ser Ser Lys 370 375 380Thr Gln Asp Leu Leu Leu Leu Asp Val Ala Pro Leu Ser Leu Gly Ile385 390 395 400Glu Thr Ala Gly Gly Val Met Thr Lys Leu Ile Pro Arg Asn Ser Thr 405 410 415Ile Pro Thr Lys Lys Ser Glu Val Phe Ser Thr Tyr Ala Asp Asn Gln 420 425 430Pro Gly Val Leu Ile Gln Val Phe Glu Gly Glu Arg Ala Lys Thr Lys 435 440 445Asp Asn Asn Leu Leu Gly Lys Phe Glu Leu Ser Gly Ile Pro Pro Ala 450 455 460Pro Arg Gly Val Pro Gln Ile Glu Val Thr Phe Asp Val Asp Ser Asn465 470 475 480Gly Ile Leu Asn Val Ser Ala Val Glu Lys Gly Thr Gly Lys Ser Asn 485 490 495Lys Ile Thr Ile Thr Asn Asp Lys Gly Arg Leu Ser Lys Glu Asp Ile 500 505 510Glu Lys Met Val Ala Glu Ala Glu Lys Phe Lys Glu Glu Asp Glu Lys 515 520 525Glu Ser Gln Arg Ile Ala Ser Lys Asn Gln Leu Glu Ser Ile Ala Tyr 530 535 540Ser Leu Lys Asn Thr Ile Ser Glu Ala Gly Asp Lys Leu Glu Gln Ala545 550 555 560Asp Lys Asp Ala Val Thr Lys Lys Ala Glu Glu Thr Ile Ala Trp Leu 565 570 575Asp Ser Asn Thr Thr Ala Thr Lys Glu Glu Phe Asp Asp Gln Leu Lys 580 585 590Glu Leu Gln Glu Val Ala Asn Pro Ile Met Ser Lys Leu Tyr Gln Ala 595 600 605Gly Gly Ala Pro Glu Gly Ala Ala Pro Gly Gly Phe Pro Gly Gly Ala 610 615 620Pro Pro Ala Pro Glu Ala Glu Gly Pro Thr Val Glu Glu Val Asp625 630 635161920DNASaccharomyces cerevisiae 16atgtctaaag ctgtcggtat tgatttaggt actacctact cctgtgttgc tcacttctct 60aatgatcgtg ttgacattat tgccaacgac caaggtaaca gaaccactcc atctttcgtt 120ggtttcactg atactgaaag attgattggt gacgctgcta agaaccaagc tgctatgaac 180ccagctaaca ctgttttcga cgctaagcgt ttgatcggta gaaacttcaa tgacccagaa 240gtccaaggtg atatgaagca cttcccattc aagttgatcg atgttgacgg taagccacaa 300attcaagttg aatttaaggg tgaaaccaag aactttaccc cagaacaaat ctcctccatg 360gtcttgggta agatgaagga aactgccgaa tcttacttgg gtgccaaggt caatgacgct 420gtcgtcactg tcccagctta cttcaacgat tctcaaagac aagctaccaa ggatgctggt 480accattgctg gtttgaatgt cttgcgtatt attaacgaac ctaccgccgc tgccattgct 540tacggtttgg acaagaaggg taaggaagaa cacgtcttga ttttcgactt gggtggtggt 600actttcgatg tctctttgtt gtccattgaa gacggtatct ttgaagttaa ggccaccgct 660ggtgacaccc atttgggtgg tgaagatttt gacaacagat tggtcaacca cttcatccaa 720gaattcaaga gaaagaacaa gaaggacttg tctaccaacc aaagagcttt gagaagatta 780agaactgctt gtgaaagagc caagagaact ttgtcttcct ccgctcaaac ttccgttgaa 840attgactctt tgttcgaagg tatcgatttc tacacttcca tcaccagagc cagattcgaa 900gaattgtgtg ctgacttgtt cagatctact ttggacccag ttgaaaaggt cttgagagat 960gctaaattgg ataaatctca agtcgatgaa attgtcttgg tcggtggttc taccagaatt 1020ccaaaggtcc aaaaattggt cactgactac ttcaacggta aggaaccaaa cagatctatc 1080aacccagatg aagctgttgc ttacggtgct gctgttcaag ctgctatttt gactggtgac 1140gaatcttcca agactcaaga tctattgttg ttggatgtcg ctccattatc cttgggtatt 1200gaaactgctg gtggtgtcat gaccaagttg attccaagaa actctaccat tccaactaag 1260aaatccgaag ttttctctac ttatgctgac aaccaaccag gtgtcttgat tcaagtcttt 1320gaaggtgaaa gagccaagac taaggacaac aacttgttgg gtaagttcga attgagtggt 1380attccaccag ctccaagagg tgtcccacaa attgaagtca ctttcgatgt cgactctaac 1440ggtattttga atgtttccgc cgtcgaaaag ggtactggta agtctaacaa gatcactatt 1500accaacgaca agggtagatt gtccaaggaa gatatcgaaa agatggttgc tgaagccgaa 1560aaattcaagg aagaagatga aaaggaatct caaagaattg cttccaagaa ccaattggaa 1620tccattgctt actctttgaa gaacaccatt tctgaagctg gtgacaagct agagcaagct 1680gacaaggacg ctgtcactaa gaaggctgaa gaaactattg cttggttaga cagcaacacc 1740actgctacca aggaagaatt cgatgaccaa ttgaaggaat tgcaagaggt tgccaaccca 1800atcatgtcta aattgtacca agctggtggt gctccagaag gcgcagctcc aggtggtttc 1860ccaggtggtg ctcctccagc tccagaagct gaaggtccaa ctgtcgaaga agttgattaa 192017649PRTSaccharomyces cerevisiae 17Met Ser Arg Ala Val Gly Ile Asp Leu Gly Thr Thr Tyr Ser Cys Val1 5 10 15Ala His Phe Ser Asn Asp Arg Val Glu Ile Ile Ala Asn Asp Gln Gly 20 25 30Asn Arg Thr Thr Pro Ser Tyr Val Ala Phe Thr Asp Thr Glu Arg Leu 35 40 45Ile Gly Asp Ala Ala Lys Asn Gln Ala Ala Ile Asn Pro His Asn Thr 50 55 60Val Phe Asp Ala Lys Arg Leu Ile Gly Arg Lys Phe Asp Asp Pro Glu65 70 75 80Val Thr Thr Asp Ala Lys His Phe Pro Phe Lys Val Ile Ser Arg Asp 85 90 95Gly Lys Pro Val Val Gln Val Glu Tyr Lys Gly Glu Thr Lys Thr Phe 100 105 110Thr Pro Glu Glu Ile Ser Ser Met Val Leu Ser Lys Met Lys Glu Thr 115 120 125Ala Glu Asn Tyr Leu Gly Thr Thr Val Asn Asp Ala Val Val Thr Val 130 135 140Pro Ala Tyr Phe Asn Asp Ser Gln Arg Gln Ala Thr Lys Asp Ala Gly145 150 155 160Thr Ile Ala Gly Met Asn Val Leu Arg Ile Ile Asn Glu Pro Thr Ala 165 170 175Ala Ala Ile Ala Tyr Gly Leu Asp Lys Lys Gly Arg Ala Glu His Asn 180 185 190Val Leu Ile Phe Asp Leu Gly Gly Gly Thr Phe Asp Val Ser Leu Leu 195 200 205Ser Ile Asp Glu Gly Val Phe Glu Val Lys Ala Thr Ala Gly Asp Thr 210 215 220His Leu Gly Gly Glu Asp Phe Asp Asn Arg Leu Val Asn His Leu Ala225 230 235 240Thr Glu Phe Lys Arg Lys Thr Lys Lys Asp Ile Ser Asn Asn Gln Arg 245 250 255Ser Leu Arg Arg Leu Arg Thr Ala Ala Glu Arg Ala Lys Arg Ala Leu 260 265 270Ser Ser Ser Ser Gln Thr Ser Ile Glu Ile Asp Ser Leu Phe Glu Gly 275 280 285Met Asp Phe Tyr Thr Ser Leu Thr Arg Ala Arg Phe Glu Glu Leu Cys 290 295 300Ala Asp Leu Phe Arg Ser Thr Leu Glu Pro Val Glu Lys Val Leu Lys305 310 315 320Asp Ser Lys Leu Asp Lys Ser Gln Ile Asp Glu Ile Val Leu Val Gly 325 330 335Gly Ser Thr Arg Ile Pro Lys Ile Gln Lys Leu Val Ser Asp Phe Phe 340 345 350Asn Gly Lys Glu Pro Asn Arg Ser Ile Asn Pro Asp Glu Ala Val Ala 355 360 365Tyr Gly Ala Ala Val Gln Ala Ala Ile Leu Thr Gly Asp Gln Ser Thr 370 375 380Lys Thr Gln Asp Leu Leu Leu Leu Asp Val Ala Pro Leu Ser Leu Gly385 390 395 400Ile Glu Thr Ala Gly Gly Ile Met Thr Lys Leu Ile Pro Arg Asn Ser 405 410 415Thr Ile Pro Thr Lys Lys Ser Glu Thr Phe Ser Thr Tyr Ala Asp Asn 420 425 430Gln Pro Gly Val Leu Ile Gln Val Phe Glu Gly Glu Arg Thr Arg Thr 435 440 445Lys Asp Asn Asn Leu Leu Gly Lys Phe Glu Leu Ser Gly Ile Pro Pro 450 455 460Ala Pro Arg Gly Val Pro Gln Ile Asp Val Thr Phe Asp Ile Asp Ala465 470 475 480Asn Gly Ile Leu Asn Val Ser Ala Leu Glu Lys Gly Thr Gly Lys Ser 485 490 495Asn Lys Ile Thr Ile Thr Asn Asp Lys Gly Arg Leu Ser Lys Asp Asp 500 505 510Ile Asp Arg Met Val Ser Glu Ala Glu Lys Tyr Arg Ala Asp Asp Glu 515 520 525Arg Glu Ala Glu Arg Val Gln Ala Lys Asn Gln Leu Glu Ser Tyr Ala 530 535 540Phe Thr Leu Lys Asn Thr Ile Asn Glu Ala Ser Phe Lys Glu Lys Val545 550 555 560Gly Glu Asp Asp Ala Lys Arg Leu Glu Thr Ala Ser Gln Glu Thr Ile 565 570 575Asp Trp Leu Asp Ala Ser Gln Ala Ala Ser Thr Asp Glu Tyr Lys Asp 580 585 590Arg Gln Lys Glu Leu Glu Gly Ile Ala Asn Pro Ile Met Thr Lys Phe 595 600 605Tyr Gly Ala Gly Ala Gly Ala Gly Pro Gly Ala Gly Glu Ser Gly Gly 610 615 620Phe Pro Gly Ser Met Pro Asn Ser Gly Ala Thr Gly Gly Gly Glu Asp625 630 635 640Thr Gly Pro Thr Val Glu Glu Val Asp 645181950DNASaccharomyces cerevisiae 18atgtctagag cagttggtat tgatttggga acaacttact cgtgtgttgc tcatttttcc 60aatgataggg tagagataat tgcaaatgat caaggtaata ggaccactcc atcgtatgtg 120gctttcacag acaccgaaag attaattggt gacgccgcca aaaatcaagc tgcaatcaat 180cctcataata cagtttttga tgcaaagcgg ttaattggtc gtaaatttga

tgatcctgaa 240gtgacgacag atgccaagca cttccctttc aaagttatat ccagagatgg taaacctgta 300gtgcaagtag aatataaggg tgaaacgaaa acatttacgc ctgaggaaat ttcttccatg 360gttttaagca aaatgaagga aactgctgag aactatttgg gaactacggt caatgatgct 420gttgtaactg ttcctgcata tttcaatgat tctcaaagac aagccactaa ggatgcagga 480actattgcag ggatgaacgt tttacgtatt atcaatgaac ccactgcagc agcaattgct 540tatggcttgg ataagaaagg cagggctgag cacaatgtcc tgatttttga tttgggtggt 600ggtacttttg acgtctcttt actttcaatt gatgagggtg tttttgaggt taaggctacc 660gcaggagaca ctcatttagg tggtgaagat tttgataata ggttggtgaa ccatttagcc 720actgaattca aaaggaaaac gaaaaaggac atctctaata atcaaagatc gttaagaaga 780ttgagaactg cggcagaaag agctaagaga gcgctttctt cctcatctca aacctcgatc 840gagatcgatt ctttatttga aggtatggat ttctacactt cgttaacaag ggcaaggttt 900gaagagctat gtgctgattt attcagatcc acattggaac cagtagaaaa ggttcttaaa 960gattcgaagc tggacaagtc ccaaattgat gagattgtgt tagtcggtgg atctaccaga 1020atcccaaaga ttcagaaatt agtttctgac ttcttcaatg gcaaagagcc taatcgttct 1080atcaacccgg atgaggctgt tgcttatggt gcagccgttc aagctgccat tttaaccggc 1140gatcaatcaa caaagacaca agatttacta ttattggatg ttgcgccatt gtccctagga 1200attgaaactg caggcggcat aatgactaag ctaattccta gaaactcaac gattccaaca 1260aagaaatcgg aaaccttctc tacctatgca gataatcaac ctggtgtttt aattcaagtc 1320tttgaaggtg aaagaacaag aacaaaggat aataacttac ttggtaaatt cgaattaagt 1380ggcattccgc ctgctcccag aggtgtgcct caaattgatg ttacctttga tatcgacgct 1440aatggtattc ttaatgtgtc tgctttggaa aagggtactg gtaagagtaa caaaatcacg 1500atcactaacg ataaaggtag gctctcgaag gatgatattg ataggatggt ttctgaagct 1560gaaaaatata gggctgacga tgaaagggag gcagaacgag ttcaggctaa gaatcagctt 1620gaatcgtatg catttacttt gaagaatacc ataaacgaag caagtttcaa agagaaagta 1680ggtgaagatg atgcaaagag attagaaaca gcgtctcagg aaaccattga ctggttagat 1740gcatcgcagg cagcctctac ggacgaatat aaggatagac aaaaggagtt ggaaggcatt 1800gccaatccaa taatgacgaa attttacggt gctggtgccg gcgcaggtcc tggagcgggg 1860gaatccggtg gattccccgg atccatgccc aactcgggtg ctacgggagg tggagaagat 1920acaggtccaa cagtggaaga ggttgattga 195019642PRTSaccharomyces cerevisiae 19Met Ser Lys Ala Val Gly Ile Asp Leu Gly Thr Thr Tyr Ser Cys Val1 5 10 15Ala His Phe Ala Asn Asp Arg Val Glu Ile Ile Ala Asn Asp Gln Gly 20 25 30Asn Arg Thr Thr Pro Ser Tyr Val Ala Phe Thr Asp Thr Glu Arg Leu 35 40 45Ile Gly Asp Ala Ala Lys Asn Gln Ala Ala Met Asn Pro His Asn Thr 50 55 60Val Phe Asp Ala Lys Arg Leu Ile Gly Arg Lys Phe Asp Asp Pro Glu65 70 75 80Val Thr Asn Asp Ala Lys His Tyr Pro Phe Lys Val Ile Asp Lys Gly 85 90 95Gly Lys Pro Val Val Gln Val Glu Tyr Lys Gly Glu Thr Lys Thr Phe 100 105 110Thr Pro Glu Glu Ile Ser Ser Met Ile Leu Thr Lys Met Lys Glu Thr 115 120 125Ala Glu Asn Phe Leu Gly Thr Glu Val Lys Asp Ala Val Val Thr Val 130 135 140Pro Ala Tyr Phe Asn Asp Ser Gln Arg Gln Ala Thr Lys Asp Ala Gly145 150 155 160Thr Ile Ala Gly Leu Asn Val Leu Arg Ile Ile Asn Glu Pro Thr Ala 165 170 175Ala Ala Ile Ala Tyr Gly Leu Asp Lys Lys Ser Gln Lys Glu His Asn 180 185 190Val Leu Ile Phe Asp Leu Gly Gly Gly Thr Phe Asp Val Ser Leu Leu 195 200 205Ser Ile Asp Glu Gly Val Phe Glu Val Lys Ala Thr Ala Gly Asp Thr 210 215 220His Leu Gly Gly Glu Asp Phe Asp Ser Arg Leu Val Asn Phe Leu Ala225 230 235 240Glu Glu Phe Lys Arg Lys Asn Lys Lys Asp Leu Thr Thr Asn Gln Arg 245 250 255Ser Leu Arg Arg Leu Arg Thr Ala Ala Glu Arg Ala Lys Arg Thr Leu 260 265 270Ser Ser Ser Ala Gln Thr Ser Ile Glu Ile Asp Ser Leu Phe Glu Gly 275 280 285Ile Asp Phe Tyr Thr Ser Ile Thr Arg Ala Arg Phe Glu Glu Leu Cys 290 295 300Ala Asp Leu Phe Arg Ser Thr Leu Glu Pro Val Glu Lys Val Leu Ala305 310 315 320Asp Ser Lys Leu Asp Lys Ser Gln Ile Asp Glu Ile Val Leu Val Gly 325 330 335Gly Ser Thr Arg Ile Pro Lys Val Gln Lys Leu Val Ser Asp Phe Phe 340 345 350Asn Gly Lys Glu Pro Asn Arg Ser Ile Asn Pro Asp Glu Ala Val Ala 355 360 365Tyr Gly Ala Ala Val Gln Ala Ala Ile Leu Thr Gly Asp Gln Ser Ser 370 375 380Thr Thr Gln Asp Leu Leu Leu Leu Asp Val Ala Pro Leu Ser Leu Gly385 390 395 400Ile Glu Thr Ala Gly Gly Ile Met Thr Lys Leu Ile Pro Arg Asn Ser 405 410 415Thr Ile Pro Thr Lys Lys Ser Glu Val Phe Ser Thr Tyr Ala Asp Asn 420 425 430Gln Pro Gly Val Leu Ile Gln Val Phe Glu Gly Glu Arg Thr Arg Thr 435 440 445Lys Asp Asn Asn Leu Leu Gly Lys Phe Glu Leu Ser Gly Ile Pro Pro 450 455 460Ala Pro Arg Gly Val Pro Gln Ile Glu Val Thr Phe Asp Ile Asp Ala465 470 475 480Asn Gly Ile Leu Asn Val Ser Ala Val Glu Lys Gly Thr Gly Lys Ser 485 490 495Asn Lys Ile Thr Ile Thr Asn Asp Lys Gly Arg Leu Ser Lys Glu Asp 500 505 510Ile Asp Lys Met Val Ala Glu Ala Glu Lys Phe Lys Ala Glu Asp Glu 515 520 525Gln Glu Ala Gln Arg Val Gln Ala Lys Asn Gln Leu Glu Ser Tyr Ala 530 535 540Phe Thr Leu Lys Asn Ser Val Ser Glu Asn Asn Phe Lys Glu Lys Val545 550 555 560Gly Glu Glu Asp Ala Arg Lys Leu Glu Ala Ala Ala Gln Asp Ala Ile 565 570 575Asn Trp Leu Asp Ala Ser Gln Ala Ala Ser Thr Glu Glu Tyr Lys Glu 580 585 590Arg Gln Lys Glu Leu Glu Gly Val Ala Asn Pro Ile Met Ser Lys Phe 595 600 605Tyr Gly Ala Ala Gly Gly Ala Pro Gly Ala Gly Pro Val Pro Gly Ala 610 615 620Gly Ala Gly Pro Thr Gly Ala Pro Asp Asn Gly Pro Thr Val Glu Glu625 630 635 640Val Asp201929DNASaccharomyces cerevisiae 20atgtcaaaag ctgttggtat tgatttaggt acaacctatt catgtgttgc tcattttgca 60aacgataggg ttgaaattat cgctaacgat caaggtaata gaacgacgcc ttcttatgtg 120gcttttactg acacagaaag gctaattggt gacgctgcga agaatcaagc tgcgatgaac 180ccacataata cagtattcga tgctaagcgt ctgatcggac gtaaattcga tgatccagaa 240gtgacgaacg atgctaagca ttacccattc aaagtgattg acaagggagg taaaccggta 300gtgcaagtgg aatataaagg cgagacaaag acatttactc cagaagaaat ttcctcaatg 360atcttgacaa agatgaagga gactgctgag aactttttag gaacagaagt gaaagatgct 420gtagtaacgg ttccagccta tttcaacgat tcacaaaggc aagcaacaaa agatgccggt 480acaatcgcgg gcttgaacgt tcttcgtatc attaatgaac ctacagctgc cgctattgcg 540tatgggctgg acaagaaatc gcagaaggag cacaacgtct tgatctttga tttaggtggt 600ggtacttttg atgtctctct gctatccata gatgaaggtg tctttgaggt taaggctact 660gctggtgaca ctcacttggg tggtgaagat ttcgatagta ggctggttaa ctttctagcc 720gaggagttca aaagaaaaaa taaaaaggat ctaacaacta accaaaggtc cctaaggagg 780ttaaggaccg ccgctgaaag ggccaagaga actctgtctt cgtctgctca gacatctata 840gaaatagatt cattatttga gggtatcgat ttctatactt ccattacaag ggcaagattt 900gaagaattat gtgctgattt gtttagatct acattggagc cagtggaaaa agttttggct 960gattcaaaat tagataagtc acaaattgat gaaattgtac ttgttggtgg ttcaacaaga 1020attccaaaag tacaaaaact ggtttctgat tttttcaatg gtaaagaacc aaaccgttcg 1080attaaccctg atgaggccgt cgcttatggt gctgccgtac aggctgccat cttaacgggt 1140gaccagtcgt cgacgaccca agatttactg ttgctggatg ttgcaccatt atctctaggt 1200attgaaactg caggtggtat tatgacaaag ttgatcccaa gaaattcgac tatcccaaca 1260aaaaaatcgg aagtgttttc cacctacgct gacaaccaac ctggtgtgtt gatacaagtt 1320tttgagggtg aaaggacaag gacaaaagac aacaatctac tgggtaaatt tgagttgagc 1380ggtattccac ccgctccaag aggcgtacca caaattgaag ttacatttga tatcgatgca 1440aatggtattc tgaacgtatc tgccgttgaa aaaggtactg gtaaatctaa caagattaca 1500attactaacg ataagggaag attatcgaag gaagatatcg ataaaatggt tgctgaggca 1560gaaaagttca aggccgaaga tgaacaagaa gctcaacgtg ttcaagctaa gaatcagcta 1620gaatcgtacg cgtttacttt gaaaaattct gtgagcgaaa ataacttcaa ggagaaggtg 1680ggtgaagagg atgccaggaa attggaagcc gccgcccaag atgctataaa ttggttagat 1740gcttcgcaag cggcctccac cgaggaatac aaggaaaggc aaaaggaact agaaggtgtt 1800gcaaacccca ttatgagtaa attttacgga gctgcaggtg gtgccccagg agcaggccca 1860gttccgggtg ctggagcagg ccccactgga gcaccagaca acggcccaac ggttgaagag 1920gttgattag 192921693PRTSaccharomyces cerevisiae 21Met Ser Thr Pro Phe Gly Leu Asp Leu Gly Asn Asn Asn Ser Val Leu1 5 10 15Ala Val Ala Arg Asn Arg Gly Ile Asp Ile Val Val Asn Glu Val Ser 20 25 30Asn Arg Ser Thr Pro Ser Val Val Gly Phe Gly Pro Lys Asn Arg Tyr 35 40 45Leu Gly Glu Thr Gly Lys Asn Lys Gln Thr Ser Asn Ile Lys Asn Thr 50 55 60Val Ala Asn Leu Lys Arg Ile Ile Gly Leu Asp Tyr His His Pro Asp65 70 75 80Phe Glu Gln Glu Ser Lys His Phe Thr Ser Lys Leu Val Glu Leu Asp 85 90 95Asp Lys Lys Thr Gly Ala Glu Val Arg Phe Ala Gly Glu Lys His Val 100 105 110Phe Ser Ala Thr Gln Leu Ala Ala Met Phe Ile Asp Lys Val Lys Asp 115 120 125Thr Val Lys Gln Asp Thr Lys Ala Asn Ile Thr Asp Val Cys Ile Ala 130 135 140Val Pro Pro Trp Tyr Thr Glu Glu Gln Arg Tyr Asn Ile Ala Asp Ala145 150 155 160Ala Arg Ile Ala Gly Leu Asn Pro Val Arg Ile Val Asn Asp Val Thr 165 170 175Ala Ala Gly Val Ser Tyr Gly Ile Phe Lys Thr Asp Leu Pro Glu Gly 180 185 190Glu Glu Lys Pro Arg Ile Val Ala Phe Val Asp Ile Gly His Ser Ser 195 200 205Tyr Thr Cys Ser Ile Met Ala Phe Lys Lys Gly Gln Leu Lys Val Leu 210 215 220Gly Thr Ala Cys Asp Lys His Phe Gly Gly Arg Asp Phe Asp Leu Ala225 230 235 240Ile Thr Glu His Phe Ala Asp Glu Phe Lys Thr Lys Tyr Lys Ile Asp 245 250 255Ile Arg Glu Asn Pro Lys Ala Tyr Asn Arg Ile Leu Thr Ala Ala Glu 260 265 270Lys Leu Lys Lys Val Leu Ser Ala Asn Thr Asn Ala Pro Phe Ser Val 275 280 285Glu Ser Val Met Asn Asp Val Asp Val Ser Ser Gln Leu Ser Arg Glu 290 295 300Glu Leu Glu Glu Leu Val Lys Pro Leu Leu Glu Arg Val Thr Glu Pro305 310 315 320Val Thr Lys Ala Leu Ala Gln Ala Lys Leu Ser Ala Glu Glu Val Asp 325 330 335Phe Val Glu Ile Ile Gly Gly Thr Thr Arg Ile Pro Thr Leu Lys Gln 340 345 350Ser Ile Ser Glu Ala Phe Gly Lys Pro Leu Ser Thr Thr Leu Asn Gln 355 360 365Asp Glu Ala Ile Ala Lys Gly Ala Ala Phe Ile Cys Ala Ile His Ser 370 375 380Pro Thr Leu Arg Val Arg Pro Phe Lys Phe Glu Asp Ile His Pro Tyr385 390 395 400Ser Val Ser Tyr Ser Trp Asp Lys Gln Val Glu Asp Glu Asp His Met 405 410 415Glu Val Phe Pro Ala Gly Ser Ser Phe Pro Ser Thr Lys Leu Ile Thr 420 425 430Leu Asn Arg Thr Gly Asp Phe Ser Met Ala Ala Ser Tyr Thr Asp Ile 435 440 445Thr Gln Leu Pro Pro Asn Thr Pro Glu Gln Ile Ala Asn Trp Glu Ile 450 455 460Thr Gly Val Gln Leu Pro Glu Gly Gln Asp Ser Val Pro Val Lys Leu465 470 475 480Lys Leu Arg Cys Asp Pro Ser Gly Leu His Thr Ile Glu Glu Ala Tyr 485 490 495Thr Ile Glu Asp Ile Glu Val Glu Glu Pro Ile Pro Leu Pro Glu Asp 500 505 510Ala Pro Glu Asp Ala Glu Gln Glu Phe Lys Lys Val Thr Lys Thr Val 515 520 525Lys Lys Asp Asp Leu Thr Ile Val Ala His Thr Phe Gly Leu Asp Ala 530 535 540Lys Lys Leu Asn Glu Leu Ile Glu Lys Glu Asn Glu Met Leu Ala Gln545 550 555 560Asp Lys Leu Val Ala Glu Thr Glu Asp Arg Lys Asn Thr Leu Glu Glu 565 570 575Tyr Ile Tyr Thr Leu Arg Gly Lys Leu Glu Glu Glu Tyr Ala Pro Phe 580 585 590Ala Ser Asp Ala Glu Lys Thr Lys Leu Gln Gly Met Leu Asn Lys Ala 595 600 605Glu Glu Trp Leu Tyr Asp Glu Gly Phe Asp Ser Ile Lys Ala Lys Tyr 610 615 620Ile Ala Lys Tyr Glu Glu Leu Ala Ser Leu Gly Asn Ile Ile Arg Gly625 630 635 640Arg Tyr Leu Ala Lys Glu Glu Glu Lys Lys Gln Ala Ile Arg Ser Lys 645 650 655Gln Glu Ala Ser Gln Met Ala Ala Met Ala Glu Lys Leu Ala Ala Gln 660 665 670Arg Lys Ala Glu Ala Glu Lys Lys Glu Glu Lys Lys Asp Thr Glu Gly 675 680 685Asp Val Asp Met Asp 690222082DNASaccharomyces cerevisiae 22atgagtactc catttggttt agatttaggt aacaataact ctgtccttgc cgttgctaga 60aacagaggta tcgacattgt cgttaatgaa gtctctaacc gttccacccc atctgttgtt 120ggttttggtc caaagaacag atacttgggt gaaactggta agaacaagca gacttccaac 180atcaagaaca ctgtcgccaa cttgaaaaga attattggtt tggattacca ccatccagat 240ttcgagcaag aatctaagca cttcacctct aagttggttg aattggatga caagaagact 300ggtgccgaag ttagattcgc tggtgagaaa catgtttttt cagctactca actagctgcc 360atgttcatcg acaaagtcaa ggacaccgtc aagcaggaca caaaggcaaa tattaccgat 420gtttgtattg ctgtcccacc ttggtacacc gaagaacaac gttacaacat tgctgatgct 480gctagaattg ctggtttgaa ccctgttaga attgtcaacg acgttactgc tgccggtgtt 540tcttacggta tcttcaagac tgatttgcct gaaggcgaag aaaagccaag aattgttgcc 600tttgttgata ttggtcactc ttcctacacc tgttctatca tggccttcaa gaagggtcaa 660ttgaaagtct taggaactgc ctgcgacaag cattttggtg gtagggactt cgatttggct 720ataacagaac atttcgccga tgagttcaaa actaaataca agattgacat cagagaaaat 780ccaaaggctt acaacagaat tctaactgct gctgaaaagt tgaagaaagt tttgtctgct 840aatactaatg ccccattctc tgttgaatcc gtcatgaacg acgttgatgt ttcctctcaa 900ttatctcgtg aagaattaga agaattggtc aagccattgt tggaacgtgt tactgaacca 960gttaccaaag ctttagctca agccaaatta tctgctgaag aagttgattt tgttgaaatt 1020attggtggta ctactcgtat cccaacattg aaacaatcca tttctgaagc cttcggcaag 1080ccattgtcca ccactttgaa ccaagatgaa gccatcgcca agggtgccgc ctttatttgc 1140gccattcact ctccaactct aagagttaga ccattcaagt ttgaggatat ccatccttac 1200tctgtctctt actcttggga caagcaagtt gaggacgaag accacatgga agttttccca 1260gctggttcat ccttcccatc tactaaattg atcactttga accgtacggg tgacttttca 1320atggctgcta gctacactga catcacacag ttaccaccaa acactccaga acaaatcgct 1380aactgggaga tcactggtgt tcaattacca gaaggtcaag actctgttcc tgttaagtta 1440aagttgagat gcgacccctc tggtttacac acaattgaag aggcttacac tattgaagat 1500attgaagttg aagaacctat tccattacca gaagatgctc cagaagatgc tgagcaagaa 1560tttaagaagg ttactaaaac tgtaaagaag gatgacttaa ccatcgttgc acacaccttt 1620ggcctagacg ctaaaaagtt gaatgaatta attgaaaaag aaaatgaaat gcttgctcaa 1680gataagctag ttgctgagac agaagaccgt aagaacactc ttgaagagta catctacaca 1740ttgcgtggta agttggaaga agagtatgct ccatttgctt ccgatgctga aaagacgaag 1800ttacaaggta tgttaaacaa ggccgaagag tggttatacg atgaaggttt cgattccatc 1860aaagctaagt acattgccaa atacgaagaa ttggcttctc taggtaacat tattagaggt 1920agatacttgg ctaaagaaga agaaaagaag caagctataa gatctaagca agaagcatcc 1980caaatggctg ctatggctga aaagttggct gctcaaagaa aggcagaagc tgaaaagaag 2040gaagaaaaga aggacactga aggtgatgtt gacatggact aa 208223693PRTSaccharomyces cerevisiae 23Met Ser Thr Pro Phe Gly Leu Asp Leu Gly Asn Asn Asn Ser Val Leu1 5 10 15Ala Val Ala Arg Asn Arg Gly Ile Asp Val Val Val Asn Glu Val Ser 20 25 30Asn Arg Ser Thr Pro Ser Leu Val Gly Phe Gly Pro Arg Asn Arg Tyr 35 40 45Leu Gly Glu Ser Gly Lys Thr Lys Gln Thr Ser Asn Val Lys Asn Thr 50 55 60Val Glu Asn Leu Lys Arg Ile Ile Gly Leu Lys Phe Lys Asp Pro Glu65 70 75 80Phe Asp Ile Glu Asn Lys Phe Phe Thr Ser Lys Leu Val Gln Leu Lys 85 90 95Asn Gly Lys Val Gly Val Glu Val Glu Phe Gly Gly Lys Thr His Val 100 105 110Phe Ser Ala Thr Gln Leu Thr Ala Met Phe Ile Asp Lys Val Lys His 115 120 125Thr Val Gln Glu Glu Thr Lys Ser Ser Ile Thr Asp Val Cys Leu Ala 130 135 140Val Pro Val Trp Tyr Ser Glu Glu Gln Arg Tyr Asn Ile Ala Asp Ala145 150 155

160Ala Arg Ile Ala Gly Leu Asn Pro Val Arg Ile Val Asn Asp Val Thr 165 170 175Ala Ala Ala Val Ser Tyr Gly Val Phe Lys Asn Asp Leu Pro Gly Pro 180 185 190Glu Glu Lys Pro Arg Ile Ile Gly Leu Val Asp Ile Gly His Ser Thr 195 200 205Tyr Thr Cys Ser Ile Met Ala Phe Arg Lys Gly Glu Met Lys Val Leu 210 215 220Gly Thr Ala Tyr Asp Lys His Phe Gly Gly Arg Asp Phe Asp Arg Ala225 230 235 240Ile Thr Glu His Phe Ala Asp Gln Phe Lys Asp Lys Tyr Lys Ile Asp 245 250 255Ile Arg Lys Asn Pro Lys Ala Tyr Asn Arg Ile Leu Ile Ala Ala Glu 260 265 270Lys Leu Lys Lys Val Leu Ser Ala Asn Thr Thr Ala Pro Phe Ser Val 275 280 285Glu Ser Val Met Asp Asp Ile Asp Val Ser Ser Gln Leu Ser Arg Glu 290 295 300Glu Leu Glu Glu Leu Val Glu Pro Leu Leu Lys Arg Val Thr Tyr Pro305 310 315 320Ile Thr Asn Ala Leu Ala Gln Ala Lys Leu Thr Val Asn Asp Ile Asp 325 330 335Phe Val Glu Ile Ile Gly Gly Thr Thr Arg Ile Pro Val Leu Lys Lys 340 345 350Ser Ile Ser Asp Val Phe Gly Lys Pro Leu Ser Ser Thr Leu Asn Gln 355 360 365Asp Glu Ala Val Ala Lys Gly Ala Ala Phe Ile Cys Ala Ile His Ser 370 375 380Pro Thr Leu Arg Val Arg Pro Phe Lys Phe Glu Asp Ile Asp Pro Tyr385 390 395 400Ser Val Ser Tyr Thr Trp Asp Lys Gln Val Asp Asp Glu Asp Arg Leu 405 410 415Glu Val Phe Pro Ala Asn Ser Ser Tyr Pro Ser Thr Lys Leu Ile Thr 420 425 430Leu His Arg Thr Gly Asp Phe Ser Met Lys Ala Val Tyr Thr His Pro 435 440 445Ser Lys Leu Pro Lys Gly Thr Ser Thr Thr Ile Ala Lys Trp Ser Phe 450 455 460Thr Gly Val Lys Val Pro Lys Asp Gln Asp Phe Ile Pro Val Lys Val465 470 475 480Lys Leu Arg Cys Asp Pro Ser Gly Leu His Ile Ile Glu Asn Ala Tyr 485 490 495Thr Thr Glu Asp Ile Thr Val Gln Glu Pro Val Pro Leu Pro Glu Asp 500 505 510Ala Pro Glu Asp Ala Glu Pro Gln Phe Lys Glu Val Thr Lys Thr Ile 515 520 525Lys Lys Asp Val Leu Gly Met Thr Ala Lys Thr Phe Ala Leu Asn Pro 530 535 540Val Glu Leu Asn Asp Leu Ile Glu Lys Glu Asn Glu Leu Arg Asn Gln545 550 555 560Asp Lys Leu Val Ala Glu Thr Glu Asp Arg Lys Asn Ala Leu Glu Glu 565 570 575Tyr Ile Tyr Thr Leu Arg Ala Lys Leu Asp Asp Glu Tyr Ser Asp Phe 580 585 590Ala Ser Asp Ala Glu Lys Glu Lys Leu Lys Asn Met Leu Ala Thr Thr 595 600 605Glu Asn Trp Leu Tyr Gly Asp Gly Asp Asp Ser Thr Lys Ala Lys Tyr 610 615 620Ile Ala Lys Tyr Glu Glu Leu Ala Ser Leu Gly Asn Ile Ile Arg Gly625 630 635 640Arg Tyr Leu Ala Lys Glu Glu Glu Lys Arg Gln Ala Leu Arg Ala Asn 645 650 655Gln Glu Thr Ser Lys Met Asn Asp Ile Ala Glu Lys Leu Ala Glu Gln 660 665 670Arg Arg Ala Arg Ala Ala Ser Asp Asp Ser Asp Asp Asn Asn Asp Glu 675 680 685Asn Met Asp Leu Asp 690242082DNASaccharomyces cerevisiae 24atgagcactc catttggctt agatttaggt aacaataact cagtactagc agttgccaga 60aataggggta ttgatgtcgt tgtcaatgaa gtttctaata ggtctacacc atccttggtc 120ggctttggcc ccagaaatag gtacttaggt gaatctggta aaactaagca aacatcgaat 180gttaaaaaca ctgtggaaaa cttgaaaaga atcattggac taaagttcaa agaccctgaa 240tttgatatcg agaataagtt cttcacttcg aaattggtac agctaaaaaa tggtaaagtt 300ggtgtggaag tggagttcgg cggtaaaaca cacgtatttt cagctactca actgactgct 360atgttcattg ataaggtgaa gcacaccgtt caagaggaaa cgaagtcatc aattaccgat 420gtctgcctcg cagttcctgt atggtattcg gaagaacaac gttataacat agccgatgct 480gccagaattg caggattaaa tcctgtaagg attgtcaacg atgtgactgc agccgccgtt 540tcgtacggcg tcttcaagaa tgatctgcca ggtcctgaag aaaagccaag aatcattggc 600ttagtggaca ttgggcattc tacctacacc tgttctatta tggctttccg caaaggcgaa 660atgaaagtat taggtactgc ttatgacaag cactttggtg gtagagattt cgatcgcgca 720atcacagaac attttgctga tcagtttaag gacaagtaca agattgacat taggaaaaat 780ccgaaagctt ataacagaat tttaatcgct gctgaaaaat taaaaaaagt gctttctgcg 840aacactactg cccccttctc cgttgaatct gttatggatg atatcgacgt ttcctctcaa 900ttgagccgtg aagagctgga agaattagta gagcccttgt tgaagcgtgt gacgtatcca 960atcaccaatg cattggctca agctaaatta actgtcaatg atattgactt cgtagaaata 1020attggtggta caacccgtat cccagtttta aagaagtcaa tttctgatgt ttttggaaaa 1080cctttgtcat ctactttaaa tcaagacgaa gctgtggcca agggggccgc tttcatatgt 1140gccattcact ctccaacttt aagggtcagg ccgtttaaat ttgaagatat tgatccgtat 1200tcagtgtcat acacttggga taagcaggtc gatgacgaag accgtttgga agtattccct 1260gctaattcat catatccatc aactaaacta attactttac atcgtactgg agatttcagc 1320atgaaagcgg tgtacactca tccttcgaaa ctgccaaaag gtacttccac cactattgca 1380aaatggagct tcactggggt caaggttcct aaagatcaag attttattcc tgtaaaggtc 1440aagttaagat gcgatccttc cggcttgcat attatcgaga acgcttacac aacggaagat 1500attacggttc aagagccagt gcctttaccg gaagacgcac cagaagatgc cgagccccag 1560tttaaagaag ttactaaaac aattaagaaa gatgtgctag gtatgactgc aaaaacattc 1620gcgctaaacc cggttgagtt gaacgatcta attgaaaaag agaatgaatt aagaaaccag 1680gataagttag ttgccgaaac cgaggatcgc aaaaatgccc ttgaagagta tatttatacc 1740cttcgtgcca aactcgatga tgaatactcc gattttgcgt ctgacgcaga aaaagaaaag 1800ctaaaaaaca tgttagccac tactgaaaat tggttatatg gtgatggtga cgattctacc 1860aaggcaaaat acattgctaa atatgaggag ctggcatcgt tggggaatat tattagaggt 1920agatatttag caaaggagga agaaaaaaga caagcactca gagcgaatca agaaacttct 1980aaaatgaatg atattgctga aaaattggct gagcaaagaa gggcacgcgc tgcaagtgat 2040gatagcgatg acaacaatga tgaaaacatg gaccttgatt aa 208225613PRTSaccharomyces cerevisiae 25Met Ala Glu Gly Val Phe Gln Gly Ala Ile Gly Ile Asp Leu Gly Thr1 5 10 15Thr Tyr Ser Cys Val Ala Thr Tyr Glu Ser Ser Val Glu Ile Ile Ala 20 25 30Asn Glu Gln Gly Asn Arg Val Thr Pro Ser Phe Val Ala Phe Thr Pro 35 40 45Glu Glu Arg Leu Ile Gly Asp Ala Ala Lys Asn Gln Ala Ala Leu Asn 50 55 60Pro Arg Asn Thr Val Phe Asp Ala Lys Arg Leu Ile Gly Arg Arg Phe65 70 75 80Asp Asp Glu Ser Val Gln Lys Asp Met Lys Thr Trp Pro Phe Lys Val 85 90 95Ile Asp Val Asp Gly Asn Pro Val Ile Glu Val Gln Tyr Leu Glu Glu 100 105 110Thr Lys Thr Phe Ser Pro Gln Glu Ile Ser Ala Met Val Leu Thr Lys 115 120 125Met Lys Glu Ile Ala Glu Ala Lys Ile Gly Lys Lys Val Glu Lys Ala 130 135 140Val Ile Thr Val Pro Ala Tyr Phe Asn Asp Ala Gln Arg Gln Ala Thr145 150 155 160Lys Asp Ala Gly Ala Ile Ser Gly Leu Asn Val Leu Arg Ile Ile Asn 165 170 175Glu Pro Thr Ala Ala Ala Ile Ala Tyr Gly Leu Gly Ala Gly Lys Ser 180 185 190Glu Lys Glu Arg His Val Leu Ile Phe Asp Leu Gly Gly Gly Thr Phe 195 200 205Asp Val Ser Leu Leu His Ile Ala Gly Gly Val Tyr Thr Val Lys Ser 210 215 220Thr Ser Gly Asn Thr His Leu Gly Gly Gln Asp Phe Asp Thr Asn Leu225 230 235 240Leu Glu His Phe Lys Ala Glu Phe Lys Lys Lys Thr Gly Leu Asp Ile 245 250 255Ser Asp Asp Ala Arg Ala Leu Arg Arg Leu Arg Thr Ala Ala Glu Arg 260 265 270Ala Lys Arg Thr Leu Ser Ser Val Thr Gln Thr Thr Val Glu Val Asp 275 280 285Ser Leu Phe Asp Gly Glu Asp Phe Glu Ser Ser Leu Thr Arg Ala Arg 290 295 300Phe Glu Asp Leu Asn Ala Ala Leu Phe Lys Ser Thr Leu Glu Pro Val305 310 315 320Glu Gln Val Leu Lys Asp Ala Lys Ile Ser Lys Ser Gln Ile Asp Glu 325 330 335Val Val Leu Val Gly Gly Ser Thr Arg Ile Pro Lys Val Gln Lys Leu 340 345 350Leu Ser Asp Phe Phe Asp Gly Lys Gln Leu Glu Lys Ser Ile Asn Pro 355 360 365Asp Glu Ala Val Ala Tyr Gly Ala Ala Val Gln Gly Ala Ile Leu Thr 370 375 380Gly Gln Ser Thr Ser Asp Glu Thr Lys Asp Leu Leu Leu Leu Asp Val385 390 395 400Ala Pro Leu Ser Leu Gly Val Gly Met Gln Gly Asp Met Phe Gly Ile 405 410 415Val Val Pro Arg Asn Thr Thr Val Pro Thr Ile Lys Arg Arg Thr Phe 420 425 430Thr Thr Cys Ala Asp Asn Gln Thr Thr Val Gln Phe Pro Val Tyr Gln 435 440 445Gly Glu Arg Val Asn Cys Lys Glu Asn Thr Leu Leu Gly Glu Phe Asp 450 455 460Leu Lys Asn Ile Pro Met Met Pro Ala Gly Glu Pro Val Leu Glu Ala465 470 475 480Ile Phe Glu Val Asp Ala Asn Gly Ile Leu Lys Val Thr Ala Val Glu 485 490 495Lys Ser Thr Gly Lys Ser Ser Asn Ile Thr Ile Ser Asn Ala Val Gly 500 505 510Arg Leu Ser Ser Glu Glu Ile Glu Lys Met Val Asn Gln Ala Glu Glu 515 520 525Phe Lys Ala Ala Asp Glu Ala Phe Ala Lys Lys His Glu Ala Arg Gln 530 535 540Arg Leu Glu Ser Tyr Val Ala Ser Ile Glu Gln Thr Val Thr Asp Pro545 550 555 560Val Leu Ser Ser Lys Leu Lys Arg Gly Ser Lys Ser Lys Ile Glu Ala 565 570 575Ala Leu Ser Asp Ala Leu Ala Ala Leu Gln Ile Glu Asp Pro Ser Ala 580 585 590Asp Glu Leu Arg Lys Ala Glu Val Gly Leu Lys Arg Val Val Thr Lys 595 600 605Ala Met Ser Ser Arg 610261842DNASaccharomyces cerevisiae 26atggctgaag gtgttttcca aggtgctatc ggtatcgatt taggtacaac ctactcttgt 60gttgctactt acgaatcctc cgttgaaatt attgccaacg aacaaggtaa cagagtcacc 120ccatctttcg ttgctttcac tccagaagaa agattgattg gtgatgctgc caagaaccaa 180gctgctttga acccaagaaa cactgtcttc gatgctaagc gtttgattgg tagaagattc 240gacgacgaat ctgttcaaaa ggacatgaag acctggcctt tcaaggttat cgacgtcgat 300ggtaacccag tcatcgaagt ccaatacttg gaagaaacca agactttctc cccacaagaa 360atttccgcta tggttttgac caagatgaag gaaattgctg aagctaagat tggtaagaag 420gttgaaaagg ccgtcattac tgtcccagct tactttaacg acgctcaaag acaagctacc 480aaggatgccg gtgccatttc tggtttgaac gttttgcgta tcatcaacga acctactgcc 540gctgctattg cttacggtct aggtgctggt aagtccgaaa aggaaagaca tgttttgatt 600ttcgatttgg gtggtggtac tttcgatgtt tccttgttgc acattgctgg tggtgtttac 660actgttaaat ctacttccgg taacactcac ttgggtggtc aagatttcga caccaacttg 720ttggaacact tcaaggctga attcaagaag aagactggtt tggacatctc cgacgatgcc 780agagctttga gaagattgag aactgctgct gaaagagcta agagaacctt atcttctgtc 840actcaaacta ccgttgaagt tgactctttg tttgacggtg aagatttcga atcctctttg 900actagagcta gatttgaaga cttgaacgcc gcattgttca agtctacttt ggaacctgtt 960gaacaagttt tgaaggatgc taagatctct aagtctcaaa tcgacgaagt tgtcttggtt 1020ggtggttcca ccagaattcc aaaggtccaa aagttgttgt ctgacttctt tgacggtaag 1080caattggaaa aatctattaa cccagatgaa gctgttgctt acggtgctgc tgttcaaggt 1140gctatcttga ccggccaatc cacatctgac gaaaccaagg acttgttgtt gttagatgtt 1200gctccattat ctctaggtgt tggtatgcaa ggtgacatgt tcggtatcgt tgttccaaga 1260aacactactg ttccaaccat caagagaaga acctttacta catgtgctga caaccaaacc 1320accgttcaat tcccagtcta ccaaggtgaa cgtgttaact gtaaagaaaa cactttgttg 1380ggtgaattcg acttgaagaa catcccaatg atgccagctg gtgaaccagt cttggaagct 1440atcttcgaag ttgatgctaa cggtatcttg aaggttactg ccgtcgaaaa gtctaccggt 1500aagtcttcta acatcactat ctctaacgct gttggtagat tgtcttctga agaaattgaa 1560aagatggtta accaagctga agagttcaag gctgccgatg aagcttttgc caagaagcac 1620gaagctagac aaagattgga atcctacgtt gcctccatcg aacaaactgt cactgaccca 1680gtcttgtctt ctaaattgaa gagaggttcc aagtccaaga ttgaagctgc tttgtccgat 1740gctttggctg ctttgcaaat cgaagaccca tctgctgatg aattgagaaa ggctgaagtt 1800ggtttgaaga gagttgtcac caaggccatg tcttctcgtt aa 184227613PRTSaccharomyces cerevisiae 27Met Ala Glu Gly Val Phe Gln Gly Ala Ile Gly Ile Asp Leu Gly Thr1 5 10 15Thr Tyr Ser Cys Val Ala Thr Tyr Glu Ser Ser Val Glu Ile Ile Ala 20 25 30Asn Glu Gln Gly Asn Arg Val Thr Pro Ser Phe Val Ala Phe Thr Pro 35 40 45Gln Glu Arg Leu Ile Gly Asp Ala Ala Lys Asn Gln Ala Ala Leu Asn 50 55 60Pro Arg Asn Thr Val Phe Asp Ala Lys Arg Leu Ile Gly Arg Arg Phe65 70 75 80Asp Asp Glu Ser Val Gln Lys Asp Met Lys Thr Trp Pro Phe Lys Val 85 90 95Ile Asp Val Asp Gly Asn Pro Val Ile Glu Val Gln Tyr Leu Glu Glu 100 105 110Thr Lys Thr Phe Ser Pro Gln Glu Ile Ser Ala Met Val Leu Thr Lys 115 120 125Met Lys Glu Ile Ala Glu Ala Lys Ile Gly Lys Lys Val Glu Lys Ala 130 135 140Val Ile Thr Val Pro Ala Tyr Phe Asn Asp Ala Gln Arg Gln Ala Thr145 150 155 160Lys Asp Ala Gly Ala Ile Ser Gly Leu Asn Val Leu Arg Ile Ile Asn 165 170 175Glu Pro Thr Ala Ala Ala Ile Ala Tyr Gly Leu Gly Ala Gly Lys Ser 180 185 190Glu Lys Glu Arg His Val Leu Ile Phe Asp Leu Gly Gly Gly Thr Phe 195 200 205Asp Val Ser Leu Leu His Ile Ala Gly Gly Val Tyr Thr Val Lys Ser 210 215 220Thr Ser Gly Asn Thr His Leu Gly Gly Gln Asp Phe Asp Thr Asn Leu225 230 235 240Leu Glu His Phe Lys Ala Glu Phe Lys Lys Lys Thr Gly Leu Asp Ile 245 250 255Ser Asp Asp Ala Arg Ala Leu Arg Arg Leu Arg Thr Ala Ala Glu Arg 260 265 270Ala Lys Arg Thr Leu Ser Ser Val Thr Gln Thr Thr Val Glu Val Asp 275 280 285Ser Leu Phe Asp Gly Glu Asp Phe Glu Ser Ser Leu Thr Arg Ala Arg 290 295 300Phe Glu Asp Leu Asn Ala Ala Leu Phe Lys Ser Thr Leu Glu Pro Val305 310 315 320Glu Gln Val Leu Lys Asp Ala Lys Ile Ser Lys Ser Gln Ile Asp Glu 325 330 335Val Val Leu Val Gly Gly Ser Thr Arg Ile Pro Lys Val Gln Lys Leu 340 345 350Leu Ser Asp Phe Phe Asp Gly Lys Gln Leu Glu Lys Ser Ile Asn Pro 355 360 365Asp Glu Ala Val Ala Tyr Gly Ala Ala Val Gln Gly Ala Ile Leu Thr 370 375 380Gly Gln Ser Thr Ser Asp Glu Thr Lys Asp Leu Leu Leu Leu Asp Val385 390 395 400Ala Pro Leu Ser Leu Gly Val Gly Met Gln Gly Asp Ile Phe Gly Ile 405 410 415Val Val Pro Arg Asn Thr Thr Val Pro Thr Ile Lys Arg Arg Thr Phe 420 425 430Thr Thr Val Ser Asp Asn Gln Thr Thr Val Gln Phe Pro Val Tyr Gln 435 440 445Gly Glu Arg Val Asn Cys Lys Glu Asn Thr Leu Leu Gly Glu Phe Asp 450 455 460Leu Lys Asn Ile Pro Met Met Pro Ala Gly Glu Pro Val Leu Glu Ala465 470 475 480Ile Phe Glu Val Asp Ala Asn Gly Ile Leu Lys Val Thr Ala Val Glu 485 490 495Lys Ser Thr Gly Lys Ser Ser Asn Ile Thr Ile Ser Asn Ala Val Gly 500 505 510Arg Leu Ser Ser Glu Glu Ile Glu Lys Met Val Asn Gln Ala Glu Glu 515 520 525Phe Lys Ala Ala Asp Glu Ala Phe Ala Lys Lys His Glu Ala Arg Gln 530 535 540Arg Leu Glu Ser Tyr Val Ala Ser Ile Glu Gln Thr Val Thr Asp Pro545 550 555 560Val Leu Ser Ser Lys Leu Lys Arg Gly Ser Lys Ser Lys Ile Glu Ala 565 570 575Ala Leu Ser Asp Ala Leu Ala Ala Leu Gln Ile Glu Asp Pro Ser Ala 580 585 590Asp Glu Leu Arg Lys Ala Glu Val Gly Leu Lys Arg Val Val Thr Lys 595 600 605Ala Met Ser Ser Arg 610281842DNASaccharomyces cerevisiae 28atggctgaag gtgttttcca aggtgctatc ggtatcgatt taggtacaac atactcttgt 60gttgctactt atgaatcttc cgttgaaatt attgccaacg aacaaggtaa cagagttact 120ccatctttcg ttgccttcac cccacaggaa agattgatcg gtgatgctgc caagaaccaa 180gctgctttga acccaagaaa cactgttttt gatgctaagc gtttgattgg tagaagattc

240gacgacgagt ctgtccaaaa ggacatgaag acctggcctt tcaaggttat cgacgtcgat 300ggtaacccag tcattgaagt ccaatacttg gaagaaacca agactttctc cccacaagaa 360atttccgcta tggtcttgac caagatgaag gaaattgctg aagctaagat tggtaagaag 420gttgaaaagg ctgtcattac tgtcccagct tactttaacg atgcccaaag acaagctacc 480aaggatgccg gtgccatttc tggtttgaac gttttgcgta tcatcaacga acctactgcc 540gctgctattg cttacggtct aggtgctggt aagtccgaaa aggaaagaca tgttttgatt 600ttcgatttgg gtggtggtac tttcgatgtt tccttgttgc acattgctgg tggtgtttac 660actgttaaat ctacttccgg taacactcac ttgggtggtc aagatttcga caccaacttg 720ttggaacact tcaaggctga attcaagaag aagactggtt tggacatctc cgacgatgcc 780agagctttga gaagattgag aactgctgct gaaagagcta agagaacctt atcttctgtc 840actcaaacta ccgttgaagt tgactctttg tttgacggtg aagatttcga atcctctttg 900actagagcta gatttgaaga cttgaacgcc gcattgttca agtctacttt ggaacctgtt 960gaacaagttt tgaaggatgc taagatctct aagtctcaaa tcgacgaagt tgtcttggtt 1020ggtggttcta ccagaattcc aaaggtccaa aagttgttgt ctgacttctt tgacggtaag 1080caattggaaa aatctattaa cccagatgaa gctgttgctt acggtgctgc tgttcaaggt 1140gctatcttga ctggccaatc cacatctgac gaaaccaagg acttgttgtt gttagatgtt 1200gctccattat ctctaggtgt tggtatgcaa ggtgacattt tcggtattgt tgtcccaaga 1260aacacaactg ttccaaccat caagagaaga accttcacaa ctgtcagtga caaccaaacc 1320accgttcaat tcccagtcta ccaaggtgaa cgtgtcaact gtaaagaaaa cactttgttg 1380ggtgaattcg acttgaagaa catcccaatg atgccagctg gtgaaccagt cttggaagct 1440atcttcgaag ttgatgctaa cggtatcttg aaggttactg ccgtcgaaaa gtctaccggt 1500aagtcttcta acatcactat ctccaacgct gtcggtagat tgtcttctga agaaattgaa 1560aagatggtta accaagccga agagttcaag gctgctgatg aagcttttgc taagaagcac 1620gaagctagac aaagactaga atcctacgtc gcttccatcg aacaaaccgt cactgaccca 1680gtcttgtctt ctaaattgaa gagaggttcc aagtccaaga tcgaagctgc tttgtccgat 1740gctttggctg ctttgcaaat cgaagaccca tccgctgatg agttgagaaa ggcagaagtt 1800ggtttgaaga gagttgtcac caaggccatg tcttctcgtt aa 184229644PRTSaccharomyces cerevisiae 29Met Leu Pro Ser Trp Lys Ala Phe Lys Ala His Asn Ile Leu Arg Ile1 5 10 15Leu Thr Arg Phe Gln Ser Thr Lys Ile Pro Asp Ala Val Ile Gly Ile 20 25 30Asp Leu Gly Thr Thr Asn Ser Ala Val Ala Ile Met Glu Gly Lys Val 35 40 45Pro Arg Ile Ile Glu Asn Ala Glu Gly Ser Arg Thr Thr Pro Ser Val 50 55 60Val Ala Phe Thr Lys Asp Gly Glu Arg Leu Val Gly Glu Pro Ala Lys65 70 75 80Arg Gln Ser Val Ile Asn Ser Glu Asn Thr Leu Phe Ala Thr Lys Arg 85 90 95Leu Ile Gly Arg Arg Phe Glu Asp Ala Glu Val Gln Arg Asp Ile Asn 100 105 110Gln Val Pro Phe Lys Ile Val Lys His Ser Asn Gly Asp Ala Trp Val 115 120 125Glu Ala Arg Asn Arg Thr Tyr Ser Pro Ala Gln Ile Gly Gly Phe Ile 130 135 140Leu Asn Lys Met Lys Glu Thr Ala Glu Ala Tyr Leu Ala Lys Ser Val145 150 155 160Lys Asn Ala Val Val Thr Val Pro Ala Tyr Phe Asn Asp Ala Gln Arg 165 170 175Gln Ala Thr Lys Asp Ala Gly Gln Ile Ile Gly Leu Asn Val Leu Arg 180 185 190Val Val Asn Glu Pro Thr Ala Ala Ala Leu Ala Tyr Gly Leu Asp Lys 195 200 205Ser Glu Pro Lys Val Ile Ala Val Phe Asp Leu Gly Gly Gly Thr Phe 210 215 220Asp Ile Ser Ile Leu Asp Ile Asp Asn Gly Ile Phe Glu Val Lys Ser225 230 235 240Thr Asn Gly Asp Thr His Leu Gly Gly Glu Asp Phe Asp Ile Tyr Leu 245 250 255Leu Gln Glu Ile Ile Ser His Phe Lys Lys Glu Thr Gly Ile Asp Leu 260 265 270Ser Asn Asp Arg Met Ala Val Gln Arg Ile Arg Glu Ala Ala Glu Lys 275 280 285Ala Lys Ile Glu Leu Ser Ser Thr Leu Ser Thr Glu Ile Asn Leu Pro 290 295 300Phe Ile Thr Ala Asp Ala Ala Gly Pro Lys His Ile Arg Met Pro Phe305 310 315 320Ser Arg Val Gln Leu Glu Asn Ile Thr Ala Pro Leu Ile Asp Arg Thr 325 330 335Val Asp Pro Val Lys Lys Ala Leu Lys Asp Ala Arg Ile Thr Ala Ser 340 345 350Asp Ile Ser Asp Val Leu Leu Val Gly Gly Met Ser Arg Met Pro Lys 355 360 365Val Ala Asp Thr Val Lys Lys Leu Phe Gly Lys Asp Ala Ser Lys Ala 370 375 380Val Asn Pro Asp Glu Ala Val Ala Leu Gly Ala Ala Ile Gln Ala Ala385 390 395 400Val Leu Ser Gly Glu Val Thr Asp Val Leu Leu Leu Asp Val Thr Pro 405 410 415Leu Ser Leu Gly Ile Glu Thr Leu Gly Gly Val Phe Thr Lys Leu Ile 420 425 430Pro Arg Asn Ser Thr Ile Pro Asn Lys Lys Ser Gln Ile Phe Ser Thr 435 440 445Ala Ala Ser Gly Gln Thr Ser Val Glu Val Lys Val Phe Gln Gly Glu 450 455 460Arg Glu Leu Val Lys Asp Asn Lys Leu Ile Gly Asn Phe Thr Leu Ala465 470 475 480Gly Ile Pro Pro Ala Pro Lys Gly Thr Pro Gln Ile Glu Val Thr Phe 485 490 495Asp Ile Asp Ala Asn Gly Ile Ile Asn Val Ser Ala Lys Asp Leu Ala 500 505 510Ser His Lys Asp Ser Ser Ile Thr Val Ala Gly Ala Ser Gly Leu Ser 515 520 525Asp Thr Glu Ile Asp Arg Met Val Asn Glu Ala Glu Arg Tyr Lys Asn 530 535 540Gln Asp Arg Ala Arg Arg Asn Ala Ile Glu Thr Ala Asn Lys Ala Asp545 550 555 560Gln Leu Ala Asn Asp Thr Glu Asn Ser Ile Lys Glu Phe Glu Gly Lys 565 570 575Leu Asp Lys Thr Asp Ser Gln Arg Leu Lys Asp Gln Ile Ser Ser Leu 580 585 590Arg Glu Leu Val Ser Arg Ser Gln Ala Gly Asp Glu Val Asn Asp Asp 595 600 605Asp Val Gly Thr Lys Ile Asp Asn Leu Arg Thr Ser Ser Met Lys Leu 610 615 620Phe Glu Gln Leu Tyr Lys Asn Ser Asp Asn Pro Glu Thr Lys Asn Gly625 630 635 640Arg Glu Asn Lys301935DNASaccharomyces cerevisiae 30atgttaccat catggaaagc ctttaaagca cataatatac ttcgtattct gacccgtttc 60cagtcaacca aaattccaga tgcagttatc ggtattgatt taggtactac caattctgcg 120gtagctatta tggaaggtaa agttccgaga attatcgaaa atgcagaagg ctcaagaact 180actccgtctg tagtggcttt cactaaagac ggagaacgtt tagttggtga gccagccaaa 240cgacaatccg tcataaactc agaaaacact ttgtttgcta ctaagcgttt aatcggccgc 300cgtttcgagg acgctgaagt ccaaagagat attaatcagg ttcctttcaa aatcgtcaag 360cattctaatg gagatgcctg ggtagaggct agaaacagaa cgtactcccc cgcccaaata 420ggaggtttta tcttaaataa aatgaaggaa acagcggagg cttacttagc gaagagcgtc 480aaaaatgctg ttgtcaccgt tcctgcttac ttcaatgatg cccaaagaca agctactaaa 540gacgcaggac aaattattgg gcttaatgta ttacgtgttg tcaacgaacc aacagctgct 600gccctagctt acggtctaga taaatcagag ccaaaagtca ttgctgtttt cgacttgggc 660ggtggtactt tcgatatttc aatcctggac atcgataacg gtatctttga ggttaaatct 720accaatggtg acacccattt gggtggcgaa gattttgaca tttatttgtt gcaagaaatt 780atttctcatt tcaagaaaga aaccggtatc gatttgagta atgaccgtat ggctgtccaa 840agaataagag aagccgctga aaaggctaaa atcgaactgt cttctacact ctctacagaa 900ataaacttgc ctttcataac tgctgatgct gcaggcccaa agcatattcg tatgcccttt 960tctagggttc agcttgagaa tataaccgcc ccattgattg atagaacggt tgatcctgtc 1020aaaaaagcac tgaaagacgc aagaattacc gcctcagata tatcggatgt tttattagtt 1080ggtggtatgt caaggatgcc caaggttgca gatactgtaa agaaattatt cggtaaggat 1140gcatcaaaag ctgttaaccc tgatgaagca gtcgctttag gggccgctat acaggctgcg 1200gtcttgtctg gtgaagttac cgatgttttg ttgctagatg tcactcccct atcattgggt 1260attgaaactt taggaggagt ttttacaaaa ttaatcccaa gaaattctac aattcccaat 1320aagaaatctc aaattttttc aactgcggca tcaggtcaaa catcggtgga agttaaagtt 1380ttccaaggtg agagggagtt agtcaaggat aacaaattaa taggtaattt tactcttgcg 1440ggcattcctc cagctccaaa aggtacccca caaattgaag tcacttttga tatcgatgcg 1500aacggcatca tcaacgtttc agcaaaagat ctcgccagcc acaaagactc ttccatcact 1560gttgccggag cgtctgggct atctgatacg gagattgatc gaatggttaa tgaagcggaa 1620agatataaaa atcaggatag agccagaagg aatgccatcg aaaccgctaa caaagctgac 1680cagctagcta atgacacaga aaattccatt aaggaattcg aaggtaagct agataaaact 1740gattctcaaa gactaaaaga tcaaatttca tccttaaggg aattggtttc tcggagtcaa 1800gctggagatg aggttaatga tgacgatgtt ggaacaaaaa ttgacaattt gcgaacttca 1860tcgatgaaac tttttgaaca gttatacaag aacagtgaca atcctgaaac taagaacggg 1920agagaaaata aataa 193531511PRTSaccharomyces cerevisiae 31Met Ala Phe Gln Gln Gly Val Leu Ser Arg Cys Ser Gly Val Phe Arg1 5 10 15His His Val Gly His Ser Arg His Ile Asn Asn Ile Leu Tyr Arg His 20 25 30Ala Ile Ala Phe Ala Ser Ile Ala Pro Arg Ile Pro Lys Ser Ser Phe 35 40 45His Thr Ser Ala Ile Arg Asn Asn Glu Ala Phe Lys Asp Pro Tyr Asp 50 55 60Thr Leu Gly Leu Lys Lys Ser Ala Thr Gly Ala Glu Ile Lys Lys Ala65 70 75 80Tyr Tyr Lys Leu Ala Lys Lys Tyr His Pro Asp Ile Asn Lys Glu Pro 85 90 95Asp Ala Glu Lys Lys Phe His Asp Leu Gln Asn Ala Tyr Glu Ile Leu 100 105 110Ser Asp Glu Thr Lys Arg Gln Gln Tyr Asp Gln Phe Gly Pro Ala Ala 115 120 125Phe Gly Gly Gly Gly Ala Ala Gly Gly Ala Gly Gly Gly Ser Gly Ser 130 135 140Pro Phe Gly Ser Gln Phe His Asp Phe Ser Gly Phe Thr Ser Ala Gly145 150 155 160Gly Ser Pro Phe Gly Gly Ile Asn Phe Glu Asp Leu Phe Gly Ala Ala 165 170 175Phe Gly Gly Gly Gly Arg Gly Ser Gly Gly Ala Ser Arg Ser Ser Ser 180 185 190Met Phe Arg Gln Tyr Arg Gly Asp Pro Ile Glu Ile Val His Lys Val 195 200 205Ser Phe Lys Asp Ala Val Phe Gly Ser Lys Asn Val Gln Leu Arg Phe 210 215 220Ser Ala Leu Asp Pro Cys Ser Thr Cys Ser Gly Thr Gly Met Lys Pro225 230 235 240Asn Thr His Lys Val Ser Cys Ser Thr Cys His Gly Thr Gly Thr Thr 245 250 255Val His Ile Arg Gly Gly Phe Gln Met Met Ser Thr Cys Pro Thr Cys 260 265 270Asn Gly Glu Gly Thr Met Lys Arg Pro Gln Asp Asn Cys Thr Lys Cys 275 280 285His Gly Glu Gly Val Gln Val Asn Arg Ala Lys Thr Ile Thr Val Asp 290 295 300Leu Pro His Gly Leu Gln Asp Gly Asp Val Val Arg Ile Pro Gly Gln305 310 315 320Gly Ser Tyr Pro Asp Ile Ala Val Glu Ala Asp Leu Lys Asp Ser Val 325 330 335Lys Leu Ser Arg Gly Asp Ile Leu Val Arg Ile Arg Val Asp Lys Asp 340 345 350Pro Asn Phe Ser Ile Lys Asn Lys Tyr Asp Ile Trp Tyr Asp Lys Glu 355 360 365Ile Pro Ile Thr Thr Ala Ala Leu Gly Gly Thr Val Thr Ile Pro Thr 370 375 380Val Glu Gly Gln Lys Ile Arg Ile Lys Val Ala Pro Gly Thr Gln Tyr385 390 395 400Asn Gln Val Ile Ser Ile Pro Asn Met Gly Val Pro Lys Thr Ser Thr 405 410 415Ile Arg Gly Asp Met Lys Val Gln Tyr Lys Ile Val Val Lys Lys Pro 420 425 430Gln Ser Leu Ala Glu Lys Cys Leu Trp Glu Ala Leu Ala Asp Val Thr 435 440 445Asn Asp Asp Met Ala Lys Lys Thr Met Gln Pro Gly Thr Ala Ala Gly 450 455 460Thr Ala Ile Asn Glu Glu Ile Leu Lys Lys Gln Lys Gln Glu Glu Glu465 470 475 480Lys His Ala Lys Lys Asp Asp Asp Asn Thr Leu Lys Arg Leu Glu Asn 485 490 495Phe Ile Thr Asn Thr Phe Arg Lys Ile Lys Gly Asp Lys Lys Asn 500 505 510321536DNASaccharomyces cerevisiae 32atggctttcc aacaaggtgt attgtcaagg tgttccggtg tctttagaca ccatgtggga 60cattctcgcc atatcaataa tattctttat agacatgcca tcgcgtttgc atccatcgct 120ccacgaatac caaaatctag cttccatact tctgcaatca gaaacaacga agcattcaag 180gacccgtacg atactttagg cttgaagaaa tctgctacag gtgcggaaat caaaaaagca 240tactacaaac tggcaaagaa gtaccacccg gatatcaaca aggaaccgga tgctgagaag 300aaattccacg atttacagaa cgcttatgaa attctgtcag acgaaacgaa gaggcagcag 360tacgatcaat ttgggcccgc tgccttcggc ggcggcggtg ccgctggagg tgccggtggt 420ggtagtggct ctccctttgg ttcccaattt catgatttct caggattcac cagtgcaggc 480ggctcgccat ttggcggtat caattttgaa gacctgtttg gtgctgcatt tggtggtggt 540ggccgcggta gcggtggcgc aagcaggtcg tcatctatgt tcagacaata taggggcgac 600ccaatcgaga ttgtccataa agtgtctttc aaggacgcag tgtttgggtc caagaacgtt 660cagttaagat tctctgcgct ggacccttgt agtacctgtt cagggacggg aatgaaacca 720aacacgcata aggtcagttg tagcacttgt cacggaacag gaaccactgt tcacattagg 780ggcggatttc agatgatgtc gacttgtcct acttgcaacg gtgaaggtac catgaaacgg 840cctcaggaca attgtaccaa gtgccatggt gagggtgttc aggtcaacag ggcaaagaca 900attacggtgg acttgccaca tggattacag gacggcgacg tggtcaggat ccctggccaa 960ggctcatacc ctgacatcgc tgtagaggcg gacttgaaag attcagtcaa gttatcaaga 1020ggtgatattt tggtgagaat tcgtgtcgac aaggatccca acttttcgat aaagaacaag 1080tacgatattt ggtacgacaa ggagattcct ataaccacag ctgcacttgg tggtactgtc 1140actatcccca ctgtggaggg acaaaagatc aggataaagg tcgctccagg gactcaatac 1200aatcaagtga tatccattcc taacatgggt gttcctaaaa catcaaccat tcgcggtgat 1260atgaaagtcc agtacaagat cgttgttaag aaaccgcaat cgctggcaga aaaatgcttg 1320tgggaggcac tggcagatgt caccaacgat gacatggcca agaaaaccat gcaaccgggc 1380acagccgcgg gtacagccat taatgaagag atactgaaga aacaaaaaca agaagaggaa 1440aaacacgcaa aaaaggatga cgacaacact ttgaagagac tagaaaattt cattaccaac 1500acattcagga agatcaaagg tgacaaaaaa aattaa 153633146PRTSaccharomyces cerevisiae 33Met Val Leu Pro Ile Ile Ile Gly Leu Gly Val Thr Met Val Ala Leu1 5 10 15Ser Val Lys Ser Gly Leu Asn Ala Trp Thr Val Tyr Lys Thr Leu Ser 20 25 30Pro Leu Thr Ile Ala Lys Leu Asn Asn Ile Arg Ile Glu Asn Pro Thr 35 40 45Ala Gly Tyr Arg Asp Ala Leu Lys Phe Lys Ser Ser Leu Ile Asp Glu 50 55 60Glu Leu Lys Asn Arg Leu Asn Gln Tyr Gln Gly Gly Phe Ala Pro Arg65 70 75 80Met Thr Glu Pro Glu Ala Leu Leu Ile Leu Asp Ile Ser Ala Arg Glu 85 90 95Ile Asn His Leu Asp Glu Lys Leu Leu Lys Lys Lys His Arg Lys Ala 100 105 110Met Val Arg Asn His Pro Asp Arg Gly Gly Ser Pro Tyr Met Ala Ala 115 120 125Lys Ile Asn Glu Ala Lys Glu Val Leu Glu Arg Ser Val Leu Leu Arg 130 135 140Lys Arg14534441DNASaccharomyces cerevisiae 34atggttttgc ctataataat tggtttgggc gtgacaatgg ttgctctaag tgtcaagtct 60ggtctcaatg catggaccgt ctacaagacc ctgtcccctt taactattgc aaaactaaat 120aacattcgca tagaaaaccc gacggcgggc taccgcgatg cacttaagtt caaaagctca 180ctgatagacg aagaactgaa aaatagatta aaccagtacc agggaggctt tgcaccgcga 240atgacagagc ccgaagcctt gctcatcttg gatatctccg ccagagagat taatcacttg 300gatgaaaaat tactgaaaaa aaagcacagg aaggctatgg ttcgtaacca cccagacaga 360ggagggagtc cctacatggc ggccaagata aatgaggcga aagaagttct cgaaagaagt 420gttttactaa gaaagagata a 44135563PRTSaccharomyces cerevisiae 35Met Arg Leu Arg Thr Ala Ile Ala Thr Leu Cys Leu Thr Ala Phe Thr1 5 10 15Ser Ala Thr Ser Asn Asn Ser Tyr Ile Ala Thr Asp Gln Thr Gln Asn 20 25 30Ala Phe Asn Asp Thr His Phe Cys Lys Val Asp Arg Asn Asp His Val 35 40 45Ser Pro Ser Cys Asn Val Thr Phe Asn Glu Leu Asn Ala Ile Asn Glu 50 55 60Asn Ile Arg Asp Asp Leu Ser Ala Leu Leu Lys Ser Asp Phe Phe Lys65 70 75 80Tyr Phe Arg Leu Asp Leu Tyr Lys Gln Cys Ser Phe Trp Asp Ala Asn 85 90 95Asp Gly Leu Cys Leu Asn Arg Ala Cys Ser Val Asp Val Val Glu Asp 100 105 110Trp Asp Thr Leu Pro Glu Tyr Trp Gln Pro Glu Ile Leu Gly Ser Phe 115 120 125Asn Asn Asp Thr Met Lys Glu Ala Asp Asp Ser Asp Asp Glu Cys Lys 130 135 140Phe Leu Asp Gln Leu Cys Gln Thr Ser Lys Lys Pro Val Asp Ile Glu145 150 155 160Asp Thr Ile Asn Tyr Cys Asp Val Asn Asp Phe Asn Gly Lys Asn Ala 165 170 175Val Leu Ile Asp Leu Thr Ala Asn Pro Glu Arg Phe Thr Gly Tyr Gly 180 185 190Gly Lys Gln Ala Gly Gln Ile Trp Ser Thr Ile Tyr Gln Asp Asn Cys 195 200 205Phe Thr Ile Gly Glu Thr Gly Glu Ser Leu Ala Lys Asp Ala Phe Tyr 210

215 220Arg Leu Val Ser Gly Phe His Ala Ser Ile Gly Thr His Leu Ser Lys225 230 235 240Glu Tyr Leu Asn Thr Lys Thr Gly Lys Trp Glu Pro Asn Leu Asp Leu 245 250 255Phe Met Ala Arg Ile Gly Asn Phe Pro Asp Arg Val Thr Asn Met Tyr 260 265 270Phe Asn Tyr Ala Val Val Ala Lys Ala Leu Trp Lys Ile Gln Pro Tyr 275 280 285Leu Pro Glu Phe Ser Phe Cys Asp Leu Val Asn Lys Glu Ile Lys Asn 290 295 300Lys Met Asp Asn Val Ile Ser Gln Leu Asp Thr Lys Ile Phe Asn Glu305 310 315 320Asp Leu Val Phe Ala Asn Asp Leu Ser Leu Thr Leu Lys Asp Glu Phe 325 330 335Arg Ser Arg Phe Lys Asn Val Thr Lys Ile Met Asp Cys Val Gln Cys 340 345 350Asp Arg Cys Arg Leu Trp Gly Lys Ile Gln Thr Thr Gly Tyr Ala Thr 355 360 365Ala Leu Lys Ile Leu Phe Glu Ile Asn Asp Ala Asp Glu Phe Thr Lys 370 375 380Gln His Ile Val Gly Lys Leu Thr Lys Tyr Glu Leu Ile Ala Leu Leu385 390 395 400Gln Thr Phe Gly Arg Leu Ser Glu Ser Ile Glu Ser Val Asn Met Phe 405 410 415Glu Lys Met Tyr Gly Lys Arg Leu Asn Gly Ser Glu Asn Arg Leu Ser 420 425 430Ser Phe Phe Gln Asn Asn Phe Phe Asn Ile Leu Lys Glu Ala Gly Lys 435 440 445Ser Ile Arg Tyr Thr Ile Glu Asn Ile Asn Ser Thr Lys Glu Gly Lys 450 455 460Lys Lys Thr Asn Asn Ser Gln Ser His Val Phe Asp Asp Leu Lys Met465 470 475 480Pro Lys Ala Glu Ile Val Pro Arg Pro Ser Asn Gly Thr Val Asn Lys 485 490 495Trp Lys Lys Ala Trp Asn Thr Glu Val Asn Asn Val Leu Glu Ala Phe 500 505 510Arg Phe Ile Tyr Arg Ser Tyr Leu Asp Leu Pro Arg Asn Ile Trp Glu 515 520 525Leu Ser Leu Met Lys Val Tyr Lys Phe Trp Asn Lys Phe Ile Gly Val 530 535 540Ala Asp Tyr Val Ser Glu Glu Thr Arg Glu Pro Ile Ser Tyr Lys Leu545 550 555 560Asp Ile Gln361692DNASaccharomyces cerevisiae 36atgagattaa gaaccgccat tgccacactg tgcctcacgg cttttacatc tgcaacttca 60aacaatagct acatcgccac cgaccaaaca caaaatgcct ttaatgacac tcacttttgt 120aaggtcgaca ggaatgatca cgttagtccc agttgtaacg taacattcaa tgaattaaat 180gccataaatg aaaacattag agatgatctt tcggcgttat taaaatctga tttcttcaaa 240tactttcggc tggatttata caagcaatgt tcattttggg acgccaacga tggtctgtgc 300ttaaaccgcg cttgctctgt tgatgtcgta gaggactggg atacactgcc tgagtactgg 360cagcctgaga tcttgggtag tttcaataat gatacaatga aggaagcgga tgatagcgat 420gacgaatgta agttcttaga tcaactatgt caaaccagta aaaaacctgt agatatcgaa 480gacaccatca actactgtga tgtaaatgac tttaacggta aaaacgccgt tctgattgat 540ttaacagcaa atccggaacg atttacaggt tatggtggta agcaagctgg tcaaatttgg 600tctactatct accaagacaa ctgttttaca attggcgaaa ctggtgaatc attggccaaa 660gatgcatttt atagacttgt atccggtttc catgcctcta tcggtactca cttatcaaag 720gaatatttga acacgaaaac tggtaaatgg gagcccaatc tggatttgtt tatggcaaga 780atcgggaact ttcctgatag agtgacaaac atgtatttca attatgctgt tgtagctaag 840gctctctgga aaattcaacc atatttacca gaattttcat tctgtgatct agtcaataaa 900gaaatcaaaa acaaaatgga taacgttatt tcccagctgg acacaaaaat ttttaacgaa 960gacttagttt ttgccaacga cctaagtttg actttgaagg acgaattcag atctcgcttc 1020aagaatgtca cgaagattat ggattgtgtg caatgtgata gatgtagatt gtggggcaaa 1080attcaaacta ccggttacgc aactgccttg aaaattttgt ttgaaatcaa cgacgctgat 1140gaattcacca aacaacatat tgttggtaag ttaaccaaat atgagttgat tgcactatta 1200cagactttcg gtagattatc tgaatctatt gaatctgtta acatgttcga aaaaatgtac 1260gggaaaaggt taaacggttc tgaaaacagg ttaagctcat tcttccaaaa taacttcttc 1320aacattttga aggaggcagg caaatcgatt cgttacacca tagagaacat caattccact 1380aaagaaggaa agaaaaagac taacaattct caatcacatg tatttgatga tttaaaaatg 1440cccaaagcag aaatagttcc aaggccctct aacggtacag taaataaatg gaagaaagct 1500tggaatactg aagttaacaa cgttttagaa gcattcagat ttatttatag aagctatttg 1560gatttaccca ggaacatctg ggaattatct ttgatgaagg tatacaaatt ttggaataaa 1620ttcatcggtg ttgctgatta cgttagtgag gagacacgag agcctatttc ctataagcta 1680gatatacaat aa 169237196PRTSaccharomyces cerevisiae 37Met Lys Gln Ile Val Lys Arg Ser His Ala Ile Arg Ile Val Ala Ala1 5 10 15Leu Gly Ile Ile Gly Leu Trp Met Phe Phe Ser Ser Asn Glu Leu Ser 20 25 30Ile Ala Thr Pro Gly Leu Ile Lys Ala Lys Ser Gly Ile Asp Glu Val 35 40 45Gln Gly Ala Ala Ala Glu Lys Asn Asp Ala Arg Leu Lys Glu Ile Glu 50 55 60Lys Gln Thr Ile Met Pro Leu Met Gly Asp Asp Lys Val Lys Lys Glu65 70 75 80Val Gly Arg Ala Ser Trp Lys Tyr Phe His Thr Leu Leu Ala Arg Phe 85 90 95Pro Asp Glu Pro Thr Pro Glu Glu Arg Glu Lys Leu His Thr Phe Ile 100 105 110Gly Leu Tyr Ala Glu Leu Tyr Pro Cys Gly Glu Cys Ser Tyr His Phe 115 120 125Val Lys Leu Ile Glu Lys Tyr Pro Val Gln Thr Ser Ser Arg Thr Ala 130 135 140Ala Ala Met Trp Gly Cys His Ile His Asn Lys Val Asn Glu Tyr Leu145 150 155 160Lys Lys Asp Ile Tyr Asp Cys Ala Thr Ile Leu Glu Asp Tyr Asp Cys 165 170 175Gly Cys Ser Asp Ser Asp Gly Lys Arg Val Ser Leu Glu Lys Glu Ala 180 185 190Lys Gln His Gly 19538591DNASaccharomyces cerevisiae 38atgaaacaga tagtcaaaag aagccatgcc atcagaatag ttgcagcatt aggaatcata 60ggcctgtgga tgtttttctc gtctaatgaa ctatccatcg ctacgccggg cctaatcaag 120gcgaagtctg gtatagatga agtgcaaggg gcggctgctg agaagaacga cgctcggttg 180aaagagatcg agaagcaaac cattatgcca ttgatgggcg atgacaaggt gaagaaggaa 240gtgggcaggg cgtcgtggaa gtacttccat accctgctgg cccgttttcc ggacgagcct 300actcctgaag aaagagagaa actgcacacg tttattgggt tgtatgcaga actctatcca 360tgcggggaat gttcatatca ctttgtaaag ttgattgaga agtatcccgt acagacatct 420agcaggacgg ctgccgcaat gtggggatgc cacattcaca acaaggtgaa cgaataccta 480aagaaagaca tatatgactg tgctaccatc ctggaggact acgattgtgg atgtagtgac 540agcgacggta aacgcgtgtc tctcgagaag gaggctaaac agcacggttg a 59139517PRTSaccharomyces cerevisiae 39Met Gln Val Thr Thr Arg Phe Ile Ser Ala Ile Val Ser Phe Cys Leu1 5 10 15Phe Ala Ser Phe Thr Leu Ala Glu Asn Ser Ala Arg Ala Thr Pro Gly 20 25 30Ser Asp Leu Leu Val Leu Thr Glu Lys Lys Phe Lys Ser Phe Ile Glu 35 40 45Ser His Pro Leu Val Leu Val Glu Phe Phe Ala Pro Trp Cys Leu His 50 55 60Ser Gln Ile Leu Arg Pro His Leu Glu Glu Ala Ala Ser Ile Leu Lys65 70 75 80Glu His Asn Val Pro Val Val Gln Ile Asp Cys Glu Ala Asn Ser Met 85 90 95Val Cys Leu Gln Gln Thr Ile Asn Thr Tyr Pro Thr Leu Lys Ile Phe 100 105 110Lys Asn Gly Arg Ile Phe Asp Gly Gln Val Tyr Arg Gly Val Lys Ile 115 120 125Thr Asp Glu Ile Thr Gln Tyr Met Ile Gln Leu Tyr Glu Ala Ser Val 130 135 140Ile Tyr Leu Asn Ser Glu Asp Glu Ile Gln Pro Tyr Leu Glu Asn Ala145 150 155 160Thr Leu Pro Val Val Ile Asn Arg Gly Leu Thr Gly Leu Asn Glu Thr 165 170 175Tyr Gln Glu Val Ala Leu Asp Leu Ala Glu Asp Tyr Val Phe Leu Ser 180 185 190Leu Leu Asp Ser Glu Asp Lys Ser Leu Ser Ile His Leu Pro Asn Thr 195 200 205Thr Glu Pro Ile Leu Phe Asp Gly Asn Val Asp Ser Leu Val Gly Asn 210 215 220Ser Val Ala Leu Thr Gln Trp Leu Lys Val Val Ile Leu Pro Tyr Phe225 230 235 240Thr Asp Ile Glu Pro Asp Leu Phe Pro Lys Tyr Ile Ser Ser Asn Leu 245 250 255Pro Leu Ala Tyr Phe Phe Tyr Thr Ser Glu Glu Glu Leu Glu Asp Tyr 260 265 270Thr Asp Leu Phe Thr Gln Leu Gly Lys Glu Asn Arg Gly Gln Ile Asn 275 280 285Phe Ile Ala Leu Asn Ser Thr Met Phe Pro His His Val Arg Phe Leu 290 295 300Asn Met Arg Glu Gln Phe Pro Leu Phe Ala Ile His Asn Met Ile Asn305 310 315 320Asn Leu Lys Tyr Gly Leu Pro Gln Leu Pro Glu Glu Glu Tyr Ala Lys 325 330 335Leu Glu Lys Pro Gln Pro Leu Asp Arg Asp Met Ile Val Gln Leu Val 340 345 350Lys Asp Tyr Arg Glu Gly Thr Ala Lys Pro Ile Val Lys Ser Glu Glu 355 360 365Ile Pro Lys Glu Gln Lys Ser Asn Val Tyr Lys Ile Val Gly Lys Thr 370 375 380His Asp Asp Ile Val His Asp Asp Asp Lys Asp Val Leu Val Lys Tyr385 390 395 400Tyr Ala Thr Trp Cys Ile His Ser Lys Arg Phe Ala Pro Ile Tyr Glu 405 410 415Glu Ile Ala Asn Val Leu Ala Ser Asp Glu Ser Val Arg Asp Lys Ile 420 425 430Leu Ile Ala Glu Val Asp Ser Gly Ala Asn Asp Ile Leu Ser Phe Pro 435 440 445Val Thr Gly Tyr Pro Thr Ile Ala Leu Tyr Pro Ala Gly Asn Asn Ser 450 455 460Lys Pro Ile Ile Phe Asn Lys Ile Arg Asn Leu Glu Asp Val Phe Glu465 470 475 480Phe Ile Lys Glu Ser Gly Thr His His Ile Asp Gly Gln Ala Ile Tyr 485 490 495Asp Lys Leu His Gln Ala Lys Asp Ser Glu Val Ser Thr Glu Asp Thr 500 505 510Val His Asp Glu Leu 515401554DNASaccharomyces cerevisiae 40atgcaagtga ccacaagatt tatatctgcg atagtctcgt tttgcctgtt tgcttctttc 60acgttggctg aaaacagcgc aagagctacg ccgggatcag atttactcgt tctaacagag 120aagaaattta aatcattcat cgaatctcat ccgttagtcc tcgtcgagtt ttttgctcca 180tggtgtttgc attctcagat cttacgccct cacttagaag aggccgcctc tattttaaag 240gagcataacg tcccagttgt tcaaattgat tgtgaggcta acagtatggt ttgcctgcaa 300caaactataa atacctaccc aaccttgaaa atctttaaaa atggtcgtat ttttgatggt 360caagtctatc gcggtgtcaa gatcaccgat gaaatcactc agtacatgat tcagctatac 420gaggcttctg tcatttattt aaattccgaa gatgaaatcc aaccatactt ggaaaatgca 480actttaccag tagtaataaa cagaggcttg acaggcttga atgaaacgta tcaagaagtc 540gcactggacc ttgctgagga ttacgtcttt ttatcccttc tagattcaga agataagtca 600ttatcaatcc acttgccaaa cactacagaa ccaattctgt ttgatggaaa tgtagactct 660ttggtcggaa attccgttgc tctaactcag tggttaaaag tggtaatttt accttacttt 720accgacatcg aacctgatct cttccccaag tacatttcta gcaatttgcc gttggcttac 780ttcttttata cttctgagga agaattggaa gattacactg atcttttcac gcagttaggt 840aaggaaaatc gtggccaaat aaatttcatt gcattaaact ctacaatgtt cccacaccac 900gttagattcc taaatatgag agaacagttc ccattatttg ctatccataa tatgatcaat 960aatctgaaat atggtttacc acaactacca gaagaagagt acgcgaaatt agaaaaacca 1020caaccactag acagagatat gatcgttcag ttggtaaaag attaccgtga aggtactgcc 1080aagccaattg ttaagtcaga agagattcca aaagaacaaa agtccaatgt ttataaaata 1140gttgggaaga cacatgacga cattgttcat gatgatgaca aggatgtcct tgtcaaatat 1200tacgcgacat ggtgtattca tagtaaaagg tttgcgccta tttacgaaga aattgcaaat 1260gtcttagcat ctgatgaatc tgttcgcgat aaaatcttga tcgccgaagt agattcaggg 1320gcaaatgata tcttaagttt tcctgtgaca ggatatccaa ccattgcttt gtatcctgcc 1380ggaaataact ctaagcctat tatcttcaat aaaattagaa atttggaaga tgttttcgaa 1440tttatcaagg aatcaggtac acatcacatt gacggccagg caatttatga taaattgcac 1500caggccaagg attctgaagt gtctactgaa gataccgtac atgatgaatt ataa 155441318PRTSaccharomyces cerevisiae 41Met Leu Phe Leu Asn Ile Ile Lys Leu Leu Leu Gly Leu Phe Ile Met1 5 10 15Asn Glu Val Lys Ala Gln Asn Phe Tyr Asp Ser Asp Pro His Ile Ser 20 25 30Glu Leu Thr Pro Lys Ser Phe Asp Lys Ala Ile His Asn Thr Asn Tyr 35 40 45Thr Ser Leu Val Glu Phe Tyr Ala Pro Trp Cys Gly His Cys Lys Lys 50 55 60Leu Ser Ser Thr Phe Arg Lys Ala Ala Lys Arg Leu Asp Gly Val Val65 70 75 80Gln Val Ala Ala Val Asn Cys Asp Leu Asn Lys Asn Lys Ala Leu Cys 85 90 95Ala Lys Tyr Asp Val Asn Gly Phe Pro Thr Leu Met Val Phe Arg Pro 100 105 110Pro Lys Ile Asp Leu Ser Lys Pro Ile Asp Asn Ala Lys Lys Ser Phe 115 120 125Ser Ala His Ala Asn Glu Val Tyr Ser Gly Ala Arg Thr Leu Ala Pro 130 135 140Ile Val Asp Phe Ser Leu Ser Arg Ile Arg Ser Tyr Val Lys Lys Phe145 150 155 160Val Arg Ile Asp Thr Leu Gly Ser Leu Leu Arg Lys Ser Pro Lys Leu 165 170 175Ser Val Val Leu Phe Ser Lys Gln Asp Lys Ile Ser Pro Val Tyr Lys 180 185 190Ser Ile Ala Leu Asp Trp Leu Gly Lys Phe Asp Phe Tyr Ser Ile Ser 195 200 205Asn Lys Lys Leu Lys Gln Leu Thr Asp Met Asn Pro Thr Tyr Glu Lys 210 215 220Thr Pro Glu Ile Phe Lys Tyr Leu Gln Lys Val Ile Pro Glu Gln Arg225 230 235 240Gln Ser Asp Lys Ser Lys Leu Val Val Phe Asp Ala Asp Lys Asp Lys 245 250 255Phe Trp Glu Tyr Glu Gly Asn Ser Ile Asn Lys Asn Asp Ile Ser Lys 260 265 270Phe Leu Arg Asp Thr Phe Ser Ile Thr Pro Asn Glu Gly Pro Phe Ser 275 280 285Arg Arg Ser Glu Tyr Ile Ala Tyr Leu Lys Thr Gly Lys Lys Pro Ile 290 295 300Lys Lys Asn His Ser Ser Ser Gly Asn Lys His Asp Glu Leu305 310 31542957DNASaccharomyces cerevisiae 42atgttatttc ttaatattat taagctcctt ttgggacttt ttattatgaa tgaagtaaag 60gcgcaaaact tttacgattc cgatcctcat atatcagagt taacgccaaa aagcttcgat 120aaagcgatcc ataacacaaa ttacacatca ttagtggaat tttatgctcc gtggtgcggc 180cattgtaaga agctctctag tacgttccgc aaggcagcaa aaagattgga tggtgtagtc 240caagttgctg ctgtaaactg tgaccttaac aagaataagg ctttgtgtgc taaatacgac 300gtaaacggat ttcccacgtt aatggtattt aggcccccaa aaattgacct atctaagcca 360atagataacg ccaaaaaaag tttcagcgct catgccaatg aagtgtactc aggtgcaaga 420actctcgcgc ctattgttga tttttctctt tcaagaataa ggtcatatgt caaaaagttt 480gtccgtatag atacacttgg ctctttactt agaaagtcac ccaaactttc cgtggtgttg 540ttttccaaac aagacaaaat ttcaccggtt tataaaagca ttgcccttga ttggttagga 600aagttcgatt tttattcaat ttcaaacaaa aaactcaagc aactaaccga tatgaaccca 660acatatgaaa aaactcctga gattttcaaa tatttgcaga aggtcattcc tgaacagcga 720cagagcgata aaagtaagct tgtcgttttt gatgcagaca aagataaatt ttgggagtat 780gaagggaact caatcaacaa aaatgacatt tccaaatttc tgcgggacac ttttagtatt 840acccccaatg agggtccttt tagtagacgt tctgaatata ttgcttactt aaaaactggc 900aagaagccaa ttaaaaagaa ccattcctcc tcaggaaaca agcacgacga attgtag 95743277PRTSaccharomyces cerevisiae 43Met Lys Leu His Gly Phe Leu Phe Ser Val Leu Ser Thr Cys Val Val1 5 10 15Ile Leu Pro Ala Leu Ala Tyr Ser Glu Ala Val Thr Met Val Lys Ser 20 25 30Ile Glu Gln Tyr Phe Asp Ile Cys Asn Arg Asn Asp Ser Tyr Thr Met 35 40 45Ile Lys Tyr Tyr Thr Ser Trp Cys Gln His Cys Lys Thr Leu Ala Pro 50 55 60Val Tyr Glu Glu Leu Gly Glu Leu Tyr Ala Lys Lys Ala Asn Lys Asp65 70 75 80Asp Thr Pro Ile Asn Phe Leu Glu Val Asn Cys Glu Phe Phe Gly Pro 85 90 95Thr Leu Cys Thr Asp Leu Pro Gly Phe Pro Ile Ile Glu Leu Val Lys 100 105 110Pro Arg Thr Lys Pro Leu Val Leu Pro Lys Leu Asp Trp Ser Ser Met 115 120 125Lys Phe His Glu Arg Leu Trp Gln Arg Ile Lys Thr Trp Phe Asn Asn 130 135 140Pro Lys Tyr Gln Leu Asp Thr Ser Arg Val Val Arg Phe Glu Gly Ser145 150 155 160Arg Asn Leu Lys Ser Leu Ser Asn Phe Ile Asp Thr Val Arg Ser Lys 165 170 175Asp Thr Glu Glu Arg Phe Ile Glu His Ile Phe Asp Asp Ser Arg Asn 180 185 190Cys Asn Glu Glu Leu Arg Ser Gln Gln Leu Leu Cys Lys Ala Gly Lys 195 200 205Glu Tyr Tyr Ser Asp Thr Leu Ser Lys Leu Tyr Gly Asp Val Asn Gly 210 215 220Leu Glu Lys Glu Arg Arg Arg Leu Glu Ala Leu Ile Lys Gln Asn Gly225 230 235 240Asp Asp Leu Ser Lys Glu Val Lys Glu Lys Leu Lys Ile Ile Arg Leu 245 250 255Gln Leu Ser Leu Leu Ser His Ile Glu Asp

Gln Leu Glu Asp Thr Ser 260 265 270Ser His Asp Glu Leu 27544834DNASaccharomyces cerevisiae 44atgaaattgc acggcttttt attttccgta ttatcaacat gcgtcgtcat tttaccagcg 60ttggcctaca gtgaagctgt cacgatggtc aagtcgattg agcagtactt cgatatctgc 120aataggaatg attcttacac aatgataaaa tactacactt cttggtgcca acattgtaaa 180actctggccc cagtatacga agagcttggt gagctatacg ccaaaaaagc taataaagat 240gataccccaa ttaacttcct tgaagttaac tgtgaattct tcgggccaac tttatgtacc 300gacttgcctg gatttccaat aattgaactg gtcaaacctc gtactaagcc cttagttctt 360ccgaagctcg attggtcgtc tatgaaattt catgaaagac tatggcaaag aatcaagacg 420tggttcaaca atcctaagta ccaactggat acgtctaggg ttgttcgttt tgaagggagt 480aggaacctaa agagtttaag caactttatc gatactgtaa gaagtaaaga tacagaagaa 540agattcatag aacatatttt cgatgattct aggaattgca atgaagaatt acgttctcaa 600cagcttctgt gtaaagctgg taaagaatac tactctgata ctttatctaa attatacggt 660gacgtgaatg ggctggaaaa ggaaaggcga agactagaag ctttaattaa gcaaaatgga 720gatgacttga gtaaagaagt taaagaaaaa ctgaaaatca ttcgtctaca attgagccta 780ttatcacaca tagaagacca gttagaagat accagtagtc atgacgagct ttga 83445701PRTSaccharomyces cerevisiae 45Met Lys Met Asn Leu Lys Arg Leu Val Val Thr Phe Phe Ser Cys Ile1 5 10 15Thr Phe Leu Leu Lys Phe Thr Ile Ala Ala Ala Glu Pro Pro Glu Gly 20 25 30Phe Pro Glu Pro Leu Asn Pro Thr Asn Phe Lys Glu Glu Leu Ser Lys 35 40 45Gly Leu His Ile Ile Asp Phe Tyr Ser Pro Tyr Cys Pro His Cys Lys 50 55 60His Leu Ala Pro Val Trp Met Glu Thr Trp Glu Glu Phe Lys Glu Glu65 70 75 80Ser Lys Thr Leu Asn Ile Thr Phe Ser Gln Val Asn Cys Ile Glu Ser 85 90 95Ala Asp Leu Cys Gly Asp Glu Asn Ile Glu Tyr Phe Pro Glu Ile Arg 100 105 110Leu Tyr Asn Pro Ser Gly Tyr Ile Lys Ser Phe Thr Glu Thr Pro Arg 115 120 125Thr Lys Glu Ser Leu Ile Ala Phe Ala Arg Arg Glu Ser Met Asp Pro 130 135 140Asn Asn Leu Asp Thr Asp Leu Asp Ser Ala Lys Ser Glu Ser Gln Tyr145 150 155 160Leu Glu Gly Phe Asp Phe Leu Glu Leu Ile Ala Gly Lys Ala Thr Arg 165 170 175Pro His Leu Val Ser Phe Trp Pro Thr Lys Asp Met Lys Asn Ser Asp 180 185 190Asp Ser Leu Glu Phe Lys Asn Cys Asp Lys Cys His Glu Phe Gln Arg 195 200 205Thr Trp Lys Ile Ile Ser Arg Gln Leu Ala Val Asp Asp Ile Asn Thr 210 215 220Gly His Val Asn Cys Glu Ser Asn Pro Thr Ile Cys Glu Glu Leu Gly225 230 235 240Phe Gly Asp Leu Val Lys Ile Thr Asn His Arg Ala Asp Arg Glu Pro 245 250 255Lys Val Ala Leu Val Leu Pro Asn Lys Thr Ser Asn Asn Leu Phe Asp 260 265 270Tyr Pro Asn Gly Tyr Ser Ala Lys Ser Asp Gly Tyr Val Asp Phe Ala 275 280 285Arg Arg Thr Phe Thr Asn Ser Lys Phe Pro Asn Ile Thr Glu Gly Glu 290 295 300Leu Glu Lys Lys Ala Asn Arg Asp Ile Asp Phe Leu Gln Glu Arg Gly305 310 315 320Arg Val Thr Asn Asn Asp Ile His Leu Val Phe Ser Tyr Asp Pro Glu 325 330 335Thr Val Val Ile Glu Asp Phe Asp Ile Leu Glu Tyr Leu Ile Glu Pro 340 345 350Leu Ser Lys Ile Pro Asn Ile Tyr Leu His Gln Ile Asp Lys Asn Leu 355 360 365Ile Asn Leu Ser Arg Asn Leu Phe Gly Arg Met Tyr Glu Lys Ile Asn 370 375 380Tyr Asp Ala Ser Gln Thr Gln Lys Val Phe Asn Lys Glu Tyr Phe Thr385 390 395 400Met Asn Thr Val Thr Gln Leu Pro Thr Phe Phe Met Phe Lys Asp Gly 405 410 415Asp Pro Ile Ser Tyr Val Phe Pro Gly Tyr Ser Thr Thr Glu Met Arg 420 425 430Asn Ile Asp Ala Ile Met Asp Trp Val Lys Lys Tyr Ser Asn Pro Leu 435 440 445Val Thr Glu Val Asp Ser Ser Asn Leu Lys Lys Leu Ile Ser Phe Gln 450 455 460Thr Lys Ser Tyr Ser Asp Leu Ala Ile Gln Leu Ile Ser Ser Thr Asp465 470 475 480His Lys His Ile Lys Gly Ser Asn Lys Leu Ile Lys Asn Leu Leu Leu 485 490 495Ala Ser Trp Glu Tyr Glu His Ile Arg Met Glu Asn Asn Phe Glu Glu 500 505 510Ile Asn Glu Arg Arg Ala Arg Lys Ala Asp Gly Ile Lys Lys Ile Lys 515 520 525Glu Lys Lys Ala Pro Ala Asn Lys Ile Val Asp Lys Met Arg Glu Glu 530 535 540Ile Pro His Met Asp Gln Lys Lys Leu Leu Leu Gly Tyr Leu Asp Ile545 550 555 560Ser Lys Glu Lys Asn Phe Phe Arg Lys Tyr Gly Ile Thr Gly Glu Tyr 565 570 575Lys Ile Gly Asp Val Ile Ile Ile Asp Lys Ser Asn Asn Tyr Tyr Tyr 580 585 590Asn Lys Asp Asn Phe Gly Asn Ser Leu Thr Ser Asn Asn Pro Gln Leu 595 600 605Leu Arg Glu Ala Phe Val Ser Leu Asn Ile Pro Ser Lys Ala Leu Tyr 610 615 620Ser Ser Lys Leu Lys Gly Arg Leu Ile Asn Ser Pro Phe His Asn Val625 630 635 640Leu Ser Phe Leu Asp Ile Ile His Gly Asn Gly Met Pro Gly Tyr Leu 645 650 655Ile Val Ile Val Leu Phe Ile Ala Ile Leu Lys Gly Pro Ser Ile Tyr 660 665 670Arg Arg Tyr Lys Val Arg Lys His Tyr Arg Ala Lys Arg Asn Ala Val 675 680 685Gly Ile Leu Gly Asn Met Glu Lys Lys Lys Asn Gln Asp 690 695 700462106DNASaccharomyces cerevisiae 46atgaaaatga atctgaaaag gctcgtagtt accttcttct catgcatcac ctttctgctg 60aaattcacta tagccgccgc tgaaccacca gagggctttc cagagccctt aaatccaaca 120aacttcaaag aagagctatc taaggggctg catattattg acttctatag tccatactgt 180ccgcactgca aacatttagc acctgtttgg atggaaacat gggaggagtt taaagaggag 240agcaaaacac tgaacataac attttcacag gttaactgca tcgagagcgc cgatttgtgt 300ggagatgaaa atattgaata cttccctgaa attagacttt ataacccctc aggatacatc 360aaatcgttca ctgaaacacc gaggaccaaa gaatcattaa ttgcatttgc acgcagggag 420tctatggacc caaataacct cgatactgat ctggattctg ctaaaagtga gagccagtat 480ctcgaaggct ttgattttct cgagctgatc gctggtaagg cgactaggcc acatttggtt 540tccttctggc caacaaaaga tatgaaaaat agcgatgatt cactagaatt caaaaactgt 600gacaaatgcc atgaattcca aaggacttgg aagatcattt caagacagtt agccgtggat 660gatatcaaca cgggccacgt taattgcgaa tctaatccaa caatctgtga agaactgggc 720tttggcgact tggtgaaaat aaccaaccac agagccgata gagaacccaa ggtagcatta 780gtcctaccca ataaaacctc aaataatttg ttcgactatc ccaatggcta ctcagcgaag 840tcagatggct atgtagattt tgccaggagg acttttacaa acagtaaatt tcccaatata 900acagaagggg agctcgaaaa aaaagcaaac agagacattg attttctgca agaaagggga 960cgagtaacta ataatgatat ccatttagtt ttttcatatg accccgaaac tgttgttatt 1020gaagattttg acattttgga gtatttaatc gagcctttgt caaaaattcc aaacatatat 1080ttgcaccaaa ttgacaagaa tctaataaat ttgtcacgta atctttttgg aagaatgtat 1140gaaaagatca actacgacgc cagccaaact caaaaggttt ttaacaaaga atactttact 1200atgaatacgg ttacgcaact cccaactttt ttcatgttta aagatggtga tcccatatcc 1260tatgttttcc ccggatactc cacaacagaa atgagaaata ttgatgccat tatggattgg 1320gtaaaaaagt attctaatcc cttagttacc gaagttgact cttctaattt gaaaaaatta 1380atttccttcc aaaccaagag ctacagtgat ttagcaattc agttaataag tagcactgac 1440cacaaacata tcaaaggaag caacaagctt attaaaaact tgctcctcgc aagttgggag 1500tatgaacata ttcggatgga aaataacttc gaagaaatta atgagagaag ggcaaggaaa 1560gcagacggga tcaagaaaat aaaggaaaaa aaggctccgg ctaacaaaat tgttgataaa 1620atgcgtgaag agattcccca tatggatcaa aaaaaattgt tattaggata tttagatatt 1680tcaaaggaga agaatttttt tagaaaatat ggtattactg gagaatataa aattggtgat 1740gtgattatca ttgataaatc aaataattac tactacaata aagataattt tggcaactcc 1800ttgacttcta acaaccctca attgctgaga gaagcattcg tgtccttaaa tattccatca 1860aaagctctat acagctctaa gttgaagggg agattgataa attctccatt ccataatgtc 1920ctcagtttcc tagacataat ccacgggaac ggcatgcccg gttacttaat tgttattgtt 1980ttgtttatcg caatactcaa aggtccatct atttacagaa gatacaaagt aaggaaacac 2040tatagggcga aaaggaacgc tgtcggtatc ctaggaaata tggagaaaaa aaaaaatcaa 2100gattaa 210647522PRTSaccharomyces cerevisiae 47Met Lys Phe Ser Ala Gly Ala Val Leu Ser Trp Ser Ser Leu Leu Leu1 5 10 15Ala Ser Ser Val Phe Ala Gln Gln Glu Ala Val Ala Pro Glu Asp Ser 20 25 30Ala Val Val Lys Leu Ala Thr Asp Ser Phe Asn Glu Tyr Ile Gln Ser 35 40 45His Asp Leu Val Leu Ala Glu Phe Phe Ala Pro Trp Cys Gly His Cys 50 55 60Lys Asn Met Ala Pro Glu Tyr Val Lys Ala Ala Glu Thr Leu Val Glu65 70 75 80Lys Asn Ile Thr Leu Ala Gln Ile Asp Cys Thr Glu Asn Gln Asp Leu 85 90 95Cys Met Glu His Asn Ile Pro Gly Phe Pro Ser Leu Lys Ile Phe Lys 100 105 110Asn Ser Asp Val Asn Asn Ser Ile Asp Tyr Glu Gly Pro Arg Thr Ala 115 120 125Glu Ala Ile Val Gln Phe Met Ile Lys Gln Ser Gln Pro Ala Val Ala 130 135 140Val Val Ala Asp Leu Pro Ala Tyr Leu Ala Asn Glu Thr Phe Val Thr145 150 155 160Pro Val Ile Val Gln Ser Gly Lys Ile Asp Ala Asp Phe Asn Ala Thr 165 170 175Phe Tyr Ser Met Ala Asn Lys His Phe Asn Asp Tyr Asp Phe Val Ser 180 185 190Ala Glu Asn Ala Asp Asp Asp Phe Lys Leu Ser Ile Tyr Leu Pro Ser 195 200 205Ala Met Asp Glu Pro Val Val Tyr Asn Gly Lys Lys Ala Asp Ile Ala 210 215 220Asp Ala Asp Val Phe Glu Lys Trp Leu Gln Val Glu Ala Leu Pro Tyr225 230 235 240Phe Gly Glu Ile Asp Gly Ser Val Phe Ala Gln Tyr Val Glu Ser Gly 245 250 255Leu Pro Leu Gly Tyr Leu Phe Tyr Asn Asp Glu Glu Glu Leu Glu Glu 260 265 270Tyr Lys Pro Leu Phe Thr Glu Leu Ala Lys Lys Asn Arg Gly Leu Met 275 280 285Asn Phe Val Ser Ile Asp Ala Arg Lys Phe Gly Arg His Ala Gly Asn 290 295 300Leu Asn Met Lys Glu Gln Phe Pro Leu Phe Ala Ile His Asp Met Thr305 310 315 320Glu Asp Leu Lys Tyr Gly Leu Pro Gln Leu Ser Glu Glu Ala Phe Asp 325 330 335Glu Leu Ser Asp Lys Ile Val Leu Glu Ser Lys Ala Ile Glu Ser Leu 340 345 350Val Lys Asp Phe Leu Lys Gly Asp Ala Ser Pro Ile Val Lys Ser Gln 355 360 365Glu Ile Phe Glu Asn Gln Asp Ser Ser Val Phe Gln Leu Val Gly Lys 370 375 380Asn His Asp Glu Ile Val Asn Asp Pro Lys Lys Asp Val Leu Val Leu385 390 395 400Tyr Tyr Ala Pro Trp Cys Gly His Cys Lys Arg Leu Ala Pro Thr Tyr 405 410 415Gln Glu Leu Ala Asp Thr Tyr Ala Asn Ala Thr Ser Asp Val Leu Ile 420 425 430Ala Lys Leu Asp His Thr Glu Asn Asp Val Arg Gly Val Val Ile Glu 435 440 445Gly Tyr Pro Thr Ile Val Leu Tyr Pro Gly Gly Lys Lys Ser Glu Ser 450 455 460Val Val Tyr Gln Gly Ser Arg Ser Leu Asp Ser Leu Phe Asp Phe Ile465 470 475 480Lys Glu Asn Gly His Phe Asp Val Asp Gly Lys Ala Leu Tyr Glu Glu 485 490 495Ala Gln Glu Lys Ala Ala Glu Glu Ala Asp Ala Asp Ala Glu Leu Ala 500 505 510Asp Glu Glu Asp Ala Ile His Asp Glu Leu 515 52048530PRTSaccharomyces cerevisiae 48Met Lys Phe Ser Ala Gly Ala Val Leu Ser Trp Ser Ser Leu Leu Leu1 5 10 15Ala Ser Ser Val Phe Ala Gln Gln Glu Ala Val Ala Pro Glu Asp Ser 20 25 30Ala Val Val Lys Leu Ala Thr Asp Ser Phe Asn Glu Tyr Ile Gln Ser 35 40 45His Asp Leu Val Leu Ala Glu Phe Phe Ala Pro Trp Cys Gly His Cys 50 55 60Lys Asn Met Ala Pro Glu Tyr Val Lys Ala Ala Glu Thr Leu Val Glu65 70 75 80Lys Asn Ile Thr Leu Ala Gln Ile Asp Cys Thr Glu Asn Gln Asp Leu 85 90 95Cys Met Glu His Asn Ile Pro Gly Phe Pro Ser Leu Lys Ile Phe Lys 100 105 110Asn Arg Asp Val Asn Asn Ser Ile Asp Tyr Glu Gly Pro Arg Thr Ala 115 120 125Glu Ala Ile Val Gln Phe Met Ile Lys Gln Ser Gln Pro Ala Val Ala 130 135 140Val Val Ala Asp Leu Pro Ala Tyr Leu Ala Asn Glu Thr Phe Val Thr145 150 155 160Pro Val Ile Val Gln Ser Gly Lys Ile Asp Ala Asp Phe Asn Ala Thr 165 170 175Phe Tyr Ser Met Ala Asn Lys His Phe Asn Asp Tyr Asp Phe Val Ser 180 185 190Ala Glu Asn Ala Asp Asp Asp Phe Lys Leu Ser Ile Tyr Leu Pro Ser 195 200 205Ala Met Asp Glu Pro Val Val Tyr Asn Gly Lys Lys Ala Asp Ile Ala 210 215 220Asp Ala Asp Val Phe Glu Lys Trp Leu Gln Val Glu Ala Leu Pro Tyr225 230 235 240Phe Gly Glu Ile Asp Gly Ser Val Phe Ala Gln Tyr Val Glu Ser Gly 245 250 255Leu Pro Leu Gly Tyr Leu Phe Tyr Asn Asp Glu Glu Glu Leu Glu Glu 260 265 270Tyr Lys Pro Leu Phe Thr Glu Leu Ala Lys Lys Asn Arg Gly Leu Met 275 280 285Asn Phe Val Ser Ile Asp Ala Arg Lys Phe Gly Arg His Ala Gly Asn 290 295 300Leu Asn Met Lys Glu Gln Phe Pro Leu Phe Ala Ile His Asp Met Thr305 310 315 320Glu Asp Leu Lys Tyr Gly Leu Pro Gln Leu Ser Glu Glu Ala Phe Asp 325 330 335Glu Leu Ser Asp Lys Ile Val Leu Glu Ser Lys Ala Ile Glu Ser Leu 340 345 350Val Lys Asp Phe Leu Lys Gly Asp Ala Ser Pro Ile Val Lys Ser Gln 355 360 365Glu Ile Phe Glu Asn Gln Asp Ser Ser Val Phe Gln Leu Val Gly Lys 370 375 380Asn His Asp Glu Ile Val Asn Asp Pro Lys Lys Asp Val Leu Val Leu385 390 395 400Tyr Tyr Ala Pro Trp Cys Gly His Cys Lys Arg Leu Ala Pro Thr Tyr 405 410 415Gln Glu Leu Ala Asp Thr Tyr Ala Asn Ala Thr Ser Asp Val Leu Ile 420 425 430Ala Lys Leu Asp His Thr Glu Asn Asp Val Arg Gly Val Val Ile Glu 435 440 445Gly Tyr Pro Thr Ile Val Leu Tyr Pro Gly Gly Lys Lys Ser Glu Ser 450 455 460Val Val Tyr Gln Gly Ser Arg Ser Leu Asp Ser Leu Phe Asp Phe Ile465 470 475 480Lys Glu Asn Gly His Phe Asp Val Asp Gly Lys Ala Leu Tyr Glu Glu 485 490 495Ala Gln Glu Lys Ala Ala Glu Glu Ala Glu Ala Asp Ala Glu Ala Glu 500 505 510Ala Asp Ala Asp Ala Glu Leu Ala Asp Glu Glu Asp Ala Ile His Asp 515 520 525Glu Leu 53049211PRTSaccharomyces cerevisiae 49Met Asp Ala Val Ile Leu Asn Leu Leu Gly Asp Ile Pro Leu Val Thr1 5 10 15Arg Leu Trp Thr Ile Gly Cys Leu Val Leu Ser Gly Leu Thr Ser Leu 20 25 30Arg Ile Val Asp Pro Gly Lys Val Val Tyr Ser Tyr Asp Leu Val Phe 35 40 45Lys Lys Gly Gln Tyr Gly Arg Leu Leu Tyr Ser Ile Phe Asp Tyr Gly 50 55 60Ala Phe Asn Trp Ile Ser Met Ile Asn Ile Phe Val Ser Ala Asn His65 70 75 80Leu Ser Thr Leu Glu Asn Ser Phe Asn Leu Arg Arg Lys Phe Cys Trp 85 90 95Ile Ile Phe Leu Leu Leu Val Ile Leu Val Lys Met Thr Ser Ile Glu 100 105 110Gln Pro Ala Ala Ser Leu Gly Val Leu Leu His Glu Asn Leu Val Tyr 115 120 125Tyr Glu Leu Lys Lys Asn Gly Asn Gln Met Asn Val Arg Phe Phe Gly 130 135 140Ala Ile Asp Val Ser Pro Ser Ile Phe Pro Ile Tyr Met Asn Ala Val145 150 155 160Met Tyr Phe Val Tyr Lys Arg Ser Trp Leu Glu Ile Ala Met Asn Phe 165 170 175Met Pro Gly His Val Ile Tyr Tyr Met Asp Asp Ile

Ile Gly Lys Ile 180 185 190Tyr Gly Ile Asp Leu Cys Lys Ser Pro Tyr Asp Trp Phe Arg Asn Thr 195 200 205Glu Thr Pro 21050636DNASaccharomyces cerevisiae 50atggatgctg taatactgaa tctcttaggc gacattcctt tggtcacaag attatggaca 60attggctgtc ttgtactatc aggtctcaca agtctccgga ttgtggatcc agggaaggta 120gtgtacagtt atgatttagt attcaaaaag ggacaatatg gaagactact ttattcgata 180ttcgattacg gcgcatttaa ttggatatcc atgataaaca tctttgtcag cgctaatcac 240ttatcaactt tggaaaactc attcaatctg agaagaaaat tctgttggat aatattttta 300ctgttggtga tactggtaaa gatgaccagc attgaacaac ctgcagcatc actcggtgtg 360ttattgcatg agaatctcgt gtactacgaa ctgaaaaaga acggaaacca aatgaacgta 420cgattcttcg gtgccattga tgtttcacca tctatattcc caatctacat gaatgcagta 480atgtattttg tatataagcg tagctggtta gaaattgcca tgaatttcat gccaggtcac 540gtaatttact acatggatga tataataggg aagatttatg gcatcgattt gtgtaaatct 600ccgtacgact ggttccgcaa cactgaaaca ccctaa 63651551PRTSaccharomyces cerevisiae 51Met Val Pro Glu Asn Arg Arg Lys Gln Leu Ala Ile Phe Val Val Val1 5 10 15Thr Tyr Leu Leu Thr Phe Tyr Cys Val Tyr Ser Ala Thr Lys Thr Ser 20 25 30Val Ser Phe Leu Gln Val Thr Leu Lys Leu Asn Glu Gly Phe Asn Leu 35 40 45Met Val Leu Ser Ile Phe Ile Leu Leu Asn Ser Thr Leu Leu Trp Gln 50 55 60Leu Leu Thr Lys Leu Leu Phe Gly Glu Leu Arg Leu Ile Glu His Glu65 70 75 80His Ile Phe Glu Arg Leu Pro Phe Thr Ile Ile Asn Thr Leu Phe Met 85 90 95Ser Ser Leu Phe His Glu Arg Tyr Phe Phe Thr Val Ala Phe Phe Gly 100 105 110Leu Leu Leu Leu Tyr Leu Lys Val Phe His Trp Ile Leu Lys Asp Arg 115 120 125Leu Glu Ala Leu Leu Gln Ser Ile Asn Asp Ser Thr Thr Met Lys Thr 130 135 140Leu Ile Phe Ser Arg Phe Ser Phe Asn Leu Val Leu Leu Ala Val Val145 150 155 160Asp Tyr Gln Ile Ile Thr Arg Cys Ile Ser Ser Ile Tyr Thr Asn Gln 165 170 175Lys Ser Asp Ile Glu Ser Thr Ser Leu Tyr Leu Ile Gln Val Met Glu 180 185 190Phe Thr Met Leu Leu Ile Asp Leu Leu Asn Leu Phe Leu Gln Thr Cys 195 200 205Leu Asn Phe Trp Glu Phe Tyr Arg Ser Gln Gln Ser Leu Ser Asn Glu 210 215 220Asn Asn His Ile Val His Gly Asp Pro Thr Asp Glu Asn Thr Val Glu225 230 235 240Ser Asp Gln Ser Gln Pro Val Leu Asn Asp Asp Asp Asp Asp Asp Asp 245 250 255Asp Asp Arg Gln Phe Thr Gly Leu Glu Gly Lys Phe Met Tyr Glu Lys 260 265 270Ala Ile Asp Val Phe Thr Arg Phe Leu Lys Thr Ala Leu His Leu Ser 275 280 285Met Leu Ile Pro Phe Arg Met Pro Met Met Leu Leu Lys Asp Val Val 290 295 300Trp Asp Ile Leu Ala Leu Tyr Gln Ser Gly Thr Ser Leu Trp Lys Ile305 310 315 320Trp Arg Asn Asn Lys Gln Leu Asp Asp Thr Leu Val Thr Val Thr Val 325 330 335Glu Gln Leu Gln Asn Ser Ala Asn Asp Asp Asn Ile Cys Ile Ile Cys 340 345 350Met Asp Glu Leu Ile His Ser Pro Asn Gln Gln Thr Trp Lys Asn Lys 355 360 365Asn Lys Lys Pro Lys Arg Leu Pro Cys Gly His Ile Leu His Leu Ser 370 375 380Cys Leu Lys Asn Trp Met Glu Arg Ser Gln Thr Cys Pro Ile Cys Arg385 390 395 400Leu Pro Val Phe Asp Glu Lys Gly Asn Val Val Gln Thr Thr Phe Thr 405 410 415Ser Asn Ser Asp Ile Thr Thr Gln Thr Thr Val Thr Asp Ser Thr Gly 420 425 430Ile Ala Thr Asp Gln Gln Gly Phe Ala Asn Glu Val Asp Leu Leu Pro 435 440 445Thr Arg Thr Thr Ser Pro Asp Ile Arg Ile Val Pro Thr Gln Asn Ile 450 455 460Asp Thr Leu Ala Met Arg Thr Arg Ser Thr Ser Thr Pro Ser Pro Thr465 470 475 480Trp Tyr Thr Phe Pro Leu His Lys Thr Gly Asp Asn Ser Val Gly Ser 485 490 495Ser Arg Ser Ala Tyr Glu Phe Leu Ile Thr Asn Ser Asp Glu Lys Glu 500 505 510Asn Gly Ile Pro Val Lys Leu Thr Ile Glu Asn His Glu Val Asn Ser 515 520 525Leu His Gly Asp Gly Gly Glu Gln Ile Ala Lys Lys Ile Val Ile Pro 530 535 540Asp Lys Phe Ile Gln His Ile545 550521656DNASaccharomyces cerevisiae 52atggtgccag aaaatagaag gaaacagttg gcaatttttg tagttgtcac atatttgctc 60acattttatt gcgtgtattc agccaccaag acaagcgttt cctttttgca agtaacactg 120aagctaaatg aaggcttcaa tctaatggtt ttgtcgatat tcatcttatt aaattctacc 180ttactatggc aactcctaac gaaactatta tttggtgaac tgaggcttat tgagcatgag 240cacatttttg aaaggttacc atttaccatt ataaacacct tgtttatgtc ctcactgttc 300cacgaacggt attttttcac agtggcattt tttggactat tactactcta tctgaaagtt 360ttccattgga ttttaaagga taggctggag gccttattac agtcaataaa tgattccacc 420acaatgaaaa cccttatctt tagtagattc tcatttaacc tcgtactatt ggcggttgta 480gactaccaga taataacacg atgcatctcc tccatatata caaaccaaaa gagtgatatt 540gaatccacat ccctttacct gatacaagta atggagttta ccatgctttt gattgatttg 600ctaaatttat tcctacagac ttgtttgaat ttctgggaat tttatcgctc acaacaaagt 660ctgtctaatg agaacaacca tattgtccat ggcgatccta cagatgaaaa cacggttgag 720tctgatcaat ctcagccagt gctgaatgac gacgacgatg acgacgatga tgatagacaa 780tttaccggcc tggagggtaa attcatgtat gaaaaagcaa ttgacgtatt cacaagattc 840ttaaaaacgg cacttcattt gtctatgcta ataccattta ggatgcctat gatgcttttg 900aaagatgtgg tgtgggatat cttggcacta tatcaaagtg gcacaagttt gtggaaaatc 960tggagaaata acaaacagct cgacgacact cttgtcactg tcaccgtaga acagctacaa 1020aattctgcaa atgatgacaa tatttgtatc atttgtatgg atgagttaat acattctcca 1080aaccagcaga cgtggaagaa taaaaacaag aaacccaaaa ggttaccttg tggccacata 1140cttcatttgt cgtgtttaaa gaattggatg gaacgttctc agacttgtcc tatttgtaga 1200ttgcctgtct ttgatgaaaa aggtaatgtt gtgcaaacga ctttcacttc caatagtgat 1260atcacgacac agaccaccgt aacagatagc actgggatag cgacagatca acaaggtttc 1320gcaaacgaag tagatctact tcccacaaga acaacttccc ctgatataag gatagtgcct 1380actcaaaata tagacacatt agcaatgaga acaaggtcaa cctctacacc atctcctacg 1440tggtatacgt tcccattaca taaaactggt gataattctg ttgggtcaag ccgatcagcc 1500tacgaatttt tgatcacaaa ttcagatgag aaagaaaatg gtattcctgt caaattaaca 1560atagaaaatc acgaagtaaa ttctctgcat ggagacgggg gcgagcaaat tgccaagaaa 1620attgtcatac cagataaatt tatccagcat atctag 165653833PRTSaccharomyces cerevisiae 53Met Ile Thr Leu Leu Leu Tyr Leu Cys Val Ile Cys Asn Ala Ile Val1 5 10 15Leu Ile Arg Ala Asp Ser Ile Ala Asp Pro Trp Pro Glu Ala Arg His 20 25 30Leu Leu Asn Thr Ile Ala Lys Ser Arg Asp Pro Met Lys Glu Ala Ala 35 40 45Met Glu Pro Asn Ala Asp Glu Phe Val Gly Phe Tyr Val Pro Met Asp 50 55 60Tyr Ser Pro Arg Asn Glu Glu Lys Asn Tyr Gln Ser Ile Trp Gln Asn65 70 75 80Glu Ile Thr Asp Ser Gln Arg His Ile Tyr Glu Leu Leu Val Gln Ser 85 90 95Ser Glu Gln Phe Asn Asn Ser Glu Ala Thr Tyr Thr Leu Ser Gln Ile 100 105 110His Leu Trp Ser Gln Tyr Asn Phe Pro His Asn Met Thr Leu Ala His 115 120 125Lys Tyr Leu Glu Lys Phe Asn Asp Leu Thr His Phe Thr Asn His Ser 130 135 140Ala Ile Phe Asp Leu Ala Val Met Tyr Ala Thr Gly Gly Cys Ala Ser145 150 155 160Gly Asn Asp Gln Thr Val Ile Pro Gln Asp Ser Ala Lys Ala Leu Leu 165 170 175Tyr Tyr Gln Arg Ala Ala Gln Leu Gly Asn Leu Lys Ala Lys Gln Val 180 185 190Leu Ala Tyr Lys Tyr Tyr Ser Gly Phe Asn Val Pro Arg Asn Phe His 195 200 205Lys Ser Leu Val Leu Tyr Arg Asp Ile Ala Glu Gln Leu Arg Lys Ser 210 215 220Tyr Ser Arg Asp Glu Trp Asp Ile Val Phe Pro Tyr Trp Glu Ser Tyr225 230 235 240Asn Val Arg Ile Ser Asp Phe Glu Ser Gly Leu Leu Gly Lys Gly Leu 245 250 255Asn Ser Val Pro Ser Ser Thr Val Arg Lys Arg Thr Thr Arg Pro Asp 260 265 270Ile Gly Ser Pro Phe Ile Ala Gln Val Asn Gly Val Gln Met Thr Leu 275 280 285Gln Ile Glu Pro Met Gly Arg Phe Ala Phe Asn Gly Asn Asp Gly Asn 290 295 300Ile Asn Gly Asp Glu Asp Asp Glu Asp Ala Ser Glu Arg Arg Ile Ile305 310 315 320Arg Ile Tyr Tyr Ala Ala Leu Asn Asp Tyr Lys Gly Thr Tyr Ser Gln 325 330 335Ser Arg Asn Cys Glu Arg Ala Lys Asn Leu Leu Glu Leu Thr Tyr Lys 340 345 350Glu Phe Gln Pro His Val Asp Asn Leu Asp Pro Leu Gln Val Phe Tyr 355 360 365Tyr Val Arg Cys Leu Gln Leu Leu Gly His Met Tyr Phe Thr Gly Glu 370 375 380Gly Ser Ser Lys Pro Asn Ile His Met Ala Glu Glu Ile Leu Thr Thr385 390 395 400Ser Leu Glu Ile Ser Arg Arg Ala Gln Gly Pro Ile Gly Arg Ala Cys 405 410 415Ile Asp Leu Gly Leu Ile Asn Gln Tyr Ile Thr Asn Asn Ile Ser Gln 420 425 430Ala Ile Ser Tyr Tyr Met Lys Ala Met Lys Thr Gln Ala Asn Asn Gly 435 440 445Ile Val Glu Phe Gln Leu Ser Lys Leu Ala Thr Ser Phe Pro Glu Glu 450 455 460Lys Ile Gly Asp Pro Phe Asn Leu Met Glu Thr Ala Tyr Leu Asn Gly465 470 475 480Phe Ile Pro Ala Ile Tyr Glu Phe Ala Val Met Ile Glu Ser Gly Met 485 490 495Asn Ser Lys Ser Ser Val Glu Asn Thr Ala Tyr Leu Phe Lys Thr Phe 500 505 510Val Asp Lys Asn Glu Ala Ile Met Ala Pro Lys Leu Arg Thr Ala Phe 515 520 525Ala Ala Leu Ile Asn Asp Arg Ser Glu Val Ala Leu Trp Ala Tyr Ser 530 535 540Gln Leu Ala Glu Gln Gly Tyr Glu Thr Ala Gln Val Ser Ala Ala Tyr545 550 555 560Leu Met Tyr Gln Leu Pro Tyr Glu Phe Glu Asp Pro Pro Arg Thr Thr 565 570 575Asp Gln Arg Lys Thr Leu Ala Ile Ser Tyr Tyr Thr Arg Ala Phe Lys 580 585 590Gln Gly Asn Ile Asp Ala Gly Val Val Ala Gly Asp Ile Tyr Phe Gln 595 600 605Met Gln Asn Tyr Ser Lys Ala Met Ala Leu Tyr Gln Gly Ala Ala Leu 610 615 620Lys Tyr Ser Ile Gln Ala Ile Trp Asn Leu Gly Tyr Met His Glu His625 630 635 640Gly Leu Gly Val Asn Arg Asp Phe His Leu Ala Lys Arg Tyr Tyr Asp 645 650 655Gln Val Ser Glu His Asp His Arg Phe Tyr Leu Ala Ser Lys Leu Ser 660 665 670Val Leu Lys Leu His Leu Lys Ser Trp Leu Thr Trp Ile Thr Arg Glu 675 680 685Lys Val Asn Tyr Trp Lys Pro Ser Ser Pro Leu Asn Pro Asn Glu Asp 690 695 700Thr Gln His Ser Lys Thr Ser Trp Tyr Lys Gln Leu Thr Lys Ile Leu705 710 715 720Gln Arg Met Arg His Lys Glu Asp Ser Asp Lys Ala Ala Glu Asp Ser 725 730 735His Lys His Arg Thr Val Val Gln Asn Gly Ala Asn His Arg Gly Asp 740 745 750Asp Gln Glu Glu Ala Ser Glu Ile Leu Gly Phe Gln Met Glu Asp Leu 755 760 765Val Thr Met Gly Cys Ile Leu Gly Ile Phe Leu Leu Ser Ile Leu Met 770 775 780Ser Thr Leu Ala Ala Arg Arg Gly Trp Asn Val Arg Phe Asn Gly Ala785 790 795 800Gln Leu Asn Ala Asn Gly Asn Arg Gln Gln Glu Gln Gln Gln Gln Gln 805 810 815Gln Ala Gln Gly Pro Pro Gly Trp Asp Phe Asn Val Gln Ile Phe Ala 820 825 830Ile 542502DNASaccharomyces cerevisiae 54atgataacac tcttattata cctgtgcgta atatgtaacg caatagtgtt aataagggct 60gattcgatag cggacccttg gcctgaagcg cgacatctac taaataccat agctaagtcc 120agagacccaa tgaaagaagc tgctatggaa cccaatgcag atgaatttgt tggattctat 180gtaccgatgg attattcccc acgtaatgag gaaaaaaact accagagcat ttggcaaaac 240gaaatcacag attctcaacg tcatatttat gaattacttg tacaatcaag tgaacaattc 300aacaactcag aagcaacata tacacttagc cagattcacc tttggagtca atataatttc 360ccgcataata tgactttggc acacaaatac ttagaaaaat tcaatgatct aacccacttc 420accaatcatt cggccatctt cgacttagct gtgatgtatg ccactggggg atgtgcttct 480ggtaatgatc aaaccgtgat ccctcaggat tctgctaaag cactgctata ttaccaaagg 540gctgcccaac tagggaattt aaaggctaag caagtgctag cttataaata ctattctggc 600ttcaatgtcc cacgaaattt tcataaatct ttagtattgt acagggacat tgctgaacag 660ctgagaaagt cgtactccag ggacgaatgg gatattgtct tcccctattg ggaaagttac 720aacgtgagaa tatcggattt tgagagtggc ctattaggta aaggtttgaa ttccgttcca 780tcttctacag taaggaaaag aactacgaga ccagatattg gttcaccctt tattgcgcaa 840gttaacggtg tacagatgac cttgcaaatc gaaccgatgg gtaggttcgc tttcaacggt 900aacgatggca acataaatgg cgacgaagat gacgaggatg ccagtgaaag acgaatcatt 960cggatatatt atgcagcttt gaatgattat aaaggaacat attcacaaag cagaaattgt 1020gagcgcgcca aaaacttgtt ggaattaacg tacaaggaat ttcagcctca tgtcgacaat 1080ttggatcctt tgcaagtatt ttactacgtc cgttgcttac aattattggg gcacatgtat 1140ttcaccggcg aaggctcctc gaagcctaat attcatatgg ccgaagagat cctgaccacg 1200tcgctagaaa taagcagaag ggcacaggga cctataggta gagcgtgcat agatctgggc 1260ttaataaatc aatacatcac aaacaatatt tctcaagcaa tttcgtatta tatgaaagct 1320atgaaaacac aagctaacaa tggaatcgta gaattccaat tatccaaatt ggccacttca 1380ttccctgaag aaaaaatcgg cgacccattt aacttaatgg aaactgccta cttgaatgga 1440ttcattccag ccatatatga gtttgcagta atgatcgaat ctggaatgaa cagtaagagt 1500agtgtggaaa acactgctta cctgttcaaa acattcgttg acaaaaacga agctattatg 1560gcacctaaac tgaggacagc atttgccgca ttaatcaacg atcgttcaga agtggcttta 1620tgggcttatt cccaactagc cgagcaaggc tacgagactg ctcaagtctc tgccgcctac 1680ttaatgtacc agttgccata tgagtttgag gatcctccaa gaaccacaga tcagagaaaa 1740actttggcaa tttcctacta tacaagagcg tttaaacagg gaaatataga tgctggtgtt 1800gtcgcgggag atatctattt tcagatgcag aattacagta aagctatggc tctttatcag 1860ggtgcagctt tgaagtactc tatacaggct atctggaact tagggtacat gcatgagcat 1920gggctaggtg taaacagaga tttccatctt gctaaacgtt actacgacca agtttcagaa 1980cacgatcata gattttactt ggcttccaaa ttgagtgttt taaaattaca cctaaagtca 2040tggttgactt ggatcaccag agaaaaagta aactactgga aaccttcctc gccacttaac 2100cctaacgaag atactcagca ctcgaagact tcatggtaca agcaattgac gaagattcta 2160caaagaatga gacataagga ggatagtgac aaagctgcgg aagattctca caaacacaga 2220actgtagtgc agaatggagc taaccatagg ggtgacgacc aagaggaggc ttccgagatt 2280ttgggcttcc aaatggagga tcttgttacg atgggatgta tcttggggat attcctatta 2340agtatattaa tgagtacact ggcggcccgt agaggctgga atgtccgttt caatggagca 2400caattaaatg caaatggtaa ccggcagcaa gagcaacaac aacaacaaca agcacaaggt 2460cccccgggct gggacttcaa tgttcagata ttcgccatat ga 250255165PRTSaccharomyces cerevisiae 55Met Ser Lys Thr Ala Gln Lys Arg Leu Leu Lys Glu Leu Gln Gln Leu1 5 10 15Ile Lys Asp Ser Pro Pro Gly Ile Val Ala Gly Pro Lys Ser Glu Asn 20 25 30Asn Ile Phe Ile Trp Asp Cys Leu Ile Gln Gly Pro Pro Asp Thr Pro 35 40 45Tyr Ala Asp Gly Val Phe Asn Ala Lys Leu Glu Phe Pro Lys Asp Tyr 50 55 60Pro Leu Ser Pro Pro Lys Leu Thr Phe Thr Pro Ser Ile Leu His Pro65 70 75 80Asn Ile Tyr Pro Asn Gly Glu Val Cys Ile Ser Ile Leu His Ser Pro 85 90 95Gly Asp Asp Pro Asn Met Tyr Glu Leu Ala Glu Glu Arg Trp Ser Pro 100 105 110Val Gln Ser Val Glu Lys Ile Leu Leu Ser Val Met Ser Met Leu Ser 115 120 125Glu Pro Asn Ile Glu Ser Gly Ala Asn Ile Asp Ala Cys Ile Leu Trp 130 135 140Arg Asp Asn Arg Pro Glu Phe Glu Arg Gln Val Lys Leu Ser Ile Leu145 150 155 160Lys Ser Leu Gly Phe 16556498DNASaccharomyces cerevisiae 56atgtcgaaaa ccgctcagaa acgtctcctc aaggagcttc aacagttaat taaagattct 60ccacctggta tagtggctgg tcccaaatcg gagaataaca tattcatttg ggactgccta 120attcaagggc ctccagatac gccatacgct gatggtgttt ttaatgctaa gctagagttt 180cctaaagact atccgttatc tccacctaaa cttactttca cacccagcat actacatcca 240aatatttatc caaatgggga agtgtgcata tccattctac actcccctgg tgatgatcct 300aacatgtacg aattagcgga agaaagatgg tcgccagtgc aaagtgtaga aaaaattcta 360ttaagtgtta tgagcatgtt

gagtgagccc aatatcgaaa gtggtgccaa cattgatgct 420tgcatcttgt ggagagataa tagacctgaa tttgagagac aggtaaagtt atccattttg 480aaatcattag gattctga 49857926PRTSaccharomyces cerevisiae 57Met Glu Gln Asn Ile Ile Ser Thr Ile Arg Asp Glu Cys Ile Arg His1 5 10 15Arg Ser Lys Tyr Leu Thr Ile Ala Gln Leu Thr Ala Ile Ala Glu Ala 20 25 30Lys Ile Asn Glu Phe Ile Ile Thr Gly Lys Ala Lys Asp Gln Asp Leu 35 40 45Ser Ser Leu Leu Asp Lys Cys Ile Asp Ile Leu Ser Ile Tyr Lys Lys 50 55 60Asn Ser Lys Asp Ile Lys Asn Ile Ile Ser Cys Lys Asn Lys Gly Ala65 70 75 80Met Ile Ser Ser Asn Ser Val Met Ile Ile Gln Leu Asn Tyr Val Tyr 85 90 95Tyr Lys Val Ile His Ile Ile Val Thr Thr Asn Ile Pro His Leu Ser 100 105 110Glu Phe Ala Lys Ile Lys Leu His Lys Ser Thr Ser Asp Glu Gly Asn 115 120 125Gly Asn Asn Asn Asn Asn Glu Phe Gln Leu Met Asn Ile Tyr Asn Thr 130 135 140Leu Leu Glu Thr Leu Leu Lys Asp Glu Asn Ile Ala Lys Ile Lys Ser145 150 155 160Phe Ile Lys Ser Ser Ile Lys Gln Thr Lys Leu Asn His Glu Gln Glu 165 170 175Glu Cys Asn Leu Met Arg Thr Gly Ser Tyr Ile Thr Ser Asn Gln Leu 180 185 190Asn Ser Leu Ile Ser Ser Ser Ala Asn Ser Ala Ser Ser Gln Met Glu 195 200 205Ile Leu Leu Ile Asp Ile Arg Ser Arg Leu Glu Phe Asn Lys Ser His 210 215 220Ile Asp Thr Lys Asn Ile Ile Cys Leu Glu Pro Ile Ser Phe Lys Met225 230 235 240Ser Tyr Ser Asp His Asp Leu Glu Lys Lys Ser Leu Ile Thr Ser Pro 245 250 255Asn Ser Glu Ile Lys Met Phe Gln Ser Arg Asn Leu Phe Lys Phe Ile 260 265 270Ile Leu Tyr Thr Asp Ala Asn Glu Tyr Asn Val Lys Gln Gln Ser Val 275 280 285Leu Leu Asp Ile Leu Val Asn His Ser Phe Glu Lys Pro Ile Ser Asp 290 295 300Asp Phe Thr Lys Ile Phe Ile Leu Glu Ser Gly Phe Pro Gly Trp Leu305 310 315 320Lys Ser Asn Tyr Gly Arg Gln Val Ser Ser Ser Phe Pro Ser Asn Asn 325 330 335Asn Ile Lys Asp Asp Ser Val Tyr Ile Asn Gly Asn Thr Ser Gly Leu 340 345 350Ser Leu Gln His Leu Pro Lys Met Ser Pro Ser Ile Arg His Ser Met 355 360 365Asp Asp Ser Met Lys Glu Met Leu Val Ala Pro Thr Pro Leu Asn His 370 375 380Leu Gln Gln Gln Gln Gln Gln Gln Ser Asp Asn Asp His Val Leu Lys385 390 395 400Arg Ser Ser Ser Phe Lys Lys Leu Phe Ser Asn Tyr Thr Ser Pro Asn 405 410 415Pro Lys Asn Ser Asn Ser Asn Leu Tyr Ser Ile Ser Ser Leu Ser Ile 420 425 430Ser Ser Ser Pro Ser Pro Leu Pro Leu His Ser Pro Asp Pro Val Lys 435 440 445Gly Asn Ser Leu Pro Ile Asn Tyr Pro Glu Thr Pro His Leu Trp Lys 450 455 460Asn Ser Glu Thr Asp Phe Met Thr Asn Gln Arg Glu Gln Leu Asn His465 470 475 480Asn Ser Phe Ala His Ile Ala Pro Ile Asn Thr Lys Ala Ile Thr Ser 485 490 495Pro Ser Arg Thr Ala Thr Pro Lys Leu Gln Arg Phe Pro Gln Thr Ile 500 505 510Ser Met Asn Leu Asn Met Asn Ser Asn Gly His Ser Ser Ala Thr Ser 515 520 525Thr Ile Gln Pro Ser Cys Leu Ser Leu Ser Asn Asn Asp Ser Leu Asp 530 535 540His Thr Asp Val Thr Pro Thr Ser Ser His Asn Tyr Asp Leu Asp Phe545 550 555 560Ala Val Gly Leu Glu Asn Leu Gly Asn Ser Cys Tyr Met Asn Cys Ile 565 570 575Ile Gln Cys Ile Leu Gly Thr His Glu Leu Thr Gln Ile Phe Leu Asp 580 585 590Asp Ser Tyr Ala Lys His Ile Asn Ile Asn Ser Lys Leu Gly Ser Lys 595 600 605Gly Ile Leu Ala Lys Tyr Phe Ala Arg Leu Val His Met Met Tyr Lys 610 615 620Glu Gln Val Asp Gly Ser Lys Lys Ile Ser Ile Ser Pro Ile Lys Phe625 630 635 640Lys Leu Ala Cys Gly Ser Val Asn Ser Leu Phe Lys Thr Ala Ser Gln 645 650 655Gln Asp Cys Gln Glu Phe Cys Gln Phe Leu Leu Asp Gly Leu His Glu 660 665 670Asp Leu Asn Gln Cys Gly Ser Asn Pro Pro Leu Lys Glu Leu Ser Gln 675 680 685Glu Ala Glu Ala Arg Arg Glu Lys Leu Ser Leu Arg Ile Ala Ser Ser 690 695 700Ile Glu Trp Glu Arg Phe Leu Thr Thr Asp Phe Ser Val Ile Val Asp705 710 715 720Leu Phe Gln Gly Gln Tyr Ala Ser Arg Leu Lys Cys Lys Val Cys Ser 725 730 735His Thr Ser Thr Thr Tyr Gln Pro Phe Thr Val Leu Ser Ile Pro Ile 740 745 750Pro Lys Lys Asn Ser Arg Asn Asn Ile Thr Ile Glu Asp Cys Phe Arg 755 760 765Glu Phe Thr Lys Cys Glu Asn Leu Glu Val Asp Glu Gln Trp Leu Cys 770 775 780Pro His Cys Glu Lys Arg Gln Pro Ser Thr Lys Gln Leu Thr Ile Thr785 790 795 800Arg Leu Pro Arg Asn Leu Ile Val His Leu Lys Arg Phe Asp Asn Leu 805 810 815Leu Asn Lys Asn Asn Asp Phe Val Ile Tyr Pro Phe Leu Leu Asp Leu 820 825 830Thr Pro Phe Trp Ala Asn Asp Phe Asp Gly Val Phe Pro Pro Gly Val 835 840 845Asn Asp Asp Glu Leu Pro Ile Arg Gly Gln Ile Pro Pro Phe Lys Tyr 850 855 860Glu Leu Tyr Gly Val Ala Cys His Phe Gly Thr Leu Tyr Gly Gly His865 870 875 880Tyr Thr Ala Tyr Val Lys Lys Gly Leu Lys Lys Gly Trp Leu Tyr Phe 885 890 895Asp Asp Thr Lys Tyr Lys Pro Val Lys Asn Lys Ala Asp Ala Ile Asn 900 905 910Ser Asn Ala Tyr Val Leu Phe Tyr His Arg Val Tyr Gly Val 915 920 925582781DNASaccharomyces cerevisiae 58atggagcaga atattattag taccataagg gatgagtgta ttcgtcaccg gtcgaagtac 60cttacgatag cacaactaac cgctattgca gaggctaaaa ttaacgaatt catcataact 120ggtaaggcaa aagatcaaga tttgagcagt cttctagata aatgcatcga tattttatct 180atttacaaga agaactcgaa agatatcaaa aatattatat cgtgcaaaaa taagggtgca 240atgattagtt caaattccgt aatgattatt caattaaatt atgtttacta caaggtaatt 300cacattattg taacaaccaa tattcctcat ttaagtgaat tcgccaagat taaattacat 360aagagcacga gtgatgaggg caacggtaat aacaacaata atgaatttca actcatgaac 420atttacaaca ctttgctgga aaccttatta aaagatgaaa acattgcaaa aataaaaagt 480ttcattaagt cttccataaa acaaacaaaa ttgaaccatg agcaagaaga atgtaacctg 540atgagaacgg gttcctatat cacttccaat caattaaact ccctaataag ttcatcagca 600aattctgctt cctcccaaat ggagatacta ctgatagata tacgatcaag gttggaattc 660aacaagtcac atattgatac aaaaaatatt atatgcctgg agcctatttc ttttaaaatg 720tcatattcag atcatgattt ggagaaaaaa tcattaatta cttctcctaa tagtgagatt 780aaaatgtttc aaagtagaaa tcttttcaag tttatcattc tctatacaga cgcaaacgaa 840tacaatgtta aacagcagtc tgtcctgttg gacattctgg tgaatcattc ctttgaaaaa 900ccaatatccg atgactttac caaaattttc attctggaat ctggttttcc aggttggctt 960aagtcaaatt atgggaggca agtatcatca tcttttccat caaataacaa tattaaagat 1020gatagtgttt atattaatgg taacacttct ggcctaagtt tacaacattt acctaagatg 1080tctcccagta taagacattc aatggacgac tctatgaaag aaatgctagt tgcgcctact 1140ccattaaatc atcttcaaca acagcaacaa cagcaatcag acaatgatca tgtgctaaaa 1200agatcttcaa gtttcaaaaa attattctca aattatacgt ctcctaatcc gaagaattca 1260aattcaaact tatattctat atcttcgttg tccatatcta gttcaccatc gcctttacct 1320ctacattcgc ctgacccagt taagggcaat tcattgccaa tcaattatcc ggaaacgcca 1380catctttgga aaaacagtga gacagatttt atgacaaatc aaagagaaca gttgaatcac 1440aactcttttg ctcacatagc tcctatcaac acgaaggcca tcacttctcc atcaagaact 1500gccacaccga agttacaacg cttcccgcaa acaattagta tgaaccttaa tatgaactcc 1560aatggacaca gttctgccac ctctaccatt caaccttcgt gtctatcctt gtctaataat 1620gactctttag atcatacaga tgttacacca acttcttctc ataattatga ccttgatttc 1680gcggttggtt tggaaaatct aggaaattcg tgttacatga actgtatcat tcagtgtatc 1740ttaggtacac acgaattaac ccaaatcttt ttggacgatt catatgctaa acacatcaat 1800attaatagta agttgggatc gaaaggtatt ctggcaaaat attttgcaag gttggttcat 1860atgatgtata aggaacaggt tgatggttca aagaaaattt ccatatcacc gataaaattt 1920aaattggcat gtggatctgt taactcatta tttaagactg catcccaaca ggactgccaa 1980gagttttgcc aattccttct agatggtctt catgaagact tgaaccaatg cggttcaaac 2040ccacctttga aggagctttc tcaagaagct gaggcgagaa gagaaaaact gtctttgcga 2100attgcctcgt caattgagtg ggaacgattc ttgactactg atttcagtgt tattgtcgac 2160ttatttcagg gacaatacgc ctcacgacta aaatgtaaag tctgtagtca tacctcgaca 2220acataccaac cttttacggt gctgtcaatc cctattccta aaaaaaattc ccgaaataat 2280attaccattg aagattgttt cagagagttc accaaatgtg agaacttgga agtggatgag 2340caatggttgt gcccacattg tgaaaaaagg cagccctcca cgaaacaatt gacaataacg 2400agattaccga ggaatctgat agtccattta aagagatttg ataatttatt aaacaaaaat 2460aatgacttcg tcatataccc ttttttgttg gacttgactc cattttgggc caatgatttt 2520gacggggttt ttcctccagg tgttaatgac gatgaactac caataagggg acaaatacca 2580ccttttaagt atgaattata tggtgtagca tgccactttg gtactttgta tggtggtcat 2640tatacagcct atgtgaaaaa gggattaaag aagggatggc tatattttga tgataccaaa 2700tataaacctg tcaaaaacaa agccgatgca attaactcta atgcatacgt tttgttttat 2760caccgcgtct acggtgtttg a 278159238PRTSaccharomyces cerevisiae 59Met Glu Met Thr Asp Phe Glu Leu Thr Ser Asn Ser Gln Ser Asn Leu1 5 10 15Ala Ile Pro Thr Asn Phe Lys Ser Thr Leu Pro Pro Arg Lys Arg Ala 20 25 30Lys Thr Lys Glu Glu Lys Glu Gln Arg Arg Ile Glu Arg Ile Leu Arg 35 40 45Asn Arg Arg Ala Ala His Gln Ser Arg Glu Lys Lys Arg Leu His Leu 50 55 60Gln Tyr Leu Glu Arg Lys Cys Ser Leu Leu Glu Asn Leu Leu Asn Ser65 70 75 80Val Asn Leu Glu Lys Leu Ala Asp His Glu Asp Ala Leu Thr Cys Ser 85 90 95His Asp Ala Phe Val Ala Ser Leu Asp Glu Tyr Arg Asp Phe Gln Ser 100 105 110Thr Arg Gly Ala Ser Leu Asp Thr Arg Ala Ser Ser His Ser Ser Ser 115 120 125Asp Thr Phe Thr Pro Ser Pro Leu Asn Cys Thr Met Glu Pro Ala Thr 130 135 140Leu Ser Pro Lys Ser Met Arg Asp Ser Ala Ser Asp Gln Glu Thr Ser145 150 155 160Trp Glu Leu Gln Met Phe Lys Thr Glu Asn Val Pro Glu Ser Thr Thr 165 170 175Leu Pro Ala Val Asp Asn Asn Asn Leu Phe Asp Ala Val Ala Ser Pro 180 185 190Leu Ala Asp Pro Leu Cys Asp Asp Ile Ala Gly Asn Ser Leu Pro Phe 195 200 205Asp Asn Ser Ile Asp Leu Asp Asn Trp Arg Asn Pro Glu Ala Gln Ser 210 215 220Gly Leu Asn Ser Phe Glu Leu Asn Asp Phe Phe Ile Thr Ser225 230 23560717DNASaccharomyces cerevisiae 60atggaaatga ctgattttga actaactagt aattcgcaat cgaacttggc tatccctacc 60aacttcaagt cgactctgcc tccaaggaaa agagccaaga caaaagagga aaaggaacag 120cgaaggatcg agcgtatttt gagaaacaga agagctgctc accagagcag agagaaaaaa 180agactacatc tgcagtatct cgagagaaaa tgttctcttt tggaaaattt actgaacagc 240gtcaaccttg aaaaactggc tgaccacgaa gacgcgttga cttgcagcca cgacgctttt 300gttgcttctc ttgacgagta cagggatttc cagagcacga ggggcgcttc actggacacc 360agggccagtt cgcactcgtc gtctgatacg ttcacacctt cacctctgaa ctgtacaatg 420gagcctgcga ctttgtcgcc caagagtatg cgcgattccg cgtcggacca agagacttca 480tgggagctgc agatgtttaa gacggaaaat gtaccagagt cgacgacgct acctgccgta 540gacaacaaca atttgtttga tgcggtggcc tcgccgttgg cagacccact ctgcgacgat 600atagcgggaa acagtctacc ctttgacaat tcaattgatc ttgacaattg gcgtaatcca 660gaagcgcagt caggtttgaa ttcatttgaa ttgaatgatt tcttcatcac ttcatga 71761663PRTSaccharomyces cerevisiae 61Met Pro Thr Asn Tyr Glu Tyr Asp Glu Ala Ser Glu Thr Trp Pro Ser1 5 10 15Phe Ile Leu Thr Gly Leu Leu Met Val Val Gly Pro Met Thr Leu Leu 20 25 30Gln Ile Tyr Gln Ile Phe Phe Gly Ala Asn Ala Glu Asp Gly Asn Ser 35 40 45Gly Lys Ser Lys Glu Phe Asn Glu Glu Val Phe Lys Asn Leu Asn Glu 50 55 60Glu Tyr Thr Ser Asp Glu Ile Lys Gln Phe Arg Arg Lys Phe Asp Lys65 70 75 80Asn Ser Asn Lys Lys Ser Lys Ile Trp Ser Arg Arg Asn Ile Ile Ile 85 90 95Ile Val Gly Trp Ile Leu Val Ala Ile Leu Leu Gln Arg Ile Asn Ser 100 105 110Asn Asp Ala Ile Lys Asp Ala Ala Thr Lys Leu Phe Asp Pro Tyr Glu 115 120 125Ile Leu Gly Ile Ser Thr Ser Ala Ser Asp Arg Asp Ile Lys Ser Ala 130 135 140Tyr Arg Lys Leu Ser Val Lys Phe His Pro Asp Lys Leu Ala Lys Gly145 150 155 160Leu Thr Pro Asp Glu Lys Ser Val Met Glu Glu Thr Tyr Val Gln Ile 165 170 175Thr Lys Ala Tyr Glu Ser Leu Thr Asp Glu Leu Val Arg Gln Asn Tyr 180 185 190Leu Lys Tyr Gly His Pro Asp Gly Pro Gln Ser Thr Ser His Gly Ile 195 200 205Ala Leu Pro Arg Phe Leu Val Asp Gly Ser Ala Ser Pro Leu Leu Val 210 215 220Val Cys Tyr Val Ala Leu Leu Gly Leu Ile Leu Pro Tyr Phe Val Ser225 230 235 240Arg Trp Trp Ala Arg Thr Gln Ser Tyr Thr Lys Lys Gly Ile His Asn 245 250 255Val Thr Ala Ser Asn Phe Val Ser Asn Leu Val Asn Tyr Lys Pro Ser 260 265 270Glu Ile Val Thr Thr Asp Leu Ile Leu His Trp Leu Ser Phe Ala His 275 280 285Glu Phe Lys Gln Phe Phe Pro Asp Leu Gln Pro Thr Asp Phe Glu Lys 290 295 300Leu Leu Gln Asp His Ile Asn Arg Arg Asp Ser Gly Lys Leu Asn Asn305 310 315 320Ala Lys Phe Arg Ile Val Ala Lys Cys His Ser Leu Leu His Gly Leu 325 330 335Leu Asp Ile Ala Cys Gly Phe Arg Asn Leu Asp Ile Ala Leu Gly Ala 340 345 350Ile Asn Thr Phe Lys Cys Ile Val Gln Ala Val Pro Leu Thr Pro Asn 355 360 365Cys Gln Ile Leu Gln Leu Pro Asn Val Asp Lys Glu His Phe Ile Thr 370 375 380Lys Thr Gly Asp Ile His Thr Leu Gly Lys Leu Phe Thr Leu Glu Asp385 390 395 400Ala Lys Ile Gly Glu Val Leu Gly Ile Lys Asp Gln Ala Lys Leu Asn 405 410 415Glu Thr Leu Arg Val Ala Ser His Ile Pro Asn Leu Lys Ile Ile Lys 420 425 430Ala Asp Phe Leu Val Pro Gly Glu Asn Gln Val Thr Pro Ser Ser Thr 435 440 445Pro Tyr Ile Ser Leu Lys Val Leu Val Arg Ser Ala Lys Gln Pro Leu 450 455 460Ile Pro Thr Ser Leu Ile Pro Glu Glu Asn Leu Thr Glu Pro Gln Asp465 470 475 480Phe Glu Ser Gln Arg Asp Pro Phe Ala Met Met Ser Lys Gln Pro Leu 485 490 495Val Pro Tyr Ser Phe Ala Pro Phe Phe Pro Thr Lys Arg Arg Gly Ser 500 505 510Trp Cys Cys Leu Val Ser Ser Gln Lys Asp Gly Lys Ile Leu Gln Thr 515 520 525Pro Ile Ile Ile Glu Lys Leu Ser Tyr Lys Asn Leu Asn Asp Asp Lys 530 535 540Asp Phe Phe Asp Lys Arg Ile Lys Met Asp Leu Thr Lys His Glu Lys545 550 555 560Phe Asp Ile Asn Asp Trp Glu Ile Gly Thr Ile Lys Ile Pro Leu Gly 565 570 575Gln Pro Ala Pro Glu Thr Val Gly Asp Phe Phe Phe Arg Val Ile Val 580 585 590Lys Ser Thr Asp Tyr Phe Thr Thr Asp Leu Asp Ile Thr Met Asn Met 595 600 605Lys Val Arg Asp Ser Pro Ala Val Glu Gln Val Glu Val Tyr Ser Glu 610 615 620Glu Asp Asp Glu Tyr Ser Thr Asp Asp Asp Glu Thr Glu Ser Asp Asp625 630 635 640Glu Ser Asp Ala Ser Asp Tyr Thr Asp Ile Asp Thr Asp Thr Glu Ala 645 650 655Glu Asp Asp Glu Ser Pro Glu 660621992DNASaccharomyces cerevisiae 62atgcctacaa attacgagta tgatgaggct agtgagacgt ggccgtcctt cattttaacg 60gggctcttga tggtcgtcgg

gcctatgaca ctgcttcaaa tataccaaat tttttttggg 120gccaatgctg aagatgggaa ttcagggaag agtaaggagt ttaatgagga agttttcaag 180aacttgaatg aagaatacac cagtgatgaa atcaaacaat ttagaaggaa gtttgataaa 240aatagtaata agaagtccaa aatatggagc aggagaaata ttataattat tgtgggttgg 300atcttagttg caattcttct gcaaaggatt aatagtaatg acgcgattaa agacgctgct 360acaaaattat ttgatcctta tgaaatcctt ggtatctcta ctagtgcttc cgatagagac 420atcaaatctg cttatagaaa attatctgtt aaatttcatc cagataaatt agcaaagggc 480ctaacacctg atgagaaaag tgtgatggaa gaaacttatg ttcagattac gaaggcttac 540gaatccctta ctgacgaatt ggttaggcaa aactatttga aatacggtca tccagatggc 600ccacaatcta cttcacatgg tatcgctcta ccaagatttt tggtagatgg aagtgcatct 660ccattattag tggtttgtta tgttgcgcta ctaggtttaa tcttgccata ttttgttagt 720agatggtggg caagaacaca atcgtatact aagaagggaa tacataatgt gacggcttct 780aattttgtta gtaacttagt caattacaag ccatctgaga ttgtcaccac agatttgatc 840ttacactggt tatcatttgc tcatgaattt aaacaattct tcccggattt gcaaccaacg 900gattttgaaa aacttttgca agatcatatt aaccgcagag atagtggtaa acttaacaat 960gcgaaattta gaatagtggc caaatgtcac tctttgttac acggtttatt ggatattgct 1020tgtggattca gaaatttaga tattgcattg ggtgcaatca atactttcaa gtgtattgtt 1080caggctgtac cattaacacc aaactgtcaa atccttcaat tgccgaacgt agataaagag 1140cactttatta ccaaaaccgg agatattcat acattaggta aattgtttac tttagaagat 1200gccaagattg gtgaggttct tggaataaag gatcaagcaa agttaaacga aactttgaga 1260gttgcatcgc atattccaaa tctaaagatc atcaaggcag acttccttgt cccaggtgag 1320aaccaagtaa caccatcatc taccccatac atttctttga aagtactggt tcgttctgct 1380aaacagccat tgataccaac tagcttaatt cctgaagaaa atttaacaga acctcaagat 1440tttgaatctc aaagagatcc atttgctatg atgagtaaac agccactcgt cccatattcc 1500tttgcaccat ttttccctac aaagagacgt gggagttggt gctgtctggt aagttctcaa 1560aaagatggta aaatacttca aacgccaatt atcattgaaa agctatctta caagaacttg 1620aacgatgaca aagatttctt tgataagagg ataaaaatgg atttaaccaa acacgaaaaa 1680ttcgatataa atgattggga aatcgggacc ataaaaattc cattaggtca gcctgcacct 1740gaaactgttg gtgatttctt ttttagagta atcgttaaat ccacagatta tttcactaca 1800gatttggata ttaccatgaa tatgaaagtt cgtgattctc ctgcagtgga acaagtagag 1860gtgtattctg aggaggatga tgagtactct actgatgacg acgaaaccga aagtgatgat 1920gaaagtgatg ctagcgatta tactgatatc gatacggata cagaagctga agatgatgaa 1980tcaccagaat ag 199263409PRTSaccharomyces cerevisiae 63Met Val Lys Glu Thr Lys Phe Tyr Asp Ile Leu Gly Val Pro Val Thr1 5 10 15Ala Thr Asp Val Glu Ile Lys Lys Ala Tyr Arg Lys Cys Ala Leu Lys 20 25 30Tyr His Pro Asp Lys Asn Pro Ser Glu Glu Ala Ala Glu Lys Phe Lys 35 40 45Glu Ala Ser Ala Ala Tyr Glu Ile Leu Ser Asp Pro Glu Lys Arg Asp 50 55 60Ile Tyr Asp Gln Phe Gly Glu Asp Gly Leu Ser Gly Ala Gly Gly Ala65 70 75 80Gly Gly Phe Pro Gly Gly Gly Phe Gly Phe Gly Asp Asp Ile Phe Ser 85 90 95Gln Phe Phe Gly Ala Gly Gly Ala Gln Arg Pro Arg Gly Pro Gln Arg 100 105 110Gly Lys Asp Ile Lys His Glu Ile Ser Ala Ser Leu Glu Glu Leu Tyr 115 120 125Lys Gly Arg Thr Ala Lys Leu Ala Leu Asn Lys Gln Ile Leu Cys Lys 130 135 140Glu Cys Glu Gly Arg Gly Gly Lys Lys Gly Ala Val Lys Lys Cys Thr145 150 155 160Ser Cys Asn Gly Gln Gly Ile Lys Phe Val Thr Arg Gln Met Gly Pro 165 170 175Met Ile Gln Arg Phe Gln Thr Glu Cys Asp Val Cys His Gly Thr Gly 180 185 190Asp Ile Ile Asp Pro Lys Asp Arg Cys Lys Ser Cys Asn Gly Lys Lys 195 200 205Val Glu Asn Glu Arg Lys Ile Leu Glu Val His Val Glu Pro Gly Met 210 215 220Lys Asp Gly Gln Arg Ile Val Phe Lys Gly Glu Ala Asp Gln Ala Pro225 230 235 240Asp Val Ile Pro Gly Asp Val Val Phe Ile Val Ser Glu Arg Pro His 245 250 255Lys Ser Phe Lys Arg Asp Gly Asp Asp Leu Val Tyr Glu Ala Glu Ile 260 265 270Asp Leu Leu Thr Ala Ile Ala Gly Gly Glu Phe Ala Leu Glu His Val 275 280 285Ser Gly Asp Trp Leu Lys Val Gly Ile Val Pro Gly Glu Val Ile Ala 290 295 300Pro Gly Met Arg Lys Val Ile Glu Gly Lys Gly Met Pro Ile Pro Lys305 310 315 320Tyr Gly Gly Tyr Gly Asn Leu Ile Ile Lys Phe Thr Ile Lys Phe Pro 325 330 335Glu Asn His Phe Thr Ser Glu Glu Asn Leu Lys Lys Leu Glu Glu Ile 340 345 350Leu Pro Pro Arg Ile Val Pro Ala Ile Pro Lys Lys Ala Thr Val Asp 355 360 365Glu Cys Val Leu Ala Asp Phe Asp Pro Ala Lys Tyr Asn Arg Thr Arg 370 375 380Ala Ser Arg Gly Gly Ala Asn Tyr Asp Ser Asp Glu Glu Glu Gln Gly385 390 395 400Gly Glu Gly Val Gln Cys Ala Ser Gln 405641230DNASaccharomyces cerevisiae 64atggttaaag aaactaagtt ttacgatatt ctaggtgttc cagtaactgc cactgatgtc 60gaaattaaga aagcttatag aaaatgcgcc ttaaaatacc atccagataa gaatccaagt 120gaggaagctg cagaaaagtt caaagaagct tcagcagcct atgaaatttt atcagatcct 180gaaaagagag atatatatga ccaatttggt gaagatggtc taagtggtgc tggtggcgct 240ggcggattcc caggtggtgg attcggtttt ggtgacgata tcttttccca attctttggt 300gctggtggcg cacaaagacc aagaggtccc caaagaggta aagatatcaa gcatgaaatt 360tctgcctcac ttgaagaatt atataagggt aggacagcta agttagccct taacaaacag 420atcctatgta aagaatgtga aggtcgtggt ggtaagaaag gcgccgtcaa gaagtgtacc 480agctgtaatg gtcaaggtat taaatttgta acaagacaaa tgggtccaat gatccaaaga 540ttccaaacag agtgtgatgt ctgtcacggt actggtgata tcattgatcc taaggatcgt 600tgtaaatctt gtaacggtaa gaaagttgaa aacgaaagga agatcctaga agtccatgtc 660gaaccaggta tgaaagatgg tcaaagaatc gttttcaaag gtgaagctga ccaagcccca 720gatgtcattc caggtgatgt tgtcttcata gtttctgaga gaccacacaa gagcttcaag 780agagatggtg atgatttagt atatgaggct gaaattgatc tattgactgc tatcgctggt 840ggtgaatttg cattggaaca tgtttctggt gattggttaa aggtcggtat tgttccaggt 900gaagttattg ccccaggtat gcgtaaggtc atcgaaggta aaggtatgcc aattccaaaa 960tacggtggct atggtaattt aatcatcaaa tttactatca agttcccaga aaaccatttc 1020acatcagaag aaaacttgaa gaagttagaa gaaattttgc ctccaagaat tgtcccagcc 1080attccaaaga aagctactgt ggacgaatgt gtactcgcag actttgaccc agccaaatac 1140aacagaacac gggcctccag gggtggtgca aactatgatt ccgatgaaga agaacaaggt 1200ggcgaaggtg ttcaatgtgc atctcaatga 123065459PRTSaccharomyces cerevisiae 65Met Ser Gly Ser Asp Arg Gly Asp Arg Leu Tyr Asp Val Leu Gly Val1 5 10 15Thr Arg Asp Ala Thr Val Gln Glu Ile Lys Thr Ala Tyr Arg Lys Leu 20 25 30Ala Leu Lys His His Pro Asp Lys Tyr Val Asp Gln Asp Ser Lys Glu 35 40 45Val Asn Glu Ile Lys Phe Lys Glu Ile Thr Ala Ala Tyr Glu Ile Leu 50 55 60Ser Asp Pro Glu Lys Lys Ser His Tyr Asp Leu Tyr Gly Asp Asp Asn65 70 75 80Gly Ala Ala Ser Ser Gly Gly Ala Asn Gly Phe Gly Asp Glu Asp Phe 85 90 95Met Asn Phe Phe Asn Asn Phe Phe Asn Asn Gly Ser His Asp Gly Asn 100 105 110Asn Phe Pro Gly Glu Tyr Asp Ala Tyr Glu Glu Gly Asn Ser Thr Ser 115 120 125Ser Lys Asp Ile Asp Ile Asp Ile Ser Leu Thr Leu Lys Asp Leu Tyr 130 135 140Met Gly Lys Lys Leu Lys Phe Asp Leu Lys Arg Gln Val Ile Cys Ile145 150 155 160Lys Cys His Gly Ser Gly Trp Lys Pro Lys Arg Lys Ile His Val Thr 165 170 175His Asp Val Glu Cys Glu Ser Cys Ala Gly Lys Gly Ser Lys Glu Arg 180 185 190Leu Lys Arg Phe Gly Pro Gly Leu Val Ala Ser Gln Trp Val Val Cys 195 200 205Glu Lys Cys Asn Gly Lys Gly Lys Tyr Thr Lys Arg Pro Lys Asn Pro 210 215 220Lys Asn Phe Cys Pro Asp Cys Ala Gly Leu Gly Leu Leu Ser Lys Lys225 230 235 240Glu Ile Ile Thr Val Asn Val Ala Pro Gly His His Phe Asn Asp Val 245 250 255Ile Thr Val Lys Gly Met Ala Asp Glu Glu Ile Asp Lys Thr Thr Cys 260 265 270Gly Asp Leu Lys Phe His Leu Thr Glu Lys Gln Glu Asn Leu Glu Gln 275 280 285Lys Gln Ile Phe Leu Lys Asn Phe Asp Asp Gly Ala Gly Glu Asp Leu 290 295 300Tyr Thr Ser Ile Thr Ile Ser Leu Ser Glu Ala Leu Thr Gly Phe Glu305 310 315 320Lys Phe Leu Thr Lys Thr Phe Asp Asp Arg Leu Leu Thr Leu Ser Val 325 330 335Lys Pro Gly Arg Val Val Arg Pro Gly Asp Thr Ile Lys Ile Ala Asn 340 345 350Glu Gly Trp Pro Ile Leu Asp Asn Pro His Gly Arg Cys Gly Asp Leu 355 360 365Tyr Val Phe Val His Ile Glu Phe Pro Pro Asp Asn Trp Phe Asn Glu 370 375 380Lys Ser Glu Leu Leu Ala Ile Lys Thr Asn Leu Pro Ser Ser Ser Ser385 390 395 400Cys Ala Ser His Ala Thr Val Asn Thr Glu Asp Asp Ser Asn Leu Thr 405 410 415Asn Asn Glu Thr Ile Ser Asn Phe Arg Ile Ile His Thr Asp Asp Leu 420 425 430Pro Glu Gly Ile Arg Pro Phe Lys Pro Glu Ala Gln Asp Ser Ala His 435 440 445Gln Lys Ala Arg Ser Ser Tyr Cys Cys Ile Gln 450 455661380DNASaccharomyces cerevisiae 66atgagtggca gtgatagagg agaccggtta tacgatgtgt tgggggtgac gagagatgcg 60accgtgcaag agattaaaac tgcttacaga aagcttgccc tgaaacatca tccggacaag 120tatgtggatc aagactcaaa ggaggtaaat gaaatcaaat tcaaagagat cactgccgct 180tacgagatct tgagcgatcc ggagaagaaa tcacattacg acttgtatgg tgatgataat 240ggtgccgcta gcagcggtgg cgctaatggc tttggagatg aagattttat gaacttcttt 300aacaatttct tcaataatgg aagtcacgat ggaaataatt tccctggcga gtatgatgcg 360tacgaagagg gcaactctac aagctctaag gatatcgata tcgatatatc tcttactttg 420aaggatttgt acatgggcaa gaagctgaag tttgatttaa agagacaggt catctgtata 480aagtgccacg gttctggctg gaaaccaaag aggaaaattc acgttacaca cgatgtggaa 540tgtgaatcat gcgctggaaa gggttcaaag gaacgtctga agaggtttgg tcccggtttg 600gtagcttcgc aatgggtggt ctgtgagaaa tgtaatggta aggggaagta cactaaaaga 660cccaagaatc caaagaactt ttgccccgat tgcgcaggct tggggctcct gtcaaagaag 720gaaatcatca cagtgaacgt ggctccggga caccacttta acgacgtaat tacagtcaag 780gggatggcgg acgaggaaat cgataagacc acatgtggtg atttaaagtt ccatctcact 840gaaaaacaag aaaacttgga gcagaagcaa atctttttga agaactttga cgacggcgcc 900ggggaagatt tgtatacaag cattaccata tcgttaagcg aggccttgac gggatttgag 960aaatttttga caaaaacctt cgacgacagg ttactaacat tgagcgttaa acctggcaga 1020gtagtaagac ctggtgacac catcaaaatc gccaatgaag gttggcccat tttagataac 1080cctcatggcc ggtgcggcga tctgtatgtt ttcgttcata ttgaatttcc accagataac 1140tggttcaatg aaaaatcaga actactagca ataaaaacga atctgccgtc atcttcatct 1200tgtgcctcac atgcgactgt aaatactgaa gatgacagca acctgactaa caacgaaact 1260atatcaaatt tccggatcat tcacacggac gatcttccag aagggataag gccgttcaag 1320ccagaagcac aggattcagc gcatcagaaa gcaagaagtt cgtactgctg tatccaatga 138067528PRTSaccharomyces cerevisiae 67Met Gln Gln Asn Thr Ser Leu Tyr Asp Ser Leu Asn Val Thr Ala Ala1 5 10 15Ala Ser Thr Ser Glu Ile Lys Lys Ala Tyr Arg Asn Ala Ala Leu Lys 20 25 30Tyr His Pro Asp Lys Asn Asn His Thr Glu Glu Ser Lys Arg Lys Phe 35 40 45Gln Glu Ile Cys Gln Ala Tyr Glu Ile Leu Lys Asp Asn Arg Leu Arg 50 55 60Ala Leu Tyr Asp Gln Tyr Gly Thr Thr Asp Glu Val Leu Ile Gln Glu65 70 75 80Gln Gln Ala Gln Ala Gln Arg Gln Gln Ala Gly Pro Phe Ser Ser Ser 85 90 95Ser Asn Phe Asp Thr Glu Ala Met Ser Phe Pro Asp Leu Ser Pro Gly 100 105 110Asp Leu Phe Ala Gln Phe Phe Asn Ser Ser Ala Thr Pro Ser Ser Asn 115 120 125Gly Ser Lys Ser Ser Phe Asn Phe Ser Phe Asn Asn Ser Ser Thr Pro 130 135 140Ser Phe Ser Phe Val Asn Gly Ser Gly Val Asn Asn Leu Tyr Ser Ser145 150 155 160Ser Ala Lys Tyr Asn Ser Asn Asp Glu Asp His His Leu Asp Arg Gly 165 170 175Pro Asp Ile Lys His Asn Leu Lys Cys Thr Leu Lys Glu Leu Tyr Met 180 185 190Gly Lys Thr Ala Lys Leu Gly Leu Asn Arg Thr Arg Ile Cys Ser Val 195 200 205Cys Asp Gly His Gly Gly Leu Lys Lys Cys Thr Cys Lys Thr Cys Lys 210 215 220Gly Gln Gly Ile Gln Thr Gln Thr Arg Arg Met Gly Pro Leu Val Gln225 230 235 240Ser Trp Ser Gln Thr Cys Ala Asp Cys Gly Gly Ala Gly Val Phe Val 245 250 255Lys Asn Lys Asp Ile Cys Gln Gln Cys Gln Gly Leu Gly Phe Ile Lys 260 265 270Glu Arg Lys Ile Leu Gln Val Thr Val Gln Pro Gly Ser Cys His Asn 275 280 285Gln Leu Ile Val Leu Thr Gly Glu Gly Asp Glu Val Ile Ser Thr Lys 290 295 300Gly Gly Gly His Glu Lys Val Ile Pro Gly Asp Val Val Ile Thr Ile305 310 315 320Leu Arg Leu Lys Asp Pro Asn Phe Gln Val Ile Asn Tyr Ser Asn Leu 325 330 335Ile Cys Lys Lys Cys Lys Ile Asp Phe Met Thr Ser Leu Cys Gly Gly 340 345 350Val Val Tyr Ile Glu Gly His Pro Ser Gly Lys Leu Ile Lys Leu Asp 355 360 365Ile Ile Pro Gly Glu Ile Leu Lys Pro Gly Cys Phe Lys Thr Val Glu 370 375 380Asp Met Gly Met Pro Lys Phe Ile Asn Gly Val Arg Ser Gly Phe Gly385 390 395 400His Leu Tyr Val Lys Phe Asp Val Thr Tyr Pro Glu Arg Leu Glu Pro 405 410 415Glu Asn Ala Lys Lys Ile Gln Asn Ile Leu Ala Asn Asp Lys Tyr Ile 420 425 430Lys Ala Glu Arg Ser Thr Met Glu Thr Ala Asp Ser Asp Cys Tyr Cys 435 440 445Asp Leu Glu Lys Ser Tyr Asp Ser Val Glu Glu His Val Leu Ser Ser 450 455 460Phe Glu Ala Pro Asn Leu Asn Asn Glu Val Ile Glu Asp Asp Asp Leu465 470 475 480Gly Asp Leu Ile Asn Glu Arg Asp Ser Arg Lys Arg Asn Asn Arg Arg 485 490 495Phe Asp Glu Ser Asn Ile Asn Asn Asn Asn Glu Thr Lys Arg Asn Lys 500 505 510Tyr Ser Ser Pro Val Ser Gly Phe Tyr Asp His Asp Ile Asn Gly Tyr 515 520 525681587DNASaccharomyces cerevisiae 68atgcaacaaa acacgtcttt atatgactct ttgaacgtta ctgccgctgc atccacatct 60gagattaaga aagcttacag gaacgctgca ttaaaatatc atcctgataa aaacaatcat 120acagaagaat ccaagcgaaa gtttcaagag atatgccagg catacgaaat acttaaagac 180aatcgtttaa gagctttgta tgaccagtac ggtaccacag atgaagtcct gattcaagag 240cagcaggcgc aggcgcaacg ccaacaagcc gggccgttca gttcatcctc aaatttcgat 300acggaagcaa tgtcattccc ggatctatct ccaggtgatc ttttcgcgca gttttttaat 360agttctgcta ccccctcttc taatggctcc aaaagcagtt ttaattttag cttcaataat 420agctctacgc cgagcttctc ctttgttaat ggcagtggcg tgaacaatct gtactcctcg 480tcagcaaaat acaactccaa cgatgaggac catcatttgg atagaggccc tgatatcaaa 540cataatctaa agtgcacatt gaaggaactc tacatgggta agactgcaaa gttgggtttg 600aataggacaa ggatttgcag tgtttgtgat gggcacggtg gtctaaagaa atgcacttgt 660aaaacatgca aagggcaagg tattcaaacc caaactaggc gtatgggacc tctagtacaa 720agttggtctc aaacttgtgc agattgcggg ggtgccgggg tttttgtcaa aaataaagat 780atttgccaac agtgccaagg tcttggcttc attaaggaga ggaagattct acaagtcacc 840gttcaaccgg gatcgtgtca taaccaactt atagtactta cgggcgaagg tgacgaagtt 900attagtacta agggaggcgg tcacgaaaag gtaatacctg gtgacgtcgt tatcaccatt 960ttacgtttaa aagatccgaa tttccaggtt atcaactact ccaatttgat atgtaagaag 1020tgcaaaatcg acttcatgac cagtttatgt ggaggcgtag tttatattga agggcaccct 1080agcggtaagt tgatcaaact tgatattata cctggcgaga tactgaagcc tggttgtttc 1140aagactgttg aggacatggg gatgcccaag tttatcaacg gtgttcggag cggtttcggt 1200catctatatg tcaaattcga tgtgacgtat ccagagagac tggaacctga aaatgctaag 1260aaaatacaaa atattctggc taatgataaa tacattaaag cagaacgttc caccatggaa 1320accgcagatt cagactgcta ttgcgatttg gagaagtcat atgacagtgt ggaagagcat 1380gtgttaagta gctttgaggc ccctaattta aacaatgaag ttattgaaga cgacgacctt 1440ggtgatttga ttaatgaaag agattctcgg aaaaggaaca accgtcgatt cgacgaaagt 1500aatattaata ataataatga aacgaaacga aataaatatt cttcaccggt aagcggtttt 1560tatgaccatg atattaatgg atattga 158769352PRTSaccharomyces cerevisiae 69Met Val Lys Glu Thr Lys Leu Tyr Asp Leu Leu Gly Val Ser Pro Ser1 5 10 15Ala Asn Glu Gln Glu Leu Lys Lys Gly Tyr Arg Lys Ala Ala

Leu Lys 20 25 30Tyr His Pro Asp Lys Pro Thr Gly Asp Thr Glu Lys Phe Lys Glu Ile 35 40 45Ser Glu Ala Phe Glu Ile Leu Asn Asp Pro Gln Lys Arg Glu Ile Tyr 50 55 60Asp Gln Tyr Gly Leu Glu Ala Ala Arg Ser Gly Gly Pro Ser Phe Gly65 70 75 80Pro Gly Gly Pro Gly Gly Ala Gly Gly Ala Gly Gly Phe Pro Gly Gly 85 90 95Ala Gly Gly Phe Ser Gly Gly His Ala Phe Ser Asn Glu Asp Ala Phe 100 105 110Asn Ile Phe Ser Gln Phe Phe Gly Gly Ser Ser Pro Phe Gly Gly Ala 115 120 125Asp Asp Ser Gly Phe Ser Phe Ser Ser Tyr Pro Ser Gly Gly Gly Ala 130 135 140Gly Met Gly Gly Met Pro Gly Gly Met Gly Gly Met His Gly Gly Met145 150 155 160Gly Gly Met Pro Gly Gly Phe Arg Ser Ala Ser Ser Ser Pro Thr Tyr 165 170 175Pro Glu Glu Glu Thr Val Gln Val Asn Leu Pro Val Ser Leu Glu Asp 180 185 190Leu Phe Val Gly Lys Lys Lys Ser Phe Lys Ile Gly Arg Lys Gly Pro 195 200 205His Gly Ala Ser Glu Lys Thr Gln Ile Asp Ile Gln Leu Lys Pro Gly 210 215 220Trp Lys Ala Gly Thr Lys Ile Thr Tyr Lys Asn Gln Gly Asp Tyr Asn225 230 235 240Pro Gln Thr Gly Arg Arg Lys Thr Leu Gln Phe Val Ile Gln Glu Lys 245 250 255Ser His Pro Asn Phe Lys Arg Asp Gly Asp Asp Leu Ile Tyr Thr Leu 260 265 270Pro Leu Ser Phe Lys Glu Ser Leu Leu Gly Phe Ser Lys Thr Ile Gln 275 280 285Thr Ile Asp Gly Arg Thr Leu Pro Leu Ser Arg Val Gln Pro Val Gln 290 295 300Pro Ser Gln Thr Ser Thr Tyr Pro Gly Gln Gly Met Pro Thr Pro Lys305 310 315 320Asn Pro Ser Gln Arg Gly Asn Leu Ile Val Lys Tyr Lys Val Asp Tyr 325 330 335Pro Ile Ser Leu Asn Asp Ala Gln Lys Arg Ala Ile Asp Glu Asn Phe 340 345 350701059DNASaccharomyces cerevisiae 70atggtcaagg agacaaaact ttatgattta cttggagtat ctccaagtgc taatgagcaa 60gaactgaaaa agggttatag aaaagcagct ctaaaatatc atccagataa gccaacaggt 120gacacagaaa agtttaagga gatatcagag gcctttgaaa ttttaaatga tcctcaaaaa 180agggaaatat atgatcaata cggtctcgag gctgctagat ctggtggtcc aagctttggt 240cctggtggtc ctggcggtgc tggaggtgct ggaggcttcc ctggcggtgc gggcggattc 300tccggaggac atgcgttcag taatgaggat gctttcaata ttttttcaca attctttggc 360ggcagttccc cattcggtgg tgctgatgac agtggcttca gtttctctag ttatccatct 420ggcggcggtg ctggtatggg aggtatgcct ggaggaatgg gaggaatgca tggcggcatg 480ggaggtatgc ctggcggctt tagatcagca tcaagctctc ccacgtatcc agaggaagaa 540acagttcaag ttaatttacc agttagtcta gaagatttgt ttgttggtaa aaagaagtca 600tttaaaattg gaagaaaggg cccacatggg gcctctgaaa agacacaaat tgacattcaa 660ttaaaaccgg gttggaaagc tggtaccaaa ataacataca agaaccaggg tgattacaat 720cctcaaacgg gccgtagaaa gactttgcag tttgtcatcc aggaaaagag ccatccaaac 780tttaaaagag acggtgatga cctaatttac actctgccac tatctttcaa ggaatcattg 840ttaggttttt caaaaactat ccaaacaatt gatggcagaa ccttaccttt gtcgagagta 900cagcctgtcc aaccctcaca aacttctact tatcctggtc aaggtatgcc aactccaaag 960aacccatctc agagaggtaa tttgattgta aaatataaag tggactatcc aatatcacta 1020aacgacgctc aaaaacgtgc tatagatgaa aatttttaa 105971432PRTSaccharomyces cerevisiae 71Met Val Val Asp Thr Glu Tyr Tyr Asp Leu Leu Gly Val Ser Thr Thr1 5 10 15Ala Ser Ser Ile Glu Ile Lys Lys Ala Tyr Arg Lys Lys Ser Ile Gln 20 25 30Glu His Pro Asp Lys Asn Pro Asn Asp Pro Thr Ala Thr Glu Arg Phe 35 40 45Gln Ala Ile Ser Glu Ala Tyr Gln Val Leu Gly Asp Asp Asp Leu Arg 50 55 60Ala Lys Tyr Asp Lys Tyr Gly Arg Lys Glu Ala Ile Pro Gln Gly Gly65 70 75 80Phe Glu Asp Ala Ala Glu Gln Phe Ser Val Ile Phe Gly Gly Asp Ala 85 90 95Phe Ala Ser Tyr Ile Gly Glu Leu Met Leu Leu Lys Asn Leu Gln Lys 100 105 110Thr Glu Glu Leu Asn Ala Glu Asp Glu Ala Glu Lys Glu Lys Glu Asn 115 120 125Val Glu Thr Met Glu Glu Ser Pro Ala Asp Gly Lys Thr Asn Gly Thr 130 135 140Thr Asn Ala Val Asp Ala Ala Leu Gly Asn Thr Asn Glu Lys Asp Asp145 150 155 160Lys Asn Lys Ala Arg Thr Thr Ser Gly Asn Leu Thr Val His Asp Gly 165 170 175Asn Lys Lys Asn Glu Gln Val Gly Ala Glu Ala Lys Lys Lys Lys Thr 180 185 190Lys Leu Glu Gln Phe Glu Glu Glu Gln Glu Val Glu Lys Gln Lys Arg 195 200 205Val Asp Gln Leu Ser Lys Thr Leu Ile Glu Arg Leu Ser Ile Leu Thr 210 215 220Glu Ser Val Tyr Asp Asp Ala Cys Lys Asp Ser Phe Lys Lys Lys Phe225 230 235 240Glu Glu Glu Ala Asn Leu Leu Lys Met Glu Ser Phe Gly Leu Asp Ile 245 250 255Leu His Thr Ile Gly Asp Val Tyr Tyr Glu Lys Ala Glu Ile Phe Leu 260 265 270Ala Ser Gln Asn Leu Phe Gly Met Gly Gly Ile Phe His Ser Met Lys 275 280 285Ala Lys Gly Gly Val Phe Met Asp Thr Leu Arg Thr Val Ser Ala Ala 290 295 300Ile Asp Ala Gln Asn Thr Met Lys Glu Leu Glu Lys Met Lys Glu Ala305 310 315 320Ser Thr Asn Asn Glu Pro Leu Phe Asp Lys Asp Gly Asn Glu Gln Ile 325 330 335Lys Pro Thr Thr Glu Glu Leu Ala Gln Gln Glu Gln Leu Leu Met Gly 340 345 350Lys Val Leu Ser Ala Ala Trp His Gly Ser Lys Tyr Glu Ile Thr Ser 355 360 365Thr Leu Arg Gly Val Cys Lys Lys Val Leu Glu Asp Asp Ser Val Ser 370 375 380Lys Lys Thr Leu Ile Arg Arg Ala Glu Ala Met Lys Leu Leu Gly Glu385 390 395 400Val Phe Lys Lys Thr Phe Arg Thr Lys Val Glu Gln Glu Glu Ala Gln 405 410 415Ile Phe Glu Glu Leu Val Ala Glu Ala Thr Lys Lys Lys Arg His Thr 420 425 430721299DNASaccharomyces cerevisiae 72atggttgttg atactgagta ttacgatttg ttaggtgtgt ctaccactgc atcttccatt 60gaaataaaaa aggcctatag aaagaaatct attcaagagc atcctgataa gaatcccaat 120gaccccacgg ctaccgaaag gtttcaagca atatccgaag cttatcaagt tttaggtgac 180gatgatcttc gcgcaaagta tgataagtat ggaagaaaag aagctattcc tcagggcggc 240tttgaagatg cagctgaaca gttctctgtc atctttggtg gagatgcgtt tgcctcatat 300attggcgaac tgatgctatt aaagaaccta cagaaaactg aggagctaaa tgctgaagac 360gaagctgaaa aggagaagga gaatgtggaa acaatggaag aatcacctgc agacggtaag 420acgaatggca ccactaacgc tgttgatgca gcattgggca atactaacga aaaagatgac 480aaaaataagg cgaggacaac ttctggtaat ttaactgtac acgatggaaa caagaaaaat 540gagcaggtag gagcagaagc taagaagaag aagacaaaat tagagcagtt tgaggaagaa 600caagaggtag aaaagcaaaa aagagtagac caattaagca aaacattgat tgaaagatta 660tcgatattaa cagaaagtgt ctatgatgat gcatgtaaag attcctttaa aaaaaagttc 720gaagaggaag ccaatctttt aaagatggaa tcatttggtc tggacatatt acacacaata 780ggcgacgttt actacgaaaa agctgaaatt tttcttgcat cccagaacct gttcggaatg 840ggtggtatat ttcattctat gaaggctaaa gggggagtat ttatggatac actaagaact 900gtttcggcag ccatagacgc tcagaatact atgaaggagc ttgaaaaaat gaaagaagct 960agcacgaata atgagccttt gtttgacaaa gacggaaatg agcaaattaa gccaaccact 1020gaggaactgg cgcagcaaga gcagctattg atgggcaaag tattgtcggc tgcttggcat 1080ggttctaaat atgaaataac atccacttta cgtggcgttt gtaaaaaagt actagaagat 1140gactcggtaa gtaagaaaac gcttatcaga agagctgaag caatgaaact attgggtgaa 1200gtctttaaga aaactttcag aaccaaagtc gaacaagaag aggcacagat ctttgaagaa 1260cttgtagcag aagctacaaa aaagaagaga catacatga 129973433PRTSaccharomyces cerevisiae 73Met Phe Ser Leu Pro Thr Leu Thr Ser Asp Ile Thr Val Glu Val Asn1 5 10 15Ser Ser Ala Thr Lys Thr Pro Phe Val Arg Arg Pro Val Glu Pro Val 20 25 30Gly Lys Phe Phe Leu Gln His Ala Gln Arg Thr Leu Arg Asn His Thr 35 40 45Trp Ser Glu Phe Glu Arg Ile Glu Ala Glu Lys Asn Val Lys Thr Val 50 55 60Asp Glu Ser Asn Val Asp Pro Asp Glu Leu Leu Phe Asp Thr Glu Leu65 70 75 80Ala Asp Glu Asp Leu Leu Thr His Asp Ala Arg Asp Trp Lys Thr Ala 85 90 95Asp Leu Tyr Ala Ala Met Gly Leu Ser Lys Leu Arg Phe Arg Ala Thr 100 105 110Glu Ser Gln Ile Ile Lys Ala His Arg Lys Gln Val Val Lys Tyr His 115 120 125Pro Asp Lys Gln Ser Ala Ala Gly Gly Ser Leu Asp Gln Asp Gly Phe 130 135 140Phe Lys Ile Ile Gln Lys Ala Phe Glu Thr Leu Thr Asp Ser Asn Lys145 150 155 160Arg Ala Gln Tyr Asp Ser Cys Asp Phe Val Ala Asp Val Pro Pro Pro 165 170 175Lys Lys Gly Thr Asp Tyr Asp Phe Tyr Glu Ala Trp Gly Pro Val Phe 180 185 190Glu Ala Glu Ala Arg Phe Ser Lys Lys Thr Pro Ile Pro Ser Leu Gly 195 200 205Asn Lys Asp Ser Ser Lys Lys Glu Val Glu Gln Phe Tyr Ala Phe Trp 210 215 220His Arg Phe Asp Ser Trp Arg Thr Phe Glu Phe Leu Asp Glu Asp Val225 230 235 240Pro Asp Asp Ser Ser Asn Arg Asp His Lys Arg Tyr Ile Glu Arg Lys 245 250 255Asn Lys Ala Ala Arg Asp Lys Lys Lys Thr Ala Asp Asn Ala Arg Leu 260 265 270Val Lys Leu Val Glu Arg Ala Val Ser Glu Asp Pro Arg Ile Lys Met 275 280 285Phe Lys Glu Glu Glu Lys Lys Glu Lys Glu Arg Arg Lys Trp Glu Arg 290 295 300Glu Ala Gly Ala Arg Ala Glu Ala Glu Ala Lys Ala Lys Ala Glu Ala305 310 315 320Glu Ala Lys Ala Lys Ala Glu Ser Glu Ala Lys Ala Asn Ala Ser Ala 325 330 335Lys Ala Asp Lys Lys Lys Ala Lys Glu Ala Ala Lys Ala Ala Lys Lys 340 345 350Lys Asn Lys Arg Ala Ile Arg Asn Ser Ala Lys Glu Ala Asp Tyr Phe 355 360 365Gly Asp Ala Asp Lys Ala Thr Thr Ile Asp Glu Gln Val Gly Leu Ile 370 375 380Val Asp Ser Leu Asn Asp Glu Glu Leu Val Ser Thr Ala Asp Lys Ile385 390 395 400Lys Ala Asn Ala Ala Gly Ala Lys Glu Val Leu Lys Glu Ser Ala Lys 405 410 415Thr Ile Val Asp Ser Gly Lys Leu Pro Ser Ser Leu Leu Ser Tyr Phe 420 425 430Val 741302DNASaccharomyces cerevisiae 74atgttttctt tacctaccct aacctcagac atcactgttg aagtcaacag ttccgctacc 60aaaaccccat tcgtccgtcg tccggtcgaa ccggttggta agttcttttt gcaacatgct 120caaagaactt tgagaaacca cacctggtct gaatttgaaa gaattgaagc tgaaaagaac 180gtcaaaaccg ttgatgaatc caatgtcgac ccagatgagt tgttattcga cactgaattg 240gccgatgaag atttactgac tcatgatgct agagactgga aaactgccga tttgtatgct 300gctatgggtt tgtctaagtt gcgtttcaga gctactgaaa gtcaaatcat caaggctcac 360agaaaacaag ttgtcaagta ccatccagac aagcaatctg ctgctggtgg tagtttggac 420caagatggct ttttcaagat tattcaaaag gcctttgaaa ctttgactga ttccaacaag 480agagctcagt acgactcatg tgattttgtt gccgatgttc ctcctccaaa gaagggtacc 540gattatgact tttatgaagc ttggggcccc gttttcgaag ctgaagctcg tttttctaag 600aagactccta ttccttctct aggtaacaaa gattcttcca agaaggaagt tgaacaattc 660tatgctttct ggcacagatt tgactcctgg agaacctttg agttcttgga cgaagatgtc 720ccagatgact cttctaacag agaccacaag cgttacattg aaagaaagaa caaggccgca 780agagacaaga agaagactgc tgataacgct agattggtca aacttgttga aagagctgtc 840agtgaagatc cccgtatcaa aatgttcaaa gaagaagaga agaaggaaaa ggaaagaaga 900aaatgggaaa gagaagccgg tgccagagct gaagctgaag ctaaggccaa ggccgaagct 960gaagcgaagg ctaaagctga atctgaagcc aaggctaacg cctccgcaaa agctgacaaa 1020aagaaggcta aggaagctgc taaggccgcc aagaaaaaga acaagagagc catccgtaac 1080tctgctaagg aagctgacta ctttggtgat gctgacaagg ccaccacgat tgacgaacaa 1140gttggtttga tcgttgacag tttgaatgac gaagagttag tgtccaccgc cgataagatc 1200aaggccaatg ctgctggtgc caaggaagtt ttgaaggaat ctgcaaagac tattgtcgat 1260tctggcaaac taccatccag cttgttgtcc tacttcgtgt ga 130275668PRTSaccharomyces cerevisiae 75Met Ser Asp Pro Phe Ala His Leu Leu Thr Ser Leu Lys Asn Lys Asp1 5 10 15Ser Ala Ser Ala Ser Lys Glu Thr Thr Pro Gln Ser Ser Asn Ser Pro 20 25 30Ser Ile Thr Gly Ser Ala Val Ala Asp Val Ala Arg Thr Asp Lys Ser 35 40 45Pro Asn Asp Ser Leu His Ser Ile Ser Ala Pro Pro Leu Ile Pro Ser 50 55 60Pro Lys Val Asp Phe Ser Ala Pro Pro Leu Val Pro Thr Asn Ser Thr65 70 75 80Thr Lys Ser Asn Thr Ala Asn Asn Thr Pro Pro Ser Ala Leu Ala Asn 85 90 95Thr Asp Asp Asp Phe Asn Gln Leu Phe Gly Met Gly Thr Val Thr Thr 100 105 110Thr Asp Thr Ile Gln Lys Pro Asp Glu Asp Tyr Tyr Gly Ser Lys Glu 115 120 125Asp His Leu Tyr Asn Gly Asp Asp Ala Leu Val Asp Glu Val Lys Asp 130 135 140Met Glu Ile Ala Arg Leu Met Ser Leu Gly Leu Ser Ile Glu Glu Ala145 150 155 160Thr Glu Phe Tyr Glu Asn Asp Val Thr Tyr Glu Arg Tyr Leu Glu Ile 165 170 175Leu Lys Ser Lys Gln Lys Glu Arg Asn Asp Leu Ala Ile Arg Lys Lys 180 185 190Glu Ser Gly Ile Lys Met Glu Lys Ser Gly Leu Ser Asn Ile Val Gly 195 200 205Thr Asp Ser Asn Asn Leu Phe Ser Met Ala Thr Asp Phe Phe Asn Lys 210 215 220Gly Lys Lys Leu Val Asp Gln Trp Thr Ser Phe Pro Pro Glu Ala Asn225 230 235 240Asp Arg Leu Asn Asn Tyr Ser Lys Thr His Asp Lys Val Glu Asp Tyr 245 250 255Asp Leu Pro Gln Val Asn Asp Ser Pro Asn Arg Ile Leu Phe Glu Asp 260 265 270Asn Glu Val Val Glu Asn Leu Pro Pro Ala Asp Asn Pro Asp Gln Asp 275 280 285Leu Leu Thr Asp Phe Glu Thr Lys Ile Asp Ile Thr Lys Arg Thr Ala 290 295 300Pro Asp Val Ser His Ser Ser Ser Pro Thr Ser Gly Ile Leu Ile Glu305 310 315 320Glu Asn Ser Arg Arg Asn Glu Pro Leu Ile Glu Asp Ser Leu Leu Asp 325 330 335Phe Ser Glu Gly Asn Leu Thr Asn Ser Lys Ser Asn Glu Asp Ser Thr 340 345 350Leu Phe Asn Glu Asn Ser Asn Thr Asp Ser Thr Ile Pro Ile Ser Asp 355 360 365Ile Glu Leu Ser Gly Tyr Asn Glu Phe Lys Ala Lys Gly Thr Ser Leu 370 375 380Phe Lys Asn Gly Asp Tyr Ile Asn Ser Leu Gln Glu Tyr Glu Lys Ser385 390 395 400Leu Asn Thr Leu Pro Leu Asn His Pro Leu Arg Ile Ile Ala Leu Ser 405 410 415Asn Ile Ile Ala Ser Gln Leu Lys Ile Gly Glu Tyr Ser Lys Ser Ile 420 425 430Glu Asn Ser Ser Met Ala Leu Glu Leu Phe Pro Ser Ser Lys Ala Lys 435 440 445Trp Lys Asn Lys Ile Ser Asn Ser Asp Pro Glu Arg Ser Phe Asn Asp 450 455 460Ile Trp Pro Lys Ile Met Ile Arg Arg Ala Glu Ser Phe Glu His Leu465 470 475 480Glu Ser Phe Lys Lys Ala Leu Glu Thr Tyr Gln Glu Leu Ile Lys Lys 485 490 495Asn Phe Phe Asp Asp Lys Ile Met Gln Gly Lys Arg Arg Cys Gln Asp 500 505 510Phe Ile Asn Pro Pro Pro Val Lys Lys Ser Met Pro Val Lys Lys Lys 515 520 525Thr Thr Thr Thr Ser Pro Ala Thr Lys Lys Gln Asn Leu Thr Ala Ser 530 535 540Ser Ser Asn Ser Pro Ile Ser Val Asp Ser Thr Ser Glu Ile Lys Lys545 550 555 560Arg Glu Leu Glu Asn Ala Lys Leu Ala Leu Tyr Asp Lys Val Phe Glu 565 570 575Lys Ile Ser Ser Trp Lys Asp Gly Lys Asp Asp Asp Ile Arg His Leu 580 585 590Leu Ala Asn Leu Ser Ser Leu Leu Thr Trp Cys Asn Trp Lys Asp Val 595 600 605Ser Met Gln Asp Leu Val Met Pro Lys Arg Val Lys Ile Thr Tyr Met 610 615 620Lys Ala Val Ala Lys Thr His Pro Asp Lys Ile Pro Glu Ser Leu Ser625 630 635 640Leu Glu

Asn Lys Met Ile Ala Glu Asn Ile Phe Ser Thr Leu Ser Ile 645 650 655Ala Trp Asp Lys Phe Lys Leu Gln Asn Asp Ile Asn 660 665762007DNASaccharomyces cerevisiae 76atgtcagatc catttgcaca tttactgact tctttgaaga ataaggactc tgcatctgca 60tccaaggaaa caactcctca gagcagcaat tcgccttcca ttactggttc cgctgttgca 120gatgttgcaa ggacggataa aagccccaat gatagtctgc attcaatttc agctcctccg 180ctgataccgt caccgaaggt agatttttct gcacctcctt tggtcccaac taatagcacc 240actaaatcta atactgccaa caacacacct ccctcggctc ttgccaatac cgatgacgac 300ttcaatcaac tatttggtat gggcacagta actacaacgg atacgatcca aaaaccggat 360gaggattact atggaagcaa ggaagaccac ctttacaatg gtgatgacgc cttagttgat 420gaagttaagg atatggaaat agcaagattg atgtctctag gtttatcaat tgaagaagcc 480actgagtttt acgaaaatga cgtaacttat gaaagatatt tggagatttt aaagtcaaag 540caaaaggagc gcaacgatct agctataaga aagaaagaaa gtggtataaa aatggaaaag 600tcaggattat ccaacattgt tggtacagat agcaataatt tattcagcat ggccactgat 660tttttcaata agggtaagaa actggtagac caatggacct ccttcccacc tgaggcaaat 720gatagactga ataattactc aaaaactcat gataaggttg aggattatga tttgcctcaa 780gtaaacgact cacccaatag aattttgttt gaagataatg aagtcgtaga gaacttacca 840cctgccgata atccggatca agatctttta actgatttcg aaacaaagat tgatataaca 900aagaggacag cgcctgatgt ctcccactcc tcctcaccga cttctggtat actaattgaa 960gaaaattcgc gaagaaatga gcccctgata gaggatagtc ttctcgactt ttcagaagga 1020aatctcacca atagtaaaag caatgaagat agcaccctct tcaatgaaaa cagcaacact 1080gactctacaa tacccatctc agatattgaa ttatcggggt ataacgaatt taaggcgaaa 1140ggtactagtt tgttcaagaa cggggattat attaactcat tacaagaata tgaaaagtct 1200ttaaatacat tgcctttaaa tcatccattg aggatcattg cattatcaaa cattattgcc 1260tcgcaactga aaatcggtga gtactctaag tccatagaaa actccagcat ggctttggaa 1320ttattcccat caagcaaagc taagtggaag aataaaatct caaatagtga ccctgaaaga 1380tcatttaacg acatctggcc aaagattatg attaggcgtg ctgagtcttt tgaacattta 1440gaaagtttca aaaaagcact agaaacatac caagagctga ttaagaagaa tttttttgat 1500gataaaatca tgcagggaaa aagaagatgc caagacttta ttaatcctcc ccctgttaaa 1560aaatccatgc ccgttaagaa gaagacaacg acaacctcgc ctgcaacaaa aaaacagaac 1620ttaaccgctt cttcttcaaa ttctccaatt tctgttgata gcacttcaga aataaaaaaa 1680cgggagctag aaaacgctaa actggcgcta tatgataaag tatttgagaa aattagctcc 1740tggaaggatg gcaaagacga tgacattcgt catctgttag caaatttatc cagcttacta 1800acatggtgca attggaagga tgtctctatg caagatttgg ttatgcctaa gagggtcaaa 1860attacataca tgaaagctgt agccaagaca catcctgata agataccaga gtccttgtcc 1920ctggaaaata agatgattgc agagaatatt ttcagtactt taagtattgc ttgggataag 1980ttcaaactgc agaatgacat taactga 200777590PRTSaccharomyces cerevisiae 77Met Lys Thr Cys Tyr Tyr Glu Leu Leu Gly Val Glu Thr His Ala Ser1 5 10 15Asp Leu Glu Leu Lys Lys Ala Tyr Arg Lys Lys Ala Leu Gln Tyr His 20 25 30Pro Asp Lys Asn Pro Asp Asn Val Glu Glu Ala Thr Gln Lys Phe Ala 35 40 45Val Ile Arg Ala Ala Tyr Glu Val Leu Ser Asp Pro Gln Glu Arg Ala 50 55 60Trp Tyr Asp Ser His Lys Glu Gln Ile Leu Asn Asp Thr Pro Pro Ser65 70 75 80Thr Asp Asp Tyr Tyr Asp Tyr Glu Val Asp Ala Thr Val Thr Gly Val 85 90 95Thr Thr Asp Glu Leu Leu Leu Phe Phe Asn Ser Ala Leu Tyr Thr Lys 100 105 110Ile Asp Asn Ser Ala Ala Gly Ile Tyr Gln Ile Ala Gly Lys Ile Phe 115 120 125Ala Lys Leu Ala Lys Asp Glu Ile Leu Ser Gly Lys Arg Leu Gly Lys 130 135 140Phe Ser Glu Tyr Gln Asp Asp Val Phe Glu Gln Asp Ile Asn Ser Ile145 150 155 160Gly Tyr Leu Lys Ala Cys Asp Asn Phe Ile Asn Lys Thr Asp Lys Leu 165 170 175Leu Tyr Pro Leu Phe Gly Tyr Ser Pro Thr Asp Tyr Glu Tyr Leu Lys 180 185 190His Phe Tyr Lys Thr Trp Ser Ala Phe Asn Thr Leu Lys Ser Phe Ser 195 200 205Trp Lys Asp Glu Tyr Met Tyr Ser Lys Asn Tyr Asp Arg Arg Thr Lys 210 215 220Arg Glu Val Asn Arg Arg Asn Glu Lys Ala Arg Gln Gln Ala Arg Asn225 230 235 240Glu Tyr Asn Lys Thr Val Lys Arg Phe Val Val Phe Ile Lys Lys Leu 245 250 255Asp Lys Arg Met Lys Glu Gly Ala Lys Ile Ala Glu Glu Gln Arg Lys 260 265 270Leu Lys Glu Gln Gln Arg Lys Asn Glu Leu Asn Asn Arg Arg Lys Phe 275 280 285Gly Asn Asp Asn Asn Asp Glu Glu Lys Phe His Leu Gln Ser Trp Gln 290 295 300Thr Val Lys Glu Glu Asn Trp Asp Glu Leu Glu Lys Val Tyr Asp Asn305 310 315 320Phe Gly Glu Phe Glu Asn Ser Lys Asn Asp Lys Glu Gly Glu Val Leu 325 330 335Ile Tyr Glu Cys Phe Ile Cys Asn Lys Thr Phe Lys Ser Glu Lys Gln 340 345 350Leu Lys Asn His Ile Asn Thr Lys Leu His Lys Lys Asn Met Glu Glu 355 360 365Ile Arg Lys Glu Met Glu Glu Glu Asn Ile Thr Leu Gly Leu Asp Asn 370 375 380Leu Ser Asp Leu Glu Lys Phe Asp Ser Ala Asp Glu Ser Val Lys Glu385 390 395 400Lys Glu Asp Ile Asp Leu Gln Ala Leu Gln Ala Glu Leu Ala Glu Ile 405 410 415Glu Arg Lys Leu Ala Glu Ser Ser Ser Glu Asp Glu Ser Glu Asp Asp 420 425 430Asn Leu Asn Ile Glu Met Asp Ile Glu Val Glu Asp Val Ser Ser Asp 435 440 445Glu Asn Val His Val Asn Thr Lys Asn Lys Lys Lys Arg Lys Lys Lys 450 455 460Lys Lys Ala Lys Val Asp Thr Glu Thr Glu Glu Ser Glu Ser Phe Asp465 470 475 480Asp Thr Lys Asp Lys Arg Ser Asn Glu Leu Asp Asp Leu Leu Ala Ser 485 490 495Leu Gly Asp Lys Gly Leu Gln Thr Asp Asp Asp Glu Asp Trp Ser Thr 500 505 510Lys Ala Lys Lys Lys Lys Gly Lys Gln Pro Lys Lys Asn Ser Lys Ser 515 520 525Thr Lys Ser Thr Pro Ser Leu Ser Thr Leu Pro Ser Ser Met Ser Pro 530 535 540Thr Ser Ala Ile Glu Val Cys Thr Thr Cys Gly Glu Ser Phe Asp Ser545 550 555 560Arg Asn Lys Leu Phe Asn His Val Lys Ile Ala Gly His Ala Ala Val 565 570 575Lys Asn Val Val Lys Arg Lys Lys Val Lys Thr Lys Arg Ile 580 585 590781773DNASaccharomyces cerevisiae 78atgaagacct gctactatga gcttttaggg gtcgaaacgc atgcttctga tcttgagtta 60aaaaaagctt accgtaaaaa ggccctacaa tatcacccag ataaaaaccc agataatgtt 120gaagaagcca cacaaaaatt tgctgtgatt cgagccgctt atgaagtact gtctgacccc 180caggaaagag catggtatga ctcacataag gaacaaattt taaatgatac tccaccaagc 240actgatgatt actatgatta tgaggtagac gctacagtca caggtgtcac aactgatgaa 300ttactcttat tttttaactc tgctctttat actaaaatag acaactcagc tgctgggata 360tatcaaattg caggaaaaat atttgccaag ttagctaaag atgagatttt aagtggtaag 420cgactgggga aattttccga gtatcaagat gatgtattcg aacaggatat taatagtatt 480ggctatttga aagcctgcga taactttatt aacaagacgg ataaactttt atatccttta 540tttggatatt cgccaacgga ttatgaatat ttgaaacatt tctataagac ttggtcagcg 600ttcaatacct tgaaaagttt tagctggaaa gacgagtaca tgtactctaa aaactatgac 660agaagaacca agagggaagt taatagaaga aatgagaagg ctaggcaaca agctcgaaat 720gaatacaaca aaaccgtgaa aaggtttgta gttttcataa aaaagctcga taaaagaatg 780aaagaaggtg caaaaattgc agaagaacag cgtaaactaa aagaacaaca gaggaaaaat 840gagttaaata acagaagaaa gtttgggaac gacaacaatg acgaagaaaa atttcattta 900caaagctggc aaacggtaaa agaagaaaac tgggatgaac tggaaaaggt atatgataat 960tttggagaat tcgaaaattc taagaatgat aaggaaggtg aagtattgat ttacgagtgt 1020tttatctgca acaagacatt taagtcggaa aagcaattga aaaaccacat aaacactaaa 1080ctgcataaga aaaatatgga agagatacgg aaagaaatgg aagaggaaaa cataacgctt 1140gggttggata atctctccga tctcgagaaa tttgattcag cagatgaaag tgttaaagaa 1200aaagaagata ttgatctgca agcattgcaa gctgaactcg ctgaaattga aagaaaactg 1260gcagaatcgt cttctgaaga cgaaagtgaa gatgacaatc tcaacataga aatggatata 1320gaggtagaag acgtcagttc ggatgaaaat gtacatgtga atacgaagaa taaaaagaaa 1380agaaaaaaga aaaaaaaagc aaaggttgac acagaaacag aggaatctga atcgttcgat 1440gatactaaag acaaacggag taatgagttg gatgatcttt tggcatcact aggagacaag 1500ggcttacaaa cggatgacga tgaagattgg tctactaaag cgaaaaagaa aaagggcaaa 1560caacctaaaa agaattctaa atccacaaaa agcactccgt ccttgtcgac tctaccgtcc 1620tctatgtctc caacctccgc gatcgaggtg tgcactacat gcggagaatc atttgatagt 1680cgaaataagc tattcaacca cgtgaagata gcagggcatg cggcagtgaa aaacgtagtg 1740aaaagaaaga aagtcaagac caaaagaata tag 177379583PRTSaccharomyces cerevisiae 79Met Ser Gln Val Ile Glu Pro Gln Leu Asp Arg Thr Thr Tyr Tyr Ser1 5 10 15Ile Leu Gly Leu Thr Ser Asn Ala Thr Ser Ser Glu Val His Lys Ser 20 25 30Tyr Leu Lys Leu Ala Arg Leu Leu His Pro Asp Lys Thr Lys Ser Asp 35 40 45Lys Ser Glu Glu Leu Phe Lys Ala Val Val His Ala His Ser Ile Leu 50 55 60Thr Asp Glu Asp Gln Lys Leu Arg Tyr Asp Arg Asp Leu Lys Ile Lys65 70 75 80Gly Leu His Thr Tyr Gln Pro Lys Lys Asn Cys His Ile Phe Lys Thr 85 90 95Lys Ala Lys Glu Ser Gln Gly Ala Ser Pro Thr Leu Gly Gln Ser Glu 100 105 110Ala Tyr His Arg Gln Asn Lys Pro Tyr Glu Gln Gln Pro Tyr Gly Phe 115 120 125Gly Val Gly Lys Lys Met Thr Ser Ser Ser Lys Ser Lys Val Pro Ile 130 135 140Phe Lys Ser Phe Asn Leu Lys Ser Tyr Gln Arg Asn His Tyr Tyr Ser145 150 155 160Ser Lys Lys Glu Arg Lys His Gly Ser Pro Asp Ile Asp Ser Leu Phe 165 170 175His Glu Thr Asn Gly Ala Ser Lys Val Arg Met Thr Asp Ala Gly Lys 180 185 190Met Asp Thr Asn Ser Gln Phe Gln Glu Ile Trp Glu Ile Leu Gly Lys 195 200 205Asn Ala Tyr Thr His Lys Ser Tyr Ser Glu Asp Pro Asn Ser Cys Leu 210 215 220Gly Ser Ala Leu Ser Asp His Glu Glu Glu Glu Glu Ala Gly Lys Gln225 230 235 240Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln Gln His Tyr Gly Met 245 250 255Thr Ser Lys Ser Ser Ser Pro Asp Glu Glu Lys Lys Asn Asn Lys Glu 260 265 270Pro Lys Arg Glu Ser Arg Val Ser Pro Glu Glu Asn Gly Glu Glu Glu 275 280 285Thr Gly His Lys Gln Phe Lys Leu Pro Lys Thr Ser Thr Phe Ser Ser 290 295 300Gly Ser His Asp Ser Asn Leu Gln Ser Pro Phe Tyr Asn His Glu Tyr305 310 315 320Arg His Tyr Ala Arg Ser Lys Phe Glu Cys Lys Asn Gln Phe Arg Lys 325 330 335Ser Val Ser Pro Ile Lys Glu Ile Pro Ala Thr Thr Ser Ala Asn Glu 340 345 350Gly Trp Asn Ile Leu Arg Asp Ile Ile Glu Lys Leu Asn Ile Ser Asn 355 360 365Val Asp Asp Arg Asn Lys Asp Leu Leu Phe Arg Arg Asp Glu Ile Gly 370 375 380Asp Lys Asn His Ser Asp Ser Ile Asp Ile Glu Asn Leu Ser Ile Lys385 390 395 400Glu Pro Lys Gly Met Lys Arg Arg Lys Lys Asp Asp Ile Ser Leu Glu 405 410 415Glu Leu Phe Gln Ser Leu Pro Arg Glu Lys Asp Tyr Phe Met Met Asp 420 425 430Ala Ile Asn Asp Ser Leu Glu Ser Ile Asn Leu Phe Lys Lys Pro Lys 435 440 445Thr Thr Gln Ser His Glu Gln Gly Gly Thr Phe Ala Gln Ala Glu Ser 450 455 460Asn Arg Ala Lys Phe Lys Pro Leu Leu Glu Gln Cys Gly Ile Thr Pro465 470 475 480Glu Ile Leu Asp Leu Glu Ile Pro Glu Ile Pro Glu Phe Asp Ala Val 485 490 495Ala Asp Leu Glu Thr Leu Lys Leu Asn Val Gln Leu Phe Asn Asn Gln 500 505 510Cys Asn Lys Leu Lys Glu Thr Ile His Gln Val Ser Leu Gln Arg Leu 515 520 525Arg Ala Asp Thr Gln Phe Ser Asp Met Leu Thr Gln Lys Gln Ser Ile 530 535 540Met Val Trp Lys Thr Tyr Leu Glu Phe Asp Lys Ser Leu Met Asp Lys545 550 555 560Leu Asn Ile Leu Gln Glu Arg Gln Met Gln Val Ile Lys Ile Phe Ser 565 570 575Glu Arg Cys Asp Gly Lys Val 580801752DNASaccharomyces cerevisiae 80atgtcacagg taatagaacc acaattagat agaacaacct attattccat attaggcttg 60acatcaaatg cgacttcctc cgaagtacat aaatcatatc taaaactggc cagattactt 120cacccagata aaacaaaatc tgataagtct gaggaattat tcaaagctgt ggtgcatgca 180cattcaattt taactgatga agatcaaaaa cttcgatatg atcgagattt gaaaatcaaa 240ggtttacaca cttaccagcc gaagaaaaac tgtcatattt tcaagaccaa ggcaaaggaa 300tcacaagggg ctagtcccac acttggtcaa tcagaagctt atcataggca aaataaacct 360tatgagcaac agccctacgg tttcggtgta ggcaaaaaaa tgacctcaag ctctaagagt 420aaggttccga tattcaagtc cttcaattta aaaagctacc aacgaaacca ctattattca 480tccaaaaagg aaaggaaaca tggaagtcct gatattgatt ctttgttcca tgaaaccaat 540ggagcctcaa aagtaagaat gactgatgcc ggtaaaatgg atacgaactc tcagttccaa 600gaaatatggg aaatattggg taaaaatgcg tacacacata aatcttactc tgaagatcca 660aattcatgtt tgggatcagc actaagcgat catgaagaag aagaagaagc aggaaaacaa 720caacagcaac agcagcaaca acagcaacag cagcaacatt atggaatgac gtcgaagtct 780agcagtcctg atgaagaaaa aaaaaataat aaagaaccga aaagggaaag cagagtctct 840ccagaggaaa atggcgaaga agaaacggga cacaaacaat ttaaattgcc caagaccagt 900actttttcta gtggatccca tgattcaaat ttgcaatctc ctttttacaa tcatgagtat 960cgacattacg caagaagtaa attcgaatgc aagaatcagt ttagaaagtc agtttctccc 1020attaaagaga tacctgcaac aactagtgcc aatgaaggat ggaacatttt gagagacatt 1080attgaaaaac tcaatataag caatgtagac gatcgaaata aagacttgct gtttcgtcgg 1140gatgaaatag gtgataaaaa tcacagcgac tcaatcgaca tagaaaattt atctatcaaa 1200gaacctaaag ggatgaaaag gagaaagaaa gatgatatat ctttagaaga attgttccaa 1260tctttaccaa gagaaaaaga ttattttatg atggatgcaa ttaatgactc gttagaatca 1320atcaatcttt ttaaaaagcc gaagaccact cagagtcacg aacaaggtgg aacttttgcc 1380caagcagaaa gtaatcgtgc aaaattcaaa ccgttactag aacagtgtgg aattacaccc 1440gagatcttag atttggaaat accagagatt ccggaatttg atgcagtggc tgaccttgaa 1500acattgaagc ttaacgtgca gctgtttaat aaccaatgta acaaacttaa agaaacaata 1560catcaagtat cattacagcg cctgagagca gatacgcagt tcagtgatat gttaacccaa 1620aagcaaagta ttatggtttg gaaaacatac ctagaatttg ataaaagttt aatggacaaa 1680ttgaacatct tacaagaaag acagatgcag gtcattaaaa ttttttccga aagatgtgac 1740ggtaaagtat aa 175281172PRTSaccharomyces cerevisiae 81Met Ser Leu Val Asn Ser Leu Thr His Tyr Glu Ile Leu Arg Ile Pro1 5 10 15Ser Asp Ala Thr Gln Asp Glu Ile Lys Lys Ala Tyr Arg Asn Arg Leu 20 25 30Leu Asn Thr His Pro Asp Lys Leu Ser Lys Ser Ile His Asp Thr Val 35 40 45Ser Asn Val Thr Ile Asn Lys Ile Gln Asp Ala Tyr Lys Ile Leu Ser 50 55 60Asn Ile Lys Thr Arg Arg Glu Tyr Asp Arg Leu Ile Leu Glu Asn Tyr65 70 75 80Lys Arg Gln Gly Phe His Asn Cys Gly Asp Gly Leu Asp Glu Phe Ser 85 90 95Leu Asp Asp Phe Ser Phe Asp Glu Asp Lys Leu Glu Phe Met Met Asn 100 105 110Cys Pro Arg Cys Gln Phe Val Gly Gly Phe His Phe Ser Glu Ser Leu 115 120 125Leu Asp Glu Cys Ile Asp Asn Val Asp Ala Met Glu Arg Ser His Ser 130 135 140Gly Tyr Gln Leu Leu Thr Gln Cys Ser Ala Cys Ser Leu Trp Leu Lys145 150 155 160Val Asn Phe Asp Ile Glu Glu Glu Gln Glu Gly Gln 165 17082519DNASaccharomyces cerevisiae 82atgtcattgg tgaattcgtt aacacactac gaaattttaa gaattccatc ggatgcaaca 60caagatgaaa tcaaaaaggc atataggaat cggttactaa atacgcaccc cgataaactt 120tctaaaagca tacatgatac ggttagcaac gtcacaatca ataagattca agatgcttat 180aaaatactat cgaatataaa aactcgtcgc gaatatgata ggttgatcct tgaaaactat 240aaacgccaag gatttcataa ttgtggtgat gggctggatg aattttcctt agacgatttc 300tcatttgatg aagataagct ggagtttatg atgaattgtc ctcgctgtca atttgttggt 360ggttttcatt ttagtgagag tttgttagat gaatgcattg ataatgtaga cgctatggaa 420cggagtcatt ctggttatca attattaacc caatgtagcg catgcagctt atggctgaag 480gttaattttg acatcgagga agagcaagaa ggacaataa 51983391PRTSaccharomyces cerevisiae 83Met Val Lys Glu Thr Glu Tyr Tyr Asp Ile Leu Gly Ile Lys Pro Glu1 5 10 15Ala Thr Pro Thr Glu Ile Lys Lys Ala Tyr Arg Arg Lys Ala Met Glu 20 25 30Thr His Pro Asp Lys His Pro Asp Asp Pro Asp Ala Gln Ala Lys Phe 35

40 45Gln Ala Val Gly Glu Ala Tyr Gln Val Leu Ser Asp Pro Gly Leu Arg 50 55 60Ser Lys Tyr Asp Gln Phe Gly Lys Glu Asp Ala Val Pro Gln Gln Gly65 70 75 80Phe Glu Asp Ala Ser Glu Tyr Phe Thr Ala Ile Phe Gly Gly Asp Gly 85 90 95Phe Lys Asp Trp Ile Gly Glu Phe Ser Leu Phe Lys Glu Leu Asn Glu 100 105 110Ala Thr Glu Met Phe Gly Lys Glu Asp Glu Glu Gly Thr Ala Ala Thr 115 120 125Glu Thr Glu Lys Ala Asp Glu Ser Thr Asp Gly Gly Met Val Lys His 130 135 140Asp Thr Asn Lys Ala Glu Ser Leu Lys Lys Asp Lys Leu Ser Lys Glu145 150 155 160Gln Arg Glu Lys Leu Met Glu Met Glu Lys Lys Arg Arg Glu Asp Met 165 170 175Met Lys Gln Val Asp Glu Leu Ala Glu Lys Leu Asn Glu Lys Ile Ser 180 185 190Arg Tyr Leu Ile Ala Val Lys Ser Asn Asn Leu Glu Glu Phe Thr Arg 195 200 205Lys Leu Asp Gln Glu Ile Glu Asp Leu Lys Leu Glu Ser Phe Gly Leu 210 215 220Glu Leu Leu Tyr Leu Leu Ala Arg Val Tyr Lys Thr Lys Ala Asn Asn225 230 235 240Phe Ile Met Ser Lys Lys Thr Tyr Gly Ile Ser Lys Ile Phe Thr Gly 245 250 255Thr Arg Asp Asn Ala Arg Ser Val Lys Ser Ala Tyr Asn Leu Leu Ser 260 265 270Thr Gly Leu Glu Ala Gln Lys Ala Met Glu Lys Met Ser Glu Val Asn 275 280 285Thr Asp Glu Leu Asp Gln Tyr Glu Arg Ala Lys Phe Glu Ser Thr Met 290 295 300Ala Gly Lys Ala Leu Gly Val Met Trp Ala Met Ser Lys Phe Glu Leu305 310 315 320Glu Arg Lys Leu Lys Asp Val Cys Asn Lys Ile Leu Asn Asp Lys Lys 325 330 335Val Pro Ser Lys Glu Arg Ile Ala Lys Ala Lys Ala Met Leu Phe Ile 340 345 350Ala His Lys Phe Ala Ser Ala Arg Arg Ser Pro Glu Glu Ala Glu Glu 355 360 365Ala Arg Val Phe Glu Glu Leu Ile Leu Gly Glu Gln Glu Lys Glu His 370 375 380Lys Lys His Thr Val Ala Arg385 390841176DNASaccharomyces cerevisiae 84atggtaaagg agacggagta ttatgatatt ttgggcatca agcctgaggc cacgcccact 60gaaatcaaaa aggcctatcg tagaaaggct atggaaacac atccggacaa gcatcctgat 120gacccagatg ctcaagcaaa gtttcaagcc gtaggcgagg cctaccaagt cttaagtgat 180ccagggcttc gttccaagta tgaccagttt ggtaaggagg atgctgttcc tcagcaagga 240tttgaagatg cttctgaata ctttacagca atattcggtg gtgatggctt caaagattgg 300attggagaat tttctttgtt caaagagcta aacgaggcaa cagaaatgtt tggaaaggaa 360gatgaggagg gtacagcagc cactgaaacc gaaaaagcag atgagagcac tgatggtgga 420atggttaagc atgacactaa taaagctgaa tctttgaaaa aagataaatt atcgaaggag 480caaagagaga agctaatgga aatggagaaa aaaagacggg aagatatgat gaaacaagtc 540gacgagttgg cagaaaaact gaacgaaaaa atctctaggt acttaattgc tgtgaagtcc 600aataacttgg aggaatttac gcgaaaacta gatcaagaaa tcgaggattt gaaattagaa 660agttttggtc tagagttatt gtatttattg gccagggttt acaagacaaa agcgaataat 720tttatcatgt ccaagaagac ttacggaatt tctaaaatat tcactggtac acgcgacaat 780gctagatctg ttaaatcagc atacaattta ttgtctacag gcttagaagc tcaaaaagcc 840atggaaaaaa tgagtgaagt caatactgac gaactagacc aatatgaacg tgccaaattt 900gagtccacaa tggctggtaa ggcacttggt gtcatgtggg ctatgtcgaa atttgaactg 960gaaagaaaac taaaagacgt ttgcaataag attctaaacg ataaaaaggt cccttccaag 1020gaacgtattg caaaggcaaa agcaatgctg tttattgccc acaagtttgc cagtgctaga 1080aggtcaccag aagaagctga agaagctaga gtttttgaag agctaatcct aggtgagcag 1140gagaaggaac acaaaaaaca tactgtggcc agataa 117685283PRTSaccharomyces cerevisiae 85Met Pro Gly His Glu Leu Glu Asp Val Ile Asn Gln Arg Leu Asn Leu1 5 10 15Tyr Asp Val Leu Glu Leu Pro Thr Pro Leu Asp Val His Thr Ile Tyr 20 25 30Asp Asp Leu Pro Gln Ile Lys Arg Lys Tyr Arg Thr Leu Ala Leu Lys 35 40 45Tyr His Pro Asp Lys His Pro Asp Asn Pro Ser Ile Ile His Lys Phe 50 55 60His Leu Leu Ser Thr Ala Thr Asn Ile Leu Thr Asn Ala Asp Val Arg65 70 75 80Pro His Tyr Asp Arg Trp Leu Ile Glu Phe Leu Arg Lys Thr Asn Asp 85 90 95Ile Glu Arg Asn Lys Leu Ile Gln Lys Leu Glu Glu Ser Glu Ser Ser 100 105 110Thr Ile Pro Thr Thr Thr Pro His Pro Asp Leu Leu Gln Ile Gln Arg 115 120 125His Gly Glu Leu Leu Arg Lys Leu Lys His Phe Asn Leu Pro Tyr Gly 130 135 140Asp Trp Lys His Leu Asn Thr Gln Asp Gln Glu Asn Ala Ser Gln His145 150 155 160Pro Tyr Tyr Asp Cys Ser Thr Leu Arg Ile Val Leu Asp Asn Phe Leu 165 170 175Gln Ser Asn Asn Lys Ser Asn Cys Leu Ser His Leu Arg Asn Gln Val 180 185 190Phe Ile Thr Leu Ser Ala Asn Glu Ile Tyr Asp Ile Tyr Phe Ser Glu 195 200 205Arg Asn Asn Tyr Ser Lys Asp Asp Ser Ile Ile Ile Tyr Thr Val Phe 210 215 220Asp Thr Pro Ile Thr Ala Gln His Val Phe Arg Asn Trp Ser Ser Gly225 230 235 240Asn Leu Ile Pro Thr Val Lys Asp Ile Ser Pro Leu Ile Pro Leu His 245 250 255Tyr Tyr Ser Asp Phe Asn Leu Glu Thr Glu Leu Asn Asp Asp Ile Ala 260 265 270Arg Leu Val Ser Asn Glu Pro Ile Leu Leu Asp 275 28086852DNASaccharomyces cerevisiae 86atgccaggac acgaattgga agacgtaata aatcaacgtt tgaacctata tgatgtatta 60gaattaccga cccccctgga cgtccatacc atctacgatg atttgcccca aattaaacgc 120aaatacagga cccttgccct gaagtatcat cctgacaaac acccggacaa tccatcaatt 180atacacaaat tccacttatt atcgaccgca actaatatcc tcaccaatgc agacgtgaga 240ccccattacg accgctggtt aattgagttc ctacggaaaa caaacgacat tgaaagaaat 300aaacttatac aaaagctgga agaatctgaa tcgagtacga tacccaccac cacaccacat 360cctgatttat tgcaaatcca acgccacggc gagctactca ggaaactaaa acatttcaac 420ttgccctatg gtgactggaa acatctcaac acacaagacc aagaaaatgc ttcgcaacat 480ccgtattacg attgctctac tttgagaatt gtccttgaca acttcctgca atcaaataat 540aaatcaaact gcttatctca tttgcgcaat caagtattca tcacgctaag tgctaatgaa 600atctacgaca tctacttctc tgaaagaaac aactactcga aggatgattc aatcatcata 660tatactgtat tcgatactcc catcacagcg cagcacgtat tccgaaactg gtcaagtggg 720aacctcatac ccacggtcaa ggatatttcg cccttgatcc cgctacatta ctactctgat 780tttaatttgg agacggaact gaatgacgat attgcaagac tggtctctaa tgaacctatc 840ctactcgact ag 85287168PRTSaccharomyces cerevisiae 87Met Ser Ser Gln Ser Asn Thr Gly Asn Ser Ile Glu Ala Pro Gln Leu1 5 10 15Pro Ile Pro Gly Gln Thr Asn Gly Ser Ala Asn Val Thr Val Asp Gly 20 25 30Ala Gly Val Asn Val Gly Ile Gln Asn Gly Ser Gln Gly Gln Lys Thr 35 40 45Gly Met Asp Leu Tyr Phe Asp Gln Ala Leu Asn Tyr Met Gly Glu His 50 55 60Pro Val Ile Thr Gly Phe Gly Ala Phe Leu Thr Leu Tyr Phe Thr Ala65 70 75 80Gly Ala Tyr Lys Ser Ile Ser Lys Gly Leu Asn Gly Gly Lys Ser Thr 85 90 95Thr Ala Phe Leu Lys Gly Gly Phe Asp Pro Lys Met Asn Ser Lys Glu 100 105 110Ala Leu Gln Ile Leu Asn Leu Thr Glu Asn Thr Leu Thr Lys Lys Lys 115 120 125Leu Lys Glu Val His Arg Lys Ile Met Leu Ala Asn His Pro Asp Lys 130 135 140Gly Gly Ser Pro Phe Leu Ala Thr Lys Ile Asn Glu Ala Lys Asp Phe145 150 155 160Leu Glu Lys Arg Gly Ile Ser Lys 16588507DNASaccharomyces cerevisiae 88atgagttctc aaagtaatac tggtaattct attgaggcac cacaactacc cattcctggt 60caaactaatg gctctgcgaa cgttactgtt gatggagctg gtgttaatgt cggtatccag 120aatggttcgc agggtcaaaa gaccggaatg gacctttatt ttgatcaagc tttgaactac 180atgggagaac atcctgtgat aacaggtttt ggggcctttt taactttata ttttacagcc 240ggtgcatata aatcaatatc gaagggactt aacggtggaa aatccactac tgccttcttg 300aaaggcggat ttgacccgaa aatgaattct aaagaggctc tacagatttt gaatttgaca 360gaaaatacat tgactaaaaa aaagttgaaa gaggttcata ggaaaattat gttagctaat 420catcctgaca aaggtggttc tccatttttg gccactaaga taaacgaagc taaggacttt 480ttggaaaaaa ggggtattag caaataa 50789184PRTSaccharomyces cerevisiae 89Met Leu Lys Tyr Leu Val Gln Arg Arg Phe Thr Ser Thr Phe Tyr Glu1 5 10 15Leu Phe Pro Lys Thr Phe Pro Lys Lys Leu Pro Ile Trp Thr Ile Asp 20 25 30Gln Ser Arg Leu Arg Lys Glu Tyr Arg Gln Leu Gln Ala Gln His His 35 40 45Pro Asp Met Ala Gln Gln Gly Ser Glu Gln Ser Ser Thr Leu Asn Gln 50 55 60Ala Tyr His Thr Leu Lys Asp Pro Leu Arg Arg Ser Gln Tyr Met Leu65 70 75 80Lys Leu Leu Arg Asn Ile Asp Leu Thr Gln Glu Gln Thr Ser Asn Glu 85 90 95Val Thr Thr Ser Asp Pro Gln Leu Leu Leu Lys Val Leu Asp Ile His 100 105 110Asp Glu Leu Ser Gln Met Asp Asp Glu Ala Gly Val Lys Leu Leu Glu 115 120 125Lys Gln Asn Lys Glu Arg Ile Gln Asp Ile Glu Ala Gln Leu Gly Gln 130 135 140Cys Tyr Asn Asp Lys Asp Tyr Ala Ala Ala Val Lys Leu Thr Val Glu145 150 155 160Leu Lys Tyr Trp Tyr Asn Leu Ala Lys Ala Phe Lys Asp Trp Ala Pro 165 170 175Gly Lys Gln Leu Glu Met Asn His 18090555DNASaccharomyces cerevisiae 90atgttgaaat acttggttca acgaagattc acttctacat tttacgagct gttcccaaag 60accttcccca aaaagctacc catttggact atcgatcaat ccagattaag gaaggagtat 120aggcaattac aagcacagca ccatccagac atggcccaac aaggtagtga acagtcatca 180actcttaatc aagcttacca tactctcaaa gatcccctta gaaggtcaca atatatgcta 240aaactcttgc gcaatatcga tttgacgcaa gaacagacct caaatgaagt aactaccagt 300gatccacagt tactattgaa agttctagac atccatgatg aattatccca gatggacgac 360gaagctggtg tgaagctgct tgaaaagcaa aacaaggaaa gaattcaaga tattgaagcc 420cagttgggac aatgctacaa tgacaaggat tacgccgccg cagtgaagtt gaccgtggag 480ctaaagtact ggtacaactt ggccaaggca ttcaaagact gggctccagg aaaacaattg 540gaaatgaatc actaa 55591301PRTSaccharomyces cerevisiae 91Met Leu His His Lys Phe Val Tyr Pro Phe Leu Phe Lys Trp His Leu1 5 10 15Ser Cys Val Glu Lys Cys Pro Pro Gln Ile Thr Phe Ile Ala Lys Tyr 20 25 30Ala Thr Ala Asn Asp Lys Asn Gly Asn Arg Lys Leu Thr Ile Arg Asp 35 40 45Glu Gln Trp Pro Glu Leu Ala Asp Pro Thr Pro Tyr Asp Ile Phe Gly 50 55 60Ile Pro Lys Ala Gly Ser Gly Asn Pro Lys Leu Asp Lys Lys Ser Leu65 70 75 80Lys Lys Lys Tyr His Arg Tyr Val Lys Leu Tyr His Pro Asp His Ser 85 90 95Asp Asn Ile Gln Ile Phe Ser Ser Glu Lys Val Thr Asn Ser Asp Ser 100 105 110Lys Ser Pro Leu Leu Leu Thr Ser Ser Glu Lys Leu His Arg Phe Lys 115 120 125Val Ile Ser Gln Ala Tyr Asp Ile Leu Cys Asp Pro Lys Lys Lys Ile 130 135 140Val Tyr Asp Thr Thr Arg Gln Gly Trp Thr Thr Ser Tyr Ser Pro Arg145 150 155 160Ser Asn Val Asn Thr Glu Asn Tyr Gln Tyr Ala Gly Ser Tyr Gly Tyr 165 170 175His Ser Asn Ala Gln Tyr Glu Tyr Trp Asn Ala Gly Thr Trp Glu Asp 180 185 190Ala Asn Ser Met Lys Asn Glu Arg Ile Gln Glu Asn Ile Asn Pro Trp 195 200 205Thr Val Ile Gly Ile Ile Cys Gly Leu Ala Ile Cys Ile Glu Gly Thr 210 215 220Ala Leu Leu Ala Lys Ile Gln Glu Ser Leu Ser Lys Ala Glu Phe Thr225 230 235 240His Asp Glu Ser Gly Leu His Leu Ile Gln Ser Tyr Thr Asn Tyr Gly 245 250 255Leu Asp Thr Asp Lys Phe Ser Arg Leu Arg Arg Phe Leu Trp Phe Arg 260 265 270Thr Trp Gly Leu Tyr Lys Ser Lys Glu Asp Leu Asp Arg Glu Ala Lys 275 280 285Ile Asn Glu Glu Met Ile Arg Lys Leu Lys Ala Ala Lys 290 295 30092906DNASaccharomyces cerevisiae 92atgctacacc ataagttcgt atacccattt ttattcaagt ggcacttatc atgtgtagaa 60aagtgtcccc cacaaatcac ttttatagct aagtatgcta cagcgaacga taaaaatggc 120aatagaaaac ttacgataag ggatgaacaa tggcctgagt tggcagatcc aactccctat 180gatatttttg gcattccaaa ggccggatct ggaaatccta aactggacaa gaagtcgtta 240aaaaaaaaat atcatcgtta tgtaaaattg taccaccctg accattccga taacattcaa 300atatttagct cagaaaaggt taccaacagt gatagtaaat caccgctgct gctaacatca 360agcgaaaaac tacatagatt taaagtcatc tctcaagcat atgatattct ttgtgaccca 420aagaaaaaga tcgtatatga cacaacgagg caaggctgga ccacatcgta ttcaccacgt 480tctaacgtta atactgaaaa ttaccaatat gccggctctt atggctacca ctctaacgcg 540cagtatgaat actggaacgc tgggacttgg gaagacgcaa atagcatgaa aaacgaaaga 600attcaagaaa acatcaaccc atggaccgtt attggcataa tttgtggcct agctatatgc 660atcgaaggga ctgcgttgtt agccaaaatc caggagtctc tgagcaaggc cgaatttact 720catgacgaaa gtggattaca tttgattcag tcatacacga attatggtct tgatactgac 780aaattttcca gattgaggcg gttcttatgg tttagaactt ggggacttta caagtcgaaa 840gaggatttag atagagaagc caagatcaat gaagaaatga tacgcaaact gaaagcagct 900aaatga 90693224PRTSaccharomyces cerevisiae 93Met Ser Phe Thr Glu Asp Gln Glu Lys Ile Ala Leu Glu Ile Leu Ser1 5 10 15Lys Asp Lys His Glu Phe Tyr Glu Ile Leu Lys Val Asp Arg Lys Ala 20 25 30Thr Asp Ser Glu Ile Lys Lys Ala Tyr Arg Lys Leu Ala Ile Lys Leu 35 40 45His Pro Asp Lys Asn Ser His Pro Lys Ala Gly Glu Ala Phe Lys Val 50 55 60Ile Asn Arg Ala Phe Glu Val Leu Ser Asn Glu Glu Lys Arg Ser Ile65 70 75 80Tyr Asp Arg Ile Gly Arg Asp Pro Asp Asp Arg Gln Met Pro Ser Arg 85 90 95Gly Ala Ala Ser Gly Phe Arg Gly Ser Ala Gly Gly Ser Pro Met Gly 100 105 110Gly Gly Phe Glu Asp Met Phe Phe Asn Ser Arg Phe Gly Gly Gln Arg 115 120 125Ala Gly Pro Pro Glu Asp Ile Phe Asp Phe Leu Phe Asn Ala Gly Gly 130 135 140Ser Pro Phe Gly Ala Ser Pro Phe Gly Pro Ser Ala Ser Thr Phe Ser145 150 155 160Phe Gly Gly Pro Gly Gly Phe Arg Val Tyr Thr Asn Asn Arg Gly Gly 165 170 175Ser Pro Phe Met Arg Gln Gln Pro Arg Ser Arg Gln Gln Gln Gln Gln 180 185 190Ala Glu Glu Asn Ala Val Asn Ser Gln Leu Lys Asn Met Leu Val Leu 195 200 205Phe Ile Ile Phe Ile Val Leu Pro Met Ile Lys Asp Tyr Leu Phe Ser 210 215 22094675DNASaccharomyces cerevisiae 94atgtctttca ctgaggatca agaaaaaatc gcgctagaaa tactgtcaaa agacaagcat 60gagttttacg aaattttgaa ggtagatagg aaagccacag atagtgagat caagaaggca 120tacagaaaac tagcaatcaa attgcatcct gataaaaact ctcatccaaa agcgggagaa 180gctttcaaag taattaatag ggcatttgaa gtactaagca atgaggaaaa gcgcagtatt 240tatgacagga taggtaggga tcctgacgat agacaaatgc catccagagg tgctgcttca 300gggttccgag gaagtgcagg tgggtctcca atgggtggcg gatttgaaga catgtttttc 360aattcacgtt tcggtggtca aagagctgga ccaccagagg acatattcga ctttttgttc 420aacgcaggcg gcagcccatt cggcgcttca ccatttgggc cttctgcttc cactttttca 480tttggaggcc ccggtggttt cagagtttat actaataatc gtggtggctc accgttcatg 540cgtcaacaac cccgctcaag acagcagcaa caacaagcag aagaaaatgc agtgaattcg 600caattaaaaa atatgctcgt tcttttcatc atctttattg ttcttcctat gattaaagat 660tacctgttta gttaa 67595295PRTSaccharomyces cerevisiae 95Met Asn Gly Tyr Trp Lys Pro Ala Leu Val Val Leu Gly Leu Val Ser1 5 10 15Leu Ser Tyr Ala Phe Thr Thr Ile Glu Thr Glu Ile Phe Gln Leu Gln 20 25 30Asn Glu Ile Ser Thr Lys Tyr Gly Pro Asp Met Asn Phe Tyr Lys Phe 35 40 45Leu Lys Leu Pro Lys Leu Gln Asn Ser Ser Thr Lys Glu Ile Thr Lys 50 55 60Asn Leu Arg Lys Leu Ser Lys Lys Tyr His Pro Asp Lys Asn Pro Lys65 70 75 80Tyr Arg Lys Leu Tyr Glu Arg Leu Asn Leu Ala Thr Gln Ile Leu Ser 85 90 95Asn Ser Ser Asn Arg Lys Ile Tyr Asp Tyr Tyr Leu Gln Asn Gly Phe 100

105 110Pro Asn Tyr Asp Phe His Lys Gly Gly Phe Tyr Phe Ser Arg Met Lys 115 120 125Pro Lys Thr Trp Phe Leu Leu Ala Phe Ile Trp Ile Val Val Asn Ile 130 135 140Gly Gln Tyr Ile Ile Ser Ile Ile Gln Tyr Arg Ser Gln Arg Ser Arg145 150 155 160Ile Glu Asn Phe Ile Ser Gln Cys Lys Gln Gln Asp Asp Thr Asn Gly 165 170 175Leu Gly Val Lys Gln Leu Thr Phe Lys Gln His Glu Lys Asp Glu Gly 180 185 190Lys Ser Leu Val Val Arg Phe Ser Asp Val Tyr Val Val Glu Pro Asp 195 200 205Gly Ser Glu Thr Leu Ile Ser Pro Asp Thr Leu Asp Lys Pro Ser Val 210 215 220Lys Asn Cys Leu Phe Trp Arg Ile Pro Ala Ser Val Trp Asn Met Thr225 230 235 240Phe Gly Lys Ser Val Gly Ser Ala Gly Lys Glu Glu Ile Ile Thr Asp 245 250 255Ser Lys Lys Tyr Asp Gly Asn Gln Thr Lys Lys Gly Asn Lys Val Lys 260 265 270Lys Gly Ser Ala Lys Lys Gly Gln Lys Lys Met Glu Leu Pro Asn Gly 275 280 285Lys Val Ile Tyr Ser Arg Lys 290 29596888DNASaccharomyces cerevisiae 96atgaacggtt actggaaacc tgcgttggtt gtcctgggat tggtatctct atcatatgct 60tttaccacca ttgaaacaga aattttccaa ttacaaaatg aaataagtac gaaatatggc 120ccagatatga acttctacaa gttcttgaag ttacctaaac tgcagaattc tagtacaaag 180gagattacaa aaaacttaag aaagctatcc aagaagtacc atccggataa gaaccctaaa 240taccgtaaat tgtatgaaag gttaaacctc gctactcaaa ttctttcaaa cagctctaat 300cgtaagattt atgattatta tctacagaat ggctttccaa actatgattt ccataagggt 360ggtttttatt tttccagaat gaagcctaag acttggttcc tgctggcctt tatttggata 420gtcgttaata ttgggcagta tatcatttct attattcaat atcgttctca aagatcaaga 480attgaaaact tcatcagtca gtgtaaacaa caggatgata ccaatggact aggcgtaaaa 540caactaacgt ttaaacaaca tgaaaaggat gagggtaaaa gtttggttgt aaggtttagc 600gatgtctatg ttgtagagcc tgatggaagt gaaacactaa tttcgccaga taccttggat 660aaaccttcag taaagaactg tttgttttgg agaatacctg cttcggtttg gaacatgacg 720tttggcaaat ctgttggtag cgcaggaaaa gaagaaataa taacggatag taaaaagtat 780gatggtaacc aaacaaaaaa ggggaacaaa gtaaaaaagg gttctgcaaa gaaaggccaa 840aagaaaatgg aattgcctaa cggtaaagtg atctattcac gtaaatga 88897228PRTSaccharomyces cerevisiae 97Met Arg Ala Phe Ser Ala Ala Thr Val Arg Ala Thr Thr Arg Lys Ser1 5 10 15Phe Ile Pro Met Ala Pro Arg Thr Pro Phe Val Thr Pro Ser Phe Thr 20 25 30Lys Asn Val Gly Ser Met Arg Arg Met Arg Phe Tyr Ser Asp Glu Ala 35 40 45Lys Ser Glu Glu Ser Lys Glu Asn Asn Glu Asp Leu Thr Glu Glu Gln 50 55 60Ser Glu Ile Lys Lys Leu Glu Ser Gln Leu Ser Ala Lys Thr Lys Glu65 70 75 80Ala Ser Glu Leu Lys Asp Arg Leu Leu Arg Ser Val Ala Asp Phe Arg 85 90 95Asn Leu Gln Gln Val Thr Lys Lys Asp Ile Gln Lys Ala Lys Asp Phe 100 105 110Ala Leu Gln Lys Phe Ala Lys Asp Leu Leu Glu Ser Val Asp Asn Phe 115 120 125Gly His Ala Leu Asn Ala Phe Lys Glu Glu Asp Leu Gln Lys Ser Lys 130 135 140Glu Ile Ser Asp Leu Tyr Thr Gly Val Arg Met Thr Arg Asp Val Phe145 150 155 160Glu Asn Thr Leu Arg Lys His Gly Ile Glu Lys Leu Asp Pro Leu Gly 165 170 175Glu Pro Phe Asp Pro Asn Lys His Glu Ala Thr Phe Glu Leu Pro Gln 180 185 190Pro Asp Lys Glu Pro Gly Thr Val Phe His Val Gln Gln Leu Gly Phe 195 200 205Thr Leu Asn Asp Arg Val Ile Arg Pro Ala Lys Val Gly Ile Val Lys 210 215 220Gly Glu Glu Asn22598687DNASaccharomyces cerevisiae 98atgagagctt tttcagcagc caccgttagg gccacaacta ggaagtcgtt catcccaatg 60gcaccaagaa ctccttttgt gactccatca tttacaaaga atgtaggctc aatgagaaga 120atgagatttt attctgatga agccaaaagt gaagaatcca aagaaaacaa tgaagatttg 180actgaagagc aatcagaaat caagaaatta gagagccagt taagcgcgaa gactaaagaa 240gcttctgaac tcaaggacag attattaaga tctgtggcag atttcagaaa tttacaacaa 300gtcacaaaga aggatattca gaaagctaag gactttgctt tacagaagtt tgcaaaggat 360ttattggaat ctgtagataa ctttggtcat gctttgaatg cttttaaaga ggaagactta 420caaaagtcca aggaaattag tgatttgtat acaggggtta gaatgacaag agatgttttt 480gaaaacaccc taagaaagca cggtattgaa aaattagacc cattgggaga accatttgat 540ccaaataaac acgaagcaac gttcgagttg ccacaacctg ataaggaacc gggtactgtt 600ttccatgtac aacaattagg tttcaccttg aatgacagag ttatcagacc agcaaaagtc 660ggaattgtta agggcgaaga gaactaa 68799290PRTSaccharomyces cerevisiae 99Met Glu Lys Leu Leu Gln Trp Ser Ile Ala Asn Ser Gln Gly Asp Lys1 5 10 15Glu Ala Met Ala Arg Ala Gly Gln Pro Asp Pro Lys Leu Leu Gln Gln 20 25 30Leu Phe Gly Gly Gly Gly Pro Asp Asp Pro Thr Leu Met Lys Glu Ser 35 40 45Met Ala Val Ile Met Asn Pro Glu Val Asp Leu Glu Thr Lys Leu Val 50 55 60Ala Phe Asp Asn Phe Glu Met Leu Ile Glu Asn Leu Asp Asn Ala Asn65 70 75 80Asn Ile Glu Asn Leu Lys Leu Trp Glu Pro Leu Leu Asp Val Leu Val 85 90 95Gln Thr Lys Asp Glu Glu Leu Arg Ala Ala Ala Leu Ser Ile Ile Gly 100 105 110Thr Ala Val Gln Asn Asn Leu Asp Ser Gln Asn Asn Phe Met Lys Tyr 115 120 125Asp Asn Gly Leu Arg Ser Leu Ile Glu Ile Ala Ser Asp Lys Thr Lys 130 135 140Pro Leu Asp Val Arg Thr Lys Ala Phe Tyr Ala Leu Ser Asn Leu Ile145 150 155 160Arg Asn His Lys Asp Ile Ser Glu Lys Phe Phe Lys Leu Asn Gly Leu 165 170 175Asp Cys Ile Ala Pro Val Leu Ser Asp Asn Thr Ala Lys Pro Lys Leu 180 185 190Lys Met Arg Ala Ile Ala Leu Leu Thr Ala Tyr Leu Ser Ser Val Lys 195 200 205Ile Asp Glu Asn Ile Ile Ser Val Leu Arg Lys Asp Gly Val Ile Glu 210 215 220Ser Thr Ile Glu Cys Leu Ser Asp Glu Ser Asn Leu Asn Ile Ile Asp225 230 235 240Arg Val Leu Ser Phe Leu Ser His Leu Ile Ser Ser Gly Ile Lys Phe 245 250 255Asn Glu Gln Glu Leu His Lys Leu Asn Glu Gly Tyr Lys His Ile Glu 260 265 270Pro Leu Lys Asp Arg Leu Asn Glu Asp Asp Tyr Leu Ala Val Lys Tyr 275 280 285Val Leu 290100873DNASaccharomyces cerevisiae 100atggaaaagc tattacagtg gtctattgcg aattctcaag gggacaaaga agctatggct 60agggccggcc aacctgatcc taaattgcta cagcagttat tcggtggtgg tggtcctgac 120gatccaacct taatgaaaga atccatggct gttattatga atccggaggt tgacttagaa 180acaaaactcg ttgcatttga caactttgaa atgttgattg agaacttaga taatgctaat 240aatatcgaaa atttaaaact gtgggagcca ttgttggatg ttcttgttca gacgaaggat 300gaagaactac gtgctgctgc tttatccatt attggaacgg ctgtgcaaaa caacttggat 360tcgcaaaata atttcatgaa atacgacaat ggtctgcgaa gccttatcga aatagctagt 420gacaagacaa agccactcga cgtgagaaca aaagcttttt acgcactatc taatctaata 480agaaaccaca aagatatctc agaaaagttt ttcaaattaa atgggctcga ctgcatagca 540cctgtattaa gtgataacac cgccaaacca aaactgaaaa tgagagccat tgccttattg 600accgcatatt tgtcatctgt taagattgat gaaaatataa tcagtgtgct gagaaaggat 660ggagtaattg aaagtacgat tgagtgcttg tctgacgaga gtaacttgaa catcatagat 720agagttctgt cttttctctc tcacctgata tcttccggaa taaaatttaa tgaacaggaa 780ttgcacaaat tgaacgaagg ttacaaacat atcgagcctc taaaggacag acttaatgaa 840gacgattatt tagccgtaaa gtatgtatta tga 87310140DNAArtificial SequencePrimer HO 5' ForNotIBbsI 101gcatgcggcc gcccgaagac cctacacagg gcttaagggc 4010235DNAArtificial SequencePrimer HO 5' RevBsiWIMluI 102ccacgcgtcg tacgggattg ctgcttatga ggata 3510337DNAArtificial SequencePrimer HO 3' ForMluIEcoRI 103acgcgtgaat tcaaaaaggg aacccgtata tttcagc 3710439DNAArtificial SequencePrimer HO 3' RevBbsIClaI 104tatcgatagt cttcctaata tacacatttt agcagatgc 39105102DNAArtificial SequencePrimer pBST HO Poly For 105gcatgcatac gcgtcacgca tgtgcctcag cggccggccg gcgccgggcc ccggaccgcc 60tgcaggctcg agttaattaa gtttaaacga attcgcatgc at 102106102DNAArtificial SequencePrimer pBST HO Poly Rev 106atgcatgcga attcgtttaa acttaattaa ctcgagcctg caggcggtcc ggggcccggc 60gccggccggc cgctgaggca catgcgtgac gcgtatgcat gc 10210762DNAArtificial SequencePrimer Ycplac33 Poly For 107ctagattgga tccctagtct aggtttaaac tagcgattca cctaggtgct aggaattcta 60gc 6210862DNAArtificial SequencePrimer Ycplac33 Poly Rev 108gctagaattc ctagcaccta ggtgaatcgc tagtttaaac ctagactagg gatccaatct 60ag 6210969DNAArtificial SequencePrimer LHS1forOverlap 109cacaatattt caagctatac caagcataca atcaactatc tcatatacaa tgcgaaacgt 60tttaaggct 6911034DNAArtificial SequencePrimer LHS1revBbvCI 110gcatgctgag ggtgccacta taatattaat gtgc 3411171DNAArtificial SequencePrimer SLS1forOverlap 111caccaacaca cacaaaaaac agtacttcac taaatttaca cacaaaacaa aatggtccgg 60attcttccca t 7111231DNAArtificial SequencePrimer SLS1revNarI 112gcatggcgcc ccacggcagg gcagttggca c 3111370DNAArtificial SequencePrimer JEM1forOverlap 113cagatcatca aggaagtaat tatctacttt ttacaacaaa tataaaacaa tgatactgat 60ctcgggatac 7011433DNAArtificial SequencePrimer JEM1revRsrII 114cgatcggtcc gagggaaata aggcagatca aag 3311572DNAArtificial SequencePrimer SCJ1forOverlap 115cacgcttact gcttttttct tcccaagatc gaaaatttac tgaattaaca atgattccaa 60aattatatat ac 7211629DNAArtificial SequencePrimer SCJ1revXhoI 116gcatctcgag gactttgaga cctgtgatc 2911738DNAArtificial SequencePrimer ADH1promForAleI 117cgatcaccga tgtggttgtt tccgggtgta caatatgg 3811871DNAArtificial SequencePrimer ADH1promRevOverlap 118cctatagcaa caaaagctgt taaaaataaa agccttaaaa cgtttcgcat tgtatatgag 60atagttgatt g 7111932DNAArtificial SequencePrimer PGK1promForPspOMI 119gcatgggccc agattcctga cttcaactca ag 3212073DNAArtificial SequencePrimer PGK1promRevOverlap 120ggcaaaataa cgctatacac taaaagacag tatcccgaga tcagtatcat tgttttatat 60ttgttgtaaa aac 7312133DNAArtificial SequencePrimer TDH1promForFseI 121gcatggccgg ccaccatatg gaggataagt tgg 3312271DNAArtificial SequencePrimer TDH1promRevOverlap 122ctaatttcga agatagggcg ctcaaaatta tgggaagaat ccggaccatt ttgttttgtg 60tgttttaaat c 7112336DNAArtificial SequencePrimer TEF1promForSbfI 123cggtagtacc tgcaggaagc aacaggcgcg ttggac 3612478DNAArtificial SequencePrimer TEF1promRevOverlap 124ggcaacaaca ataaagatag tatcaaatgt atatataatt ttggaatcat tttgtaatta 60aaacttagat tagattgc 7812532DNAArtificial SequencePrimer URA3forPac1 125ctagagttaa ttaagtttca attcaattca tc 3212632DNAArtificial SequencePrimer URA3revPme1 126gcctgagttt aaacgttttc tttccaattt tt 3212740DNAArtificial SequencePrimer A01 127gcatgcggcc gcccgaagac cctacacagg gcttaagggc 4012835DNAArtificial SequencePrimer A02 128ccacgcgtcg tacgggattg ctgcttatga ggata 3512937DNAArtificial SequencePrimer A03 129acgcgtgaat tcaaaaaggg aacccgtata tttcagc 3713039DNAArtificial SequencePrimer A04 130tatcgatagt cttcctaata tacacatttt agcagatgc 39131102DNAArtificial SequencePrimer A05 131gcatgcatac gcgtcacgca tgtgcctcag cggccggccg gcgccgggcc ccggaccgcc 60tgcaggctcg agttaattaa gtttaaacga attcgcatgc at 102132102DNAArtificial SequencePrimer A06 132atgcatgcga attcgtttaa acttaattaa ctcgagcctg caggcggtcc ggggcccggc 60gccggccggc cgctgaggca catgcgtgac gcgtatgcat gc 10213335DNAArtificial SequencePrimer A07 133ctaggtaact taattaaggg taagctgcca cagca 3513434DNAArtificial SequencePrimer A08 134ctacgtactc tagatgttaa ttcagtaaat tttc 3413530DNAArtificial SequencePrimer A09 135ctagactcta gatctctgct tttgtgcgcg 3013634DNAArtificial SequencePrimer A10 136catgctacgt ttaaacgatg atcatatgat acac 3413732DNAArtificial SequencePrimer A11 137ctagagttaa ttaagtttca attcaattca tc 3213832DNAArtificial SequencePrimer A12 138gcctgagttt aaacgttttc tttccaattt tt 3213962DNAArtificial SequencePrimer A13 139ctagattgga tccctagtct aggtttaaac tagcgattca cctaggtgct aggaattcta 60gc 6214062DNAArtificial SequencePrimer A14 140gctagaattc ctagcaccta ggtgaatcgc tagtttaaac ctagactagg gatccaatct 60ag 6214169DNAArtificial SequencePrimer C01 141cacaatattt caagctatac caagcataca atcaactatc tcatatacaa tgcgaaacgt 60tttaaggct 6914234DNAArtificial SequencePrimer C02 142gcatgctgag ggtgccacta taatattaat gtgc 3414330DNAArtificial SequencePrimer C03 143ctagatctct agaatggtcc ggattcttcc 3014431DNAArtificial SequencePrimer C04 144gcatggcgcc ccacggcagg gcagttggca c 3114530DNAArtificial SequencePrimer C05 145ctagatctct agaatgatac tgatctcggg 3014633DNAArtificial SequencePrimer C06 146cgatcggtcc gagggaaata aggcagatca aag 3314772DNAArtificial SequencePrimer C07 147cacgcttact gcttttttct tcccaagatc gaaaatttac tgaattaaca atgattccaa 60aattatatat ac 7214829DNAArtificial SequencePrimer C08 148gcatctcgag gactttgaga cctgtgatc 2914938DNAArtificial SequencePrimer C09 149cgatcaccga tgtggttgtt tccgggtgta caatatgg 3815071DNAArtificial SequencePrimer C10 150cctatagcaa caaaagctgt taaaaataaa agccttaaaa cgtttcgcat tgtatatgag 60atagttgatt g 7115132DNAArtificial SequencePrimer C11 151gcatgggccc agattcctga cttcaactca ag 3215232DNAArtificial SequencePrimer C12 152gatctagtct agatgtttta tatttgttgt aa 3215333DNAArtificial SequencePrimer C13 153gcatggccgg ccaccatatg gaggataagt tgg 3315434DNAArtificial SequencePrimer C14 154acctagtcta gatttgtttt gtgtgtaaat ttag 3415536DNAArtificial SequencePrimer C15 155cggtagtacc tgcaggaagc aacaggcgcg ttggac 3615678DNAArtificial SequencePrimer C16 156ggcaacaaca ataaagatag tatcaaatgt atatataatt ttggaatcat tttgtaatta 60aaacttagat tagattgc 7815734DNAArtificial SequencePrimer C17 157ctagtctcta gaatggaaat gactgatttt gaac 3415831DNAArtificial SequencePrimer C18 158ctagtctaga tcatgaagtg atgaagaaat c 3115923DNAArtificial SequenceACT1 Forward Primer 159cccagaagct ttgttccatc ctt 2316028DNAArtificial SequenceACT1 Reverse Primer 160atgatggagt tgtaagtagt ttggtcaa 2816120DNAArtificial SequenceACT1 Probe 161cagattccaa acccaaaaca 2016225DNAArtificial SequenceLHS1 Forward Primer 162acactactca gcccgttaca ataga 2516325DNAArtificial SequenceLHS1 Reverse Primer 163gtaaactttg caccacctag atgtg 2516423DNAArtificial SequenceLHS1 Probe 164atttgaagga tatgggtata atc 2316529DNAArtificial SequenceSIL1 Forward Primer 165gacatgtacg aaaatgacga tacaaatct 2916619DNAArtificial SequenceSIL1 Reverse Primer 166tcgtttgccc actcttgca

1916717DNAArtificial SequenceSIL1 Probe 167tttgacgacc aattctc 1716817DNAArtificial SequenceSCJ1 Forward Primer 168ggcgcaggtg gattcca 1716918DNAArtificial SequenceSCJ1 Reverse Primer 169cgccaggacc tccatgac 1817020DNAArtificial SequenceSCJ1 Probe 170catattcgaa cggatgtttc 2017118DNAArtificial SequenceJEM1 Forward Primer 171cctctccacg cacatcga 1817225DNAArtificial SequenceJEM1 Reverse Primer 172tgcttgtcga ggattgtttc gtaat 2517319DNAArtificial SequenceJEM1 Probe 173tcgttagctg ctgctatca 1917419DNAArtificial SequenceHAC1 Forward Primer 174gaagacgcgt tgacttgca 1917525DNAArtificial SequenceHAC1 Reverse Primer 175gaaatccctg tactcgtcaa gagaa 2517618DNAArtificial SequenceHAC1 Probe 176ccacgacgct tttgttgc 1817726DNAArtificial SequenceHAC1i Forward Primer 177acaattcaat tgatcttgac aattgg 2617825DNAArtificial SequenceHAC1i Reverse Primer 178tcaattcaaa tgaatcaaac ctgac 2517917DNAArtificial SequenceHAC1i Probe 179cgtaatccag aagcgca 17180157DNAArtificial SequenceOligonucleotide linker sense for construction of pDB2283 180gagtccaatt agcttcatcg ccaataaaaa aacaagctaa acctaattct aacaagcaaa 60gatgaagtgg gtaagcttaa cctaattcta acaagcaaag atgcttttgc aagccttcct 120tttccttttg gctggttttg cagccaaaat atctgca 157181161DNAArtificial SequenceSingle stranded oligonucleotide 1 for pDB2283 181ttaagagtcc aattagcttc atcgccaata aaaaaacaag ctaaacctaa ttctaacaag 60caaagatgaa gtgggtaagc ttaacctaat tctaacaagc aaagatgctt ttgcaagcct 120tccttttcct tttggctggt tttgcagcca aaatatctgc a 161182157DNAArtificial SequenceSingle stranded oligonucleotide 2 for pDB2283 182tgcagatatt ttggctgcaa aaccagccaa aaggaaaagg aaggcttgca aaagcatctt 60tgcttgttag aattaggtta agcttaccca cttcatcttt gcttgttaga attaggttta 120gcttgttttt ttattggcga tgaagctaat tggactc 157183320DNAArtificial SequenceSynthetic phosphorylated oligonucleotide linker sense for construction of pDB2284 183ttaagagtcc aattagcttc atcgccaata aaaaaacaaa ctaaacctaa ttctaacaag 60caaagatgag atttccttca atttttactg cagttttatt cgcagcatcc tccgcattag 120ctgctccagt caacactaca acagaagatg aaacggcaca aattccggct gaagctgtca 180tcggttactc agatttagaa ggggatttcg atgttgctgt tttgccattt tccaacagca 240caaataacgg gttattgttt ataaatacta ctattgccag cattgctgct aaagaagaag 300gggtaagctt ggataaaaga 320184316DNAArtificial SequenceSynthetic phosphorylated oligonucleotide linker anti sense (pDB2283) 184tcttttatcc aagcttaccc cttcttcttt agcagcaatg ctggcaatag tagtatttat 60aaacaataac ccgttatttg tgctgttgga aaatggcaaa acagcaacat cgaaatcccc 120ttctaaatct gagtaaccga tgacagcttc agccggaatt tgtgccgttt catcttctgt 180tgtagtgttg actggagcag ctaatgcgga ggatgctgcg aataaaactg cagtaaaaat 240tgaaggaaat ctcatctttg cttgttagaa ttaggtttag tttgtttttt tattggcgat 300gaagctaatt ggactc 31618585PRTSaccharomyces cerevisiae 185Met Arg Phe Pro Ser Ile Phe Thr Ala Val Leu Phe Ala Ala Ser Ser1 5 10 15Ala Leu Ala Ala Pro Val Asn Thr Thr Thr Glu Asp Glu Thr Ala Gln 20 25 30Ile Pro Ala Glu Ala Val Ile Gly Tyr Ser Asp Leu Glu Gly Asp Phe 35 40 45Asp Val Ala Val Leu Pro Phe Ser Asn Ser Thr Asn Asn Gly Leu Leu 50 55 60Phe Ile Asn Thr Thr Ile Ala Ser Ile Ala Ala Lys Glu Glu Gly Val65 70 75 80Ser Leu Asp Lys Arg 8518698DNAArtificial SequenceComplimentary SS oligo 1 186ttaagagtcc aattagcttc atcgccaata aaaaaacaaa ctaaacctaa ttctaacaag 60caaagatgag atttccttca atttttactg cagtttta 98187110DNAArtificial SequenceComplimentary SS oligo 2 187ttcgcagcat cctccgcatt agctgctcca gtcaacacta caacagaaga tgaaacggca 60caaattccgg ctgaagctgt catcggttac tcagatttag aaggggattt 110188112DNAArtificial SequenceComplimentary SS oligo 3 188cgatgttgct gttttgccat tttccaacag cacaaataac gggttattgt ttataaatac 60tactattgcc agcattgctg ctaaagaaga aggggtaagc ttggataaaa ga 112189102DNAArtificial SequenceComplimentary SS oligo 4 189tcttttatcc aagcttaccc cttcttcttt agcagcaatg ctggcaatag tagtatttat 60aaacaataac ccgttatttg tgctgttgga aaatggcaaa ac 102190110DNAArtificial SequenceComplimentary SS oligo 5 190agcaacatcg aaatcccctt ctaaatctga gtaaccgatg acagcttcag ccggaatttg 60tgccgtttca tcttctgttg tagtgttgac tggagcagct aatgcggagg 110191104DNAArtificial SequenceComplimentary SS oligo 6 191atgctgcgaa taaaactgca gtaaaaattg aaggaaatct catctttgct tgttagaatt 60aggtttagtt tgttttttta ttggcgatga agctaattgg actc 10419277DNAArtificial SequenceSINK1 192gtaccaagct ttatttccct tctttttctc tttagctcgg cttattccag gagcttggat 60aaaagagcac ccgcccg 7719378DNAArtificial SequenceSINK2 193gtgaccgggc gggtgctctt ttatccaagc tcctggaata agccgagcta aagagaaaaa 60gaagggaaat aaagcttg 78194450DNAArtificial SequenceHuman GMCSF with incorporated N-terminal Met codon 194aagcttacct gccatggcac ccgcccggtc acccagcccc agcacgcagc cctgggagca 60tgtgaatgcc atccaggagg cccggcgtct cctgaacctg agtagagaca ctgctgctga 120gatgaatgaa acagtagaag tgatatcaga aatgtttgac ctccaggagc cgacttgcct 180acagacccgc ctggagctgt acaagcaggg cctgcggggc agcctcacca agctcaaggg 240ccccttgacc atgatggcca gccactacaa gcagcactgc cctccaaccc cggaaacttc 300ctgtgcaacc cagattatca cctttgaaag tttcaaagag aacctgaagg acttcctgct 360tgtcatcccc tttgactgct gggagccagt ccaggagtga taaggatccg aattcgtaat 420catggtcata gctgtttcct gtgtgaaatt 450195128PRTArtificial SequenceHuman GMCSF with incorporated N-terminal Met codon 195Met Ala Pro Ala Arg Ser Pro Ser Pro Ser Thr Gln Pro Trp Glu His1 5 10 15Val Asn Ala Ile Gln Glu Ala Arg Arg Leu Leu Asn Leu Ser Arg Asp 20 25 30Thr Ala Ala Glu Met Asn Glu Thr Val Glu Val Ile Ser Glu Met Phe 35 40 45Asp Leu Gln Glu Pro Thr Cys Leu Gln Thr Arg Leu Glu Leu Tyr Lys 50 55 60Gln Gly Leu Arg Gly Ser Leu Thr Lys Leu Lys Gly Pro Leu Thr Met65 70 75 80Met Ala Ser His Tyr Lys Gln His Cys Pro Pro Thr Pro Glu Thr Ser 85 90 95Cys Ala Thr Gln Ile Ile Thr Phe Glu Ser Phe Lys Glu Asn Leu Lys 100 105 110Asp Phe Leu Leu Val Ile Pro Phe Asp Cys Trp Glu Pro Val Gln Glu 115 120 125

Claims

1-31. (canceled)

32. A host cell suitable for enhanced production of a protein product of choice characterised in that the host cell is genetically modified to cause over-expression of two or more helper proteins selected from a DnaJ-like protein (such as JEM1), an Hsp70 family protein (such as LHS1) and SIL1, wherein at least one of the over-expressed two or more helper proteins is selected from JEM1, LHS1 and SIL1, and wherein the DnaJ-like protein is not SCJ1.

33. The host cell of claim 32 wherein the host cell is genetically modified to cause over-expression of (a) a DnaJ-like protein and an Hsp70 family protein; or (b) a DnaJ-like protein and SIL1; or (c) an Hsp70 family protein and SIL1.

34. A host cell suitable for enhanced production of a protein product of choice characterised in that the host cell is genetically modified to cause over-expression of three or more helper proteins, wherein the three or more helper proteins comprise a DnaJ-like protein, an Hsp70 family protein and SIL1, and wherein the DnaJ-like protein is not SCJ1.

35. The host cell of claim 32 wherein the Hsp70 family protein is a protein that localises to the lumen of the ER.

36. The host cell of claim 2 wherein the Hsp70 family protein is not a prokaryotic Hsp70 family protein.

37. The host cell of claim 32 according to any one of the preceding claims wherein the Hsp70 family protein is LHS1, KAR2, SSA1, SSA2, SSA3, SSA4, SSE1, SSE2, SSB1, SSB2 or ECM10.

38. The host cell of claim 32 wherein the DnaJ-like protein is a protein that localises to the ER membrane.

39. The host cell of claim 32 wherein the DnaJ-like protein is selected from JEM1, MDJ2, SEC63, YDJ1, XDJ1, APJ1, SIS1, DJP1, ZUO1, SWA2, JJJ1, JJJ2, JJJ3, CAJ1, CWC23, PAM18, JAC1, JID1, SCJ1, HLJ1 and ERJ5.

40. The host cell of claim 32 wherein the host cell is further genetically modified to cause over-expression of at least one, two, three, four, five, six or seven proteins involved in the formation of disulphide bonds in other proteins selected from the group consisting of ERO1, ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1.

41. The host cell that is suitable for enhanced production of a protein product of choice characterised in that the host cell comprises a first gene encoding a first helper protein selected from JEM1, LHS1 or SIL1 or a variant thereof, and a second gene encoding a desired protein product of choice, wherein the host cell is genetically modified to cause over-expression of the first helper protein, and (a) wherein the first and second genes are not both present within the host cell on the same 2 .mu.m-family plasmid; and (b) wherein the host cell is not genetically modified to cause over-expression of a further helper protein that is different from the first helper protein and is selected from the group consisting of AHA1, CCT2, CCT3, CCT4, CCT5, CCT6, CCT7, CCT8, CNS1, CPR3, CPR6, ERO1, EUG1, FMO1, HCH1, HSP10, HSP12, HSP104, HSP26, HSP30, HSP42, HSP60, HSP78, HSP82, JEM1, MDJ1, MDJ2, MPD1, MPD2, PDI1, PFD1, ABC1, APJ1, ATP11, ATP12, BTT1, CDC37, CPR7, HSC82, KAR2, LHS1, MGE1, MRS11, NOB1, ECM10, SSA1, SSA2, SSA3, SSA4, SSC1, SSE2, SIL1, SLS1, ORM1, ORM2, PER1, PTC2, PSE1, UBI4 and HAC1 or a truncated intronless HAC1.

42. The host cell of claim 41, wherein the first helper protein is JEM1, LHS1 or SIL1.

43. The host cell of claim 42 wherein the first helper protein is the only helper protein that is over-expressed by the host cell.

44. The host cell of claim 32 wherein the protein product of choice is a heterologous protein and/or comprises a leader sequence effective to cause secretion.

45. The host cell of claim 32 wherein the protein product of choice is a eukaryotic protein, or a fragment or variant thereof.

46. The host cell of claim 32 wherein the protein product of choice comprises albumin, a monoclonal antibody, an etoposide, a serum protein, antistasin, a tick anticoagulant peptide, transferrin, lactoferrin, endostatin, angiostatin, collagens, immunoglobulins, or immunoglobulin-based molecules or fragment of either, a Kunitz domain protein, interferons, interleukins, leptin, CNTF and fragments thereof, IL1-receptor antagonist, erythropoietin (EPO) and EPO mimics, thrombopoietin (TPO) and TPO mimics, prosaptide, cyanovirin-N, 5-helix, T20 peptide, T1249 peptide, HIV gp41, HIV gp120, urokinase, prourokinase, tPA, hirudin, platelet derived growth factor, parathyroid hormone, proinsulin, insulin, glucagon, glucagon-like peptides, insulin-like growth factor, calcitonin, growth hormone, transforming growth factor beta, tumour necrosis factor, G-CSF, GM-CSF, M-CSF, FGF, coagulation factors in both pre and active forms, including but not limited to plasminogen, fibrinogen, thrombin, pre-thrombin, pro-thrombin, von Willebrand's factor, alpha,-antitrypsin, plasminogen activators, Factor VII, Factor VIII, Factor IX, Factor X and Factor XIII, nerve growth factor, LACI, platelet-derived endothelial cell growth factor (PD-ECGF), glucose oxidase, serum cholinesterase, inter-alpha trypsin inhibitor, antithrombin III, apo-lipoprotein species, Protein C, Protein S, or a variant or fragment of any of the above, or a fusion of albumin and any of the above.

47. The host cell of claim 32 wherein the protein product of choice comprises the sequence of albumin or a variant or fragment thereof.

48. The host cell of claim 32 wherein the protein product of choice comprises the sequence of transferrin family member, or a variant or fragment thereof.

49. The host cell of claim 32 wherein the protein product of choice comprises a fusion protein.

50. The host cell of claim 32 comprising an exogenous polynucleotide sequence that encodes the protein product of choice.

51. The host cell of claim 50 wherein the exogenous polynucleotide is integrated into the chromosome of the host cell.

52. The host cell of claim 50 wherein the exogenous polynucleotide is present in the host cell as part of a replicable vector.

53. A method for producing a protein product of choice, the method comprising: (a) providing the host cell of claim 50; and (b) growing the host cell; thereby to produce a cell culture or recombinant organism comprising an increased level of the protein product of choice compared to the level of production of the protein product of choice achieved by growing, under the same conditions, the same host cell that has not been genetically modified to cause over-expression of one or more helper proteins.

54. The method of claim 53 wherein the step of growing the host cell involves culturing the host cell in a culture medium.

55. The method of claim 53 further comprising the step of purifying the thus expressed protein product of choice from the cultured host cell, recombinant organism or culture medium.

56. Method of preparing a the host cell of claim 32, by transformation of a host cell with a polynucleotide, wherein the polynucleotide comprises a sequence encoding a helper protein selected from the list comprising (a) a chaperone selected from a DnaJ-like protein an Hsp70 family protein, and SIL1, and wherein the DnaJ-like protein is not SCJ1; and (b) a protein involved in the formation of disulphide bonds in other proteins selected from ERO1, ERV2, EUG1, MPD1, MPD2, EPS1 and PDI1.